data_2lqo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.11 27.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.217 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.45 136.74 15.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.128 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -103.35 123.54 47.0 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 31' ' ' TYR . 60.3 mt -88.76 120.25 37.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.71 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -103.54 117.66 34.93 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.004 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -161.25 167.63 25.61 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -100.68 160.44 14.35 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -72.2 -31.0 65.48 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -88.68 14.41 10.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.516 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.5 t -79.93 155.86 27.52 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.35 -37.92 13.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.783 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.57 -7.98 59.62 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.652 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.2 p -57.16 -61.94 2.11 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.242 0.473 . . . . 0.0 111.775 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.92 -21.82 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.872 0.368 . . . . 0.0 111.661 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -67.53 -51.03 55.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.57 -35.88 75.78 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.15 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.7 mmtt -55.26 -45.52 76.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.29 0.567 . . . . 0.0 110.396 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -65.43 -40.0 92.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.716 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.21 95.94 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 29' ' ' ILE . 71.3 mt -69.07 -43.17 75.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 m -61.9 -38.5 88.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -16.24 63.77 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.413 0.625 . . . . 0.0 111.548 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -110.29 9.47 23.67 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 54.92 32.64 18.34 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.054 1.342 . . . . 0.0 112.454 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 24' ' ' LEU . 66.1 mt -76.91 128.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 120.888 0.375 . . . . 0.0 110.266 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.38 122.9 29.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 8' ' ' ILE . 52.3 p90 -139.86 165.19 27.97 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.122 0.487 . . . . 0.0 112.294 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.36 142.19 50.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.24 143.55 50.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.381 0.537 . . . . 0.0 111.312 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.55 140.91 36.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.5 141.6 41.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.618 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 37.7 pt -82.81 -26.1 8.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.255 9.6 pt-20 -84.23 -11.47 56.43 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 117.917 -1.513 . . . . 0.0 111.833 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -83.34 -49.43 9.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 170.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.68 96.47 10.66 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.51 -39.16 79.33 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.722 0.809 . . . . 0.0 112.082 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.203 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.582 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -72.09 -43.35 64.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.457 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -56.5 -44.58 80.83 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 124.01 0.819 . . . . 0.0 110.972 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -62.29 -47.23 85.23 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.299 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -59.72 -56.62 19.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.354 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.7 p -62.9 -35.78 72.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.406 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.46 73.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.027 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -79.38 -37.8 36.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.885 0.374 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -94.61 5.5 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.27 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -178.81 6.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.738 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.99 79.25 1.82 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.81 -64.51 3.66 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.86 171.07 14.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -62.0 108.75 1.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.906 0.882 . . . . 0.0 111.856 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.3 t -156.16 -39.75 0.08 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.054 -0.404 . . . . 0.0 111.796 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.21 149.36 39.12 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.914 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.516 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 29.1 Cg_endo -64.44 152.65 80.73 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.35 2.033 . . . . 0.0 110.954 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.5 m -140.38 141.05 35.63 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.3 m -107.87 131.7 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.644 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.85 118.67 37.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -84.8 171.63 12.12 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.304 0.573 . . . . 0.0 112.366 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.1 -10.41 14.48 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.978 1.311 . . . . 0.0 112.305 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 -13.46 26.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.368 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.69 -21.27 39.19 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.901 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -85.32 160.83 19.72 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 117.93 0.865 . . . . 0.0 110.75 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.9 p -113.33 166.81 11.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.997 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.5 mt -138.36 116.56 11.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -62.6 139.44 58.63 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -4.69 88.16 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 126.947 2.099 . . . . 0.0 115.623 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -98.37 164.61 0.72 Allowed 'Trans proline' 0 N--CA 1.435 -1.937 0 C-N-CA 124.053 3.168 . . . . 0.0 111.949 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' HG21 ' A' ' 75' ' ' VAL . 3.1 m -90.81 171.12 9.55 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.5 84.15 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 122.638 0.375 . . . . 0.0 111.483 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.47 -47.99 83.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.126 0.488 . . . . 0.0 110.716 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.02 -42.6 99.34 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.223 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 71' ' ' SER . 11.2 m -72.21 -40.33 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -57.9 -43.55 86.21 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.029 0.443 . . . . 0.0 110.106 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.41 76.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.909 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -84.08 -50.2 8.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.136 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.4 -39.83 70.65 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.123 0.969 . . . . 0.0 113.001 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -59.21 -39.78 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -73.17 -26.79 61.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.884 0.373 . . . . 0.0 110.608 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.1 mt -75.5 -45.19 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.109 -176.533 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.17 73.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.941 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.43 140.88 21.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.18 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -106.83 124.13 49.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.384 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 HG13 ' A' ' 59' ' ' VAL . 74.8 mt -88.81 122.25 39.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.706 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 68.8 m-85 -99.65 111.6 23.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.696 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -146.18 174.12 11.6 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.62 162.38 30.49 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 t -66.95 -15.9 64.0 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.796 0.331 . . . . 0.0 111.863 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -99.31 5.6 46.47 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.64 112.95 19.3 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.749 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.59 73.63 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.19 -7.52 56.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 47.5 t -65.67 -62.04 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.894 0.378 . . . . 0.0 110.448 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 19' ' ' ARG . 1.4 pp -67.9 -21.08 65.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.966 0.888 . . . . 0.0 112.068 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' N ' HD12 ' A' ' 18' ' ' LEU . 8.9 tpt180 -66.74 -43.55 83.88 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.969 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -85.36 -32.84 22.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.504 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -53.14 -48.47 67.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.881 0.372 . . . . 0.0 111.82 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 p -64.03 -38.65 91.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.874 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.16 93.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.156 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.87 -47.6 61.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.169 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 m -61.47 -37.3 83.1 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 121.076 0.465 . . . . 0.0 110.827 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -10.06 59.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.746 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -115.75 19.41 15.24 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.194 -0.316 . . . . 0.0 111.625 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 53.87 33.01 16.21 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 125.998 1.719 . . . . 0.0 112.177 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -90.3 131.17 38.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 120.914 0.387 . . . . 0.0 110.948 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.37 143.75 26.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.05 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -158.06 166.87 31.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.691 0.282 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -129.89 142.48 50.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -128.14 142.47 51.18 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.445 0.566 . . . . 0.0 110.62 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.51 141.9 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -89.68 139.39 30.61 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.62 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 34.7 pt -85.91 -11.13 11.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.0 -40.29 75.37 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.252 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -93.27 -30.03 15.37 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.703 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -88.09 99.93 12.55 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.518 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -71.79 -35.1 69.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.06 75.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.511 . . . . 0.0 109.638 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -74.28 -43.57 56.35 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.735 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -61.25 -43.04 99.53 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.103 0.561 . . . . 0.0 111.837 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.34 -45.88 92.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -59.65 -58.49 8.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -62.59 -35.26 69.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.746 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.13 93.96 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.035 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 m -71.09 -34.81 71.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.755 0.312 . . . . 0.0 111.339 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.67 7.17 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.255 0.55 . . . . 0.0 111.411 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 -172.62 3.98 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.925 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.92 81.55 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -63.12 3.27 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -144.37 165.08 28.92 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -54.21 101.1 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.767 1.227 . . . . 0.0 112.164 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -146.66 -15.96 0.43 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.1 147.69 63.55 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 122.217 -0.302 . . . . 0.0 111.778 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 32.5 Cg_endo -64.83 137.18 52.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.72 2.28 . . . . 0.0 111.476 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -123.01 137.69 54.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' THR . 19.3 m -102.43 129.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 120.69 0.281 . . . . 0.0 110.412 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -109.94 115.41 29.75 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -81.05 166.75 20.47 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -12.67 58.85 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.455 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.48 -9.5 49.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.252 0.548 . . . . 0.0 109.567 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.56 38.68 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.765 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -73.34 144.32 46.54 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 117.57 0.685 . . . . 0.0 111.46 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -113.64 143.47 44.52 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.646 1.179 . . . . 0.0 111.399 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -126.02 128.45 47.47 Favored 'General case' 0 C--O 1.253 1.256 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -66.96 137.5 56.56 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -6.07 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.8 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -171.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.51 171.08 3.63 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.636 2.89 . . . . 0.0 112.548 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' VAL . 23.7 t -95.02 170.37 9.47 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . . . -64.89 -32.29 73.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.042 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.94 -48.93 72.51 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.31 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.23 -48.87 63.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.373 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' CG2' ' HA ' ' A' ' 72' ' ' ALA . 8.7 m -62.55 -35.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.25 -36.27 83.61 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.687 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.91 71.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.71 0.632 . . . . 0.0 111.025 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.1 mtpp -84.2 -50.22 8.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.997 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.59 -39.87 71.28 Favored 'General case' 0 C--O 1.252 1.218 0 C-N-CA 123.219 0.608 . . . . 0.0 112.621 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.74 -32.62 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -81.05 -29.14 35.1 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 78' ' ' LYS . 58.5 mt -71.73 -57.67 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.936 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.944 -176.414 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.56 -63.89 1.25 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.462 0.649 . . . . 0.0 109.72 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 132.92 11.86 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.357 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -102.79 123.17 45.96 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.45 0.643 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.7 125.59 41.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -99.79 111.34 23.67 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.658 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.26 167.3 20.09 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.481 ' OG1' HG12 ' A' ' 36' ' ' ILE . 25.1 m -138.86 158.0 45.01 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -46.32 -17.46 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 127.127 2.171 . . . . 0.0 115.028 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -77.42 -14.99 59.58 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.838 -0.538 . . . . 0.0 111.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 43.0 t -92.05 120.88 33.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.363 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.63 -30.32 68.76 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.355 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.91 -11.66 61.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 38.8 t -55.58 -55.27 33.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 110.483 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.98 -25.81 63.79 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -70.67 -44.62 66.64 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.92 -45.07 95.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.889 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.8 mmtp -55.77 -49.61 72.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.218 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 m -59.44 -43.99 93.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.999 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.35 98.42 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.34 -46.5 60.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.448 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.3 m -60.38 -37.33 80.42 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.326 0.391 . . . . 0.0 110.854 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.34 83.31 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 120.935 0.398 . . . . 0.0 112.025 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -99.77 8.76 43.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.289 0.566 . . . . 0.0 111.097 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 63.65 35.33 11.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.144 1.378 . . . . 0.0 113.388 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.86 125.88 38.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.778 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.45 123.63 26.82 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -131.23 161.64 31.77 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.425 0.631 . . . . 0.0 111.659 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.59 142.64 47.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.01 141.38 38.31 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.94 143.22 33.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.28 140.48 38.84 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.998 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 22.3 pt -83.59 -27.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.193 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -76.92 -25.29 52.77 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -70.74 -49.25 48.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.946 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -102.17 97.77 8.03 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.739 0.304 . . . . 0.0 110.705 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -56.38 -40.1 74.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.0 0.92 . . . . 0.0 112.047 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 -34.45 68.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.305 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -67.62 -38.97 84.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -64.48 -29.73 70.77 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.639 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HA ' HH21 ' A' ' 54' ' ' ARG . 7.3 tp10 -74.75 -48.52 25.22 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -53.21 -56.01 19.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.167 0.987 . . . . 0.0 111.653 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.61 -27.35 42.71 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.972 0 CA-C-O 120.66 0.267 . . . . 0.0 111.094 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.1 -38.79 63.5 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.591 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.0 m -74.27 -34.59 63.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.77 0.319 . . . . 0.0 111.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 46' ' ' VAL . 31.0 m -94.58 13.02 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 0.0 111.541 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 -174.68 3.92 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.129 0.49 . . . . 0.0 110.114 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.53 69.96 3.19 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -61.93 0.79 Allowed Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.573 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 50.1 t30 -144.49 160.06 41.73 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -62.34 116.79 5.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.635 . . . . 0.0 111.078 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -155.97 -25.27 0.1 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.759 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 m -119.54 144.13 36.13 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.632 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 19.6 Cg_endo -60.07 140.54 93.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.834 2.356 . . . . 0.0 111.405 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -124.16 141.0 52.43 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.5 m -107.5 133.04 53.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.549 0.214 . . . . 0.0 110.694 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.0 112.36 23.95 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.5 m-85 -78.52 166.06 23.02 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.23 -18.05 56.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.496 0.498 . . . . 0.0 112.07 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.76 -11.39 58.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.143 0.496 . . . . 0.0 109.754 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.05 -7.07 56.87 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.208 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -79.61 145.67 32.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.069 0.462 . . . . 0.0 110.879 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -119.09 141.18 49.0 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.0 mt -131.52 143.53 50.45 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -73.91 140.61 45.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -6.75 83.11 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 C-N-CA 126.388 1.875 . . . . 0.0 116.009 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.416 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 19.7 Cg_endo -90.25 160.26 4.67 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.781 2.987 . . . . 0.0 112.563 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 m -82.22 173.7 11.86 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -64.48 -39.01 92.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.085 0.469 . . . . 0.0 111.498 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.44 -30.84 67.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.494 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.67 -42.71 73.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 14.1 m -72.24 -35.38 52.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.732 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.534 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 10.1 mtpm? -58.13 -36.25 72.68 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 123.124 0.265 . . . . 0.0 111.417 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.61 73.97 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.976 0.797 . . . . 0.0 111.963 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 82' ' ' ILE . 8.2 mtpm? -84.08 -48.46 9.86 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.09 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 tp -54.98 -40.59 70.22 Favored 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.02 0.825 . . . . 0.0 112.445 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.83 -43.27 95.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 123.508 0.505 . . . . 0.0 110.328 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -75.15 -21.11 59.03 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.593 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 78' ' ' LYS . 63.4 mt -73.57 -36.05 46.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.91 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.686 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.66 54.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.299 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.27 135.9 23.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.305 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.6 m -103.62 124.85 49.58 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.861 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.03 118.73 34.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 80.6 m-85 -103.81 110.41 22.5 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.949 174.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.424 HG22 ' SG ' ' A' ' 17' ' ' CYS . 13.2 t -163.63 -177.66 5.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.76 152.39 51.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -54.09 -28.38 38.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.277 1.031 . . . . 0.0 113.084 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -77.63 -15.22 59.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -71.53 118.47 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.27 -43.05 93.77 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.667 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -74.1 -7.57 53.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 t -63.6 -62.48 1.64 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pp -70.56 -21.02 62.75 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.323 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -72.25 -38.73 68.82 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.123 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -84.33 -24.07 29.94 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.0 mmtt -53.9 -42.87 69.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.792 0.437 . . . . 0.0 111.812 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.8 p -67.91 -37.17 81.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.324 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.87 80.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.793 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.38 -42.97 92.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.8 m -63.11 -46.3 87.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.59 -31.92 72.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.272 0.558 . . . . 0.0 111.093 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.97 11.52 24.84 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.571 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 59.2 32.26 21.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.708 0.803 . . . . 0.0 111.446 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.53 130.59 37.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.0 0.429 . . . . 0.0 109.963 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.3 124.4 36.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.01 162.06 36.42 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.864 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' THR . 37.5 t70 -121.39 133.56 55.09 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.54 139.72 49.34 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.17 147.86 27.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -83.49 138.94 33.21 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.714 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 39.0 pt -87.04 -23.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.82 -42.63 69.98 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.126 0.488 . . . . 0.0 109.807 -171.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -77.04 -26.72 54.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -103.74 93.16 4.76 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -55.63 -44.39 77.05 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.563 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -30.93 66.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -71.12 -42.63 68.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -62.92 -36.38 83.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.599 0.562 . . . . 0.0 110.451 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.38 -47.39 79.41 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.05 -58.43 8.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.174 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -64.22 -31.73 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.77 70.33 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.201 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 p -83.02 -26.19 31.45 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 m -89.93 -11.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.124 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -73.13 167.19 21.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.053 -176.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.38 4.09 Favored Glycine 0 C--N 1.308 -1.006 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.183 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.56 -90.65 0.41 Allowed Glycine 0 C--N 1.313 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -120.24 172.21 7.95 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -64.27 54.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.56 1.544 . . . . 0.0 112.304 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -88.86 -32.05 17.97 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 122.055 -0.403 . . . . 0.0 111.925 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.37 151.87 63.46 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 12.5 Cg_endo -56.23 123.4 13.73 Favored 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.749 2.966 . . . . 0.0 111.791 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 m -106.51 133.44 51.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.19 124.8 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.072 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -105.88 125.53 51.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.85 179.22 6.03 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.96 -10.74 58.93 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.237 0.615 . . . . 0.0 111.856 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -88.71 -8.64 54.17 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.15 81.35 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.118 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -99.54 151.52 21.06 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p -117.16 150.11 39.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.504 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.8 mt -124.1 125.08 43.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -68.33 147.35 52.26 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -5.32 83.01 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 C-N-CA 127.015 2.126 . . . . 0.0 114.909 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -98.99 157.67 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.781 2.987 . . . . 0.0 112.583 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.5 p -84.4 166.2 17.55 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.808 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.41 -33.52 72.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.864 0.466 . . . . 0.0 112.079 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.84 -40.05 91.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.093 0.473 . . . . 0.0 110.521 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.22 -43.32 67.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.593 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 71' ' ' SER . 6.1 m -65.97 -35.5 75.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.116 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.34 -35.17 79.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.62 95.61 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.26 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -76.79 -38.62 53.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.126 0.488 . . . . 0.0 110.345 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.56 -36.46 84.28 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.473 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.7 -22.45 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.126 0.489 . . . . 0.0 111.243 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 7.4 mtpm? -80.17 -30.48 38.83 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -83.16 -57.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.765 -175.613 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.76 -56.19 15.16 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.623 0.577 . . . . 0.0 112.222 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.443 HD11 HG22 ' A' ' 59' ' ' VAL . 1.7 pt? -147.05 137.75 23.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.616 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -106.67 112.13 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.355 1.062 . . . . 0.0 109.648 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.3 mt -88.92 131.81 35.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 111.997 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' OH ' ' HE2' ' A' ' 60' ' ' LYS . 74.8 m-85 -111.44 104.24 12.66 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 12.6 t -165.27 142.88 5.97 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -102.99 155.99 17.98 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -63.1 -4.85 2.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -77.63 -13.62 59.86 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.558 -0.714 . . . . 0.0 111.168 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.82 144.19 39.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.02 -41.71 39.38 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.652 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.0 -5.67 49.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -50.72 -59.95 3.55 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.019 0.372 . . . . 0.0 111.877 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.36 -26.0 61.75 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.432 0.158 . . . . 0.0 111.121 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -59.69 -47.48 85.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.7 tp -67.21 -44.38 79.71 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.74 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 73.8 mmtt -57.4 -55.56 33.2 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.889 0.376 . . . . 0.0 110.723 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 m -59.65 -40.47 87.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.76 -46.74 89.28 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.893 0.377 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 67.2 mt -69.23 -43.66 73.6 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 m -62.97 -37.36 86.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.248 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.74 85.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.38 7.01 38.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 58.53 46.99 14.07 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.812 0.815 . . . . 0.0 111.64 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 24' ' ' LEU . 81.4 mt -97.96 119.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.794 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.94 115.01 11.73 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.684 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -128.29 156.86 42.36 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.809 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -115.43 142.39 46.77 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.22 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.12 139.02 44.34 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.195 -0.316 . . . . 0.0 110.39 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.08 145.12 33.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 37' ' ' GLU . 30.5 t70 -87.73 142.03 28.14 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.918 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.18 -25.7 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.59 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 43.8 tt0 -73.83 -34.41 64.54 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.266 0.555 . . . . 0.0 109.533 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -91.01 -0.19 57.69 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -133.74 99.59 4.51 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -62.5 -43.41 98.87 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.44 72.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.892 0.377 . . . . 0.0 110.749 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -71.71 -42.15 67.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.85 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.74 84.98 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.557 0.694 . . . . 0.0 110.621 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -63.73 -43.58 96.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.012 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.13 -56.74 9.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.777 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -59.62 -25.66 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.06 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.22 -42.74 96.18 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.641 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.6 m -74.41 -31.31 62.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.065 0.432 . . . . 0.0 111.846 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 58' ' ' THR . 31.0 m -91.65 8.43 4.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.904 0.859 . . . . 0.0 111.118 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.49 174.32 9.04 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.34 88.4 1.09 Allowed Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.84 -89.78 0.7 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -134.02 173.92 11.04 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 102.24 1.0 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.112 0.958 . . . . 0.0 113.08 -175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -146.79 -26.86 0.41 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.15 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 m -113.86 151.44 44.75 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.458 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 19.1 Cg_endo -60.9 143.02 99.27 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.31 2.673 . . . . 0.0 111.485 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.434 HG23 ' CG2' ' A' ' 49' ' ' VAL . 19.7 m -132.27 150.55 52.13 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 8.4 p -128.96 130.94 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HE2' ' OH ' ' A' ' 9' ' ' TYR . 32.3 mtmt -100.58 136.11 40.97 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.97 176.08 6.73 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.58 63.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.142 0.972 . . . . 0.0 109.034 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -74.97 -18.07 60.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.847 1.659 . . . . 0.0 109.534 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.99 30.09 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.354 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -74.58 152.63 39.25 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 122.309 0.244 . . . . 0.0 110.723 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.1 p -113.53 155.11 25.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.331 0.586 . . . . 0.0 112.3 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -132.71 125.26 29.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -70.63 144.52 51.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -4.87 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.477 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -100.51 -177.79 0.17 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 123.686 2.924 . . . . 0.0 112.393 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -114.6 172.73 6.85 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -43.96 78.07 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 122.772 0.429 . . . . 0.0 111.484 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.7 -52.89 54.15 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 111.681 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -62.3 -39.76 94.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.803 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -78.84 -31.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.391 -0.524 . . . . 0.0 112.249 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -60.25 -32.44 71.16 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.142 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.6 71.65 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.894 0.746 . . . . 0.0 111.286 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.9 mtpp -84.88 -44.28 13.35 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.592 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.7 tp -54.42 -41.17 69.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.575 0.75 . . . . 0.0 112.594 -176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.08 -33.2 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.58 0.55 . . . . 0.0 111.642 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -80.33 -42.51 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.297 0.57 . . . . 0.0 109.835 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 78' ' ' LYS . 53.7 mt -61.07 -31.56 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.859 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.241 -179.762 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.6 -60.19 2.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.29 143.25 22.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.176 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -102.97 124.77 49.1 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.34 112.33 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 123.601 0.761 . . . . 0.0 110.467 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 88.4 m-85 -98.85 114.27 26.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.34 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 t -163.69 149.52 11.32 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.62 152.03 21.59 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -67.37 -20.96 65.63 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.798 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -83.58 1.99 39.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.04 149.79 33.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -34.99 28.18 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.512 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -81.67 -7.11 59.56 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -54.63 -51.59 64.93 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -23.28 31.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -64.94 -41.58 95.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.858 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 70' ' ' PRO . 25.0 tp -74.5 -24.21 58.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.617 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 43.2 mmtm -62.67 -36.28 82.38 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.186 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -55.85 -47.72 76.77 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 123.794 0.684 . . . . 0.0 110.128 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.17 77.54 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.976 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.03 -44.8 79.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.359 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.9 m -66.85 -38.29 86.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -23.69 66.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.513 0.673 . . . . 0.0 111.41 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -106.75 4.72 27.96 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.069 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 50.49 44.7 27.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.921 1.288 . . . . 0.0 112.036 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.0 mt -82.72 127.82 39.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.552 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.91 134.19 35.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -147.55 164.19 34.21 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -118.68 139.11 52.06 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.15 134.99 55.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.844 0.354 . . . . 0.0 111.277 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.95 126.39 26.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.77 141.06 33.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.421 HG23 HG11 ' A' ' 46' ' ' VAL . 40.8 pt -84.85 -9.35 11.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.29 -43.7 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 109.864 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -92.27 -28.82 16.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.997 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.26 91.64 6.37 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.203 0.525 . . . . 0.0 110.532 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -76.06 -25.8 55.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.321 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -33.23 73.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.556 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -72.71 -40.06 66.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.568 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.04 84.42 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.7 -53.48 56.88 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -56.92 -57.91 10.44 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.861 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -64.62 -32.37 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.74 75.79 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.374 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -81.24 -22.1 38.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.6 13.16 8.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.709 0.766 . . . . 0.0 110.347 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.65 -173.16 2.8 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.825 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.35 71.05 2.55 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.91 -67.94 2.88 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.873 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -119.74 151.62 38.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.64 114.72 8.12 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.525 0.678 . . . . 0.0 109.52 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -154.83 -29.86 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.441 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.91 142.44 25.24 Favored Pre-proline 0 C--O 1.241 0.643 0 O-C-N 122.078 -0.389 . . . . 0.0 111.543 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 22.5 Cg_endo -62.48 131.9 35.86 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.738 2.292 . . . . 0.0 111.215 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -117.51 137.79 52.31 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.2 m -105.77 128.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 120.804 0.335 . . . . 0.0 110.746 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -104.95 119.29 38.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.52 174.4 11.47 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.538 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.81 66.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.362 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -75.92 -14.94 60.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.375 . . . . 0.0 110.77 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.01 -21.98 36.43 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.909 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 m -81.81 158.58 24.04 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 117.82 0.81 . . . . 0.0 110.459 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.1 p -113.84 163.29 15.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -134.58 121.55 21.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.2 m -62.95 137.21 58.21 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.257 24.9 p-10 -5.46 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.875 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.481 ' O ' HD13 ' A' ' 20' ' ' LEU . 92.7 Cg_endo -97.35 147.79 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.684 3.59 . . . . 0.0 111.936 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -77.37 174.48 10.76 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -55.65 -44.64 77.38 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.546 0.738 . . . . 0.0 111.972 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.68 -41.39 94.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.932 0.396 . . . . 0.0 111.799 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.2 -41.67 81.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.871 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.03 -40.88 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.998 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 61.5 mtpt -57.67 -44.39 85.7 Favored 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 123.381 0.426 . . . . 0.0 110.764 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.79 73.08 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 124.151 0.907 . . . . 0.0 112.642 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -84.35 -47.57 10.58 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.245 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.82 -36.2 76.3 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.278 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 -32.77 56.61 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.094 0.473 . . . . 0.0 111.083 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.35 -34.75 31.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.431 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.8 mt -67.26 -41.11 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.376 0.608 . . . . 0.0 109.761 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.463 178.523 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.93 -60.17 1.64 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -156.32 131.15 9.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.165 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -101.72 117.54 35.1 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.254 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 59' ' ' VAL . 97.5 mt -89.05 121.06 38.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.522 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.11 123.62 47.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -163.9 171.76 14.92 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.878 0.736 . . . . 0.0 109.187 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 p -108.69 159.17 16.96 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -76.44 -13.55 60.11 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.524 0.202 . . . . 0.0 111.35 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -86.58 -2.2 58.29 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -83.98 132.2 34.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -30.12 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.86 -19.64 62.62 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.7 t -58.6 -61.29 2.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 123.503 0.502 . . . . 0.0 110.435 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 19' ' ' ARG . 3.5 pp -65.47 -29.39 70.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.579 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 18' ' ' LEU . 20.3 tpp180 -61.8 -50.18 73.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.83 -39.95 79.72 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.71 -46.66 81.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -59.43 -46.11 89.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.95 95.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.592 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 mt -74.93 -36.84 62.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.076 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -63.68 -41.47 98.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.57 73.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 0.0 111.596 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -92.92 -1.89 56.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 56.17 52.3 10.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.946 0.879 . . . . 0.0 111.581 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.89 140.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.54 114.45 20.26 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -132.92 152.04 51.96 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.671 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 7' ' ' THR . 6.3 m-20 -114.05 116.51 29.28 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.293 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -113.31 131.16 56.05 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.247 0.546 . . . . 0.0 110.845 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.02 130.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -85.89 141.6 29.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.7 pt -83.94 -9.02 11.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.27 -26.1 68.63 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.82 -2.37 30.17 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.998 0.428 . . . . 0.0 110.875 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -124.33 88.47 2.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -69.22 -30.48 68.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.981 -171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -68.17 -35.94 78.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.603 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.61 97.97 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.375 0.607 . . . . 0.0 110.443 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.08 -46.48 84.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.18 -58.94 5.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.669 0.787 . . . . 0.0 111.28 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 42' ' ' ALA . 4.4 p -61.69 -32.25 53.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.512 ' HA3' ' NH1' ' A' ' 54' ' ' ARG . . . -69.18 -29.06 72.22 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.724 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -78.47 -28.21 46.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.355 0.598 . . . . 0.0 110.889 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.455 ' CG2' HG21 ' A' ' 58' ' ' THR . 24.5 m -101.81 13.67 6.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.759 0.79 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -173.59 3.86 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.244 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.72 78.75 0.42 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.69 -89.63 0.61 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -138.89 -175.24 4.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.512 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 2.1 mpp_? -54.58 111.78 0.87 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.498 0.499 . . . . 0.0 112.236 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.47 -33.39 0.08 Allowed 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.596 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -123.75 148.79 57.45 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.695 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.52 155.0 68.88 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.356 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.455 HG21 ' CG2' ' A' ' 49' ' ' VAL . 31.5 m -135.91 140.41 44.05 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.3 m -105.73 133.59 49.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 123.237 0.336 . . . . 0.0 110.497 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -112.41 111.68 22.7 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.4 m-85 -77.65 165.82 23.79 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.654 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.82 -11.99 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.539 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.402 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 2.1 p-10 -84.05 -9.84 58.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.5 -2.01 60.53 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.695 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -91.97 145.39 24.58 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 117.359 0.579 . . . . 0.0 110.677 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -113.38 141.25 47.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.097 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -132.53 133.2 43.45 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.0 m -70.51 139.1 51.54 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -5.48 90.87 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.728 0 C-N-CA 126.661 1.984 . . . . 0.0 115.572 -170.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.2 Cg_endo -95.18 152.8 1.67 Allowed 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 124.471 3.448 . . . . 0.0 112.915 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.6 t -71.79 163.07 28.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.38 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.46 77.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.43 0.692 . . . . 0.0 111.695 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.66 -26.72 61.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.719 0.295 . . . . 0.0 110.641 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.21 -45.57 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.4 m -64.19 -37.01 78.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.648 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -59.92 -35.57 75.17 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.334 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.09 79.0 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.435 0.46 . . . . 0.0 111.912 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 7.8 mtpm? -84.29 -45.11 13.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.103 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.69 -33.36 72.74 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.418 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.97 -31.96 54.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 CA-C-O 121.289 0.566 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -78.54 -47.34 17.46 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 78' ' ' LYS . 61.7 mt -57.73 -40.09 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.493 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 111.708 179.456 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.19 -64.03 1.28 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.458 HD22 ' CG2' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -157.11 133.04 9.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.944 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.1 m -105.52 123.72 48.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.915 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.18 130.21 42.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 124.115 0.966 . . . . 0.0 111.147 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -106.6 119.17 38.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -163.84 162.2 23.55 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.11 175.56 5.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.1 t -76.11 -21.63 56.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.491 0.186 . . . . 0.0 111.037 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -77.62 -15.31 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.499 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.42 109.37 8.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.39 -22.8 59.33 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.417 ' CD2' HG12 ' A' ' 56' ' ' VAL . 86.7 m-85 -82.55 -7.31 59.65 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.611 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 25.2 p -54.88 -59.46 4.7 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -69.98 -25.93 63.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -59.47 -50.17 74.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.988 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.37 -40.09 85.73 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.399 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.02 -45.75 79.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.613 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -56.09 -40.54 73.79 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.63 77.41 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.099 0.476 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -72.87 -42.31 63.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.716 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -64.33 -32.31 73.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.8 -27.79 69.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.627 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.96 3.27 25.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 47.36 58.44 4.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.109 0.964 . . . . 0.0 112.145 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.62 128.86 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.157 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.7 10.81 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.199 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -116.79 175.12 5.72 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.0 t70 -139.93 139.41 36.16 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.69 141.24 50.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.97 142.61 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.28 140.49 44.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.544 0.688 . . . . 0.0 111.481 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 HG23 HG13 ' A' ' 46' ' ' VAL . 38.4 pt -86.19 -24.85 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.387 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.05 -39.19 66.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.825 0.345 . . . . 0.0 111.855 -169.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -89.29 3.58 51.61 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.56 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -129.75 93.23 3.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -47.11 -55.74 7.84 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.7 74.97 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 123.481 0.488 . . . . 0.0 111.399 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.646 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.96 -47.22 66.16 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.269 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.2 -36.9 84.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.356 0.598 . . . . 0.0 111.25 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.61 -37.17 85.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.11 -60.99 1.93 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.076 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.8 p -59.16 -36.12 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.52 74.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.6 m -82.94 -30.28 28.47 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.156 0.503 . . . . 0.0 110.837 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.2 13.55 4.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-O 121.414 0.626 . . . . 0.0 111.245 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.07 173.62 12.4 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.932 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.4 63.34 3.36 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.92 -119.29 4.43 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.491 ' O ' HG21 ' A' ' 55' ' ' THR . 4.2 p-10 -93.77 164.27 13.2 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.7 110.03 0.59 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.945 0.898 . . . . 0.0 110.416 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 53' ' ' ASN . 10.2 t -162.33 -26.66 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.275 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 16' ' ' TYR . 10.7 m -113.4 150.41 43.09 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 120.486 0.184 . . . . 0.0 111.241 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.18 150.53 65.8 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.258 1.972 . . . . 0.0 110.454 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.12 136.7 47.31 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 66' ' ' THR . 10.4 p -104.77 127.87 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.017 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -113.59 111.86 22.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 64.1 m-85 -81.83 171.51 14.42 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.434 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.35 -16.83 62.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.274 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.34 -12.32 52.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.187 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.14 -18.22 42.89 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.579 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -80.69 148.95 29.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 117.27 0.535 . . . . 0.0 111.972 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.1 p -115.5 143.53 45.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.841 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.32 129.06 50.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -71.04 141.02 50.93 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -5.75 87.81 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 C-N-CA 126.565 1.946 . . . . 0.0 115.583 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -90.68 -172.48 0.52 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 124.048 3.165 . . . . 0.0 111.378 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.525 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 23.3 m -118.02 173.87 6.53 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -59.37 -43.67 92.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.92 -37.43 81.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.831 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 12.8 mp0 -63.15 -45.7 90.65 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.751 0.82 . . . . 0.0 110.877 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 71' ' ' SER . 13.7 m -70.53 -35.14 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.772 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 56.3 mtpt -61.17 -41.71 97.27 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.43 73.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.929 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -84.07 -48.03 10.31 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.27 -42.44 73.54 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.445 1.098 . . . . 0.0 112.82 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.23 -32.89 49.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.69 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -80.82 -19.94 43.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.195 0.521 . . . . 0.0 110.841 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -85.67 -46.06 17.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.665 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.24 -62.21 1.54 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 59' ' ' VAL . 1.5 pt? -151.78 130.0 11.97 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.27 119.31 38.63 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.545 0.528 . . . . 0.0 111.402 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.02 130.63 38.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.9 m-85 -114.88 109.04 17.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.271 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 6.9 t -164.28 -178.75 5.67 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.895 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' CD1' ' A' ' 13' ' ' TRP . 33.0 m -152.84 154.79 35.84 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 m -48.82 -18.35 0.26 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.482 ' CD1' ' HB ' ' A' ' 11' ' ' THR . 68.2 p-90 -77.37 -18.45 57.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 64.0 m -74.52 141.88 44.82 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.02 -49.95 43.95 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.002 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -72.93 -6.1 42.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 26.6 p -47.53 -62.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -25.88 53.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -61.58 -43.92 97.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.537 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.62 -40.65 84.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.27 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.9 mmmm -58.62 -50.62 73.15 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -61.28 -46.13 91.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.519 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.37 83.46 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.405 0.44 . . . . 0.0 111.113 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 62.8 mt -71.71 -42.24 67.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.241 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.3 m -64.24 -38.2 90.19 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.249 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.76 -30.52 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 111.622 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -100.11 22.18 11.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.025 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.258 10.9 ptp180 43.82 61.34 2.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 125.477 1.511 . . . . 0.0 114.245 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 68.8 mt -113.45 119.09 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.971 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 127.96 32.87 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.714 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -139.91 168.72 19.16 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.681 0.753 . . . . 0.0 112.599 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.03 139.98 51.69 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.631 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.44 145.71 51.92 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.52 147.37 25.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.35 140.74 41.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.732 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 25.3 pt -86.79 -29.22 5.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.483 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.94 -55.63 27.54 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.346 0.658 . . . . 0.0 112.39 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -93.97 15.49 16.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.39 0.614 . . . . 0.0 112.158 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -130.68 91.39 3.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.38 -47.35 79.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.26 -22.79 65.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.729 0.3 . . . . 0.0 111.524 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -86.65 -47.06 9.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -61.86 -43.74 98.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.257 0.551 . . . . 0.0 111.201 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.73 -38.13 89.94 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.174 0.99 . . . . 0.0 110.049 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.75 -60.0 3.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.19 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -60.44 -35.02 60.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.62 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.64 72.92 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.843 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.0 m -83.83 -32.54 25.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.767 0.317 . . . . 0.0 111.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.2 m -94.72 9.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.038 0.447 . . . . 0.0 111.043 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 175.98 8.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.198 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.32 87.06 1.55 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.12 -72.06 0.72 Allowed Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -144.73 172.62 12.75 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -61.51 109.22 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.442 0.639 . . . . 0.0 111.115 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -149.37 -34.76 0.18 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.824 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.75 152.03 50.87 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 14.6 Cg_endo -58.33 139.33 90.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.58 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' HG23 ' A' ' 46' ' ' VAL . 23.7 m -125.26 147.83 48.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 6' ' ' LEU . 14.6 p -122.13 128.64 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.797 0 O-C-N 123.491 0.494 . . . . 0.0 110.229 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.63 129.94 55.55 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -94.07 166.2 12.26 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.497 0.189 . . . . 0.0 111.359 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.31 -16.18 59.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.947 0.899 . . . . 0.0 112.898 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.71 -5.17 58.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 109.882 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.94 18.42 47.3 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.23 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -107.06 149.76 27.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.68 0.74 . . . . 0.0 110.541 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 p -114.87 154.65 28.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.995 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -131.26 126.85 36.53 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -68.46 136.04 52.59 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -5.89 91.62 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.409 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 28.9 Cg_endo -100.41 174.05 0.33 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.498 3.465 . . . . 0.0 112.439 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.46 168.2 10.53 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.415 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.48 71.01 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.65 -28.31 40.84 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.489 -1.284 . . . . 0.0 111.339 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.61 -40.67 97.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.387 0.613 . . . . 0.0 109.908 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 13.5 m -77.86 -30.95 16.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.969 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 76' ' ' LYS . 9.5 mtpm? -57.41 -40.52 78.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.95 -35.24 66.45 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 123.941 0.776 . . . . 0.0 112.009 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.4 mtpp -84.03 -50.5 7.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.038 0.447 . . . . 0.0 111.115 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.64 -38.25 71.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.829 0.852 . . . . 0.0 112.828 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.27 -32.14 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 120.899 0.38 . . . . 0.0 111.268 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.06 -44.1 18.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.35 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 78' ' ' LYS . 72.2 mt -56.97 -53.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.75 0.656 . . . . 0.0 110.789 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.675 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.396 -178.674 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 62' ' ' ALA . . . . . . . . 0 N--CA 1.435 -1.215 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -64.03 1.28 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.017 0.437 . . . . 0.0 111.478 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -152.5 139.25 18.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -105.96 124.22 49.23 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.4 mt -104.62 134.09 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.295 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -114.59 116.3 28.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.589 0.756 . . . . 0.0 109.412 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.457 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 49.5 p -129.88 156.91 43.61 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.8 p -99.47 164.92 11.89 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -78.94 -22.51 45.65 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.393 0.615 . . . . 0.0 110.561 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -101.46 -8.42 21.98 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 42.5 t -84.73 142.13 30.06 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.326 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.36 -19.21 67.07 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.707 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.62 -14.43 58.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.778 -0.836 . . . . 0.0 111.906 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 77.8 m -59.34 -59.16 5.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.336 0.398 . . . . 0.0 111.403 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -74.4 -26.44 60.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -65.61 -42.79 91.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.363 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.44 -39.28 92.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.319 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -59.02 -44.9 91.78 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -58.38 -49.37 77.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.961 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.19 98.32 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.905 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 29' ' ' ILE . 50.0 mt -70.49 -42.3 71.55 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.395 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -64.45 -34.33 77.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.612 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.39 73.75 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.21 0.529 . . . . 0.0 110.694 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -96.79 10.65 38.22 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 63.65 20.51 12.27 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.308 1.043 . . . . 0.0 111.917 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 24' ' ' LEU . 73.3 mt -73.95 128.55 36.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.319 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.69 143.42 27.59 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -152.98 172.81 16.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.116 0.484 . . . . 0.0 112.242 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -119.68 119.61 34.2 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -114.35 124.04 50.97 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.264 0.554 . . . . 0.0 110.257 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.04 137.7 48.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.11 141.73 28.27 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 117.88 -1.528 . . . . 0.0 110.729 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 10' ' ' THR . 26.2 pt -84.93 -2.85 7.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.403 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -76.27 -37.58 57.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -87.01 -42.86 12.78 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.062 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -86.67 97.34 10.52 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.435 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -71.95 -28.9 63.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.077 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.41 74.53 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.607 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -69.47 -37.84 77.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.343 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.06 98.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.175 0.59 . . . . 0.0 110.905 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.13 -45.61 92.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -56.73 -60.71 3.16 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.916 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.607 HG11 ' O ' ' A' ' 42' ' ' ALA . 4.3 p -61.21 -34.34 60.14 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.089 -178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.08 90.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.586 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.8 p -80.11 -11.37 59.77 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -115.23 13.73 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 121.813 0.816 . . . . 0.0 109.525 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -98.88 -171.84 2.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 -174.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 69.4 2.83 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.96 -96.87 1.6 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.2 174.46 5.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -76.79 111.16 12.01 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.267 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -133.46 -17.49 2.29 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.796 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 152.9 81.03 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HB3' HG21 ' A' ' 10' ' ' THR . 36.5 Cg_endo -67.29 157.72 60.39 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.204 1.936 . . . . 0.0 111.924 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -141.74 148.59 39.25 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.1 p -120.47 136.65 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 O-C-N 123.666 0.604 . . . . 0.0 109.899 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -113.15 127.55 56.22 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 97.0 m-85 -85.77 169.57 13.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . -60.79 -27.66 68.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.574 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.19 -16.68 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.661 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.11 -19.07 27.87 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-O 119.741 -0.477 . . . . 0.0 114.236 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -73.76 153.3 40.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.788 0.794 . . . . 0.0 112.616 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 p -118.26 153.66 33.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.142 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.9 mt -132.75 123.18 25.74 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.6 m -65.41 138.49 58.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -5.03 92.16 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.506 0 C-N-CA 126.873 2.069 . . . . 0.0 115.949 -170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -98.85 -169.75 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.724 2.95 . . . . 0.0 111.913 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 75' ' ' VAL . 48.2 t -117.94 172.1 7.62 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.84 -50.14 66.87 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.89 -30.2 65.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.81 -43.53 98.07 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.351 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 71' ' ' SER . 15.5 m -80.28 -30.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.08 -40.87 91.07 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.41 -36.8 64.34 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.122 0.889 . . . . 0.0 111.707 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -84.11 -48.58 9.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.18 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.58 -41.14 72.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.735 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.35 -34.54 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.217 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.37 -19.6 38.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.014 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 78' ' ' LYS . 78.2 mt -84.67 -46.21 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.263 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.258 -176.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.92 -64.43 1.13 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.531 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.5 131.98 6.64 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.918 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -102.68 127.27 49.87 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.942 -174.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.23 123.7 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 124.983 1.313 . . . . 0.0 110.659 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.8 m-85 -103.68 115.79 31.14 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -163.64 169.81 18.03 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.444 HG22 ' CG1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -123.77 161.15 25.8 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -74.36 -8.19 55.43 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.699 0.285 . . . . 0.0 111.76 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -86.95 -5.48 59.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -78.69 144.21 35.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.97 -42.8 84.48 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.218 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -82.11 -5.67 58.59 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.4 p -50.29 -63.13 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -29.53 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.282 0.563 . . . . 0.0 111.543 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -59.88 -47.19 86.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.775 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.8 tp -70.55 -34.75 72.58 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.574 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 10.2 mmmm -62.14 -47.17 85.74 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -65.41 -43.77 89.54 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.767 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -45.53 84.22 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.872 0.368 . . . . 0.0 111.675 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.85 -37.7 70.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.208 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.2 m -65.99 -43.7 86.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.78 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.23 -34.34 77.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.232 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -91.41 6.69 44.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.89 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 54.95 62.29 2.58 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.422 1.089 . . . . 0.0 112.004 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.56 133.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.537 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.85 125.35 29.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.72 159.67 41.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.323 0.582 . . . . 0.0 110.895 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 7' ' ' THR . 20.6 m-20 -122.43 142.35 50.64 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 13.7 pt-20 -137.14 139.17 41.0 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.558 0.617 . . . . 0.0 111.762 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.23 144.78 28.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.33 143.14 26.7 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 117.915 -1.514 . . . . 0.0 110.738 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 35.6 pt -84.13 -3.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.407 -1.27 . . . . 0.0 113.184 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.06 -36.94 16.67 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.493 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -77.82 -33.62 52.32 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.023 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -103.52 102.88 12.79 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -65.53 -36.5 83.99 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.486 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.79 -32.05 72.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 111.068 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -75.8 -41.03 54.0 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.043 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -64.85 -44.38 89.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.122 0.569 . . . . 0.0 111.38 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.82 -38.23 81.44 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.751 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.48 -61.44 1.77 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.207 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -57.34 -35.79 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.04 73.12 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.843 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.53 -25.78 30.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.054 0.454 . . . . 0.0 111.177 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.23 13.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.029 0.919 . . . . 0.0 110.438 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 165.83 16.22 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.986 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.62 87.18 1.39 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.67 -97.74 1.86 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 48.4 t30 -86.21 149.89 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -72.87 102.41 3.42 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.93 -8.08 0.08 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.051 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 m -126.71 144.68 50.73 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.4 Cg_endo -58.85 140.08 93.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.28 2.653 . . . . 0.0 111.477 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.7 m -128.66 138.9 52.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.9 m -102.71 133.73 45.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.378 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -110.63 112.72 24.8 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.4 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 87.7 m-85 -78.78 159.79 27.71 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 123.557 0.535 . . . . 0.0 109.732 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.42 -14.02 46.08 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 13.4 p-10 -85.63 -12.45 51.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.18 15.77 24.91 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.1 p -105.45 157.01 17.65 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.195 -0.591 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.5 p -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.58 0.229 . . . . 0.0 110.537 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -128.45 127.51 42.63 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 m -66.78 145.68 55.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -5.11 85.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 C-N-CA 126.295 1.838 . . . . 0.0 115.887 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -95.0 159.64 1.72 Allowed 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 123.761 2.974 . . . . 0.0 112.486 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 p -83.49 168.62 16.31 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.59 77.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.367 0.603 . . . . 0.0 110.634 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.97 -25.45 62.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.665 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.24 -43.88 22.88 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 122.257 -0.277 . . . . 0.0 111.538 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.89 -40.77 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.83 -34.59 71.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.39 77.41 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.652 0.595 . . . . 0.0 112.207 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -85.84 -44.69 12.23 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.061 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -53.35 -40.09 64.65 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.505 1.122 . . . . 0.0 113.15 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.91 -39.17 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.43 0.456 . . . . 0.0 111.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -79.28 -31.4 43.33 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.162 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 78' ' ' LYS . 62.8 mt -74.96 -52.85 17.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.079 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.895 -176.465 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.34 -58.89 6.59 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.421 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.19 132.16 18.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.348 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -112.18 122.64 48.31 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.4 mt -91.63 123.77 43.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.003 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 29.7 m-85 -105.43 118.88 37.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -163.84 164.31 23.55 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 162.84 14.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -71.01 -19.44 62.52 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -83.82 -1.22 53.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -80.6 123.23 27.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.14 92.98 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.549 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -82.27 -7.15 59.62 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 37.0 t -52.52 -59.41 4.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.187 0.305 . . . . 0.0 111.655 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.13 -23.15 63.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.14 -48.25 65.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.8 tp -63.88 -40.15 95.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.602 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.3 mmtp -60.16 -51.79 68.08 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.258 0.552 . . . . 0.0 110.409 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -67.73 -31.85 72.07 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.428 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.53 84.57 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 120.941 0.4 . . . . 0.0 110.488 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 55.4 mt -72.03 -40.96 68.04 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.439 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -64.76 -29.6 70.58 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.41 -31.75 58.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.206 0.526 . . . . 0.0 111.006 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -91.53 12.86 19.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 61.18 33.36 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.583 1.153 . . . . 0.0 110.43 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.3 mt -87.26 133.57 29.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.408 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.67 123.57 34.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -145.81 175.44 10.41 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.059 0.457 . . . . 0.0 111.4 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -129.27 142.08 50.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.82 126.77 38.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 133.9 43.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.01 140.69 57.71 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 40.5 pt -84.35 -18.8 9.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.99 -45.37 74.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.572 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -72.2 -36.97 69.35 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.613 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -91.05 93.4 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.024 0.44 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -55.25 -46.02 76.06 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.969 0.907 . . . . 0.0 111.802 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.19 70.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.41 81.2 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.24 -41.59 96.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.173 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.78 -43.01 90.06 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.47 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.95 -52.79 63.54 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.566 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 14.3 m -68.35 -21.97 26.9 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.52 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.27 68.35 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.058 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.89 -23.5 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.026 0.441 . . . . 0.0 110.795 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 46' ' ' VAL . 32.1 m -114.74 13.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.706 0.765 . . . . 0.0 110.606 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -88.87 -171.61 3.37 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.134 -172.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 65.87 3.18 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.87 -73.07 1.6 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -110.47 161.73 15.39 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 100.67 2.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -149.67 -17.89 0.27 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.286 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -116.91 145.62 35.97 Favored Pre-proline 0 C--O 1.248 1.013 0 O-C-N 121.907 -0.496 . . . . 0.0 111.82 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.53 127.42 26.13 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.581 2.854 . . . . 0.0 111.342 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -113.71 135.31 54.07 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.26 125.29 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.771 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.07 111.85 23.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -82.16 171.03 14.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.347 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -15.3 63.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.939 0.875 . . . . 0.0 109.104 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.47 -17.98 61.72 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.709 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 -22.67 21.35 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.508 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -73.42 151.94 40.97 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 p -119.53 143.4 47.6 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.8 mt -125.32 132.97 52.77 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -72.32 139.53 48.02 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -5.49 88.39 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -99.23 153.38 0.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 123.998 3.132 . . . . 0.0 111.145 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -86.34 172.88 10.1 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.718 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.65 55.59 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.774 0.829 . . . . 0.0 113.065 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 19.0 m-20 -69.92 -19.74 63.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -82.49 -39.35 22.59 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.36 -31.03 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 51.0 mtpt -54.5 -40.23 68.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.94 0.496 . . . . 0.0 110.832 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.73 71.38 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 124.238 0.961 . . . . 0.0 112.0 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.5 mtpp -84.15 -47.24 11.07 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.953 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.8 -39.89 78.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.797 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.95 -31.2 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.341 0.591 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -81.09 -43.04 20.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 78' ' ' LYS . 76.1 mt -59.3 -34.8 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.91 179.627 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -2.576 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 -53.18 4.23 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.877 0.846 . . . . 0.0 108.788 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.07 136.83 17.07 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.727 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.8 m -102.26 110.07 21.93 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -88.49 130.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.817 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.83 105.44 13.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.334 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 11.6 t -164.66 -171.12 2.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -149.62 164.59 34.73 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -56.01 -20.67 17.58 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.664 1.185 . . . . 0.0 113.812 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -82.09 -2.07 50.69 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -95.92 129.32 43.21 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.68 -31.94 81.52 Favored Glycine 0 N--CA 1.46 0.243 0 CA-C-O 121.493 0.496 . . . . 0.0 112.1 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -80.96 -7.94 59.64 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 31.6 t -64.57 -61.74 2.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.41 -29.2 68.63 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.723 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -62.97 -39.12 93.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.5 tp -75.89 -45.96 32.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.214 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -53.7 -49.27 68.41 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.933 0.396 . . . . 0.0 110.884 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -66.87 -37.25 84.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.103 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.28 91.33 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 120.951 0.405 . . . . 0.0 110.734 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.4 -42.35 71.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -62.71 -40.74 98.1 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.426 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.89 66.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 110.942 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -91.04 4.19 52.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.663 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 61.23 29.64 18.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 111.584 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.95 131.52 33.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.97 35.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.11 164.34 30.04 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.974 0.416 . . . . 0.0 111.799 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.82 122.52 34.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.225 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.31 129.61 56.66 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.958 0.409 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.1 138.7 53.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.43 141.33 28.85 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.004 -1.478 . . . . 0.0 111.092 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG22 HG11 ' A' ' 46' ' ' VAL . 29.2 pt -85.1 5.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.8 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.88 -45.29 12.4 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -85.27 -34.66 21.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.759 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.91 92.95 7.15 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.722 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -72.25 -28.29 63.05 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.14 76.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -71.6 -39.52 70.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.332 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.16 90.86 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 110.831 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.03 -48.67 77.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.692 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.87 -56.83 16.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.438 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -64.15 -33.29 61.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.6 73.82 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.935 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -76.18 -45.63 32.39 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.047 0.451 . . . . 0.0 110.164 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.96 3.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.458 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.78 -172.37 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.187 0.518 . . . . 0.0 109.948 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.07 64.23 2.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.14 -73.81 0.22 Allowed Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 39.9 t-20 -135.89 169.65 17.24 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -70.94 107.01 3.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.349 0.977 . . . . 0.0 110.799 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.1 t -138.14 -23.24 1.02 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.004 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.38 154.6 79.18 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 39.0 Cg_endo -67.84 145.56 69.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.316 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.8 m -128.87 143.65 50.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.4 m -111.17 134.25 54.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 123.164 0.29 . . . . 0.0 110.417 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -111.76 118.88 36.82 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.548 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 93.2 m-85 -80.09 178.59 8.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.96 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.71 58.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 33.7 p-10 -88.3 -18.48 28.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.784 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.37 -1.63 53.81 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.99 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -84.48 144.65 28.58 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.96 140.94 48.87 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.754 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.79 140.75 50.31 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.7 m -77.73 147.45 35.38 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -5.53 83.27 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.833 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -98.51 139.53 0.41 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 123.57 2.847 . . . . 0.0 112.269 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -72.11 174.53 7.01 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.648 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.01 -47.03 78.55 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 123.829 0.851 . . . . 0.0 113.176 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 15.7 m-20 -76.29 -19.76 57.96 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.383 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.28 -44.17 65.74 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 -34.99 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.812 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 55.6 mtpt -56.68 -36.53 69.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.199 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.61 73.98 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.903 0.752 . . . . 0.0 111.628 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -84.05 -40.82 17.88 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.613 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 tp -60.27 -38.27 83.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.941 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.8 -32.94 57.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.079 0 CA-C-O 121.499 0.666 . . . . 0.0 110.753 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.75 -31.24 32.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.41 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.08 -36.49 68.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.322 0.582 . . . . 0.0 109.86 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.177 177.014 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.9 -54.75 41.29 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.683 0.614 . . . . 0.0 111.519 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.15 137.87 19.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -103.45 119.39 38.8 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.406 HG12 HG13 ' A' ' 59' ' ' VAL . 92.2 mt -88.76 122.48 40.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -102.61 121.9 43.33 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -163.51 171.41 15.9 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 149.13 27.86 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.1 t -67.35 -20.95 65.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.471 0.177 . . . . 0.0 110.594 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.86 5.25 41.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.4 t -85.85 132.37 34.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.97 -32.91 58.2 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 56' ' ' VAL . 50.5 m-85 -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 51.5 t -57.11 -56.43 21.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 123.585 0.553 . . . . 0.0 110.307 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.65 -21.69 61.78 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 36.7 mmt180 -65.28 -51.1 62.97 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.09 -40.35 96.05 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.731 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.8 mmtp -60.31 -41.13 92.83 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.8 m -59.96 -45.28 93.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.052 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.35 -51.25 66.7 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.671 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.65 -44.49 86.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.9 m -64.02 -34.28 77.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.748 0.309 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.39 -25.18 67.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.141 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.83 9.26 36.99 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 122.082 -0.386 . . . . 0.0 110.74 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 54.92 41.18 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.828 0.851 . . . . 0.0 111.298 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.4 mt -84.38 138.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.15 119.31 24.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.33 168.14 20.22 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.872 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.08 142.26 47.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.15 137.78 46.38 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.442 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.94 142.4 36.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -89.25 141.7 28.29 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.508 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.454 HG23 HG11 ' A' ' 46' ' ' VAL . 43.2 pt -84.21 -7.53 10.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.664 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -71.92 -31.69 66.62 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 121.729 0.776 . . . . 0.0 108.919 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -90.16 -15.52 31.35 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.231 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -125.45 95.53 4.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.673 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.08 -34.89 79.1 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.044 0.215 . . . . 0.0 111.409 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.93 98.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.037 0.446 . . . . 0.0 110.023 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -68.1 -37.93 81.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.777 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.85 98.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.744 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.15 -39.23 94.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.03 -59.29 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.453 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.39 -31.38 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.331 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.74 -37.4 94.65 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.617 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -82.27 -13.71 56.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.75 13.34 8.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.182 0.992 . . . . 0.0 109.458 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -172.11 3.12 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.32 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.79 60.71 0.57 Allowed Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.187 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.89 -56.74 0.49 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.73 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -144.77 167.41 22.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -71.29 103.21 2.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.89 0.768 . . . . 0.0 110.005 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 -32.54 0.36 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.755 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 16' ' ' TYR . 9.1 m -115.55 149.3 42.73 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.57 147.03 93.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.906 2.404 . . . . 0.0 111.223 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.2 m -134.65 140.05 45.74 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 66' ' ' THR . 34.1 m -105.93 132.18 53.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.03 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.15 115.66 30.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.98 162.19 22.75 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.319 0.387 . . . . 0.0 110.579 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.98 56.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.567 0.699 . . . . 0.0 109.7 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.32 -12.63 59.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.595 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.1 -22.93 31.99 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 171.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -105.48 174.36 5.91 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.448 1.124 . . . . 0.0 111.11 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 p -113.62 160.23 18.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.962 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -134.15 125.97 29.02 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -67.82 141.78 56.37 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -5.13 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.519 3.014 0 C-N-CA 126.449 1.9 . . . . 0.0 115.313 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.6 Cg_endo -96.54 138.48 0.62 Allowed 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 124.271 3.314 . . . . 0.0 111.895 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -72.71 173.2 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.897 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.93 86.98 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 5.4 t70 -81.07 -19.91 42.69 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.968 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.24 -43.41 70.62 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.679 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 7.6 m -68.92 -40.6 81.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.939 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 48.4 mtpt -53.11 -39.33 63.35 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.484 0.49 . . . . 0.0 111.649 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.5 84.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.545 0.528 . . . . 0.0 111.869 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -85.96 -35.94 20.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.626 0.727 . . . . 0.0 110.573 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.1 tp -66.74 -35.31 79.8 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.394 1.478 . . . . 0.0 112.517 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.18 -31.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.929 0.492 . . . . 0.0 111.772 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' HZ2' ' HB2' ' A' ' 81' ' ' LYS . 8.5 mtmp? -70.4 -26.39 63.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.353 0.597 . . . . 0.0 110.276 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -83.93 -51.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.063 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.927 -177.187 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.82 -64.19 1.07 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.17 146.69 12.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.812 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 28.0 m -118.17 132.31 56.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.512 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.6 mt -92.71 128.7 44.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 124.061 0.944 . . . . 0.0 111.503 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.457 ' CD1' ' HB1' ' A' ' 42' ' ' ALA . 69.1 m-85 -110.09 119.09 38.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 173.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.09 -172.02 2.64 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.2 p -121.64 164.27 17.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.6 m -78.71 -7.85 58.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -102.8 2.48 35.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.175 0.512 . . . . 0.0 111.32 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 45.6 t -82.94 118.56 23.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.36 69.94 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.818 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.16 -10.48 59.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.092 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.595 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 23.0 t -61.09 -62.55 1.77 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -29.21 69.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.494 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.72 -44.19 96.87 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.364 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.65 -37.87 67.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.6 mmtp -56.93 -43.13 81.17 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 m -57.4 -53.33 59.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.962 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.24 82.94 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.097 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -70.27 -37.24 74.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.559 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -70.98 -39.09 72.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.84 64.17 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.296 0.57 . . . . 0.0 111.259 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.92 14.52 27.9 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 44.55 59.8 3.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.597 1.159 . . . . 0.0 113.054 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.53 135.15 50.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.45 131.99 34.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.61 157.29 42.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' THR . 33.9 t70 -120.7 142.32 49.61 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -127.25 138.13 53.02 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.054 0.454 . . . . 0.0 110.528 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.8 141.23 37.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.46 143.83 26.08 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.326 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 pt -82.99 -0.36 4.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.939 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.7 -38.18 16.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -76.51 -35.96 58.02 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.463 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -105.35 99.99 9.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.783 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -68.82 -32.93 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.548 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -66.13 -41.77 90.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.54 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.66 75.78 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.323 0.582 . . . . 0.0 110.987 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -70.86 -44.52 66.22 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.127 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.07 -56.62 15.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.917 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 42' ' ' ALA . 8.6 p -65.2 -27.0 41.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.36 -20.86 77.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.538 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -84.07 -24.41 30.4 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 122.616 0.366 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.12 13.12 7.98 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.07 167.58 11.69 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.315 -175.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.7 80.28 1.59 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.19 -82.92 0.34 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 32.7 t-20 -144.65 172.68 12.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.525 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -63.37 121.32 13.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.343 0.974 . . . . 0.0 111.833 -175.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.7 t -166.73 -25.62 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.43 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.99 148.38 41.26 Favored Pre-proline 0 N--CA 1.445 -0.7 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 27.2 Cg_endo -62.22 138.02 69.53 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.894 2.396 . . . . 0.0 111.583 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 m -129.22 144.29 51.16 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.8 m -109.82 129.61 64.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.855 0.359 . . . . 0.0 111.14 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -104.58 118.63 37.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -83.58 171.17 13.59 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.499 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.85 14.84 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.15 -10.46 49.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.154 0.502 . . . . 0.0 109.881 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.07 -15.15 58.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.878 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 m -94.4 166.61 11.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.476 0.638 . . . . 0.0 111.262 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -120.0 157.89 27.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.4 mt -128.19 122.31 31.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 167.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.4 m -61.73 141.33 57.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -5.18 89.67 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 127.513 2.325 . . . . 0.0 115.458 -171.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -96.24 154.8 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 124.265 3.31 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.2 t -84.96 175.32 9.14 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.31 73.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.08 -36.96 75.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.16 0.505 . . . . 0.0 110.095 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.72 -47.38 72.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -64.7 -41.0 90.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.842 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.8 -35.17 79.72 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.95 88.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.886 0.741 . . . . 0.0 111.679 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -85.35 -42.49 14.52 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.86 -37.76 77.23 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 112.302 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -31.39 45.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.438 0.637 . . . . 0.0 110.701 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -81.07 -31.04 34.59 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.045 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.51 -44.62 76.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.411 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.513 177.377 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.24 -51.99 11.97 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.335 0.588 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.02 128.47 13.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.839 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.3 m -104.9 119.1 38.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' CD1' ' A' ' 24' ' ' LEU . 80.0 mt -88.99 124.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.424 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.457 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 28.0 m-85 -103.01 113.25 26.56 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.06 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -155.34 160.34 40.65 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -93.67 151.7 19.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.827 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -69.79 -22.11 63.35 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.936 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -88.07 -1.18 57.84 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -75.28 145.84 41.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 -33.17 25.93 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.89 -8.3 57.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.0 p -57.04 -57.05 14.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.53 -21.73 60.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.586 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -67.9 -46.85 70.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.36 -34.49 78.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.3 mmtp -62.43 -45.53 92.68 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 m -60.46 -41.66 94.6 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.94 75.43 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.492 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.461 ' CD1' HD12 ' A' ' 8' ' ' ILE . 57.6 mt -70.38 -45.25 66.4 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -63.38 -35.86 81.81 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 120.708 0.289 . . . . 0.0 111.632 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -10.04 59.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -110.78 14.84 22.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.777 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 63.96 27.41 14.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 113.154 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 24' ' ' LEU . 64.3 mt -90.21 131.52 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.854 0.359 . . . . 0.0 111.175 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.86 39.1 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -148.05 174.92 11.45 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.53 137.28 51.67 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -125.94 132.57 52.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.722 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 p -139.14 151.86 23.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.05 141.38 28.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.991 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 30.9 pt -83.68 -31.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -79.97 -15.05 58.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.092 0.949 . . . . 0.0 109.006 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -91.73 -1.27 57.47 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.528 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -135.98 104.92 5.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -50.7 -51.83 45.93 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.755 0.822 . . . . 0.0 112.426 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.94 79.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.341 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.78 -43.42 75.74 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.85 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -60.89 -43.71 98.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.448 0.699 . . . . 0.0 112.129 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -22.49 62.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 112.084 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -76.97 -61.54 1.95 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.608 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.6 p -62.22 -37.04 77.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.469 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.75 90.72 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.461 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -77.74 -29.84 51.32 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.758 0.314 . . . . 0.0 111.394 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.44 11.5 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 0.0 110.855 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.18 -172.74 3.93 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.311 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.56 85.33 0.39 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.6 -116.39 4.87 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -95.32 -175.84 3.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 98.82 7.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.647 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 t -139.27 -27.67 0.8 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.641 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.43 138.56 20.24 Favored Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.29 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.47 122.31 11.29 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.177 2.585 . . . . 0.0 111.258 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -112.0 132.42 54.8 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.9 p -103.5 121.59 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.249 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -100.41 118.49 36.75 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -86.34 165.88 16.05 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.658 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.98 51.58 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -85.37 -3.45 58.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.084 -0.385 . . . . 0.0 110.67 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.18 18.38 59.32 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.721 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 t -106.76 143.14 35.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.91 141.39 48.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.483 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.52 132.35 52.63 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -67.32 136.73 55.29 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -5.98 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.564 0 C-N-CA 126.828 2.051 . . . . 0.0 116.186 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 31.5 Cg_endo -97.52 169.34 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.678 3.586 . . . . 0.0 113.495 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -83.9 161.43 20.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -62.73 -40.07 96.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.759 0.424 . . . . 0.0 111.214 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.57 -43.22 93.68 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.012 0.434 . . . . 0.0 110.611 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -63.15 -48.99 76.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.901 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 17.5 m -68.45 -33.49 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 54.7 mtpt -62.87 -34.92 78.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.67 0.213 . . . . 0.0 110.614 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.68 67.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.263 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -84.17 -46.7 11.62 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -55.69 -39.71 71.37 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.35 1.46 . . . . 0.0 112.936 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.27 -35.27 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.66 -22.38 46.88 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.81 0.814 . . . . 0.0 110.514 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.3 mt -84.99 -53.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.607 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.966 -175.754 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.86 -59.08 5.94 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.955 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.05 134.91 11.89 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.047 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -102.15 129.16 48.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.947 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.9 mt -93.48 120.44 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.18 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 60.6 m-85 -102.54 115.77 31.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -158.26 175.97 13.07 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.86 155.93 43.36 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -70.19 -15.86 62.99 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -85.46 -4.82 59.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.6 m -77.07 133.54 39.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.8 -38.9 35.28 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.979 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -75.78 -7.53 54.65 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 52.5 t -57.26 -61.74 2.26 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.4 -23.78 64.69 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -67.65 -43.08 81.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.648 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.96 -35.63 66.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -55.95 -48.41 75.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -66.28 -34.41 77.94 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.736 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.65 87.2 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.252 0.549 . . . . 0.0 110.4 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 mt -73.63 -41.96 62.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.0 m -65.31 -35.16 80.15 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.54 87.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.837 0.827 . . . . 0.0 109.974 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.46 3.03 48.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.8 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 58.7 31.54 21.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.792 0.837 . . . . 0.0 112.065 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.3 mt -75.14 137.24 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.32 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.49 119.74 32.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -134.27 163.74 28.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -128.87 135.25 48.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.61 141.19 46.67 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.606 0.241 . . . . 0.0 111.319 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.74 138.18 39.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 170.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -77.97 143.39 37.62 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.777 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 42.8 pt -83.32 -9.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.092 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.94 -32.13 27.33 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.76 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -88.04 -10.83 49.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.881 0.372 . . . . 0.0 110.761 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.73 98.06 6.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.69 -49.28 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.43 74.14 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.556 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -69.95 -42.96 72.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.388 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 110.207 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.48 -50.7 72.92 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.519 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -58.29 -56.24 24.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.406 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.1 p -64.39 -35.32 73.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.722 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.21 -34.91 89.53 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.558 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -66.75 -44.5 81.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.003 0.521 . . . . 0.0 109.91 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.58 13.11 2.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 111.868 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -172.88 3.21 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.27 2.72 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.0 -44.72 2.85 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-O 121.258 0.366 . . . . 0.0 113.044 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -119.79 142.58 48.46 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 94.22 4.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.587 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -139.68 -17.26 0.99 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.965 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -124.1 144.85 46.48 Favored Pre-proline 0 C--O 1.244 0.779 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 13.2 Cg_endo -56.63 131.61 46.69 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.682 2.922 . . . . 0.0 111.542 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -124.18 138.46 54.41 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.0 m -104.78 127.44 59.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 123.377 0.423 . . . . 0.0 110.978 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -106.71 113.89 27.66 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.1 163.23 21.01 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.954 0.407 . . . . 0.0 110.843 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.54 -17.32 59.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.014 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.82 -6.4 59.42 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.35 39.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.103 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.5 p -111.21 154.06 24.94 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.803 0.801 . . . . 0.0 111.199 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -121.21 142.03 50.3 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.948 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.29 124.99 40.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.6 m -67.36 145.76 54.76 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -4.64 85.81 0.03 OUTLIER Pre-proline 0 N--CA 1.522 3.139 0 C-N-CA 126.56 1.944 . . . . 0.0 114.793 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -97.83 161.09 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.522 3.481 . . . . 0.0 113.455 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -80.57 159.33 25.49 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.43 66.17 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.31 -43.93 98.05 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.576 0.751 . . . . 0.0 110.737 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.78 -44.9 72.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.532 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.6 m -68.22 -35.94 73.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.618 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -61.62 -42.17 98.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.537 0.335 . . . . 0.0 110.818 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.09 67.56 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.827 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -84.3 -51.85 6.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.821 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.85 -36.77 65.42 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.947 0.899 . . . . 0.0 113.272 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.09 -34.54 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.029 0.442 . . . . 0.0 111.833 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -81.38 -48.63 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.35 -45.14 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.546 1.138 . . . . 0.0 112.76 -175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.946 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.031 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.43 85.78 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.064 0.853 . . . . 0.0 109.906 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.59 131.65 14.35 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.901 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -102.5 120.48 40.6 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.43 119.57 35.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.791 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.89 114.82 29.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.589 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -163.85 -174.44 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -118.02 166.99 11.87 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 123.844 0.858 . . . . 0.0 109.253 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 m -78.84 -17.57 55.44 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.939 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -93.05 -1.93 56.1 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.3 t -81.34 131.2 35.28 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.838 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.2 -46.26 51.29 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -63.88 -15.71 59.63 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.6 t -59.14 -63.71 1.2 Allowed 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.347 0.404 . . . . 0.0 110.536 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.06 -24.62 61.55 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.823 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 29.1 mmm180 -65.8 -48.25 72.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.335 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.07 -32.14 68.73 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.07 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.5 mmmm -57.72 -43.41 85.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 m -64.1 -49.78 70.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.35 87.17 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.238 0.615 . . . . 0.0 112.492 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.78 -41.88 82.52 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.1 m -62.32 -42.12 99.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.451 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.03 66.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.781 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -103.58 9.35 37.48 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.884 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 3.6 mmp_? 62.32 43.34 8.34 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.608 0.718 . . . . 0.0 111.567 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.44 132.52 48.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.3 34.87 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -136.75 163.77 29.83 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.14 0.495 . . . . 0.0 112.198 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -121.49 142.48 50.01 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 11.9 pt-20 -132.31 139.89 48.36 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 117.918 0.326 . . . . 0.0 110.77 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.32 147.3 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.15 141.31 34.36 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.023 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 41.6 pt -83.76 -32.23 8.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.29 -14.88 60.53 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.147 -0.346 . . . . 0.0 111.648 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.53 -25.84 33.02 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.3 94.34 4.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.989 -0.445 . . . . 0.0 109.837 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.01 -45.34 64.53 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.86 92.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.631 0.253 . . . . 0.0 110.994 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -68.93 -41.44 78.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -65.82 -35.39 80.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 9.4 tp10 -70.41 -38.73 74.68 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.16 -58.46 7.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.282 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 42' ' ' ALA . 6.2 p -61.79 -35.35 67.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.1 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.77 72.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.551 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 m -83.66 -34.15 25.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.757 0.313 . . . . 0.0 111.523 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.5 10.62 4.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.776 0.798 . . . . 0.0 110.616 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -175.36 5.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.451 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.72 66.82 3.68 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.56 -66.91 0.26 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 65.3 t30 -142.12 162.06 36.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -57.6 114.33 2.2 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.887 -178.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.2 t -161.22 -30.63 0.05 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.626 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.77 152.04 44.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 36.7 Cg_endo -64.59 139.9 66.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.584 2.19 . . . . 0.0 112.119 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -126.57 136.57 52.72 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' THR . 30.7 m -105.02 129.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.133 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -103.97 119.43 38.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.4 172.25 13.9 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 120.79 0.329 . . . . 0.0 111.079 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.6 68.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.901 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -78.09 -17.96 56.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.941 0.401 . . . . 0.0 110.27 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.52 -19.54 28.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.579 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -71.59 160.51 32.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.322 0.561 . . . . 0.0 111.342 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -127.31 141.9 51.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.444 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.18 120.4 33.08 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -64.64 144.27 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -5.36 84.83 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -92.53 -170.58 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 123.612 2.875 . . . . 0.0 111.389 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' HG21 ' A' ' 75' ' ' VAL . 15.3 p -117.55 166.64 12.13 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.97 75.4 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.36 0.412 . . . . 0.0 111.776 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -69.66 -35.96 75.61 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.483 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -68.49 -45.03 73.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 71' ' ' SER . 10.8 m -67.63 -37.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.37 -31.48 71.37 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.81 80.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.553 0.533 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -84.03 -41.88 16.75 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.7 -39.0 89.91 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.528 1.131 . . . . 0.0 112.695 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.49 -35.63 55.39 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-O 120.977 0.417 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.65 -19.73 58.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.206 0.527 . . . . 0.0 111.264 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -80.86 -49.12 18.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.628 -179.546 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.4 -58.63 3.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 123.338 0.399 . . . . 0.0 111.248 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.76 144.27 13.39 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 m -110.05 124.83 52.17 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.948 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.405 HG12 HG13 ' A' ' 59' ' ' VAL . 86.8 mt -89.81 128.4 41.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 124.13 0.972 . . . . 0.0 110.512 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.16 127.24 55.52 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -163.13 170.72 17.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 162.93 21.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -59.65 -30.18 68.56 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -87.19 0.13 55.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.87 112.93 16.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.27 70.45 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-N 116.371 -0.377 . . . . 0.0 114.004 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -82.83 -6.73 59.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.3 p -54.09 -60.12 3.75 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.76 -33.76 76.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.482 0.313 . . . . 0.0 111.743 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -59.79 -47.83 84.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.693 0.759 . . . . 0.0 109.794 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 tp -64.47 -38.7 91.93 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.82 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.7 mmtp -61.07 -46.73 89.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.141 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -59.54 -47.04 87.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.36 96.68 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.37 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.61 -35.27 62.95 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.316 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -66.47 -38.62 87.72 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 123.309 0.38 . . . . 0.0 110.278 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.68 97.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 111.401 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -86.73 -5.75 59.03 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 64.38 61.73 0.86 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.055 1.342 . . . . 0.0 113.253 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.58 138.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.28 108.23 19.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -120.77 156.68 31.34 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.18 142.16 40.36 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.12 132.36 38.0 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.429 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.4 131.72 40.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.75 140.03 37.08 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.954 0.883 . . . . 0.0 109.442 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 HG21 HG11 ' A' ' 46' ' ' VAL . 37.5 pt -84.25 -15.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.359 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.93 -34.18 77.21 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.307 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -78.29 -50.18 12.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -91.44 104.87 17.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -56.53 -44.07 80.45 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 125.626 1.571 . . . . 0.0 111.238 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.43 89.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -70.92 -38.92 72.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.33 91.19 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.698 0.624 . . . . 0.0 110.696 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.44 -51.44 68.69 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.098 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -56.09 -60.43 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.016 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.2 p -65.5 -29.83 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 0.0 111.749 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.24 75.83 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.057 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -84.04 -36.87 22.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -98.41 13.33 4.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -79.33 175.79 10.28 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.514 -176.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.07 88.31 0.89 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.39 -71.96 0.44 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -144.62 162.31 36.96 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -68.7 117.18 10.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.627 0.727 . . . . 0.0 110.651 -178.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.0 t -163.81 -31.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.59 147.22 36.28 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.3 146.52 96.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.072 2.515 . . . . 0.0 111.687 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.66 144.5 50.38 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 66' ' ' THR . 16.3 m -110.97 131.58 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 123.168 0.293 . . . . 0.0 110.297 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -106.93 122.43 46.41 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.476 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 67.8 m-85 -86.83 177.91 7.15 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.275 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.12 66.38 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.516 0.727 . . . . 0.0 112.13 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.57 -11.57 58.33 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.15 0.5 . . . . 0.0 110.365 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.8 3.77 68.07 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.319 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -97.43 152.53 18.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.4 p -115.84 154.19 30.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.317 0.58 . . . . 0.0 111.916 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -130.29 125.69 35.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 m -68.99 142.14 54.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -4.76 84.85 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.792 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 35.0 Cg_endo -93.99 150.83 2.16 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 123.934 3.089 . . . . 0.0 113.231 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 m -75.89 165.66 24.66 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.14 -33.96 72.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.98 -35.68 66.93 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.321 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.62 -43.85 88.31 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.999 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.5 m -67.82 -41.97 85.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -60.61 -40.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.288 0.368 . . . . 0.0 110.756 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.95 75.88 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.777 0.673 . . . . 0.0 111.973 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 64.3 tttp -84.14 -45.42 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.584 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.65 -41.01 96.92 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.243 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.41 -38.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.782 0 O-C-N 123.448 0.468 . . . . 0.0 110.604 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.26 -25.29 63.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.78 -40.02 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.956 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.1 -60.55 3.6 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.823 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.0 135.34 12.28 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.696 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 85.5 m -102.63 123.94 47.25 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.96 124.69 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.076 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -106.51 110.81 23.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.738 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -164.02 -177.2 4.91 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 149.98 51.41 Favored 'General case' 0 N--CA 1.396 -3.143 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -58.53 -8.41 1.23 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -91.37 -1.46 57.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.605 -0.685 . . . . 0.0 112.333 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.474 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.7 t -82.6 140.45 33.21 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.49 62.97 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -82.52 -7.8 59.63 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.649 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.8 t -61.69 -63.02 1.4 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.151 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.3 -28.58 67.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.158 0.504 . . . . 0.0 110.878 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -61.25 -50.59 72.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.86 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.48 -35.42 73.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.194 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.2 mmtp -57.97 -40.41 80.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -67.4 -48.69 66.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.385 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.81 -42.64 84.68 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.601 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 mt -69.63 -38.83 77.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.662 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -65.93 -35.89 81.87 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.876 0.37 . . . . 0.0 110.798 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.53 64.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.367 0.603 . . . . 0.0 111.38 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -109.91 13.49 23.46 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 43.09 62.64 1.75 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.024 1.729 . . . . 0.0 113.418 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 89.3 mt -105.66 129.85 58.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.402 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.09 28.67 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -136.79 166.68 23.03 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.138 0.494 . . . . 0.0 111.495 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' THR . 17.2 t70 -121.34 126.08 48.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.28 137.2 54.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.262 0.554 . . . . 0.0 111.109 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.94 135.55 42.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.45 140.99 41.49 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.441 HG21 HG12 ' A' ' 46' ' ' VAL . 12.1 pt -77.46 -26.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.55 -5.12 30.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.192 0.52 . . . . 0.0 111.665 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -94.45 -26.61 16.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -120.9 108.71 14.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.655 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -51.22 -48.56 62.04 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.766 1.226 . . . . 0.0 112.278 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.73 94.84 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.49 0.662 . . . . 0.0 110.683 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.586 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -71.32 -43.72 66.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.453 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.571 ' O ' ' HD2' ' A' ' 54' ' ' ARG . . . -59.99 -37.69 80.39 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.259 0.624 . . . . 0.0 112.391 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.13 -34.91 56.55 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.1 -58.23 7.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.586 HG11 ' O ' ' A' ' 42' ' ' ALA . 6.5 p -62.77 -33.82 62.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.307 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.41 -30.23 74.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.988 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -79.99 -36.86 35.39 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.92 9.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.463 0.649 . . . . 0.0 110.537 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.25 -177.81 4.97 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.319 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.24 79.45 1.79 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.04 -98.18 1.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.58 -175.27 3.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.68 116.48 2.53 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -162.7 -34.26 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.359 172.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.06 150.0 42.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 44.7 Cg_endo -65.94 140.56 61.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.731 2.287 . . . . 0.0 111.48 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 m -129.86 140.49 50.98 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.9 m -107.38 136.7 41.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.684 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -117.79 114.88 23.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -84.69 168.13 15.53 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.453 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.08 -11.37 48.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.392 1.091 . . . . 0.0 109.546 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.22 -18.13 61.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.684 1.594 . . . . 0.0 109.643 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.09 -21.88 39.61 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.776 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.9 m -80.17 149.27 30.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.759 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.7 p -113.5 151.76 31.08 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.432 175.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.58 125.07 24.99 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -64.5 146.52 54.44 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -5.69 86.38 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.553 0 C-N-CA 127.119 2.168 . . . . 0.0 115.942 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -98.09 150.75 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 124.274 3.316 . . . . 0.0 112.907 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 168.55 19.81 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -60.05 -37.04 78.65 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.99 -34.31 75.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.476 0.655 . . . . 0.0 110.33 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -71.7 -34.85 69.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.798 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -78.34 -35.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.711 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 29.3 mtpp -63.96 -33.34 75.51 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.825 -0.17 . . . . 0.0 110.789 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.42 67.99 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.935 0.772 . . . . 0.0 111.836 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 82' ' ' ILE . 37.1 mttm -83.04 -50.7 8.25 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.898 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 tp -51.62 -37.42 50.08 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.035 0.934 . . . . 0.0 113.053 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.35 -38.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.477 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -80.86 -24.08 38.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.157 0.503 . . . . 0.0 110.313 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 78' ' ' LYS . 70.7 mt -80.22 -49.15 19.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.828 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.035 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.7 -0.19 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.27 34.0 m 51.39 18.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.416 1.487 . . . . 0.0 114.67 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -75.45 -33.55 60.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.32 80.55 3.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.11 27.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.217 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.45 136.74 15.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.128 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -103.35 123.54 47.0 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 31' ' ' TYR . 60.3 mt -88.76 120.25 37.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.71 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -103.54 117.66 34.93 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.004 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -161.25 167.63 25.61 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -100.68 160.44 14.35 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -72.2 -31.0 65.48 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -88.68 14.41 10.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.516 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.5 t -79.93 155.86 27.52 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.35 -37.92 13.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.783 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.57 -7.98 59.62 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.652 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.2 p -57.16 -61.94 2.11 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.242 0.473 . . . . 0.0 111.775 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.92 -21.82 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.872 0.368 . . . . 0.0 111.661 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -67.53 -51.03 55.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.57 -35.88 75.78 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.15 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.7 mmtt -55.26 -45.52 76.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.29 0.567 . . . . 0.0 110.396 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -65.43 -40.0 92.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.716 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.21 95.94 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 29' ' ' ILE . 71.3 mt -69.07 -43.17 75.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 m -61.9 -38.5 88.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -16.24 63.77 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.413 0.625 . . . . 0.0 111.548 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -110.29 9.47 23.67 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 54.92 32.64 18.34 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.054 1.342 . . . . 0.0 112.454 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 HD11 ' HA ' ' A' ' 24' ' ' LEU . 66.1 mt -76.91 128.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 120.888 0.375 . . . . 0.0 110.266 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.38 122.9 29.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 8' ' ' ILE . 52.3 p90 -139.86 165.19 27.97 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.122 0.487 . . . . 0.0 112.294 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.36 142.19 50.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.24 143.55 50.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.381 0.537 . . . . 0.0 111.312 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.55 140.91 36.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.5 141.6 41.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.618 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 37.7 pt -82.81 -26.1 8.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.255 9.6 pt-20 -84.23 -11.47 56.43 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 117.917 -1.513 . . . . 0.0 111.833 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -83.34 -49.43 9.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 170.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.68 96.47 10.66 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.51 -39.16 79.33 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.722 0.809 . . . . 0.0 112.082 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.203 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.582 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -72.09 -43.35 64.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.457 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -56.5 -44.58 80.83 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 124.01 0.819 . . . . 0.0 110.972 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -62.29 -47.23 85.23 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.299 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -59.72 -56.62 19.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.354 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.7 p -62.9 -35.78 72.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.406 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.46 73.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.027 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -79.38 -37.8 36.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.885 0.374 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -94.61 5.5 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.27 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -178.81 6.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.738 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.99 79.25 1.82 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.81 -64.51 3.66 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.86 171.07 14.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -62.0 108.75 1.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.906 0.882 . . . . 0.0 111.856 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.3 t -156.16 -39.75 0.08 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.054 -0.404 . . . . 0.0 111.796 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.21 149.36 39.12 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.914 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.516 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 29.1 Cg_endo -64.44 152.65 80.73 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.35 2.033 . . . . 0.0 110.954 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.5 m -140.38 141.05 35.63 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.3 m -107.87 131.7 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.644 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.85 118.67 37.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -84.8 171.63 12.12 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.304 0.573 . . . . 0.0 112.366 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.1 -10.41 14.48 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.978 1.311 . . . . 0.0 112.305 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 -13.46 26.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.368 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.69 -21.27 39.19 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.901 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -85.32 160.83 19.72 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 117.93 0.865 . . . . 0.0 110.75 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.9 p -113.33 166.81 11.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.997 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.5 mt -138.36 116.56 11.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -62.6 139.44 58.63 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -4.69 88.16 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 126.947 2.099 . . . . 0.0 115.623 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -98.37 164.61 0.72 Allowed 'Trans proline' 0 N--CA 1.435 -1.937 0 C-N-CA 124.053 3.168 . . . . 0.0 111.949 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' O ' HG21 ' A' ' 75' ' ' VAL . 3.1 m -90.81 171.12 9.55 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.5 84.15 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 122.638 0.375 . . . . 0.0 111.483 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.47 -47.99 83.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.126 0.488 . . . . 0.0 110.716 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.02 -42.6 99.34 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.223 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 71' ' ' SER . 11.2 m -72.21 -40.33 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -57.9 -43.55 86.21 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.029 0.443 . . . . 0.0 110.106 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.41 76.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.909 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -84.08 -50.2 8.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.136 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.4 -39.83 70.65 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.123 0.969 . . . . 0.0 113.001 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -59.21 -39.78 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -73.17 -26.79 61.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.884 0.373 . . . . 0.0 110.608 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.1 mt -75.5 -45.19 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.07 -47.76 23.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.109 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.92 -131.31 5.95 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 70.48 -50.82 0.66 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.54 73.22 6.22 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.244 1.021 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -174.65 -177.25 1.14 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 N--CA 1.418 -2.059 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 171.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.8 t 73.32 99.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.922 0.867 . . . . 0.0 111.137 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -43.27 68.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.105 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.2 75.32 6.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.17 73.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.941 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.43 140.88 21.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.18 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 m -106.83 124.13 49.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.384 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 HG13 ' A' ' 59' ' ' VAL . 74.8 mt -88.81 122.25 39.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.706 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.513 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 68.8 m-85 -99.65 111.6 23.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.696 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -146.18 174.12 11.6 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.62 162.38 30.49 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 t -66.95 -15.9 64.0 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.796 0.331 . . . . 0.0 111.863 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -99.31 5.6 46.47 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.64 112.95 19.3 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.749 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.59 73.63 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.19 -7.52 56.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.566 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 47.5 t -65.67 -62.04 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.894 0.378 . . . . 0.0 110.448 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 19' ' ' ARG . 1.4 pp -67.9 -21.08 65.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.966 0.888 . . . . 0.0 112.068 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' N ' HD12 ' A' ' 18' ' ' LEU . 8.9 tpt180 -66.74 -43.55 83.88 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.969 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -85.36 -32.84 22.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.504 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.566 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -53.14 -48.47 67.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.881 0.372 . . . . 0.0 111.82 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 p -64.03 -38.65 91.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.874 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.16 93.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.156 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.87 -47.6 61.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.169 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 m -61.47 -37.3 83.1 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 121.076 0.465 . . . . 0.0 110.827 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -10.06 59.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.746 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -115.75 19.41 15.24 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.194 -0.316 . . . . 0.0 111.625 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 53.87 33.01 16.21 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 125.998 1.719 . . . . 0.0 112.177 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -90.3 131.17 38.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 120.914 0.387 . . . . 0.0 110.948 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.37 143.75 26.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.05 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -158.06 166.87 31.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.691 0.282 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -129.89 142.48 50.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -128.14 142.47 51.18 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.445 0.566 . . . . 0.0 110.62 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.51 141.9 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -89.68 139.39 30.61 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.62 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 34.7 pt -85.91 -11.13 11.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.0 -40.29 75.37 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.252 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -93.27 -30.03 15.37 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.703 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -88.09 99.93 12.55 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.518 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -71.79 -35.1 69.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.06 75.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.511 . . . . 0.0 109.638 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -74.28 -43.57 56.35 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.735 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -61.25 -43.04 99.53 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.103 0.561 . . . . 0.0 111.837 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.34 -45.88 92.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -59.65 -58.49 8.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.533 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -62.59 -35.26 69.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.746 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.13 93.96 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.035 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 m -71.09 -34.81 71.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.755 0.312 . . . . 0.0 111.339 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.67 7.17 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.255 0.55 . . . . 0.0 111.411 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 -172.62 3.98 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.925 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.92 81.55 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -63.12 3.27 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -144.37 165.08 28.92 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -54.21 101.1 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.767 1.227 . . . . 0.0 112.164 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -146.66 -15.96 0.43 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.1 147.69 63.55 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 122.217 -0.302 . . . . 0.0 111.778 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 32.5 Cg_endo -64.83 137.18 52.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.72 2.28 . . . . 0.0 111.476 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -123.01 137.69 54.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' THR . 19.3 m -102.43 129.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 120.69 0.281 . . . . 0.0 110.412 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -109.94 115.41 29.75 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -81.05 166.75 20.47 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -12.67 58.85 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.455 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.48 -9.5 49.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.252 0.548 . . . . 0.0 109.567 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.56 38.68 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.765 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -73.34 144.32 46.54 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 117.57 0.685 . . . . 0.0 111.46 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -113.64 143.47 44.52 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.646 1.179 . . . . 0.0 111.399 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -126.02 128.45 47.47 Favored 'General case' 0 C--O 1.253 1.256 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -66.96 137.5 56.56 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -6.07 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.8 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -171.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.51 171.08 3.63 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.636 2.89 . . . . 0.0 112.548 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 75' ' ' VAL . 23.7 t -95.02 170.37 9.47 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . . . -64.89 -32.29 73.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.042 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.94 -48.93 72.51 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.31 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.23 -48.87 63.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.373 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' CG2' ' HA ' ' A' ' 72' ' ' ALA . 8.7 m -62.55 -35.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.25 -36.27 83.61 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.687 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.91 71.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.71 0.632 . . . . 0.0 111.025 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.1 mtpp -84.2 -50.22 8.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.997 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.59 -39.87 71.28 Favored 'General case' 0 C--O 1.252 1.218 0 C-N-CA 123.219 0.608 . . . . 0.0 112.621 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.74 -32.62 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -81.05 -29.14 35.1 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 78' ' ' LYS . 58.5 mt -71.73 -57.67 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.13 -23.55 47.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.944 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.1 44.13 88.44 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.51 -51.51 12.79 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.214 0.531 . . . . 0.0 109.598 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.82 136.83 51.99 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.123 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -104.96 -45.17 4.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.1 t60 . . . . . 0 C--N 1.311 -1.073 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.713 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.267 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.311 28.4 m -81.96 91.26 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 123.067 1.413 . . . . 0.0 113.559 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -74.44 -46.19 41.47 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.122 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.91 116.3 32.28 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.56 -63.89 1.25 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.462 0.649 . . . . 0.0 109.72 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 132.92 11.86 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.357 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -102.79 123.17 45.96 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.45 0.643 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.7 125.59 41.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -99.79 111.34 23.67 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.658 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.26 167.3 20.09 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.481 ' OG1' HG12 ' A' ' 36' ' ' ILE . 25.1 m -138.86 158.0 45.01 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -46.32 -17.46 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 127.127 2.171 . . . . 0.0 115.028 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -77.42 -14.99 59.58 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.838 -0.538 . . . . 0.0 111.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 43.0 t -92.05 120.88 33.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.363 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.63 -30.32 68.76 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.355 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.91 -11.66 61.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 38.8 t -55.58 -55.27 33.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 110.483 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.98 -25.81 63.79 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -70.67 -44.62 66.64 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.92 -45.07 95.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.889 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.613 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.8 mmtp -55.77 -49.61 72.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.218 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 m -59.44 -43.99 93.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.999 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.35 98.42 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.34 -46.5 60.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.448 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.3 m -60.38 -37.33 80.42 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.326 0.391 . . . . 0.0 110.854 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.34 83.31 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 120.935 0.398 . . . . 0.0 112.025 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -99.77 8.76 43.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.289 0.566 . . . . 0.0 111.097 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 63.65 35.33 11.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.144 1.378 . . . . 0.0 113.388 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.86 125.88 38.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.778 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.45 123.63 26.82 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -131.23 161.64 31.77 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.425 0.631 . . . . 0.0 111.659 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.59 142.64 47.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.01 141.38 38.31 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.94 143.22 33.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.28 140.48 38.84 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.998 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 22.3 pt -83.59 -27.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.193 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -76.92 -25.29 52.77 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -70.74 -49.25 48.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.946 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -102.17 97.77 8.03 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.739 0.304 . . . . 0.0 110.705 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -56.38 -40.1 74.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.0 0.92 . . . . 0.0 112.047 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 -34.45 68.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.305 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -67.62 -38.97 84.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -64.48 -29.73 70.77 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.639 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.497 ' HA ' HH21 ' A' ' 54' ' ' ARG . 7.3 tp10 -74.75 -48.52 25.22 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -53.21 -56.01 19.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.167 0.987 . . . . 0.0 111.653 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.61 -27.35 42.71 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.972 0 CA-C-O 120.66 0.267 . . . . 0.0 111.094 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.1 -38.79 63.5 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.591 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.0 m -74.27 -34.59 63.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.77 0.319 . . . . 0.0 111.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 46' ' ' VAL . 31.0 m -94.58 13.02 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 0.0 111.541 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 -174.68 3.92 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.129 0.49 . . . . 0.0 110.114 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.53 69.96 3.19 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -61.93 0.79 Allowed Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.573 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.435 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 50.1 t30 -144.49 160.06 41.73 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.497 HH21 ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -62.34 116.79 5.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.635 . . . . 0.0 111.078 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -155.97 -25.27 0.1 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.759 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 m -119.54 144.13 36.13 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.632 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 19.6 Cg_endo -60.07 140.54 93.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.834 2.356 . . . . 0.0 111.405 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -124.16 141.0 52.43 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.5 m -107.5 133.04 53.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.549 0.214 . . . . 0.0 110.694 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.0 112.36 23.95 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.5 m-85 -78.52 166.06 23.02 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.23 -18.05 56.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.496 0.498 . . . . 0.0 112.07 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.76 -11.39 58.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.143 0.496 . . . . 0.0 109.754 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.05 -7.07 56.87 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.208 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -79.61 145.67 32.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.069 0.462 . . . . 0.0 110.879 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -119.09 141.18 49.0 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.0 mt -131.52 143.53 50.45 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -73.91 140.61 45.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -6.75 83.11 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 C-N-CA 126.388 1.875 . . . . 0.0 116.009 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.416 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 19.7 Cg_endo -90.25 160.26 4.67 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.781 2.987 . . . . 0.0 112.563 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 m -82.22 173.7 11.86 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -64.48 -39.01 92.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.085 0.469 . . . . 0.0 111.498 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.44 -30.84 67.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.494 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.67 -42.71 73.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 14.1 m -72.24 -35.38 52.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.732 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.534 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 10.1 mtpm? -58.13 -36.25 72.68 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 123.124 0.265 . . . . 0.0 111.417 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.61 73.97 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.976 0.797 . . . . 0.0 111.963 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' O ' HG13 ' A' ' 82' ' ' ILE . 8.2 mtpm? -84.08 -48.46 9.86 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.09 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 tp -54.98 -40.59 70.22 Favored 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.02 0.825 . . . . 0.0 112.445 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.83 -43.27 95.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 123.508 0.505 . . . . 0.0 110.328 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -75.15 -21.11 59.03 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.593 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 78' ' ' LYS . 63.4 mt -73.57 -36.05 46.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 -39.61 10.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.686 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.02 80.17 0.88 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.1 mt -130.33 -77.02 0.53 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.45 -41.69 85.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -145.94 -56.05 0.29 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 78.9 t60 . . . . . 0 N--CA 1.409 -2.489 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 169.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 CA--C 1.504 -0.8 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.29 106.81 10.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 122.256 1.027 . . . . 0.0 109.074 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -26.13 29.51 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.051 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.13 94.32 3.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.66 54.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.299 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.27 135.9 23.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.305 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.6 m -103.62 124.85 49.58 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.861 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.0 mt -89.03 118.73 34.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.856 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 80.6 m-85 -103.81 110.41 22.5 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.949 174.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.424 HG22 ' SG ' ' A' ' 17' ' ' CYS . 13.2 t -163.63 -177.66 5.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.76 152.39 51.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -54.09 -28.38 38.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.277 1.031 . . . . 0.0 113.084 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -77.63 -15.22 59.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -71.53 118.47 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.27 -43.05 93.77 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.667 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -74.1 -7.57 53.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 t -63.6 -62.48 1.64 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pp -70.56 -21.02 62.75 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.323 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -72.25 -38.73 68.82 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.123 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -84.33 -24.07 29.94 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.0 mmtt -53.9 -42.87 69.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.792 0.437 . . . . 0.0 111.812 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.8 p -67.91 -37.17 81.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.324 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.87 80.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.793 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.38 -42.97 92.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.8 m -63.11 -46.3 87.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.59 -31.92 72.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.272 0.558 . . . . 0.0 111.093 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.97 11.52 24.84 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.571 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 59.2 32.26 21.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.708 0.803 . . . . 0.0 111.446 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.53 130.59 37.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.0 0.429 . . . . 0.0 109.963 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.3 124.4 36.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.01 162.06 36.42 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.864 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' THR . 37.5 t70 -121.39 133.56 55.09 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.54 139.72 49.34 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.17 147.86 27.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -83.49 138.94 33.21 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.714 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 39.0 pt -87.04 -23.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.82 -42.63 69.98 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.126 0.488 . . . . 0.0 109.807 -171.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -77.04 -26.72 54.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -103.74 93.16 4.76 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -55.63 -44.39 77.05 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.563 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -30.93 66.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -71.12 -42.63 68.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -62.92 -36.38 83.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.599 0.562 . . . . 0.0 110.451 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.38 -47.39 79.41 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.05 -58.43 8.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.174 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -64.22 -31.73 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.77 70.33 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.201 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 p -83.02 -26.19 31.45 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.7 m -89.93 -11.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.124 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -73.13 167.19 21.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.053 -176.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.38 4.09 Favored Glycine 0 C--N 1.308 -1.006 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.183 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.56 -90.65 0.41 Allowed Glycine 0 C--N 1.313 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -120.24 172.21 7.95 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -64.27 54.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.56 1.544 . . . . 0.0 112.304 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -88.86 -32.05 17.97 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 122.055 -0.403 . . . . 0.0 111.925 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.37 151.87 63.46 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 12.5 Cg_endo -56.23 123.4 13.73 Favored 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.749 2.966 . . . . 0.0 111.791 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 m -106.51 133.44 51.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.19 124.8 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.072 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -105.88 125.53 51.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.85 179.22 6.03 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.96 -10.74 58.93 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.237 0.615 . . . . 0.0 111.856 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -88.71 -8.64 54.17 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.15 81.35 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.118 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -99.54 151.52 21.06 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p -117.16 150.11 39.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.504 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.8 mt -124.1 125.08 43.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -68.33 147.35 52.26 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -5.32 83.01 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 C-N-CA 127.015 2.126 . . . . 0.0 114.909 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -98.99 157.67 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.781 2.987 . . . . 0.0 112.583 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 75' ' ' VAL . 30.5 p -84.4 166.2 17.55 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.808 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.41 -33.52 72.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.864 0.466 . . . . 0.0 112.079 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.84 -40.05 91.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.093 0.473 . . . . 0.0 110.521 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.22 -43.32 67.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.593 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 71' ' ' SER . 6.1 m -65.97 -35.5 75.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.116 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.34 -35.17 79.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.62 95.61 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.26 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -76.79 -38.62 53.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.126 0.488 . . . . 0.0 110.345 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.56 -36.46 84.28 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.473 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.7 -22.45 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.126 0.489 . . . . 0.0 111.243 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 7.4 mtpm? -80.17 -30.48 38.83 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -83.16 -57.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.5 -45.65 5.74 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.765 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.32 55.64 4.63 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.482 HD22 ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -70.11 -9.8 56.7 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 126.046 1.738 . . . . 0.0 111.736 -178.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.482 ' HG3' HD22 ' A' ' 85' ' ' LEU . 43.7 mt-10 -154.71 169.79 23.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -88.93 -64.9 1.08 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 C--O 1.257 1.472 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 174.858 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 CA--C 1.513 -0.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.12 84.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 t -94.79 -17.69 21.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.78 103.02 3.87 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.76 -56.19 15.16 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.623 0.577 . . . . 0.0 112.222 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD11 HG22 ' A' ' 59' ' ' VAL . 1.7 pt? -147.05 137.75 23.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.616 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -106.67 112.13 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.355 1.062 . . . . 0.0 109.648 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.3 mt -88.92 131.81 35.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 111.997 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' OH ' ' HE2' ' A' ' 60' ' ' LYS . 74.8 m-85 -111.44 104.24 12.66 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 12.6 t -165.27 142.88 5.97 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -102.99 155.99 17.98 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -63.1 -4.85 2.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -77.63 -13.62 59.86 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.558 -0.714 . . . . 0.0 111.168 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.82 144.19 39.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.02 -41.71 39.38 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.652 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.0 -5.67 49.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -50.72 -59.95 3.55 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.019 0.372 . . . . 0.0 111.877 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.36 -26.0 61.75 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.432 0.158 . . . . 0.0 111.121 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -59.69 -47.48 85.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.7 tp -67.21 -44.38 79.71 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.74 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 73.8 mmtt -57.4 -55.56 33.2 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.889 0.376 . . . . 0.0 110.723 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 m -59.65 -40.47 87.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.76 -46.74 89.28 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.893 0.377 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 67.2 mt -69.23 -43.66 73.6 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 m -62.97 -37.36 86.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.248 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.74 85.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.38 7.01 38.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 58.53 46.99 14.07 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.812 0.815 . . . . 0.0 111.64 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 24' ' ' LEU . 81.4 mt -97.96 119.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.794 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.94 115.01 11.73 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.684 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -128.29 156.86 42.36 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.809 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -115.43 142.39 46.77 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.22 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.12 139.02 44.34 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.195 -0.316 . . . . 0.0 110.39 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.08 145.12 33.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 37' ' ' GLU . 30.5 t70 -87.73 142.03 28.14 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.918 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -83.18 -25.7 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.59 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 43.8 tt0 -73.83 -34.41 64.54 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.266 0.555 . . . . 0.0 109.533 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -91.01 -0.19 57.69 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -133.74 99.59 4.51 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -62.5 -43.41 98.87 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.44 72.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.892 0.377 . . . . 0.0 110.749 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -71.71 -42.15 67.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.85 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.74 84.98 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.557 0.694 . . . . 0.0 110.621 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -63.73 -43.58 96.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.012 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.13 -56.74 9.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.777 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.537 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -59.62 -25.66 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.06 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.22 -42.74 96.18 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.641 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.6 m -74.41 -31.31 62.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.065 0.432 . . . . 0.0 111.846 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG2' HG23 ' A' ' 58' ' ' THR . 31.0 m -91.65 8.43 4.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.904 0.859 . . . . 0.0 111.118 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.49 174.32 9.04 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.34 88.4 1.09 Allowed Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.84 -89.78 0.7 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -134.02 173.92 11.04 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 102.24 1.0 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.112 0.958 . . . . 0.0 113.08 -175.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -146.79 -26.86 0.41 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.15 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 m -113.86 151.44 44.75 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.458 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 19.1 Cg_endo -60.9 143.02 99.27 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.31 2.673 . . . . 0.0 111.485 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.434 HG23 ' CG2' ' A' ' 49' ' ' VAL . 19.7 m -132.27 150.55 52.13 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 66' ' ' THR . 8.4 p -128.96 130.94 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' HE2' ' OH ' ' A' ' 9' ' ' TYR . 32.3 mtmt -100.58 136.11 40.97 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.97 176.08 6.73 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.58 63.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.142 0.972 . . . . 0.0 109.034 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -74.97 -18.07 60.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.847 1.659 . . . . 0.0 109.534 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.99 30.09 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.354 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -74.58 152.63 39.25 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 122.309 0.244 . . . . 0.0 110.723 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.1 p -113.53 155.11 25.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.331 0.586 . . . . 0.0 112.3 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -132.71 125.26 29.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -70.63 144.52 51.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -4.87 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.477 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -100.51 -177.79 0.17 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 123.686 2.924 . . . . 0.0 112.393 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -114.6 172.73 6.85 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -43.96 78.07 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 122.772 0.429 . . . . 0.0 111.484 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.7 -52.89 54.15 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 111.681 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -62.3 -39.76 94.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.803 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -78.84 -31.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.391 -0.524 . . . . 0.0 112.249 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -60.25 -32.44 71.16 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.142 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.6 71.65 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.894 0.746 . . . . 0.0 111.286 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.508 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.9 mtpp -84.88 -44.28 13.35 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.592 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.7 tp -54.42 -41.17 69.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.575 0.75 . . . . 0.0 112.594 -176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.08 -33.2 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.58 0.55 . . . . 0.0 111.642 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 88' ' ' HIS . 65.7 mttm -80.33 -42.51 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.297 0.57 . . . . 0.0 109.835 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 78' ' ' LYS . 53.7 mt -61.07 -31.56 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.859 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.23 -3.11 15.46 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.241 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.11 33.14 12.43 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 mt -131.07 171.89 12.73 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 67.88 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.321 1.448 . . . . 0.0 114.728 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.98 94.29 7.1 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 46.1 t60 . . . . . 0 C--N 1.31 -1.118 0 CA-C-O 118.383 -0.818 . . . . 0.0 108.972 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 CA--C 1.506 -0.742 0 CA-C-O 120.611 0.243 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.94 121.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 CA-C-O 122.019 0.914 . . . . 0.0 111.721 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -25.44 62.4 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.591 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.18 110.24 12.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.6 -60.19 2.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.29 143.25 22.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.176 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -102.97 124.77 49.1 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.34 112.33 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 123.601 0.761 . . . . 0.0 110.467 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 88.4 m-85 -98.85 114.27 26.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.34 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 t -163.69 149.52 11.32 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.62 152.03 21.59 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -67.37 -20.96 65.63 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.798 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -83.58 1.99 39.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.04 149.79 33.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -34.99 28.18 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.512 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -81.67 -7.11 59.56 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -54.63 -51.59 64.93 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 -23.28 31.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -64.94 -41.58 95.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.858 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 70' ' ' PRO . 25.0 tp -74.5 -24.21 58.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.617 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 43.2 mmtm -62.67 -36.28 82.38 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.186 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -55.85 -47.72 76.77 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 123.794 0.684 . . . . 0.0 110.128 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.17 77.54 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.976 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 98.3 mt -67.03 -44.8 79.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.359 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.9 m -66.85 -38.29 86.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -23.69 66.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.513 0.673 . . . . 0.0 111.41 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -106.75 4.72 27.96 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.069 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 50.49 44.7 27.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.921 1.288 . . . . 0.0 112.036 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.0 mt -82.72 127.82 39.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.552 -178.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.91 134.19 35.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -147.55 164.19 34.21 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -118.68 139.11 52.06 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.15 134.99 55.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.844 0.354 . . . . 0.0 111.277 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.95 126.39 26.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.77 141.06 33.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.421 HG23 HG11 ' A' ' 46' ' ' VAL . 40.8 pt -84.85 -9.35 11.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.29 -43.7 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 109.864 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -92.27 -28.82 16.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.997 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.26 91.64 6.37 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.203 0.525 . . . . 0.0 110.532 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -76.06 -25.8 55.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.321 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -33.23 73.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.556 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -72.71 -40.06 66.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.568 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.04 84.42 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.7 -53.48 56.88 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -56.92 -57.91 10.44 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.861 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -64.62 -32.37 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.74 75.79 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.374 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -81.24 -22.1 38.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.9 m -108.6 13.16 8.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.709 0.766 . . . . 0.0 110.347 -178.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.65 -173.16 2.8 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.825 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.35 71.05 2.55 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.91 -67.94 2.88 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.873 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -119.74 151.62 38.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.64 114.72 8.12 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.525 0.678 . . . . 0.0 109.52 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -154.83 -29.86 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.441 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.91 142.44 25.24 Favored Pre-proline 0 C--O 1.241 0.643 0 O-C-N 122.078 -0.389 . . . . 0.0 111.543 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 22.5 Cg_endo -62.48 131.9 35.86 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.738 2.292 . . . . 0.0 111.215 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.2 m -117.51 137.79 52.31 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.2 m -105.77 128.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 120.804 0.335 . . . . 0.0 110.746 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -104.95 119.29 38.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.52 174.4 11.47 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.538 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.81 66.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.362 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -75.92 -14.94 60.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.375 . . . . 0.0 110.77 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.01 -21.98 36.43 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.909 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 m -81.81 158.58 24.04 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 117.82 0.81 . . . . 0.0 110.459 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 48.1 p -113.84 163.29 15.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -134.58 121.55 21.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.2 m -62.95 137.21 58.21 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.257 24.9 p-10 -5.46 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.875 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.481 ' O ' HD13 ' A' ' 20' ' ' LEU . 92.7 Cg_endo -97.35 147.79 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.684 3.59 . . . . 0.0 111.936 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -77.37 174.48 10.76 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -55.65 -44.64 77.38 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.546 0.738 . . . . 0.0 111.972 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.68 -41.39 94.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.932 0.396 . . . . 0.0 111.799 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.2 -41.67 81.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.871 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.03 -40.88 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.998 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 61.5 mtpt -57.67 -44.39 85.7 Favored 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 123.381 0.426 . . . . 0.0 110.764 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.79 73.08 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 124.151 0.907 . . . . 0.0 112.642 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -84.35 -47.57 10.58 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.245 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.82 -36.2 76.3 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.278 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 -32.77 56.61 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.094 0.473 . . . . 0.0 111.083 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.35 -34.75 31.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.431 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.8 mt -67.26 -41.11 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.376 0.608 . . . . 0.0 109.761 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.52 -20.19 60.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.463 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.86 35.1 78.76 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.132 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.7 mt -87.38 -6.61 58.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.008 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -127.25 172.3 10.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.7 -69.77 0.42 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.462 0.167 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.509 ' HB ' ' O ' ' A' ' 4' ' ' ALA . 26.7 m -117.26 122.55 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.496 0 CA-C-O 122.625 1.202 . . . . 0.0 112.526 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -90.06 -16.94 28.7 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.27 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . -137.55 141.15 41.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.93 -60.17 1.64 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -156.32 131.15 9.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.165 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -101.72 117.54 35.1 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.254 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 59' ' ' VAL . 97.5 mt -89.05 121.06 38.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.522 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.11 123.62 47.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -163.9 171.76 14.92 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.878 0.736 . . . . 0.0 109.187 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.2 p -108.69 159.17 16.96 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -76.44 -13.55 60.11 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.524 0.202 . . . . 0.0 111.35 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -86.58 -2.2 58.29 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -83.98 132.2 34.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -30.12 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.86 -19.64 62.62 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.7 t -58.6 -61.29 2.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 123.503 0.502 . . . . 0.0 110.435 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 19' ' ' ARG . 3.5 pp -65.47 -29.39 70.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.579 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 18' ' ' LEU . 20.3 tpp180 -61.8 -50.18 73.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.83 -39.95 79.72 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.71 -46.66 81.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -59.43 -46.11 89.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.95 95.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.592 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 mt -74.93 -36.84 62.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.076 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -63.68 -41.47 98.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.57 73.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 0.0 111.596 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -92.92 -1.89 56.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 56.17 52.3 10.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.946 0.879 . . . . 0.0 111.581 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.89 140.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.54 114.45 20.26 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -132.92 152.04 51.96 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.671 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 7' ' ' THR . 6.3 m-20 -114.05 116.51 29.28 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.293 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -113.31 131.16 56.05 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.247 0.546 . . . . 0.0 110.845 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.02 130.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -85.89 141.6 29.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.7 pt -83.94 -9.02 11.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -173.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.27 -26.1 68.63 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.82 -2.37 30.17 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.998 0.428 . . . . 0.0 110.875 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -124.33 88.47 2.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -69.22 -30.48 68.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.981 -171.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.567 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -68.17 -35.94 78.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.603 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.61 97.97 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.375 0.607 . . . . 0.0 110.443 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.08 -46.48 84.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.18 -58.94 5.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.669 0.787 . . . . 0.0 111.28 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 42' ' ' ALA . 4.4 p -61.69 -32.25 53.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.512 ' HA3' ' NH1' ' A' ' 54' ' ' ARG . . . -69.18 -29.06 72.22 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.724 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -78.47 -28.21 46.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.355 0.598 . . . . 0.0 110.889 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.455 ' CG2' HG21 ' A' ' 58' ' ' THR . 24.5 m -101.81 13.67 6.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.759 0.79 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -173.59 3.86 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.244 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.72 78.75 0.42 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.69 -89.63 0.61 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -138.89 -175.24 4.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 2.1 mpp_? -54.58 111.78 0.87 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.498 0.499 . . . . 0.0 112.236 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.47 -33.39 0.08 Allowed 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.596 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -123.75 148.79 57.45 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.695 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -64.52 155.0 68.88 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.356 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.455 HG21 ' CG2' ' A' ' 49' ' ' VAL . 31.5 m -135.91 140.41 44.05 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.3 m -105.73 133.59 49.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 123.237 0.336 . . . . 0.0 110.497 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -112.41 111.68 22.7 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.462 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.4 m-85 -77.65 165.82 23.79 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.654 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.82 -11.99 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.539 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.402 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 2.1 p-10 -84.05 -9.84 58.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.5 -2.01 60.53 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.695 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -91.97 145.39 24.58 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 117.359 0.579 . . . . 0.0 110.677 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -113.38 141.25 47.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.097 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -132.53 133.2 43.45 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.0 m -70.51 139.1 51.54 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -5.48 90.87 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.728 0 C-N-CA 126.661 1.984 . . . . 0.0 115.572 -170.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.406 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.2 Cg_endo -95.18 152.8 1.67 Allowed 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 124.471 3.448 . . . . 0.0 112.915 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.6 t -71.79 163.07 28.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.38 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.46 77.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.43 0.692 . . . . 0.0 111.695 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.66 -26.72 61.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.719 0.295 . . . . 0.0 110.641 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.21 -45.57 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.4 m -64.19 -37.01 78.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.648 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -59.92 -35.57 75.17 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.334 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.09 79.0 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.435 0.46 . . . . 0.0 111.912 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 7.8 mtpm? -84.29 -45.11 13.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.103 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.69 -33.36 72.74 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.418 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.97 -31.96 54.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 CA-C-O 121.289 0.566 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -78.54 -47.34 17.46 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 78' ' ' LYS . 61.7 mt -57.73 -40.09 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.493 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.79 63.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 111.708 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.63 27.82 41.26 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -99.05 -36.67 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.225 -0.487 . . . . 0.0 109.981 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -72.52 113.59 9.72 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.154 0.502 . . . . 0.0 109.964 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -116.43 -60.57 1.84 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 67.9 t60 . . . . . 0 C--N 1.319 -0.731 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.719 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.61 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.93 77.59 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.642 1.21 . . . . 0.0 111.22 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.574 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 7.8 t -85.69 -20.73 28.94 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.139 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.51 148.76 33.58 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.19 -64.03 1.28 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.458 HD22 ' CG2' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -157.11 133.04 9.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.944 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.1 m -105.52 123.72 48.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.915 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.18 130.21 42.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 124.115 0.966 . . . . 0.0 111.147 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -106.6 119.17 38.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -163.84 162.2 23.55 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.11 175.56 5.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.1 t -76.11 -21.63 56.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.491 0.186 . . . . 0.0 111.037 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -77.62 -15.31 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.499 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.42 109.37 8.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.39 -22.8 59.33 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' CD2' HG12 ' A' ' 56' ' ' VAL . 86.7 m-85 -82.55 -7.31 59.65 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.611 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 25.2 p -54.88 -59.46 4.7 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -69.98 -25.93 63.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -59.47 -50.17 74.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.988 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.37 -40.09 85.73 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.399 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.02 -45.75 79.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.613 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -56.09 -40.54 73.79 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.63 77.41 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.099 0.476 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.1 mt -72.87 -42.31 63.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.716 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -64.33 -32.31 73.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.8 -27.79 69.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.627 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.96 3.27 25.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 47.36 58.44 4.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.109 0.964 . . . . 0.0 112.145 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.7 mt -89.62 128.86 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.157 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.7 10.81 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.199 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -116.79 175.12 5.72 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.0 t70 -139.93 139.41 36.16 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.69 141.24 50.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.97 142.61 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.28 140.49 44.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.544 0.688 . . . . 0.0 111.481 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 HG23 HG13 ' A' ' 46' ' ' VAL . 38.4 pt -86.19 -24.85 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.387 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.05 -39.19 66.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.825 0.345 . . . . 0.0 111.855 -169.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -89.29 3.58 51.61 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.56 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -129.75 93.23 3.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -47.11 -55.74 7.84 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.7 74.97 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 123.481 0.488 . . . . 0.0 111.399 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.646 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.96 -47.22 66.16 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.269 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.2 -36.9 84.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.356 0.598 . . . . 0.0 111.25 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.61 -37.17 85.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.11 -60.99 1.93 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.076 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.646 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.8 p -59.16 -36.12 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.52 74.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.6 m -82.94 -30.28 28.47 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.156 0.503 . . . . 0.0 110.837 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.2 m -98.2 13.55 4.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-O 121.414 0.626 . . . . 0.0 111.245 -177.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.07 173.62 12.4 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.932 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.4 63.34 3.36 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.92 -119.29 4.43 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.491 ' O ' HG21 ' A' ' 55' ' ' THR . 4.2 p-10 -93.77 164.27 13.2 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.7 110.03 0.59 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.945 0.898 . . . . 0.0 110.416 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 53' ' ' ASN . 10.2 t -162.33 -26.66 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.275 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 16' ' ' TYR . 10.7 m -113.4 150.41 43.09 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 120.486 0.184 . . . . 0.0 111.241 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.18 150.53 65.8 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.258 1.972 . . . . 0.0 110.454 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.12 136.7 47.31 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 66' ' ' THR . 10.4 p -104.77 127.87 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.017 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -113.59 111.86 22.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 64.1 m-85 -81.83 171.51 14.42 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.434 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.35 -16.83 62.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.274 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.34 -12.32 52.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.187 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.14 -18.22 42.89 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.579 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -80.69 148.95 29.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 117.27 0.535 . . . . 0.0 111.972 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.1 p -115.5 143.53 45.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.841 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.32 129.06 50.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -71.04 141.02 50.93 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -5.75 87.81 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 C-N-CA 126.565 1.946 . . . . 0.0 115.583 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -90.68 -172.48 0.52 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 124.048 3.165 . . . . 0.0 111.378 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.525 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 23.3 m -118.02 173.87 6.53 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.437 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -59.37 -43.67 92.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.92 -37.43 81.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.831 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.525 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 12.8 mp0 -63.15 -45.7 90.65 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.751 0.82 . . . . 0.0 110.877 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 71' ' ' SER . 13.7 m -70.53 -35.14 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.772 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 56.3 mtpt -61.17 -41.71 97.27 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.43 73.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.929 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -84.07 -48.03 10.31 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.27 -42.44 73.54 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.445 1.098 . . . . 0.0 112.82 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.23 -32.89 49.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.69 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -80.82 -19.94 43.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.195 0.521 . . . . 0.0 110.841 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -85.67 -46.06 17.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.59 -26.78 18.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.85 49.46 22.97 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.689 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.76 -70.14 0.56 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.55 81.11 7.19 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -139.04 90.39 2.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.844 -174.61 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 ttp . . . . . 0 CA--C 1.502 -0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -82.27 111.66 19.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.417 0.627 . . . . 0.0 110.323 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -100.89 -19.3 15.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.63 39.19 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.24 -62.21 1.54 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 59' ' ' VAL . 1.5 pt? -151.78 130.0 11.97 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.27 119.31 38.63 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.545 0.528 . . . . 0.0 111.402 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.02 130.63 38.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.9 m-85 -114.88 109.04 17.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.271 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 6.9 t -164.28 -178.75 5.67 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.895 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.482 ' HB ' ' CD1' ' A' ' 13' ' ' TRP . 33.0 m -152.84 154.79 35.84 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 m -48.82 -18.35 0.26 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.482 ' CD1' ' HB ' ' A' ' 11' ' ' THR . 68.2 p-90 -77.37 -18.45 57.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 64.0 m -74.52 141.88 44.82 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.02 -49.95 43.95 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.002 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -72.93 -6.1 42.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 26.6 p -47.53 -62.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -25.88 53.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -175.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -61.58 -43.92 97.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.537 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.62 -40.65 84.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.27 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.9 mmmm -58.62 -50.62 73.15 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -61.28 -46.13 91.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.519 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.37 83.46 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.405 0.44 . . . . 0.0 111.113 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 62.8 mt -71.71 -42.24 67.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.241 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.3 m -64.24 -38.2 90.19 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.249 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.76 -30.52 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 111.622 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -100.11 22.18 11.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.025 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.258 10.9 ptp180 43.82 61.34 2.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 125.477 1.511 . . . . 0.0 114.245 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.401 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 68.8 mt -113.45 119.09 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.971 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 127.96 32.87 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.714 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -139.91 168.72 19.16 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.681 0.753 . . . . 0.0 112.599 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.03 139.98 51.69 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.631 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.44 145.71 51.92 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.52 147.37 25.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.35 140.74 41.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.732 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 25.3 pt -86.79 -29.22 5.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.483 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.94 -55.63 27.54 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.346 0.658 . . . . 0.0 112.39 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -93.97 15.49 16.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.39 0.614 . . . . 0.0 112.158 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -130.68 91.39 3.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.38 -47.35 79.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.26 -22.79 65.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.729 0.3 . . . . 0.0 111.524 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.534 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -86.65 -47.06 9.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -61.86 -43.74 98.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.257 0.551 . . . . 0.0 111.201 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.73 -38.13 89.94 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.174 0.99 . . . . 0.0 110.049 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.75 -60.0 3.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.19 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.534 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -60.44 -35.02 60.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.62 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.64 72.92 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.843 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.0 m -83.83 -32.54 25.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.767 0.317 . . . . 0.0 111.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.2 m -94.72 9.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.038 0.447 . . . . 0.0 111.043 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 175.98 8.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.198 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.32 87.06 1.55 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.12 -72.06 0.72 Allowed Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -144.73 172.62 12.75 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.408 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -61.51 109.22 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.442 0.639 . . . . 0.0 111.115 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -149.37 -34.76 0.18 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.824 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.75 152.03 50.87 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 14.6 Cg_endo -58.33 139.33 90.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.58 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.418 ' OG1' HG23 ' A' ' 46' ' ' VAL . 23.7 m -125.26 147.83 48.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG22 HD13 ' A' ' 6' ' ' LEU . 14.6 p -122.13 128.64 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.797 0 O-C-N 123.491 0.494 . . . . 0.0 110.229 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.63 129.94 55.55 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -94.07 166.2 12.26 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.497 0.189 . . . . 0.0 111.359 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.31 -16.18 59.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.947 0.899 . . . . 0.0 112.898 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.71 -5.17 58.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 109.882 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.94 18.42 47.3 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.23 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -107.06 149.76 27.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.68 0.74 . . . . 0.0 110.541 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 p -114.87 154.65 28.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.995 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -131.26 126.85 36.53 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -68.46 136.04 52.59 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -5.89 91.62 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.409 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 28.9 Cg_endo -100.41 174.05 0.33 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.498 3.465 . . . . 0.0 112.439 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.46 168.2 10.53 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.415 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.48 71.01 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -79.65 -28.31 40.84 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.489 -1.284 . . . . 0.0 111.339 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.61 -40.67 97.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.387 0.613 . . . . 0.0 109.908 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 13.5 m -77.86 -30.95 16.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.969 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' HZ3' ' HB3' ' A' ' 76' ' ' LYS . 9.5 mtpm? -57.41 -40.52 78.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.95 -35.24 66.45 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 123.941 0.776 . . . . 0.0 112.009 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.4 mtpp -84.03 -50.5 7.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.038 0.447 . . . . 0.0 111.115 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.64 -38.25 71.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.829 0.852 . . . . 0.0 112.828 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.27 -32.14 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 120.899 0.38 . . . . 0.0 111.268 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.06 -44.1 18.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.35 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 78' ' ' LYS . 72.2 mt -56.97 -53.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.75 0.656 . . . . 0.0 110.789 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -33.12 73.22 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.396 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.25 27.66 35.98 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.869 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -87.15 122.04 30.42 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 63.3 -169.44 0.19 Allowed 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.036 0.835 . . . . 0.0 110.001 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -129.9 100.28 5.41 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 C--N 1.292 -1.902 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.099 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.238 0.485 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.68 132.89 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.671 0.748 . . . . 0.0 110.426 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -45.05 72.92 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.243 -177.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.532 ' O ' ' HB3' ' A' ' 62' ' ' ALA . . . -119.31 114.01 21.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -64.03 1.28 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.017 0.437 . . . . 0.0 111.478 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -152.5 139.25 18.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -105.96 124.22 49.23 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 91.4 mt -104.62 134.09 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.295 -176.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -114.59 116.3 28.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.589 0.756 . . . . 0.0 109.412 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.457 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 49.5 p -129.88 156.91 43.61 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.8 p -99.47 164.92 11.89 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -78.94 -22.51 45.65 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.393 0.615 . . . . 0.0 110.561 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -101.46 -8.42 21.98 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 42.5 t -84.73 142.13 30.06 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.326 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.36 -19.21 67.07 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.707 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.62 -14.43 58.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.778 -0.836 . . . . 0.0 111.906 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 77.8 m -59.34 -59.16 5.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.336 0.398 . . . . 0.0 111.403 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -74.4 -26.44 60.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -65.61 -42.79 91.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.363 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.44 -39.28 92.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.319 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -59.02 -44.9 91.78 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -58.38 -49.37 77.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.961 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.19 98.32 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.905 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HA ' HD13 ' A' ' 29' ' ' ILE . 50.0 mt -70.49 -42.3 71.55 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.395 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -64.45 -34.33 77.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.612 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.39 73.75 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.21 0.529 . . . . 0.0 110.694 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -96.79 10.65 38.22 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 63.65 20.51 12.27 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.308 1.043 . . . . 0.0 111.917 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 24' ' ' LEU . 73.3 mt -73.95 128.55 36.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.319 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.69 143.42 27.59 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -152.98 172.81 16.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.116 0.484 . . . . 0.0 112.242 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -119.68 119.61 34.2 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -114.35 124.04 50.97 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.264 0.554 . . . . 0.0 110.257 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.04 137.7 48.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.11 141.73 28.27 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 117.88 -1.528 . . . . 0.0 110.729 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 10' ' ' THR . 26.2 pt -84.93 -2.85 7.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.403 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -76.27 -37.58 57.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -87.01 -42.86 12.78 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.062 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -86.67 97.34 10.52 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.435 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -71.95 -28.9 63.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.077 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.41 74.53 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.607 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -69.47 -37.84 77.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.343 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.06 98.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.175 0.59 . . . . 0.0 110.905 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.13 -45.61 92.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -56.73 -60.71 3.16 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.916 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.607 HG11 ' O ' ' A' ' 42' ' ' ALA . 4.3 p -61.21 -34.34 60.14 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.089 -178.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.08 90.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.586 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.8 p -80.11 -11.37 59.77 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -115.23 13.73 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 121.813 0.816 . . . . 0.0 109.525 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -98.88 -171.84 2.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 -174.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 69.4 2.83 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.96 -96.87 1.6 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.2 174.46 5.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.45 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -76.79 111.16 12.01 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.267 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -133.46 -17.49 2.29 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.796 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 152.9 81.03 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.429 ' HB3' HG21 ' A' ' 10' ' ' THR . 36.5 Cg_endo -67.29 157.72 60.39 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.204 1.936 . . . . 0.0 111.924 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -141.74 148.59 39.25 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.1 p -120.47 136.65 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 O-C-N 123.666 0.604 . . . . 0.0 109.899 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -113.15 127.55 56.22 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.418 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 97.0 m-85 -85.77 169.57 13.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . -60.79 -27.66 68.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.574 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.19 -16.68 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.661 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.11 -19.07 27.87 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-O 119.741 -0.477 . . . . 0.0 114.236 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -73.76 153.3 40.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.788 0.794 . . . . 0.0 112.616 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 p -118.26 153.66 33.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.142 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.9 mt -132.75 123.18 25.74 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.6 m -65.41 138.49 58.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -5.03 92.16 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.506 0 C-N-CA 126.873 2.069 . . . . 0.0 115.949 -170.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -98.85 -169.75 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.724 2.95 . . . . 0.0 111.913 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.423 ' O ' HG21 ' A' ' 75' ' ' VAL . 48.2 t -117.94 172.1 7.62 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.84 -50.14 66.87 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.89 -30.2 65.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.81 -43.53 98.07 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.351 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 71' ' ' SER . 15.5 m -80.28 -30.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -60.08 -40.87 91.07 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.41 -36.8 64.34 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.122 0.889 . . . . 0.0 111.707 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -84.11 -48.58 9.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.18 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.58 -41.14 72.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.735 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.35 -34.54 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.217 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 91.6 mttt -82.37 -19.6 38.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.014 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 78' ' ' LYS . 78.2 mt -84.67 -46.21 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.79 66.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.258 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.57 -123.74 2.23 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 41.33 -87.84 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 126.661 1.984 . . . . 0.0 115.994 168.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 37.2 tt0 -99.76 109.55 21.99 Favored 'General case' 0 C--O 1.209 -1.027 0 C-N-CA 122.156 0.182 . . . . 0.0 110.546 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' A' ' 86' ' ' GLU . 63.6 t-80 162.72 -45.31 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.421 -1.895 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.486 -178.349 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 49.6 tpp . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 120.86 0.362 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.0 t 66.04 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.072 1.349 . . . . 0.0 111.659 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.9 t 173.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.04 157.62 17.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.92 -64.43 1.13 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.531 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.5 131.98 6.64 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.918 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -102.68 127.27 49.87 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.942 -174.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.23 123.7 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 124.983 1.313 . . . . 0.0 110.659 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.8 m-85 -103.68 115.79 31.14 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -163.64 169.81 18.03 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.444 HG22 ' CG1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -123.77 161.15 25.8 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -74.36 -8.19 55.43 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.699 0.285 . . . . 0.0 111.76 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -86.95 -5.48 59.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -78.69 144.21 35.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.97 -42.8 84.48 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.218 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -82.11 -5.67 58.59 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.558 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.4 p -50.29 -63.13 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -29.53 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.282 0.563 . . . . 0.0 111.543 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -59.88 -47.19 86.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.775 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.8 tp -70.55 -34.75 72.58 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.574 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 10.2 mmmm -62.14 -47.17 85.74 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -65.41 -43.77 89.54 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.767 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -45.53 84.22 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.872 0.368 . . . . 0.0 111.675 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.85 -37.7 70.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.208 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.2 m -65.99 -43.7 86.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.78 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.23 -34.34 77.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.232 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -91.41 6.69 44.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.89 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 54.95 62.29 2.58 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.422 1.089 . . . . 0.0 112.004 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.56 133.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.537 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.85 125.35 29.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.72 159.67 41.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.323 0.582 . . . . 0.0 110.895 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 7' ' ' THR . 20.6 m-20 -122.43 142.35 50.64 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 13.7 pt-20 -137.14 139.17 41.0 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.558 0.617 . . . . 0.0 111.762 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.23 144.78 28.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.33 143.14 26.7 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 117.915 -1.514 . . . . 0.0 110.738 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.529 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 35.6 pt -84.13 -3.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.407 -1.27 . . . . 0.0 113.184 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.06 -36.94 16.67 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.493 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -77.82 -33.62 52.32 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.023 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -103.52 102.88 12.79 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -65.53 -36.5 83.99 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.486 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.79 -32.05 72.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 111.068 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -75.8 -41.03 54.0 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.043 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -64.85 -44.38 89.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.122 0.569 . . . . 0.0 111.38 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.82 -38.23 81.44 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.751 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.48 -61.44 1.77 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.207 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -57.34 -35.79 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.04 73.12 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.843 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.53 -25.78 30.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.054 0.454 . . . . 0.0 111.177 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.23 13.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.029 0.919 . . . . 0.0 110.438 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 165.83 16.22 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.986 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.62 87.18 1.39 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.67 -97.74 1.86 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.497 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 48.4 t30 -86.21 149.89 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -72.87 102.41 3.42 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.93 -8.08 0.08 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.051 -172.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.7 m -126.71 144.68 50.73 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.4 Cg_endo -58.85 140.08 93.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.28 2.653 . . . . 0.0 111.477 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.7 m -128.66 138.9 52.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.9 m -102.71 133.73 45.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.378 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -110.63 112.72 24.8 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.4 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 87.7 m-85 -78.78 159.79 27.71 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 123.557 0.535 . . . . 0.0 109.732 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.42 -14.02 46.08 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 13.4 p-10 -85.63 -12.45 51.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.18 15.77 24.91 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.1 p -105.45 157.01 17.65 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.195 -0.591 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.5 p -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.58 0.229 . . . . 0.0 110.537 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -128.45 127.51 42.63 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 m -66.78 145.68 55.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -5.11 85.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 C-N-CA 126.295 1.838 . . . . 0.0 115.887 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -95.0 159.64 1.72 Allowed 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 123.761 2.974 . . . . 0.0 112.486 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 p -83.49 168.62 16.31 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.59 77.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.367 0.603 . . . . 0.0 110.634 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.97 -25.45 62.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.665 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.24 -43.88 22.88 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 122.257 -0.277 . . . . 0.0 111.538 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.89 -40.77 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.83 -34.59 71.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.39 77.41 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.652 0.595 . . . . 0.0 112.207 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -85.84 -44.69 12.23 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.061 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -53.35 -40.09 64.65 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.505 1.122 . . . . 0.0 113.15 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.91 -39.17 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.43 0.456 . . . . 0.0 111.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -79.28 -31.4 43.33 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.162 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 78' ' ' LYS . 62.8 mt -74.96 -52.85 17.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.079 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.431 ' HB1' ' SD ' ' A' ' 1' ' ' MET . . . -81.3 -36.97 29.15 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.895 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.27 77.41 1.15 Allowed Glycine 0 CA--C 1.459 -3.45 0 CA-C-O 123.247 1.471 . . . . 0.0 111.335 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -132.96 123.88 26.75 Favored 'General case' 1 N--CA 1.376 -4.126 0 CA-C-N 112.149 -2.025 . . . . 0.0 107.45 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 62.41 81.35 0.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.959 0.885 . . . . 0.0 112.725 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -97.0 149.89 21.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--N 1.295 -1.802 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.705 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.74 124.15 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -72.72 -41.43 65.21 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.355 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.67 77.93 1.09 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.34 -58.89 6.59 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.421 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.19 132.16 18.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.348 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -112.18 122.64 48.31 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 96.4 mt -91.63 123.77 43.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.003 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 29.7 m-85 -105.43 118.88 37.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -163.84 164.31 23.55 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 162.84 14.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -71.01 -19.44 62.52 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -83.82 -1.22 53.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -80.6 123.23 27.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.14 92.98 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.549 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -82.27 -7.15 59.62 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 37.0 t -52.52 -59.41 4.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.187 0.305 . . . . 0.0 111.655 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.13 -23.15 63.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.14 -48.25 65.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.431 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.8 tp -63.88 -40.15 95.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.602 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.597 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.3 mmtp -60.16 -51.79 68.08 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.258 0.552 . . . . 0.0 110.409 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.1 p -67.73 -31.85 72.07 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.428 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.53 84.57 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 120.941 0.4 . . . . 0.0 110.488 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 55.4 mt -72.03 -40.96 68.04 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.439 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -64.76 -29.6 70.58 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.411 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.41 -31.75 58.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.206 0.526 . . . . 0.0 111.006 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -91.53 12.86 19.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 61.18 33.36 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.583 1.153 . . . . 0.0 110.43 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.3 mt -87.26 133.57 29.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.408 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.67 123.57 34.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -145.81 175.44 10.41 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.059 0.457 . . . . 0.0 111.4 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -129.27 142.08 50.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.82 126.77 38.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 133.9 43.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.01 140.69 57.71 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 40.5 pt -84.35 -18.8 9.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.99 -45.37 74.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.572 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -72.2 -36.97 69.35 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.613 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -91.05 93.4 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.024 0.44 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -55.25 -46.02 76.06 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.969 0.907 . . . . 0.0 111.802 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.19 70.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.41 81.2 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.24 -41.59 96.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.173 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.78 -43.01 90.06 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.47 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.95 -52.79 63.54 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.566 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 14.3 m -68.35 -21.97 26.9 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.52 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.27 68.35 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.058 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.89 -23.5 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.026 0.441 . . . . 0.0 110.795 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 46' ' ' VAL . 32.1 m -114.74 13.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.706 0.765 . . . . 0.0 110.606 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -88.87 -171.61 3.37 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.134 -172.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 65.87 3.18 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.87 -73.07 1.6 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -110.47 161.73 15.39 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.16 100.67 2.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -149.67 -17.89 0.27 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.286 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -116.91 145.62 35.97 Favored Pre-proline 0 C--O 1.248 1.013 0 O-C-N 121.907 -0.496 . . . . 0.0 111.82 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.53 127.42 26.13 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.581 2.854 . . . . 0.0 111.342 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -113.71 135.31 54.07 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.26 125.29 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.771 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.07 111.85 23.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -82.16 171.03 14.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.347 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -15.3 63.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.939 0.875 . . . . 0.0 109.104 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.47 -17.98 61.72 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.709 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 -22.67 21.35 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.508 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -73.42 151.94 40.97 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 p -119.53 143.4 47.6 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.8 mt -125.32 132.97 52.77 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -72.32 139.53 48.02 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -5.49 88.39 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -99.23 153.38 0.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 123.998 3.132 . . . . 0.0 111.145 173.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -86.34 172.88 10.1 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.718 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.65 55.59 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.774 0.829 . . . . 0.0 113.065 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 19.0 m-20 -69.92 -19.74 63.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -82.49 -39.35 22.59 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.36 -31.03 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 51.0 mtpt -54.5 -40.23 68.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.94 0.496 . . . . 0.0 110.832 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.73 71.38 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 124.238 0.961 . . . . 0.0 112.0 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.5 mtpp -84.15 -47.24 11.07 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.953 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.8 -39.89 78.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.797 -174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.95 -31.2 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.341 0.591 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -81.09 -43.04 20.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 78' ' ' LYS . 76.1 mt -59.3 -34.8 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.67 -16.33 64.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.91 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.15 3.26 70.07 Favored Glycine 0 CA--C 1.505 -0.592 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.27 161.43 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 58.5 22.7 9.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.545 0.528 . . . . 0.0 111.685 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -128.46 98.34 5.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.3 m80 . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.45 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 CA--C 1.5 -0.98 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.51 82.97 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.47 0.652 . . . . 0.0 110.471 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -94.42 -21.57 18.85 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.08 143.45 30.43 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 -53.18 4.23 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.877 0.846 . . . . 0.0 108.788 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.07 136.83 17.07 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.727 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.8 m -102.26 110.07 21.93 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 89.9 mt -88.49 130.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.817 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.83 105.44 13.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.334 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 11.6 t -164.66 -171.12 2.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -149.62 164.59 34.73 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -56.01 -20.67 17.58 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.664 1.185 . . . . 0.0 113.812 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -82.09 -2.07 50.69 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -95.92 129.32 43.21 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.68 -31.94 81.52 Favored Glycine 0 N--CA 1.46 0.243 0 CA-C-O 121.493 0.496 . . . . 0.0 112.1 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -80.96 -7.94 59.64 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 31.6 t -64.57 -61.74 2.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.41 -29.2 68.63 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.723 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -62.97 -39.12 93.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.5 tp -75.89 -45.96 32.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.214 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -53.7 -49.27 68.41 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.933 0.396 . . . . 0.0 110.884 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -66.87 -37.25 84.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.103 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.28 91.33 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 120.951 0.405 . . . . 0.0 110.734 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.4 -42.35 71.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -62.71 -40.74 98.1 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.426 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.89 66.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 110.942 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -91.04 4.19 52.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.663 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 61.23 29.64 18.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 111.584 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.95 131.52 33.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.97 35.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.11 164.34 30.04 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.974 0.416 . . . . 0.0 111.799 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.82 122.52 34.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.225 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.31 129.61 56.66 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.958 0.409 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.1 138.7 53.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.43 141.33 28.85 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.004 -1.478 . . . . 0.0 111.092 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG22 HG11 ' A' ' 46' ' ' VAL . 29.2 pt -85.1 5.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.8 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.88 -45.29 12.4 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -85.27 -34.66 21.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.759 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.91 92.95 7.15 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.722 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -72.25 -28.29 63.05 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.14 76.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -71.6 -39.52 70.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.332 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.16 90.86 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 110.831 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.03 -48.67 77.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.692 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.87 -56.83 16.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.438 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -64.15 -33.29 61.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.6 73.82 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.935 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -76.18 -45.63 32.39 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.047 0.451 . . . . 0.0 110.164 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.96 3.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.458 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.78 -172.37 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.187 0.518 . . . . 0.0 109.948 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.07 64.23 2.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.14 -73.81 0.22 Allowed Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 39.9 t-20 -135.89 169.65 17.24 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -70.94 107.01 3.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.349 0.977 . . . . 0.0 110.799 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.1 t -138.14 -23.24 1.02 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.004 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.38 154.6 79.18 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 39.0 Cg_endo -67.84 145.56 69.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.316 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.8 m -128.87 143.65 50.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.603 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.4 m -111.17 134.25 54.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 123.164 0.29 . . . . 0.0 110.417 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -111.76 118.88 36.82 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.548 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 93.2 m-85 -80.09 178.59 8.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.96 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.71 58.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.548 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 33.7 p-10 -88.3 -18.48 28.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.784 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.37 -1.63 53.81 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.99 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -84.48 144.65 28.58 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.96 140.94 48.87 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.754 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.79 140.75 50.31 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.7 m -77.73 147.45 35.38 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -5.53 83.27 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.833 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -98.51 139.53 0.41 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 123.57 2.847 . . . . 0.0 112.269 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -72.11 174.53 7.01 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.648 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.01 -47.03 78.55 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 123.829 0.851 . . . . 0.0 113.176 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 15.7 m-20 -76.29 -19.76 57.96 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.383 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.28 -44.17 65.74 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 -34.99 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.812 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 55.6 mtpt -56.68 -36.53 69.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.199 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.61 73.98 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.903 0.752 . . . . 0.0 111.628 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -84.05 -40.82 17.88 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.613 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 tp -60.27 -38.27 83.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.941 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.8 -32.94 57.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.079 0 CA-C-O 121.499 0.666 . . . . 0.0 110.753 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.75 -31.24 32.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.41 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.08 -36.49 68.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.322 0.582 . . . . 0.0 109.86 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.4 62.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.177 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.47 18.77 79.51 Favored Glycine 0 CA--C 1.5 -0.897 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.626 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.93 -40.92 27.13 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.064 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -89.51 -48.01 7.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.675 0.75 . . . . 0.0 109.133 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -168.82 168.88 10.24 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.0 m80 . . . . . 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.234 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.836 0.35 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.69 113.28 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.279 1.038 . . . . 0.0 111.611 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 m -102.08 -42.87 5.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.705 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.49 129.95 46.8 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.9 -54.75 41.29 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.683 0.614 . . . . 0.0 111.519 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.15 137.87 19.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -103.45 119.39 38.8 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 HG12 HG13 ' A' ' 59' ' ' VAL . 92.2 mt -88.76 122.48 40.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -102.61 121.9 43.33 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -163.51 171.41 15.9 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 149.13 27.86 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.1 t -67.35 -20.95 65.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.471 0.177 . . . . 0.0 110.594 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.86 5.25 41.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.4 t -85.85 132.37 34.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.97 -32.91 58.2 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 56' ' ' VAL . 50.5 m-85 -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.646 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 51.5 t -57.11 -56.43 21.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 123.585 0.553 . . . . 0.0 110.307 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.65 -21.69 61.78 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 36.7 mmt180 -65.28 -51.1 62.97 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.09 -40.35 96.05 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.731 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.8 mmtp -60.31 -41.13 92.83 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.8 m -59.96 -45.28 93.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.052 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.35 -51.25 66.7 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.671 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.65 -44.49 86.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.9 m -64.02 -34.28 77.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.748 0.309 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.39 -25.18 67.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.141 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.83 9.26 36.99 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 122.082 -0.386 . . . . 0.0 110.74 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 54.92 41.18 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.828 0.851 . . . . 0.0 111.298 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.4 mt -84.38 138.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.15 119.31 24.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.33 168.14 20.22 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.872 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.08 142.26 47.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.15 137.78 46.38 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.442 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.94 142.4 36.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -89.25 141.7 28.29 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.508 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.454 HG23 HG11 ' A' ' 46' ' ' VAL . 43.2 pt -84.21 -7.53 10.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.664 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -71.92 -31.69 66.62 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 121.729 0.776 . . . . 0.0 108.919 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -90.16 -15.52 31.35 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.231 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -125.45 95.53 4.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.673 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.08 -34.89 79.1 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.044 0.215 . . . . 0.0 111.409 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.93 98.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.037 0.446 . . . . 0.0 110.023 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -68.1 -37.93 81.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.777 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.85 98.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.744 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.15 -39.23 94.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.03 -59.29 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.453 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.537 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.39 -31.38 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.331 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.74 -37.4 94.65 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.617 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -82.27 -13.71 56.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.75 13.34 8.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.182 0.992 . . . . 0.0 109.458 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -172.11 3.12 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.32 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.79 60.71 0.57 Allowed Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.187 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.89 -56.74 0.49 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.73 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -144.77 167.41 22.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HD2' ' H ' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -71.29 103.21 2.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.89 0.768 . . . . 0.0 110.005 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 -32.54 0.36 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.755 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 16' ' ' TYR . 9.1 m -115.55 149.3 42.73 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.57 147.03 93.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.906 2.404 . . . . 0.0 111.223 178.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.2 m -134.65 140.05 45.74 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 66' ' ' THR . 34.1 m -105.93 132.18 53.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.03 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.15 115.66 30.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.98 162.19 22.75 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.319 0.387 . . . . 0.0 110.579 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.98 56.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.567 0.699 . . . . 0.0 109.7 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.32 -12.63 59.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.595 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.1 -22.93 31.99 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 171.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -105.48 174.36 5.91 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.448 1.124 . . . . 0.0 111.11 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 p -113.62 160.23 18.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.962 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -134.15 125.97 29.02 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -67.82 141.78 56.37 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -5.13 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.519 3.014 0 C-N-CA 126.449 1.9 . . . . 0.0 115.313 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.6 Cg_endo -96.54 138.48 0.62 Allowed 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 124.271 3.314 . . . . 0.0 111.895 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -72.71 173.2 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.897 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.93 86.98 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 5.4 t70 -81.07 -19.91 42.69 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.968 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.24 -43.41 70.62 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.679 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 7.6 m -68.92 -40.6 81.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.939 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 48.4 mtpt -53.11 -39.33 63.35 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.484 0.49 . . . . 0.0 111.649 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.5 84.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.545 0.528 . . . . 0.0 111.869 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -85.96 -35.94 20.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.626 0.727 . . . . 0.0 110.573 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.1 tp -66.74 -35.31 79.8 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.394 1.478 . . . . 0.0 112.517 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.18 -31.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.929 0.492 . . . . 0.0 111.772 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' HZ2' ' HB2' ' A' ' 81' ' ' LYS . 8.5 mtmp? -70.4 -26.39 63.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.353 0.597 . . . . 0.0 110.276 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -83.93 -51.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.063 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.66 76.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.927 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 88' ' ' HIS . . . 81.09 65.36 1.7 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.158 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.3 mt -118.07 -71.56 0.73 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.135 0.493 . . . . 0.0 110.074 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.38 131.71 34.73 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.7 m80 72.75 -51.39 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.178 1.391 . . . . 0.0 113.905 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.547 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 3.4 p80 . . . . . 0 C--N 1.294 -1.843 0 C-N-CA 122.608 0.363 . . . . 0.0 111.767 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.25 144.83 36.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 t -115.67 -0.2 13.05 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.423 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.47 148.96 52.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.82 -64.19 1.07 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.17 146.69 12.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.812 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 28.0 m -118.17 132.31 56.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.512 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.6 mt -92.71 128.7 44.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 124.061 0.944 . . . . 0.0 111.503 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.457 ' CD1' ' HB1' ' A' ' 42' ' ' ALA . 69.1 m-85 -110.09 119.09 38.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 173.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.09 -172.02 2.64 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.2 p -121.64 164.27 17.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.6 m -78.71 -7.85 58.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -102.8 2.48 35.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.175 0.512 . . . . 0.0 111.32 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 45.6 t -82.94 118.56 23.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.36 69.94 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.818 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.16 -10.48 59.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.092 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.595 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 23.0 t -61.09 -62.55 1.77 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -29.21 69.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.494 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.72 -44.19 96.87 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.364 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.65 -37.87 67.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.6 mmtp -56.93 -43.13 81.17 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 m -57.4 -53.33 59.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.962 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.24 82.94 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.097 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -70.27 -37.24 74.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.559 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -70.98 -39.09 72.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.84 64.17 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.296 0.57 . . . . 0.0 111.259 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.92 14.52 27.9 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 44.55 59.8 3.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.597 1.159 . . . . 0.0 113.054 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.53 135.15 50.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.45 131.99 34.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.61 157.29 42.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 7' ' ' THR . 33.9 t70 -120.7 142.32 49.61 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -127.25 138.13 53.02 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.054 0.454 . . . . 0.0 110.528 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.8 141.23 37.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.46 143.83 26.08 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.326 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 48.6 pt -82.99 -0.36 4.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.939 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.7 -38.18 16.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -76.51 -35.96 58.02 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.463 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -105.35 99.99 9.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.783 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -68.82 -32.93 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.548 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -66.13 -41.77 90.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.54 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.66 75.78 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.323 0.582 . . . . 0.0 110.987 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -70.86 -44.52 66.22 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.127 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.07 -56.62 15.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.917 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 42' ' ' ALA . 8.6 p -65.2 -27.0 41.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.36 -20.86 77.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.538 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -84.07 -24.41 30.4 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 122.616 0.366 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.12 13.12 7.98 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.07 167.58 11.69 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.315 -175.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.7 80.28 1.59 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.19 -82.92 0.34 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 32.7 t-20 -144.65 172.68 12.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.525 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -63.37 121.32 13.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.343 0.974 . . . . 0.0 111.833 -175.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.7 t -166.73 -25.62 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.43 178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.99 148.38 41.26 Favored Pre-proline 0 N--CA 1.445 -0.7 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 27.2 Cg_endo -62.22 138.02 69.53 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.894 2.396 . . . . 0.0 111.583 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.5 m -129.22 144.29 51.16 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.8 m -109.82 129.61 64.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.855 0.359 . . . . 0.0 111.14 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -104.58 118.63 37.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -83.58 171.17 13.59 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.499 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.85 14.84 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.15 -10.46 49.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.154 0.502 . . . . 0.0 109.881 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.07 -15.15 58.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.878 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 m -94.4 166.61 11.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.476 0.638 . . . . 0.0 111.262 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -120.0 157.89 27.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.4 mt -128.19 122.31 31.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 167.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.4 m -61.73 141.33 57.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -5.18 89.67 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 127.513 2.325 . . . . 0.0 115.458 -171.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -96.24 154.8 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 124.265 3.31 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.2 t -84.96 175.32 9.14 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.31 73.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.08 -36.96 75.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.16 0.505 . . . . 0.0 110.095 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.72 -47.38 72.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -64.7 -41.0 90.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.842 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.8 -35.17 79.72 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.95 88.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.886 0.741 . . . . 0.0 111.679 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -85.35 -42.49 14.52 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.86 -37.76 77.23 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 112.302 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -31.39 45.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.438 0.637 . . . . 0.0 110.701 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -81.07 -31.04 34.59 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.045 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.51 -44.62 76.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.34 -27.71 66.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.513 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.41 50.85 Favored Glycine 0 CA--C 1.495 -1.193 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.083 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 mt -96.96 14.7 24.57 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -89.6 4.18 50.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.803 0.811 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -108.97 147.32 32.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 C--N 1.304 -1.37 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.405 179.091 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.07 140.22 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 t -84.81 -31.69 23.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.271 0.557 . . . . 0.0 109.565 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.04 111.3 17.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -75.24 -51.99 11.97 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.335 0.588 . . . . 0.0 110.314 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -149.02 128.47 13.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.839 178.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.3 m -104.9 119.1 38.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.461 HD12 ' CD1' ' A' ' 24' ' ' LEU . 80.0 mt -88.99 124.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.424 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.457 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 28.0 m-85 -103.01 113.25 26.56 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.06 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -155.34 160.34 40.65 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -93.67 151.7 19.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.827 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -69.79 -22.11 63.35 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.936 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -88.07 -1.18 57.84 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -75.28 145.84 41.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 -33.17 25.93 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.89 -8.3 57.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.0 p -57.04 -57.05 14.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.53 -21.73 60.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.586 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -67.9 -46.85 70.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.36 -34.49 78.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.3 mmtp -62.43 -45.53 92.68 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 m -60.46 -41.66 94.6 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.94 75.43 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.492 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.461 ' CD1' HD12 ' A' ' 8' ' ' ILE . 57.6 mt -70.38 -45.25 66.4 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -63.38 -35.86 81.81 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 120.708 0.289 . . . . 0.0 111.632 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -10.04 59.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -110.78 14.84 22.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.777 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 63.96 27.41 14.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 113.154 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 24' ' ' LEU . 64.3 mt -90.21 131.52 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.854 0.359 . . . . 0.0 111.175 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.86 39.1 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -148.05 174.92 11.45 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.53 137.28 51.67 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -125.94 132.57 52.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.722 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 p -139.14 151.86 23.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.05 141.38 28.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.991 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 30.9 pt -83.68 -31.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -79.97 -15.05 58.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.092 0.949 . . . . 0.0 109.006 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -91.73 -1.27 57.47 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.528 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -135.98 104.92 5.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -50.7 -51.83 45.93 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.755 0.822 . . . . 0.0 112.426 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.94 79.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.341 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.78 -43.42 75.74 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.85 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -60.89 -43.71 98.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.448 0.699 . . . . 0.0 112.129 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -22.49 62.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 112.084 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -76.97 -61.54 1.95 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.608 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.6 p -62.22 -37.04 77.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.469 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.75 90.72 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.461 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -77.74 -29.84 51.32 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.758 0.314 . . . . 0.0 111.394 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.44 11.5 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 0.0 110.855 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.18 -172.74 3.93 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.311 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.56 85.33 0.39 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.6 -116.39 4.87 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -95.32 -175.84 3.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 98.82 7.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.647 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 t -139.27 -27.67 0.8 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.641 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.43 138.56 20.24 Favored Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.29 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.47 122.31 11.29 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.177 2.585 . . . . 0.0 111.258 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -112.0 132.42 54.8 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.9 p -103.5 121.59 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.249 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -100.41 118.49 36.75 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -86.34 165.88 16.05 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.658 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.98 51.58 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -85.37 -3.45 58.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.084 -0.385 . . . . 0.0 110.67 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.18 18.38 59.32 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.721 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 t -106.76 143.14 35.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.91 141.39 48.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.483 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.52 132.35 52.63 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -67.32 136.73 55.29 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -5.98 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.564 0 C-N-CA 126.828 2.051 . . . . 0.0 116.186 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 31.5 Cg_endo -97.52 169.34 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.678 3.586 . . . . 0.0 113.495 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -83.9 161.43 20.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -62.73 -40.07 96.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.759 0.424 . . . . 0.0 111.214 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.57 -43.22 93.68 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.012 0.434 . . . . 0.0 110.611 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -63.15 -48.99 76.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.901 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.456 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 17.5 m -68.45 -33.49 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 54.7 mtpt -62.87 -34.92 78.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.67 0.213 . . . . 0.0 110.614 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.68 67.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.263 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -84.17 -46.7 11.62 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.1 tp -55.69 -39.71 71.37 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.35 1.46 . . . . 0.0 112.936 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.49 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 8.0 p -60.27 -35.27 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.66 -22.38 46.88 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.81 0.814 . . . . 0.0 110.514 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.3 mt -84.99 -53.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.607 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.96 -32.49 15.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.966 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.05 40.73 61.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.49 ' CD2' ' HA ' ' A' ' 80' ' ' VAL . 2.3 pt? -65.52 -37.16 85.96 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 109.858 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.35 126.5 32.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -81.3 -23.05 38.13 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.76 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.451 1.095 . . . . 0.0 111.351 174.177 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mmm . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.41 129.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.105 0.478 . . . . 0.0 111.241 -175.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -90.5 -23.99 20.78 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.48 88.58 3.29 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.86 -59.08 5.94 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.955 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.05 134.91 11.89 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.047 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -102.15 129.16 48.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.947 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.9 mt -93.48 120.44 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.18 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 60.6 m-85 -102.54 115.77 31.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -158.26 175.97 13.07 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.86 155.93 43.36 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -70.19 -15.86 62.99 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -85.46 -4.82 59.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.6 m -77.07 133.54 39.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.8 -38.9 35.28 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.979 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -75.78 -7.53 54.65 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 52.5 t -57.26 -61.74 2.26 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.456 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.4 -23.78 64.69 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -67.65 -43.08 81.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.648 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.96 -35.63 66.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -55.95 -48.41 75.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -66.28 -34.41 77.94 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.736 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.65 87.2 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.252 0.549 . . . . 0.0 110.4 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 mt -73.63 -41.96 62.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.0 m -65.31 -35.16 80.15 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.54 87.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.837 0.827 . . . . 0.0 109.974 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.46 3.03 48.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.8 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 58.7 31.54 21.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.792 0.837 . . . . 0.0 112.065 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.3 mt -75.14 137.24 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.32 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.49 119.74 32.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -134.27 163.74 28.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -128.87 135.25 48.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.61 141.19 46.67 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.606 0.241 . . . . 0.0 111.319 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.74 138.18 39.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 170.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -77.97 143.39 37.62 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.777 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 42.8 pt -83.32 -9.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.092 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.94 -32.13 27.33 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.76 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -88.04 -10.83 49.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.881 0.372 . . . . 0.0 110.761 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.73 98.06 6.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.69 -49.28 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.43 74.14 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.556 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -69.95 -42.96 72.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.388 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 36' ' ' ILE . . . -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 110.207 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.48 -50.7 72.92 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.519 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -58.29 -56.24 24.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.406 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.556 HG11 ' O ' ' A' ' 42' ' ' ALA . 7.1 p -64.39 -35.32 73.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.722 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.21 -34.91 89.53 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.558 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -66.75 -44.5 81.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.003 0.521 . . . . 0.0 109.91 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.2 m -92.58 13.11 2.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 111.868 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -172.88 3.21 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.27 2.72 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.0 -44.72 2.85 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-O 121.258 0.366 . . . . 0.0 113.044 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -119.79 142.58 48.46 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.4 94.22 4.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.587 176.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -139.68 -17.26 0.99 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.965 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -124.1 144.85 46.48 Favored Pre-proline 0 C--O 1.244 0.779 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 13.2 Cg_endo -56.63 131.61 46.69 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.682 2.922 . . . . 0.0 111.542 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.4 m -124.18 138.46 54.41 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.0 m -104.78 127.44 59.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 123.377 0.423 . . . . 0.0 110.978 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -106.71 113.89 27.66 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.1 163.23 21.01 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.954 0.407 . . . . 0.0 110.843 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.54 -17.32 59.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.014 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.82 -6.4 59.42 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.35 39.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.103 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.5 p -111.21 154.06 24.94 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.803 0.801 . . . . 0.0 111.199 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -121.21 142.03 50.3 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.948 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.29 124.99 40.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.6 m -67.36 145.76 54.76 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -4.64 85.81 0.03 OUTLIER Pre-proline 0 N--CA 1.522 3.139 0 C-N-CA 126.56 1.944 . . . . 0.0 114.793 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -97.83 161.09 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.522 3.481 . . . . 0.0 113.455 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -80.57 159.33 25.49 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.43 66.17 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.31 -43.93 98.05 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.576 0.751 . . . . 0.0 110.737 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.78 -44.9 72.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.532 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.6 m -68.22 -35.94 73.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.618 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -61.62 -42.17 98.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.537 0.335 . . . . 0.0 110.818 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.09 67.56 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.827 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -84.3 -51.85 6.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.821 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.85 -36.77 65.42 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.947 0.899 . . . . 0.0 113.272 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.09 -34.54 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.029 0.442 . . . . 0.0 111.833 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -81.38 -48.63 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.35 -45.14 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.546 1.138 . . . . 0.0 112.76 -175.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.45 -3.42 33.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.38 54.77 8.39 Favored Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.4 mt -124.36 -6.56 7.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.995 0.426 . . . . 0.0 110.71 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.7 -50.0 5.12 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 62.69 77.43 0.33 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.746 1.218 . . . . 0.0 111.39 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.62 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.233 0.224 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.36 79.42 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.292 1.044 . . . . 0.0 113.1 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -96.95 -30.89 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.34 107.23 9.59 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.43 85.78 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.064 0.853 . . . . 0.0 109.906 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.59 131.65 14.35 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.901 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -102.5 120.48 40.6 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.43 119.57 35.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.791 -176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -104.89 114.82 29.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.589 174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -163.85 -174.44 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -118.02 166.99 11.87 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 123.844 0.858 . . . . 0.0 109.253 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 m -78.84 -17.57 55.44 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.939 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -93.05 -1.93 56.1 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.575 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.3 t -81.34 131.2 35.28 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.838 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.435 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.2 -46.26 51.29 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -63.88 -15.71 59.63 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.6 t -59.14 -63.71 1.2 Allowed 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.347 0.404 . . . . 0.0 110.536 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.06 -24.62 61.55 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.823 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 29.1 mmm180 -65.8 -48.25 72.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.335 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.07 -32.14 68.73 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.07 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.5 mmmm -57.72 -43.41 85.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 m -64.1 -49.78 70.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.35 87.17 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.238 0.615 . . . . 0.0 112.492 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.78 -41.88 82.52 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.1 m -62.32 -42.12 99.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.451 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.03 66.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.781 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -103.58 9.35 37.48 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.884 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 3.6 mmp_? 62.32 43.34 8.34 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.608 0.718 . . . . 0.0 111.567 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.44 132.52 48.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.3 34.87 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -136.75 163.77 29.83 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.14 0.495 . . . . 0.0 112.198 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -121.49 142.48 50.01 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.449 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 11.9 pt-20 -132.31 139.89 48.36 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 117.918 0.326 . . . . 0.0 110.77 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.32 147.3 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.15 141.31 34.36 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.023 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 41.6 pt -83.76 -32.23 8.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.29 -14.88 60.53 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.147 -0.346 . . . . 0.0 111.648 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.53 -25.84 33.02 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.3 94.34 4.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.989 -0.445 . . . . 0.0 109.837 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.01 -45.34 64.53 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.86 92.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.631 0.253 . . . . 0.0 110.994 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -68.93 -41.44 78.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 36' ' ' ILE . . . -65.82 -35.39 80.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 9.4 tp10 -70.41 -38.73 74.68 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.16 -58.46 7.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.282 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 HG11 ' O ' ' A' ' 42' ' ' ALA . 6.2 p -61.79 -35.35 67.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.1 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.77 72.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.551 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 m -83.66 -34.15 25.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.757 0.313 . . . . 0.0 111.523 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.4 m -94.5 10.62 4.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.776 0.798 . . . . 0.0 110.616 -178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -175.36 5.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.451 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.72 66.82 3.68 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.56 -66.91 0.26 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 65.3 t30 -142.12 162.06 36.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -57.6 114.33 2.2 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.887 -178.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.2 t -161.22 -30.63 0.05 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.626 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.77 152.04 44.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.575 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 36.7 Cg_endo -64.59 139.9 66.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.584 2.19 . . . . 0.0 112.119 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -126.57 136.57 52.72 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' THR . 30.7 m -105.02 129.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.133 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -103.97 119.43 38.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.4 172.25 13.9 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 120.79 0.329 . . . . 0.0 111.079 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.6 68.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.901 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -78.09 -17.96 56.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.941 0.401 . . . . 0.0 110.27 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.52 -19.54 28.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.579 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -71.59 160.51 32.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.322 0.561 . . . . 0.0 111.342 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -127.31 141.9 51.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.444 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.18 120.4 33.08 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -64.64 144.27 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -5.36 84.83 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -92.53 -170.58 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 123.612 2.875 . . . . 0.0 111.389 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.486 ' O ' HG21 ' A' ' 75' ' ' VAL . 15.3 p -117.55 166.64 12.13 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.97 75.4 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.36 0.412 . . . . 0.0 111.776 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -69.66 -35.96 75.61 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.483 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -68.49 -45.03 73.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 71' ' ' SER . 10.8 m -67.63 -37.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.37 -31.48 71.37 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.81 80.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.553 0.533 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -84.03 -41.88 16.75 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.7 -39.0 89.91 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.528 1.131 . . . . 0.0 112.695 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.49 -35.63 55.39 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-O 120.977 0.417 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.65 -19.73 58.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.206 0.527 . . . . 0.0 111.264 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -80.86 -49.12 18.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.44 66.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.628 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.84 -99.83 2.29 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt 58.2 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.047 1.339 . . . . 0.0 112.298 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -88.32 -7.93 55.93 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.16 0.984 . . . . 0.0 110.597 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -136.35 159.44 41.76 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 tpp . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.421 0.153 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -83.78 132.56 31.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 O-C-N 121.894 -0.504 . . . . 0.0 111.178 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.8 t -103.87 -11.92 17.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.548 0.69 . . . . 0.0 109.905 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.63 126.05 14.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.4 -58.63 3.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 123.338 0.399 . . . . 0.0 111.248 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.76 144.27 13.39 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 m -110.05 124.83 52.17 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.948 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.405 HG12 HG13 ' A' ' 59' ' ' VAL . 86.8 mt -89.81 128.4 41.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 124.13 0.972 . . . . 0.0 110.512 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -111.16 127.24 55.52 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -163.13 170.72 17.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 162.93 21.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -59.65 -30.18 68.56 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -87.19 0.13 55.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.87 112.93 16.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.27 70.45 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-N 116.371 -0.377 . . . . 0.0 114.004 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -82.83 -6.73 59.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.3 p -54.09 -60.12 3.75 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.76 -33.76 76.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.482 0.313 . . . . 0.0 111.743 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -59.79 -47.83 84.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.693 0.759 . . . . 0.0 109.794 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 tp -64.47 -38.7 91.93 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.82 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.7 mmtp -61.07 -46.73 89.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.141 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -59.54 -47.04 87.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.36 96.68 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.37 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.61 -35.27 62.95 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.316 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -66.47 -38.62 87.72 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 123.309 0.38 . . . . 0.0 110.278 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.68 97.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 111.401 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -86.73 -5.75 59.03 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 64.38 61.73 0.86 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.055 1.342 . . . . 0.0 113.253 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.58 138.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.28 108.23 19.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -120.77 156.68 31.34 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.18 142.16 40.36 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.12 132.36 38.0 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.429 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.4 131.72 40.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.75 140.03 37.08 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.954 0.883 . . . . 0.0 109.442 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 HG21 HG11 ' A' ' 46' ' ' VAL . 37.5 pt -84.25 -15.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.359 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.93 -34.18 77.21 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.307 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -78.29 -50.18 12.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -91.44 104.87 17.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -56.53 -44.07 80.45 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 125.626 1.571 . . . . 0.0 111.238 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.43 89.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 46' ' ' VAL . . . -70.92 -38.92 72.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.33 91.19 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.698 0.624 . . . . 0.0 110.696 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.44 -51.44 68.69 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.098 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -56.09 -60.43 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.016 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 42' ' ' ALA . 7.2 p -65.5 -29.83 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 0.0 111.749 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.24 75.83 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.057 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -84.04 -36.87 22.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -98.41 13.33 4.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -79.33 175.79 10.28 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.514 -176.793 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.07 88.31 0.89 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.39 -71.96 0.44 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -144.62 162.31 36.96 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.0 OUTLIER -68.7 117.18 10.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.627 0.727 . . . . 0.0 110.651 -178.651 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.0 t -163.81 -31.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -176.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.59 147.22 36.28 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.3 146.52 96.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.072 2.515 . . . . 0.0 111.687 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.66 144.5 50.38 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 66' ' ' THR . 16.3 m -110.97 131.58 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 123.168 0.293 . . . . 0.0 110.297 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -106.93 122.43 46.41 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.476 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 67.8 m-85 -86.83 177.91 7.15 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.275 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.12 66.38 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.516 0.727 . . . . 0.0 112.13 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -82.57 -11.57 58.33 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.15 0.5 . . . . 0.0 110.365 -178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.8 3.77 68.07 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.319 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -97.43 152.53 18.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.4 p -115.84 154.19 30.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.317 0.58 . . . . 0.0 111.916 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -130.29 125.69 35.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 m -68.99 142.14 54.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -4.76 84.85 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.792 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 35.0 Cg_endo -93.99 150.83 2.16 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 123.934 3.089 . . . . 0.0 113.231 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 m -75.89 165.66 24.66 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.14 -33.96 72.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.98 -35.68 66.93 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.321 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.62 -43.85 88.31 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.999 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.431 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.5 m -67.82 -41.97 85.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -60.61 -40.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.288 0.368 . . . . 0.0 110.756 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.95 75.88 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.777 0.673 . . . . 0.0 111.973 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.476 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 64.3 tttp -84.14 -45.42 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.584 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.65 -41.01 96.92 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.243 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.41 -38.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.782 0 O-C-N 123.448 0.468 . . . . 0.0 110.604 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 87' ' ' HIS . 60.4 mttm -70.26 -25.29 63.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.78 -40.02 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.37 -38.6 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.956 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.6 -129.65 9.26 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.9 mt 68.7 -71.12 0.12 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -126.12 106.22 9.43 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.361 0.664 . . . . 0.0 110.242 -174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.3 m-70 68.67 99.31 0.06 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.072 0.949 . . . . 0.0 113.536 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--N 1.295 -1.764 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.138 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.21 86.23 2.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -89.21 -26.25 21.33 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.18 100.08 5.94 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.1 -60.55 3.6 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.823 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.0 135.34 12.28 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.696 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 85.5 m -102.63 123.94 47.25 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 75.9 mt -88.96 124.69 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.076 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -106.51 110.81 23.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.738 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -164.02 -177.2 4.91 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 149.98 51.41 Favored 'General case' 0 N--CA 1.396 -3.143 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -58.53 -8.41 1.23 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -91.37 -1.46 57.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.605 -0.685 . . . . 0.0 112.333 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.474 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.7 t -82.6 140.45 33.21 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.49 62.97 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -82.52 -7.8 59.63 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.649 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.8 t -61.69 -63.02 1.4 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.151 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -68.3 -28.58 67.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.158 0.504 . . . . 0.0 110.878 -178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -61.25 -50.59 72.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.86 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.48 -35.42 73.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.194 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.649 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.2 mmtp -57.97 -40.41 80.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -67.4 -48.69 66.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.385 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.81 -42.64 84.68 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.601 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.5 mt -69.63 -38.83 77.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.662 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -65.93 -35.89 81.87 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.876 0.37 . . . . 0.0 110.798 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.53 64.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.367 0.603 . . . . 0.0 111.38 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -109.91 13.49 23.46 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 43.09 62.64 1.75 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.024 1.729 . . . . 0.0 113.418 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 89.3 mt -105.66 129.85 58.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.402 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.09 28.67 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -136.79 166.68 23.03 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.138 0.494 . . . . 0.0 111.495 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 7' ' ' THR . 17.2 t70 -121.34 126.08 48.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.28 137.2 54.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.262 0.554 . . . . 0.0 111.109 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.94 135.55 42.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -76.45 140.99 41.49 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.441 HG21 HG12 ' A' ' 46' ' ' VAL . 12.1 pt -77.46 -26.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.55 -5.12 30.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.192 0.52 . . . . 0.0 111.665 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -94.45 -26.61 16.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -120.9 108.71 14.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.655 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -51.22 -48.56 62.04 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.766 1.226 . . . . 0.0 112.278 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.73 94.84 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.49 0.662 . . . . 0.0 110.683 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.586 ' O ' HG11 ' A' ' 46' ' ' VAL . . . -71.32 -43.72 66.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.453 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' O ' ' HD2' ' A' ' 54' ' ' ARG . . . -59.99 -37.69 80.39 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.259 0.624 . . . . 0.0 112.391 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.13 -34.91 56.55 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.1 -58.23 7.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.586 HG11 ' O ' ' A' ' 42' ' ' ALA . 6.5 p -62.77 -33.82 62.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.307 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.41 -30.23 74.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.988 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -79.99 -36.86 35.39 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.92 9.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.463 0.649 . . . . 0.0 110.537 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.25 -177.81 4.97 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.319 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.24 79.45 1.79 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.04 -98.18 1.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.58 -175.27 3.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.68 116.48 2.53 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -162.7 -34.26 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.359 172.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.06 150.0 42.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.474 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 44.7 Cg_endo -65.94 140.56 61.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.731 2.287 . . . . 0.0 111.48 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 m -129.86 140.49 50.98 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.9 m -107.38 136.7 41.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.684 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -117.79 114.88 23.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -84.69 168.13 15.53 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.453 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.08 -11.37 48.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.392 1.091 . . . . 0.0 109.546 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.22 -18.13 61.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.684 1.594 . . . . 0.0 109.643 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.09 -21.88 39.61 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.776 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.9 m -80.17 149.27 30.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.759 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.7 p -113.5 151.76 31.08 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.432 175.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.58 125.07 24.99 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -64.5 146.52 54.44 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -5.69 86.38 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.553 0 C-N-CA 127.119 2.168 . . . . 0.0 115.942 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -98.09 150.75 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 124.274 3.316 . . . . 0.0 112.907 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 168.55 19.81 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -60.05 -37.04 78.65 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.99 -34.31 75.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.476 0.655 . . . . 0.0 110.33 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -71.7 -34.85 69.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.798 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -78.34 -35.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.711 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 29.3 mtpp -63.96 -33.34 75.51 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.825 -0.17 . . . . 0.0 110.789 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.42 67.99 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.935 0.772 . . . . 0.0 111.836 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.462 ' O ' HG13 ' A' ' 82' ' ' ILE . 37.1 mttm -83.04 -50.7 8.25 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.898 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 tp -51.62 -37.42 50.08 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.035 0.934 . . . . 0.0 113.053 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.35 -38.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.477 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -80.86 -24.08 38.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.157 0.503 . . . . 0.0 110.313 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 78' ' ' LYS . 70.7 mt -80.22 -49.15 19.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.87 14.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.29 87.59 0.71 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -175.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.1 mt -128.73 -83.01 0.58 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.365 -0.491 . . . . 0.0 109.826 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 45.55 87.03 0.02 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.305 1.842 . . . . 0.0 113.775 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -172.29 -44.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 26.9 t60 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 175.072 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.11 27.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.217 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.45 136.74 15.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.128 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -103.35 123.54 47.0 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 31' ' ' TYR . 60.3 mt -88.76 120.25 37.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.71 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -103.54 117.66 34.93 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.004 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -161.25 167.63 25.61 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -100.68 160.44 14.35 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -72.2 -31.0 65.48 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -88.68 14.41 10.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.5 t -79.93 155.86 27.52 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.35 -37.92 13.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.783 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.57 -7.98 59.62 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.2 p -57.16 -61.94 2.11 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.242 0.473 . . . . 0.0 111.775 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.92 -21.82 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.872 0.368 . . . . 0.0 111.661 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -67.53 -51.03 55.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.57 -35.88 75.78 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.15 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.7 mmtt -55.26 -45.52 76.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.29 0.567 . . . . 0.0 110.396 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -65.43 -40.0 92.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.716 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.21 95.94 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 29' ' ' ILE . 71.3 mt -69.07 -43.17 75.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 m -61.9 -38.5 88.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -16.24 63.77 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.413 0.625 . . . . 0.0 111.548 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -110.29 9.47 23.67 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 54.92 32.64 18.34 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.054 1.342 . . . . 0.0 112.454 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 66.1 mt -76.91 128.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 120.888 0.375 . . . . 0.0 110.266 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.38 122.9 29.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 8' ' ' ILE . 52.3 p90 -139.86 165.19 27.97 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.122 0.487 . . . . 0.0 112.294 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.36 142.19 50.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.24 143.55 50.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.381 0.537 . . . . 0.0 111.312 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.55 140.91 36.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.5 141.6 41.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.631 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 37.7 pt -82.81 -26.1 8.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.255 9.6 pt-20 -84.23 -11.47 56.43 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 117.917 -1.513 . . . . 0.0 111.833 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -83.34 -49.43 9.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 170.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.68 96.47 10.66 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.51 -39.16 79.33 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.722 0.809 . . . . 0.0 112.082 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.203 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.09 -43.35 64.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.457 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -56.5 -44.58 80.83 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 124.01 0.819 . . . . 0.0 110.972 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -62.29 -47.23 85.23 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.299 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -59.72 -56.62 19.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.354 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.625 HG11 HG21 ' A' ' 36' ' ' ILE . 7.7 p -62.9 -35.78 72.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.406 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.46 73.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.027 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -79.38 -37.8 36.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.885 0.374 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -94.61 5.5 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.27 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -178.81 6.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.738 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.99 79.25 1.82 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.81 -64.51 3.66 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.86 171.07 14.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -62.0 108.75 1.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.906 0.882 . . . . 0.0 111.856 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.3 t -156.16 -39.75 0.08 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.054 -0.404 . . . . 0.0 111.796 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.21 149.36 39.12 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.914 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 29.1 Cg_endo -64.44 152.65 80.73 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.35 2.033 . . . . 0.0 110.954 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.5 m -140.38 141.05 35.63 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.3 m -107.87 131.7 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.644 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.85 118.67 37.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -84.8 171.63 12.12 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.304 0.573 . . . . 0.0 112.366 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.1 -10.41 14.48 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.978 1.311 . . . . 0.0 112.305 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 -13.46 26.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.368 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.69 -21.27 39.19 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.901 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -85.32 160.83 19.72 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 117.93 0.865 . . . . 0.0 110.75 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.9 p -113.33 166.81 11.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.997 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.5 mt -138.36 116.56 11.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -62.6 139.44 58.63 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -4.69 88.16 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 126.947 2.099 . . . . 0.0 115.623 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -98.37 164.61 0.72 Allowed 'Trans proline' 0 N--CA 1.435 -1.937 0 C-N-CA 124.053 3.168 . . . . 0.0 111.949 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 75' ' ' VAL . 3.1 m -90.81 171.12 9.55 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.5 84.15 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 122.638 0.375 . . . . 0.0 111.483 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.47 -47.99 83.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.126 0.488 . . . . 0.0 110.716 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.02 -42.6 99.34 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.223 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 71' ' ' SER . 11.2 m -72.21 -40.33 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -57.9 -43.55 86.21 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.029 0.443 . . . . 0.0 110.106 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.41 76.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.909 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -84.08 -50.2 8.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.136 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.4 -39.83 70.65 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.123 0.969 . . . . 0.0 113.001 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -59.21 -39.78 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -73.17 -26.79 61.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.884 0.373 . . . . 0.0 110.608 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.1 mt -75.5 -45.19 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.109 -176.533 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.17 73.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.941 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.43 140.88 21.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.18 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 22.0 m -106.83 124.13 49.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.384 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.49 HG12 HG12 ' A' ' 59' ' ' VAL . 74.8 mt -88.81 122.25 39.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.706 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 68.8 m-85 -99.65 111.6 23.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.696 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -146.18 174.12 11.6 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.62 162.38 30.49 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 t -66.95 -15.9 64.0 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.796 0.331 . . . . 0.0 111.863 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -99.31 5.6 46.47 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.64 112.95 19.3 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.749 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.59 73.63 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.19 -7.52 56.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 47.5 t -65.67 -62.04 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.894 0.378 . . . . 0.0 110.448 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 19' ' ' ARG . 1.4 pp -67.9 -21.08 65.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.966 0.888 . . . . 0.0 112.068 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 18' ' ' LEU . 8.9 tpt180 -66.74 -43.55 83.88 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.969 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -85.36 -32.84 22.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.504 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -53.14 -48.47 67.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.881 0.372 . . . . 0.0 111.82 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 p -64.03 -38.65 91.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.874 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.16 93.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.156 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.87 -47.6 61.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.169 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 m -61.47 -37.3 83.1 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 121.076 0.465 . . . . 0.0 110.827 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -10.06 59.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.746 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -115.75 19.41 15.24 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.194 -0.316 . . . . 0.0 111.625 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 53.87 33.01 16.21 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 125.998 1.719 . . . . 0.0 112.177 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -90.3 131.17 38.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 120.914 0.387 . . . . 0.0 110.948 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.37 143.75 26.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.05 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -158.06 166.87 31.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.691 0.282 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' THR . 24.8 t70 -129.89 142.48 50.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -128.14 142.47 51.18 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.445 0.566 . . . . 0.0 110.62 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.51 141.9 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -89.68 139.39 30.61 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.62 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 46' ' ' VAL . 34.7 pt -85.91 -11.13 11.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.0 -40.29 75.37 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.252 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -93.27 -30.03 15.37 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.703 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -88.09 99.93 12.55 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.518 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -71.79 -35.1 69.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.06 75.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.511 . . . . 0.0 109.638 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -74.28 -43.57 56.35 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.735 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.25 -43.04 99.53 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.103 0.561 . . . . 0.0 111.837 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.34 -45.88 92.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -59.65 -58.49 8.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 36' ' ' ILE . 7.6 p -62.59 -35.26 69.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.746 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.13 93.96 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.035 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 m -71.09 -34.81 71.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.755 0.312 . . . . 0.0 111.339 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.67 7.17 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.255 0.55 . . . . 0.0 111.411 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 -172.62 3.98 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.925 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.92 81.55 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -63.12 3.27 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -144.37 165.08 28.92 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -54.21 101.1 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.767 1.227 . . . . 0.0 112.164 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -146.66 -15.96 0.43 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.1 147.69 63.55 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 122.217 -0.302 . . . . 0.0 111.778 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 32.5 Cg_endo -64.83 137.18 52.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.72 2.28 . . . . 0.0 111.476 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -123.01 137.69 54.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 8' ' ' ILE . 19.3 m -102.43 129.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 120.69 0.281 . . . . 0.0 110.412 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -109.94 115.41 29.75 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -81.05 166.75 20.47 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -12.67 58.85 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.455 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.48 -9.5 49.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.252 0.548 . . . . 0.0 109.567 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.56 38.68 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.765 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -73.34 144.32 46.54 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 117.57 0.685 . . . . 0.0 111.46 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -113.64 143.47 44.52 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.646 1.179 . . . . 0.0 111.399 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -126.02 128.45 47.47 Favored 'General case' 0 C--O 1.253 1.256 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -66.96 137.5 56.56 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -6.07 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.8 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -171.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.51 171.08 3.63 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.636 2.89 . . . . 0.0 112.548 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 75' ' ' VAL . 23.7 t -95.02 170.37 9.47 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . . . -64.89 -32.29 73.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.042 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.94 -48.93 72.51 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.31 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.23 -48.87 63.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.373 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 72' ' ' ALA . 8.7 m -62.55 -35.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.25 -36.27 83.61 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.687 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.91 71.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.71 0.632 . . . . 0.0 111.025 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.1 mtpp -84.2 -50.22 8.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.997 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.59 -39.87 71.28 Favored 'General case' 0 C--O 1.252 1.218 0 C-N-CA 123.219 0.608 . . . . 0.0 112.621 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.74 -32.62 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -81.05 -29.14 35.1 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 78' ' ' LYS . 58.5 mt -71.73 -57.67 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.936 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.944 -176.414 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.56 -63.89 1.25 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.462 0.649 . . . . 0.0 109.72 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 132.92 11.86 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.357 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -102.79 123.17 45.96 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.45 0.643 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.7 125.59 41.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -99.79 111.34 23.67 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.658 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.26 167.3 20.09 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 36' ' ' ILE . 25.1 m -138.86 158.0 45.01 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -46.32 -17.46 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 127.127 2.171 . . . . 0.0 115.028 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -77.42 -14.99 59.58 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.838 -0.538 . . . . 0.0 111.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 43.0 t -92.05 120.88 33.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.363 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.63 -30.32 68.76 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.355 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.91 -11.66 61.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 38.8 t -55.58 -55.27 33.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 110.483 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 19' ' ' ARG . 2.2 pp -69.98 -25.81 63.79 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.4 mmm180 -70.67 -44.62 66.64 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.92 -45.07 95.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.889 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.8 mmtp -55.77 -49.61 72.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.218 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 m -59.44 -43.99 93.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.999 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.35 98.42 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.34 -46.5 60.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.448 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.3 m -60.38 -37.33 80.42 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.326 0.391 . . . . 0.0 110.854 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.34 83.31 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 120.935 0.398 . . . . 0.0 112.025 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -99.77 8.76 43.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.289 0.566 . . . . 0.0 111.097 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 63.65 35.33 11.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.144 1.378 . . . . 0.0 113.388 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.86 125.88 38.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.778 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.45 123.63 26.82 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -131.23 161.64 31.77 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.425 0.631 . . . . 0.0 111.659 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.59 142.64 47.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.01 141.38 38.31 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.94 143.22 33.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.28 140.48 38.84 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.998 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.3 pt -83.59 -27.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.193 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -76.92 -25.29 52.77 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -70.74 -49.25 48.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.946 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -102.17 97.77 8.03 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.739 0.304 . . . . 0.0 110.705 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -56.38 -40.1 74.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.0 0.92 . . . . 0.0 112.047 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 -34.45 68.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.305 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -67.62 -38.97 84.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.48 -29.73 70.77 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.639 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 7.3 tp10 -74.75 -48.52 25.22 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -53.21 -56.01 19.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.167 0.987 . . . . 0.0 111.653 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.61 -27.35 42.71 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.972 0 CA-C-O 120.66 0.267 . . . . 0.0 111.094 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.1 -38.79 63.5 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.591 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.0 m -74.27 -34.59 63.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.77 0.319 . . . . 0.0 111.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 46' ' ' VAL . 31.0 m -94.58 13.02 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 0.0 111.541 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 -174.68 3.92 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.129 0.49 . . . . 0.0 110.114 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.53 69.96 3.19 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -61.93 0.79 Allowed Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.573 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 50.1 t30 -144.49 160.06 41.73 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.487 ' NH2' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -62.34 116.79 5.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.635 . . . . 0.0 111.078 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -155.97 -25.27 0.1 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.759 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 m -119.54 144.13 36.13 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 19.6 Cg_endo -60.07 140.54 93.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.834 2.356 . . . . 0.0 111.405 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -124.16 141.0 52.43 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.5 m -107.5 133.04 53.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.549 0.214 . . . . 0.0 110.694 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.0 112.36 23.95 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.461 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.5 m-85 -78.52 166.06 23.02 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.23 -18.05 56.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.496 0.498 . . . . 0.0 112.07 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.76 -11.39 58.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.143 0.496 . . . . 0.0 109.754 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.05 -7.07 56.87 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.208 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -79.61 145.67 32.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.069 0.462 . . . . 0.0 110.879 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -119.09 141.18 49.0 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.0 mt -131.52 143.53 50.45 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -73.91 140.61 45.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -6.75 83.11 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 C-N-CA 126.388 1.875 . . . . 0.0 116.009 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 19.7 Cg_endo -90.25 160.26 4.67 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.781 2.987 . . . . 0.0 112.563 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 m -82.22 173.7 11.86 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -64.48 -39.01 92.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.085 0.469 . . . . 0.0 111.498 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.44 -30.84 67.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.494 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.67 -42.71 73.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 14.1 m -72.24 -35.38 52.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.732 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 10.1 mtpm? -58.13 -36.25 72.68 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 123.124 0.265 . . . . 0.0 111.417 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.61 73.97 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.976 0.797 . . . . 0.0 111.963 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' O ' HG13 ' A' ' 82' ' ' ILE . 8.2 mtpm? -84.08 -48.46 9.86 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.09 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 tp -54.98 -40.59 70.22 Favored 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.02 0.825 . . . . 0.0 112.445 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.83 -43.27 95.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 123.508 0.505 . . . . 0.0 110.328 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -75.15 -21.11 59.03 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.593 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 78' ' ' LYS . 63.4 mt -73.57 -36.05 46.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.91 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.686 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.66 54.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.299 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.27 135.9 23.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.305 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.6 m -103.62 124.85 49.58 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.861 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 59' ' ' VAL . 44.0 mt -89.03 118.73 34.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.856 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 80.6 m-85 -103.81 110.41 22.5 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.949 174.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.456 HG21 ' SG ' ' A' ' 17' ' ' CYS . 13.2 t -163.63 -177.66 5.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.76 152.39 51.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -54.09 -28.38 38.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.277 1.031 . . . . 0.0 113.084 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -77.63 -15.22 59.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -71.53 118.47 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.27 -43.05 93.77 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.667 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 23.7 m-85 -74.1 -7.57 53.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 t -63.6 -62.48 1.64 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 2.4 pp -70.56 -21.02 62.75 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.323 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 16' ' ' TYR . 6.7 tpm_? -72.25 -38.73 68.82 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.123 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -84.33 -24.07 29.94 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.0 mmtt -53.9 -42.87 69.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.792 0.437 . . . . 0.0 111.812 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.8 p -67.91 -37.17 81.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.324 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.87 80.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.793 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.38 -42.97 92.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.8 m -63.11 -46.3 87.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.59 -31.92 72.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.272 0.558 . . . . 0.0 111.093 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.97 11.52 24.84 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.571 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 59.2 32.26 21.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.708 0.803 . . . . 0.0 111.446 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.53 130.59 37.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.0 0.429 . . . . 0.0 109.963 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.3 124.4 36.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.01 162.06 36.42 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.864 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' THR . 37.5 t70 -121.39 133.56 55.09 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.54 139.72 49.34 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.17 147.86 27.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -83.49 138.94 33.21 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.714 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.665 HG21 HG11 ' A' ' 46' ' ' VAL . 39.0 pt -87.04 -23.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.82 -42.63 69.98 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.126 0.488 . . . . 0.0 109.807 -171.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -77.04 -26.72 54.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -103.74 93.16 4.76 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -55.63 -44.39 77.05 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.563 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -30.93 66.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.12 -42.63 68.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -62.92 -36.38 83.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.599 0.562 . . . . 0.0 110.451 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.38 -47.39 79.41 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.05 -58.43 8.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.174 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -64.22 -31.73 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.77 70.33 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.201 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 p -83.02 -26.19 31.45 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 46' ' ' VAL . 21.7 m -89.93 -11.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.124 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -73.13 167.19 21.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.053 -176.663 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.38 4.09 Favored Glycine 0 C--N 1.308 -1.006 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.183 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.56 -90.65 0.41 Allowed Glycine 0 C--N 1.313 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -120.24 172.21 7.95 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -64.27 54.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.56 1.544 . . . . 0.0 112.304 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -88.86 -32.05 17.97 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 122.055 -0.403 . . . . 0.0 111.925 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.37 151.87 63.46 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 12.5 Cg_endo -56.23 123.4 13.73 Favored 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.749 2.966 . . . . 0.0 111.791 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 m -106.51 133.44 51.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 8' ' ' ILE . 28.5 m -103.19 124.8 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.072 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -105.88 125.53 51.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.85 179.22 6.03 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.96 -10.74 58.93 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.237 0.615 . . . . 0.0 111.856 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -88.71 -8.64 54.17 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.15 81.35 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.118 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -99.54 151.52 21.06 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p -117.16 150.11 39.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.504 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.8 mt -124.1 125.08 43.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -68.33 147.35 52.26 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -5.32 83.01 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 C-N-CA 127.015 2.126 . . . . 0.0 114.909 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -98.99 157.67 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.781 2.987 . . . . 0.0 112.583 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 75' ' ' VAL . 30.5 p -84.4 166.2 17.55 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.808 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.41 -33.52 72.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.864 0.466 . . . . 0.0 112.079 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.84 -40.05 91.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.093 0.473 . . . . 0.0 110.521 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.22 -43.32 67.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.593 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 71' ' ' SER . 6.1 m -65.97 -35.5 75.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.116 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.34 -35.17 79.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.62 95.61 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.26 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -76.79 -38.62 53.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.126 0.488 . . . . 0.0 110.345 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.56 -36.46 84.28 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.473 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.7 -22.45 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.126 0.489 . . . . 0.0 111.243 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -80.17 -30.48 38.83 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -83.16 -57.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.765 -175.613 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.76 -56.19 15.16 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.623 0.577 . . . . 0.0 112.222 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 59' ' ' VAL . 1.7 pt? -147.05 137.75 23.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.616 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -106.67 112.13 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.355 1.062 . . . . 0.0 109.648 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.3 mt -88.92 131.81 35.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 111.997 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.423 ' OH ' ' HE2' ' A' ' 60' ' ' LYS . 74.8 m-85 -111.44 104.24 12.66 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 12.6 t -165.27 142.88 5.97 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -102.99 155.99 17.98 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -63.1 -4.85 2.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -77.63 -13.62 59.86 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.558 -0.714 . . . . 0.0 111.168 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.82 144.19 39.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.02 -41.71 39.38 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.652 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.0 -5.67 49.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -50.72 -59.95 3.55 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.019 0.372 . . . . 0.0 111.877 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.4 pt? -72.36 -26.0 61.75 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.432 0.158 . . . . 0.0 111.121 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -59.69 -47.48 85.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.7 tp -67.21 -44.38 79.71 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.74 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 73.8 mmtt -57.4 -55.56 33.2 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.889 0.376 . . . . 0.0 110.723 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 m -59.65 -40.47 87.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.76 -46.74 89.28 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.893 0.377 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 67.2 mt -69.23 -43.66 73.6 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 m -62.97 -37.36 86.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.248 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.74 85.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.38 7.01 38.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 58.53 46.99 14.07 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.812 0.815 . . . . 0.0 111.64 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 24' ' ' LEU . 81.4 mt -97.96 119.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.794 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.94 115.01 11.73 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.684 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -128.29 156.86 42.36 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.809 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -115.43 142.39 46.77 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.22 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.12 139.02 44.34 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.195 -0.316 . . . . 0.0 110.39 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.08 145.12 33.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 37' ' ' GLU . 30.5 t70 -87.73 142.03 28.14 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.918 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG21 HG11 ' A' ' 46' ' ' VAL . 23.6 pt -83.18 -25.7 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.59 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 43.8 tt0 -73.83 -34.41 64.54 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.266 0.555 . . . . 0.0 109.533 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -91.01 -0.19 57.69 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -133.74 99.59 4.51 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -62.5 -43.41 98.87 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.44 72.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.892 0.377 . . . . 0.0 110.749 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.71 -42.15 67.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.85 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.74 84.98 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.557 0.694 . . . . 0.0 110.621 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -63.73 -43.58 96.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.012 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.13 -56.74 9.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.777 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -59.62 -25.66 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.06 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.22 -42.74 96.18 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.641 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.6 m -74.41 -31.31 62.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.065 0.432 . . . . 0.0 111.846 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -91.65 8.43 4.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.904 0.859 . . . . 0.0 111.118 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.49 174.32 9.04 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.34 88.4 1.09 Allowed Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.84 -89.78 0.7 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -134.02 173.92 11.04 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 102.24 1.0 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.112 0.958 . . . . 0.0 113.08 -175.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -146.79 -26.86 0.41 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.15 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 m -113.86 151.44 44.75 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 19.1 Cg_endo -60.9 143.02 99.27 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.31 2.673 . . . . 0.0 111.485 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.441 HG21 ' CG2' ' A' ' 49' ' ' VAL . 19.7 m -132.27 150.55 52.13 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 6' ' ' LEU . 8.4 p -128.96 130.94 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE2' ' OH ' ' A' ' 9' ' ' TYR . 32.3 mtmt -100.58 136.11 40.97 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.97 176.08 6.73 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.58 63.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.142 0.972 . . . . 0.0 109.034 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -74.97 -18.07 60.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.847 1.659 . . . . 0.0 109.534 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.99 30.09 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.354 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -74.58 152.63 39.25 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 122.309 0.244 . . . . 0.0 110.723 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.1 p -113.53 155.11 25.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.331 0.586 . . . . 0.0 112.3 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -132.71 125.26 29.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -70.63 144.52 51.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -4.87 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.477 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -100.51 -177.79 0.17 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 123.686 2.924 . . . . 0.0 112.393 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -114.6 172.73 6.85 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -43.96 78.07 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 122.772 0.429 . . . . 0.0 111.484 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.7 -52.89 54.15 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 111.681 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -62.3 -39.76 94.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.803 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -78.84 -31.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.391 -0.524 . . . . 0.0 112.249 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -60.25 -32.44 71.16 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.142 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.6 71.65 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.894 0.746 . . . . 0.0 111.286 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.9 mtpp -84.88 -44.28 13.35 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.592 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.7 tp -54.42 -41.17 69.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.575 0.75 . . . . 0.0 112.594 -176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.08 -33.2 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.58 0.55 . . . . 0.0 111.642 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -80.33 -42.51 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.297 0.57 . . . . 0.0 109.835 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 78' ' ' LYS . 53.7 mt -61.07 -31.56 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.859 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.241 -179.762 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.6 -60.19 2.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.29 143.25 22.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.176 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -102.97 124.77 49.1 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.34 112.33 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 123.601 0.761 . . . . 0.0 110.467 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 88.4 m-85 -98.85 114.27 26.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.34 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 t -163.69 149.52 11.32 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.62 152.03 21.59 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -67.37 -20.96 65.63 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.798 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -83.58 1.99 39.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.04 149.79 33.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -34.99 28.18 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.512 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -81.67 -7.11 59.56 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -54.63 -51.59 64.93 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -83.87 -23.28 31.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -64.94 -41.58 95.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.858 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 70' ' ' PRO . 25.0 tp -74.5 -24.21 58.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.617 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 43.2 mmtm -62.67 -36.28 82.38 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.186 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -55.85 -47.72 76.77 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 123.794 0.684 . . . . 0.0 110.128 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.17 77.54 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.976 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 98.3 mt -67.03 -44.8 79.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.359 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.9 m -66.85 -38.29 86.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -23.69 66.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.513 0.673 . . . . 0.0 111.41 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -106.75 4.72 27.96 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.069 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 50.49 44.7 27.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.921 1.288 . . . . 0.0 112.036 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 24' ' ' LEU . 72.0 mt -82.72 127.82 39.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.552 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.91 134.19 35.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -147.55 164.19 34.21 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -118.68 139.11 52.06 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.15 134.99 55.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.844 0.354 . . . . 0.0 111.277 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.95 126.39 26.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.77 141.06 33.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 46' ' ' VAL . 40.8 pt -84.85 -9.35 11.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.29 -43.7 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 109.864 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -92.27 -28.82 16.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.997 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.26 91.64 6.37 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.203 0.525 . . . . 0.0 110.532 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -76.06 -25.8 55.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.321 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -33.23 73.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.71 -40.06 66.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.568 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.04 84.42 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.7 -53.48 56.88 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -56.92 -57.91 10.44 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.861 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.62 -32.37 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.74 75.79 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.374 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -81.24 -22.1 38.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG23 HG21 ' A' ' 58' ' ' THR . 35.9 m -108.6 13.16 8.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.709 0.766 . . . . 0.0 110.347 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.65 -173.16 2.8 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.825 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.35 71.05 2.55 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.91 -67.94 2.88 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.873 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -119.74 151.62 38.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.64 114.72 8.12 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.525 0.678 . . . . 0.0 109.52 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -154.83 -29.86 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.441 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.91 142.44 25.24 Favored Pre-proline 0 C--O 1.241 0.643 0 O-C-N 122.078 -0.389 . . . . 0.0 111.543 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 22.5 Cg_endo -62.48 131.9 35.86 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.738 2.292 . . . . 0.0 111.215 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.421 HG21 HG23 ' A' ' 49' ' ' VAL . 23.2 m -117.51 137.79 52.31 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.77 128.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 120.804 0.335 . . . . 0.0 110.746 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -104.95 119.29 38.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.52 174.4 11.47 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.538 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.81 66.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.362 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -75.92 -14.94 60.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.375 . . . . 0.0 110.77 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.01 -21.98 36.43 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.909 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 m -81.81 158.58 24.04 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 117.82 0.81 . . . . 0.0 110.459 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.1 p -113.84 163.29 15.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -134.58 121.55 21.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.2 m -62.95 137.21 58.21 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.257 24.9 p-10 -5.46 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.875 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HG2' HG13 ' A' ' 75' ' ' VAL . 92.7 Cg_endo -97.35 147.79 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.684 3.59 . . . . 0.0 111.936 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -77.37 174.48 10.76 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.64 77.38 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.546 0.738 . . . . 0.0 111.972 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.68 -41.39 94.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.932 0.396 . . . . 0.0 111.799 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.2 -41.67 81.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.871 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.439 HG13 ' HG2' ' A' ' 70' ' ' PRO . 5.8 m -69.03 -40.88 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.998 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -57.67 -44.39 85.7 Favored 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 123.381 0.426 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.79 73.08 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 124.151 0.907 . . . . 0.0 112.642 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -84.35 -47.57 10.58 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.245 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.82 -36.2 76.3 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.278 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 -32.77 56.61 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.094 0.473 . . . . 0.0 111.083 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.35 -34.75 31.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.431 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.8 mt -67.26 -41.11 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.376 0.608 . . . . 0.0 109.761 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.463 178.523 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.93 -60.17 1.64 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -156.32 131.15 9.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.165 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -101.72 117.54 35.1 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.254 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 59' ' ' VAL . 97.5 mt -89.05 121.06 38.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.522 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.11 123.62 47.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 8.9 t -163.9 171.76 14.92 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.878 0.736 . . . . 0.0 109.187 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 36' ' ' ILE . 9.2 p -108.69 159.17 16.96 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -76.44 -13.55 60.11 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.524 0.202 . . . . 0.0 111.35 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -86.58 -2.2 58.29 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -83.98 132.2 34.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -30.12 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.86 -19.64 62.62 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.7 t -58.6 -61.29 2.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 123.503 0.502 . . . . 0.0 110.435 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 19' ' ' ARG . 3.5 pp -65.47 -29.39 70.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.579 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' N ' HD12 ' A' ' 18' ' ' LEU . 20.3 tpp180 -61.8 -50.18 73.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.83 -39.95 79.72 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.71 -46.66 81.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -59.43 -46.11 89.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.95 95.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.592 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 mt -74.93 -36.84 62.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.076 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -63.68 -41.47 98.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.57 73.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 0.0 111.596 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -92.92 -1.89 56.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 56.17 52.3 10.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.946 0.879 . . . . 0.0 111.581 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.89 140.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.54 114.45 20.26 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -132.92 152.04 51.96 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.671 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' THR . 6.3 m-20 -114.05 116.51 29.28 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.293 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -113.31 131.16 56.05 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.247 0.546 . . . . 0.0 110.845 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.02 130.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -85.89 141.6 29.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.453 HG21 HG11 ' A' ' 46' ' ' VAL . 36.7 pt -83.94 -9.02 11.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.27 -26.1 68.63 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.82 -2.37 30.17 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.998 0.428 . . . . 0.0 110.875 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -124.33 88.47 2.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -69.22 -30.48 68.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.981 -171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.17 -35.94 78.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.603 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.61 97.97 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.375 0.607 . . . . 0.0 110.443 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.08 -46.48 84.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.18 -58.94 5.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.669 0.787 . . . . 0.0 111.28 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 42' ' ' ALA . 4.4 p -61.69 -32.25 53.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' A' ' 54' ' ' ARG . . . -69.18 -29.06 72.22 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.724 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -78.47 -28.21 46.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.355 0.598 . . . . 0.0 110.889 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG21 ' A' ' 58' ' ' THR . 24.5 m -101.81 13.67 6.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.759 0.79 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -173.59 3.86 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.244 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.72 78.75 0.42 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.69 -89.63 0.61 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -138.89 -175.24 4.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 2.1 mpp_? -54.58 111.78 0.87 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.498 0.499 . . . . 0.0 112.236 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.47 -33.39 0.08 Allowed 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.596 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -123.75 148.79 57.45 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.695 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 22.8 Cg_endo -64.52 155.0 68.88 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.356 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.47 HG21 ' CG2' ' A' ' 49' ' ' VAL . 31.5 m -135.91 140.41 44.05 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.3 m -105.73 133.59 49.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 123.237 0.336 . . . . 0.0 110.497 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -112.41 111.68 22.7 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.4 m-85 -77.65 165.82 23.79 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.654 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.82 -11.99 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.539 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 2.1 p-10 -84.05 -9.84 58.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.5 -2.01 60.53 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.695 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -91.97 145.39 24.58 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 117.359 0.579 . . . . 0.0 110.677 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -113.38 141.25 47.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.097 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -132.53 133.2 43.45 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.0 m -70.51 139.1 51.54 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -5.48 90.87 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.728 0 C-N-CA 126.661 1.984 . . . . 0.0 115.572 -170.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.2 Cg_endo -95.18 152.8 1.67 Allowed 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 124.471 3.448 . . . . 0.0 112.915 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.6 t -71.79 163.07 28.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.38 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.46 77.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.43 0.692 . . . . 0.0 111.695 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.66 -26.72 61.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.719 0.295 . . . . 0.0 110.641 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.21 -45.57 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.4 m -64.19 -37.01 78.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.648 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -59.92 -35.57 75.17 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.334 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.09 79.0 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.435 0.46 . . . . 0.0 111.912 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 7.8 mtpm? -84.29 -45.11 13.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.103 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.69 -33.36 72.74 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.418 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.97 -31.96 54.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 CA-C-O 121.289 0.566 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -78.54 -47.34 17.46 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.73 -40.09 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.493 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 111.708 179.456 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.19 -64.03 1.28 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 HD23 HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -157.11 133.04 9.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.944 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.1 m -105.52 123.72 48.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.915 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.18 130.21 42.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 124.115 0.966 . . . . 0.0 111.147 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -106.6 119.17 38.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -163.84 162.2 23.55 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.11 175.56 5.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.1 t -76.11 -21.63 56.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.491 0.186 . . . . 0.0 111.037 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -77.62 -15.31 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.499 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.42 109.37 8.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.39 -22.8 59.33 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' HG12 ' A' ' 56' ' ' VAL . 86.7 m-85 -82.55 -7.31 59.65 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 25.2 p -54.88 -59.46 4.7 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.3 pt? -69.98 -25.93 63.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -59.47 -50.17 74.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.988 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.37 -40.09 85.73 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.399 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.02 -45.75 79.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.613 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -56.09 -40.54 73.79 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.63 77.41 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.099 0.476 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 29' ' ' ILE . 57.1 mt -72.87 -42.31 63.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.716 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -64.33 -32.31 73.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.8 -27.79 69.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.627 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.96 3.27 25.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 47.36 58.44 4.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.109 0.964 . . . . 0.0 112.145 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 75.7 mt -89.62 128.86 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.157 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.7 10.81 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.199 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -116.79 175.12 5.72 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.0 t70 -139.93 139.41 36.16 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.69 141.24 50.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.97 142.61 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.28 140.49 44.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.544 0.688 . . . . 0.0 111.481 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 46' ' ' VAL . 38.4 pt -86.19 -24.85 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.387 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.05 -39.19 66.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.825 0.345 . . . . 0.0 111.855 -169.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -89.29 3.58 51.61 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.56 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -129.75 93.23 3.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -47.11 -55.74 7.84 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.7 74.97 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 123.481 0.488 . . . . 0.0 111.399 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.96 -47.22 66.16 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.269 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.2 -36.9 84.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.356 0.598 . . . . 0.0 111.25 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.61 -37.17 85.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.11 -60.99 1.93 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.076 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 36' ' ' ILE . 5.8 p -59.16 -36.12 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.52 74.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.6 m -82.94 -30.28 28.47 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.156 0.503 . . . . 0.0 110.837 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 46' ' ' VAL . 34.2 m -98.2 13.55 4.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-O 121.414 0.626 . . . . 0.0 111.245 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.07 173.62 12.4 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.932 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.4 63.34 3.36 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.92 -119.29 4.43 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' THR . 4.2 p-10 -93.77 164.27 13.2 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.7 110.03 0.59 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.945 0.898 . . . . 0.0 110.416 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.2 t -162.33 -26.66 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.275 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 16' ' ' TYR . 10.7 m -113.4 150.41 43.09 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 120.486 0.184 . . . . 0.0 111.241 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.18 150.53 65.8 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.258 1.972 . . . . 0.0 110.454 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.427 HG21 HG23 ' A' ' 49' ' ' VAL . 28.3 m -132.12 136.7 47.31 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.474 HG21 HD23 ' A' ' 6' ' ' LEU . 10.4 p -104.77 127.87 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.017 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -113.59 111.86 22.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 64.1 m-85 -81.83 171.51 14.42 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.434 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.35 -16.83 62.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.274 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.34 -12.32 52.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.187 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.14 -18.22 42.89 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.579 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -80.69 148.95 29.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 117.27 0.535 . . . . 0.0 111.972 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.1 p -115.5 143.53 45.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.841 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.32 129.06 50.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -71.04 141.02 50.93 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -5.75 87.81 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 C-N-CA 126.565 1.946 . . . . 0.0 115.583 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -90.68 -172.48 0.52 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 124.048 3.165 . . . . 0.0 111.378 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.533 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 23.3 m -118.02 173.87 6.53 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -59.37 -43.67 92.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.92 -37.43 81.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.831 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 12.8 mp0 -63.15 -45.7 90.65 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.751 0.82 . . . . 0.0 110.877 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 71' ' ' SER . 13.7 m -70.53 -35.14 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.772 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 56.3 mtpt -61.17 -41.71 97.27 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.43 73.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.929 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -84.07 -48.03 10.31 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.27 -42.44 73.54 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.445 1.098 . . . . 0.0 112.82 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.23 -32.89 49.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.69 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -80.82 -19.94 43.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.195 0.521 . . . . 0.0 110.841 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -85.67 -46.06 17.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.665 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.24 -62.21 1.54 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -151.78 130.0 11.97 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.27 119.31 38.63 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.545 0.528 . . . . 0.0 111.402 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.02 130.63 38.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.9 m-85 -114.88 109.04 17.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.271 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 6.9 t -164.28 -178.75 5.67 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.895 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.486 ' HB ' ' CD1' ' A' ' 13' ' ' TRP . 33.0 m -152.84 154.79 35.84 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 m -48.82 -18.35 0.26 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.486 ' CD1' ' HB ' ' A' ' 11' ' ' THR . 68.2 p-90 -77.37 -18.45 57.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 64.0 m -74.52 141.88 44.82 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.02 -49.95 43.95 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.002 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -72.93 -6.1 42.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 26.6 p -47.53 -62.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -76.96 -25.88 53.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -61.58 -43.92 97.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.537 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.62 -40.65 84.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.27 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.9 mmmm -58.62 -50.62 73.15 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -61.28 -46.13 91.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.519 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.37 83.46 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.405 0.44 . . . . 0.0 111.113 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 62.8 mt -71.71 -42.24 67.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.241 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.3 m -64.24 -38.2 90.19 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.249 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.76 -30.52 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 111.622 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -100.11 22.18 11.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.025 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.258 10.9 ptp180 43.82 61.34 2.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 125.477 1.511 . . . . 0.0 114.245 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 68.8 mt -113.45 119.09 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.971 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 127.96 32.87 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.714 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -139.91 168.72 19.16 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.681 0.753 . . . . 0.0 112.599 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.03 139.98 51.69 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.631 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.44 145.71 51.92 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.52 147.37 25.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.35 140.74 41.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.732 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.512 HG21 HG11 ' A' ' 46' ' ' VAL . 25.3 pt -86.79 -29.22 5.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.483 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.94 -55.63 27.54 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.346 0.658 . . . . 0.0 112.39 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -93.97 15.49 16.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.39 0.614 . . . . 0.0 112.158 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -130.68 91.39 3.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.38 -47.35 79.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.26 -22.79 65.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.729 0.3 . . . . 0.0 111.524 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -86.65 -47.06 9.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.86 -43.74 98.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.257 0.551 . . . . 0.0 111.201 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.73 -38.13 89.94 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.174 0.99 . . . . 0.0 110.049 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.75 -60.0 3.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.19 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -60.44 -35.02 60.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.62 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.64 72.92 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.843 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.0 m -83.83 -32.54 25.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.767 0.317 . . . . 0.0 111.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.2 m -94.72 9.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.038 0.447 . . . . 0.0 111.043 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 175.98 8.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.198 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.32 87.06 1.55 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.12 -72.06 0.72 Allowed Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -144.73 172.62 12.75 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -61.51 109.22 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.442 0.639 . . . . 0.0 111.115 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -149.37 -34.76 0.18 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.824 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.75 152.03 50.87 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 14.6 Cg_endo -58.33 139.33 90.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.58 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' HG23 ' A' ' 46' ' ' VAL . 23.7 m -125.26 147.83 48.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 6' ' ' LEU . 14.6 p -122.13 128.64 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.797 0 O-C-N 123.491 0.494 . . . . 0.0 110.229 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.63 129.94 55.55 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -94.07 166.2 12.26 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.497 0.189 . . . . 0.0 111.359 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.31 -16.18 59.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.947 0.899 . . . . 0.0 112.898 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.71 -5.17 58.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 109.882 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.94 18.42 47.3 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.23 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -107.06 149.76 27.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.68 0.74 . . . . 0.0 110.541 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 p -114.87 154.65 28.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.995 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -131.26 126.85 36.53 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -68.46 136.04 52.59 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 11.0 t30 -5.89 91.62 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -171.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.425 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 28.9 Cg_endo -100.41 174.05 0.33 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.498 3.465 . . . . 0.0 112.439 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.46 168.2 10.53 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.415 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.48 71.01 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 24.3 t70 -79.65 -28.31 40.84 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.489 -1.284 . . . . 0.0 111.339 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.61 -40.67 97.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.387 0.613 . . . . 0.0 109.908 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 13.5 m -77.86 -30.95 16.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.969 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 9.5 mtpm? -57.41 -40.52 78.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.95 -35.24 66.45 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 123.941 0.776 . . . . 0.0 112.009 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.4 mtpp -84.03 -50.5 7.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.038 0.447 . . . . 0.0 111.115 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.64 -38.25 71.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.829 0.852 . . . . 0.0 112.828 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.27 -32.14 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 120.899 0.38 . . . . 0.0 111.268 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.06 -44.1 18.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.35 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 72.2 mt -56.97 -53.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.75 0.656 . . . . 0.0 110.789 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.675 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.396 -178.674 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . . . . . . 0 N--CA 1.435 -1.215 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -64.03 1.28 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.017 0.437 . . . . 0.0 111.478 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt? -152.5 139.25 18.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -105.96 124.22 49.23 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 HG23 ' A' ' 10' ' ' THR . 91.4 mt -104.62 134.09 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.295 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -114.59 116.3 28.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.589 0.756 . . . . 0.0 109.412 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 57' ' ' PRO . 49.5 p -129.88 156.91 43.61 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD11 ' A' ' 36' ' ' ILE . 26.8 p -99.47 164.92 11.89 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -78.94 -22.51 45.65 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.393 0.615 . . . . 0.0 110.561 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 55' ' ' THR . 31.3 p-90 -101.46 -8.42 21.98 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 42.5 t -84.73 142.13 30.06 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.326 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.36 -19.21 67.07 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.707 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.62 -14.43 58.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.778 -0.836 . . . . 0.0 111.906 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 77.8 m -59.34 -59.16 5.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.336 0.398 . . . . 0.0 111.403 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.3 pt? -74.4 -26.44 60.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -65.61 -42.79 91.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.363 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.44 -39.28 92.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.319 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -59.02 -44.9 91.78 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -58.38 -49.37 77.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.961 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.19 98.32 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.905 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 29' ' ' ILE . 50.0 mt -70.49 -42.3 71.55 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.395 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -64.45 -34.33 77.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.612 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.39 73.75 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.21 0.529 . . . . 0.0 110.694 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -96.79 10.65 38.22 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 63.65 20.51 12.27 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.308 1.043 . . . . 0.0 111.917 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 24' ' ' LEU . 73.3 mt -73.95 128.55 36.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.319 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.69 143.42 27.59 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -152.98 172.81 16.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.116 0.484 . . . . 0.0 112.242 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -119.68 119.61 34.2 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -114.35 124.04 50.97 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.264 0.554 . . . . 0.0 110.257 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.04 137.7 48.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.11 141.73 28.27 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 117.88 -1.528 . . . . 0.0 110.729 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 HG21 HG11 ' A' ' 46' ' ' VAL . 26.2 pt -84.93 -2.85 7.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.403 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -76.27 -37.58 57.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -87.01 -42.86 12.78 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.062 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -86.67 97.34 10.52 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.435 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -71.95 -28.9 63.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.077 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.41 74.53 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.47 -37.84 77.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.343 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.06 98.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.175 0.59 . . . . 0.0 110.905 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.13 -45.61 92.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -56.73 -60.71 3.16 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.916 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG11 HG21 ' A' ' 36' ' ' ILE . 4.3 p -61.21 -34.34 60.14 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.089 -178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.08 90.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.586 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.8 p -80.11 -11.37 59.77 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -115.23 13.73 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 121.813 0.816 . . . . 0.0 109.525 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -98.88 -171.84 2.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 -174.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 69.4 2.83 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.96 -96.87 1.6 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.2 174.46 5.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -76.79 111.16 12.01 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.267 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.402 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . 9.8 t -133.46 -17.49 2.29 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.796 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 152.9 81.03 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 10' ' ' THR . 36.5 Cg_endo -67.29 157.72 60.39 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.204 1.936 . . . . 0.0 111.924 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -141.74 148.59 39.25 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.589 HG21 HD12 ' A' ' 6' ' ' LEU . 7.1 p -120.47 136.65 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 O-C-N 123.666 0.604 . . . . 0.0 109.899 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -113.15 127.55 56.22 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.43 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 97.0 m-85 -85.77 169.57 13.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -60.79 -27.66 68.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.574 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.19 -16.68 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.661 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.11 -19.07 27.87 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-O 119.741 -0.477 . . . . 0.0 114.236 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -73.76 153.3 40.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.788 0.794 . . . . 0.0 112.616 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 p -118.26 153.66 33.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.142 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.9 mt -132.75 123.18 25.74 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.6 m -65.41 138.49 58.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -5.03 92.16 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.506 0 C-N-CA 126.873 2.069 . . . . 0.0 115.949 -170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -98.85 -169.75 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.724 2.95 . . . . 0.0 111.913 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 75' ' ' VAL . 48.2 t -117.94 172.1 7.62 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.84 -50.14 66.87 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 11.1 m-20 -71.89 -30.2 65.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.81 -43.53 98.07 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.351 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 71' ' ' SER . 15.5 m -80.28 -30.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 52.5 mtpt -60.08 -40.87 91.07 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.41 -36.8 64.34 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.122 0.889 . . . . 0.0 111.707 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -84.11 -48.58 9.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.18 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.58 -41.14 72.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.735 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.35 -34.54 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.217 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.37 -19.6 38.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.014 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' LYS . 78.2 mt -84.67 -46.21 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.263 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.258 -176.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.92 -64.43 1.13 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.531 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.5 131.98 6.64 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.918 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -102.68 127.27 49.87 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.942 -174.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.23 123.7 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 124.983 1.313 . . . . 0.0 110.659 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.8 m-85 -103.68 115.79 31.14 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -163.64 169.81 18.03 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.461 HG23 ' CG1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -123.77 161.15 25.8 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -74.36 -8.19 55.43 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.699 0.285 . . . . 0.0 111.76 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -86.95 -5.48 59.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -78.69 144.21 35.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.97 -42.8 84.48 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.218 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -82.11 -5.67 58.59 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.4 p -50.29 -63.13 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -68.67 -29.53 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.282 0.563 . . . . 0.0 111.543 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -59.88 -47.19 86.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.775 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.8 tp -70.55 -34.75 72.58 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.574 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 10.2 mmmm -62.14 -47.17 85.74 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -65.41 -43.77 89.54 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.767 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -45.53 84.22 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.872 0.368 . . . . 0.0 111.675 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.85 -37.7 70.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.208 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.2 m -65.99 -43.7 86.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.78 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.23 -34.34 77.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.232 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -91.41 6.69 44.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.89 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 54.95 62.29 2.58 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.422 1.089 . . . . 0.0 112.004 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.56 133.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.537 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.85 125.35 29.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.72 159.67 41.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.323 0.582 . . . . 0.0 110.895 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' THR . 20.6 m-20 -122.43 142.35 50.64 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -137.14 139.17 41.0 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.558 0.617 . . . . 0.0 111.762 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.23 144.78 28.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.33 143.14 26.7 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 117.915 -1.514 . . . . 0.0 110.738 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 HG11 ' A' ' 46' ' ' VAL . 35.6 pt -84.13 -3.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.407 -1.27 . . . . 0.0 113.184 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.06 -36.94 16.67 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.493 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -77.82 -33.62 52.32 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.023 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -103.52 102.88 12.79 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -65.53 -36.5 83.99 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.486 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.79 -32.05 72.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 111.068 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -75.8 -41.03 54.0 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.043 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.85 -44.38 89.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.122 0.569 . . . . 0.0 111.38 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.82 -38.23 81.44 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.751 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.48 -61.44 1.77 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.207 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -57.34 -35.79 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.04 73.12 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.843 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.53 -25.78 30.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.054 0.454 . . . . 0.0 111.177 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.23 13.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.029 0.919 . . . . 0.0 110.438 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 165.83 16.22 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.986 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.62 87.18 1.39 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.67 -97.74 1.86 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 48.4 t30 -86.21 149.89 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -72.87 102.41 3.42 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 53' ' ' ASN . 8.9 t -157.93 -8.08 0.08 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.051 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 55' ' ' THR . 5.7 m -126.71 144.68 50.73 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.4 Cg_endo -58.85 140.08 93.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.28 2.653 . . . . 0.0 111.477 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.7 m -128.66 138.9 52.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.9 m -102.71 133.73 45.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.378 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -110.63 112.72 24.8 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 87.7 m-85 -78.78 159.79 27.71 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 123.557 0.535 . . . . 0.0 109.732 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.42 -14.02 46.08 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 13.4 p-10 -85.63 -12.45 51.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.18 15.77 24.91 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.1 p -105.45 157.01 17.65 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.195 -0.591 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.5 p -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.58 0.229 . . . . 0.0 110.537 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -128.45 127.51 42.63 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 m -66.78 145.68 55.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -5.11 85.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 C-N-CA 126.295 1.838 . . . . 0.0 115.887 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -95.0 159.64 1.72 Allowed 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 123.761 2.974 . . . . 0.0 112.486 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 p -83.49 168.62 16.31 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.59 77.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.367 0.603 . . . . 0.0 110.634 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.97 -25.45 62.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.665 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.24 -43.88 22.88 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 122.257 -0.277 . . . . 0.0 111.538 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.89 -40.77 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.83 -34.59 71.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.39 77.41 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.652 0.595 . . . . 0.0 112.207 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -85.84 -44.69 12.23 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.061 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -53.35 -40.09 64.65 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.505 1.122 . . . . 0.0 113.15 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.91 -39.17 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.43 0.456 . . . . 0.0 111.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -79.28 -31.4 43.33 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.162 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 78' ' ' LYS . 62.8 mt -74.96 -52.85 17.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.079 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.895 -176.465 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.34 -58.89 6.59 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.421 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.19 132.16 18.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.348 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -112.18 122.64 48.31 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' LEU . 96.4 mt -91.63 123.77 43.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.003 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.49 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 29.7 m-85 -105.43 118.88 37.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -163.84 164.31 23.55 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 162.84 14.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -71.01 -19.44 62.52 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -83.82 -1.22 53.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -80.6 123.23 27.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.14 92.98 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.549 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -82.27 -7.15 59.62 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 37.0 t -52.52 -59.41 4.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.187 0.305 . . . . 0.0 111.655 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.13 -23.15 63.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.14 -48.25 65.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.8 tp -63.88 -40.15 95.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.602 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.3 mmtp -60.16 -51.79 68.08 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.258 0.552 . . . . 0.0 110.409 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 25' ' ' THR . 17.1 p -67.73 -31.85 72.07 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.428 -177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.53 84.57 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 120.941 0.4 . . . . 0.0 110.488 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 55.4 mt -72.03 -40.96 68.04 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.439 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' THR . 4.1 t -64.76 -29.6 70.58 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.411 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.41 -31.75 58.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.206 0.526 . . . . 0.0 111.006 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -91.53 12.86 19.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 61.18 33.36 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.583 1.153 . . . . 0.0 110.43 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 24' ' ' LEU . 78.3 mt -87.26 133.57 29.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.408 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.67 123.57 34.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -145.81 175.44 10.41 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.059 0.457 . . . . 0.0 111.4 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -129.27 142.08 50.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.82 126.77 38.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 133.9 43.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.01 140.69 57.71 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 40.5 pt -84.35 -18.8 9.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.99 -45.37 74.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.572 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -72.2 -36.97 69.35 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.613 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -91.05 93.4 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.024 0.44 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -55.25 -46.02 76.06 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.969 0.907 . . . . 0.0 111.802 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.19 70.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.41 81.2 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . . . -64.24 -41.59 96.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.173 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.78 -43.01 90.06 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.47 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.95 -52.79 63.54 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.566 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 49' ' ' VAL . 14.3 m -68.35 -21.97 26.9 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.52 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.27 68.35 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.058 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.89 -23.5 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.026 0.441 . . . . 0.0 110.795 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 46' ' ' VAL . 32.1 m -114.74 13.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.706 0.765 . . . . 0.0 110.606 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -88.87 -171.61 3.37 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.134 -172.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 65.87 3.18 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.87 -73.07 1.6 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -110.47 161.73 15.39 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.421 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -71.16 100.67 2.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.211 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -149.67 -17.89 0.27 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.286 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -116.91 145.62 35.97 Favored Pre-proline 0 C--O 1.248 1.013 0 O-C-N 121.907 -0.496 . . . . 0.0 111.82 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.53 127.42 26.13 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.581 2.854 . . . . 0.0 111.342 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -113.71 135.31 54.07 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.26 125.29 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.771 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.07 111.85 23.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -82.16 171.03 14.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.347 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -15.3 63.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.939 0.875 . . . . 0.0 109.104 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.47 -17.98 61.72 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.709 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 -22.67 21.35 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.508 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -73.42 151.94 40.97 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 p -119.53 143.4 47.6 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.8 mt -125.32 132.97 52.77 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -72.32 139.53 48.02 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -5.49 88.39 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' O ' HD13 ' A' ' 20' ' ' LEU . 19.7 Cg_endo -99.23 153.38 0.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 123.998 3.132 . . . . 0.0 111.145 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -86.34 172.88 10.1 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.718 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.65 55.59 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.774 0.829 . . . . 0.0 113.065 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 19.0 m-20 -69.92 -19.74 63.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -82.49 -39.35 22.59 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.36 -31.03 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 51.0 mtpt -54.5 -40.23 68.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.94 0.496 . . . . 0.0 110.832 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.73 71.38 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 124.238 0.961 . . . . 0.0 112.0 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.5 mtpp -84.15 -47.24 11.07 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.953 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 5' ' ' ALA . 60.7 tp -57.8 -39.89 78.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.797 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.95 -31.2 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.341 0.591 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -81.09 -43.04 20.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 78' ' ' LYS . 76.1 mt -59.3 -34.8 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.91 179.627 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -2.576 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 -53.18 4.23 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.877 0.846 . . . . 0.0 108.788 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.07 136.83 17.07 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.727 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.8 m -102.26 110.07 21.93 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 59' ' ' VAL . 89.9 mt -88.49 130.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.817 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.83 105.44 13.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.334 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -164.66 -171.12 2.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -149.62 164.59 34.73 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -56.01 -20.67 17.58 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.664 1.185 . . . . 0.0 113.812 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -82.09 -2.07 50.69 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.9 t -95.92 129.32 43.21 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.68 -31.94 81.52 Favored Glycine 0 N--CA 1.46 0.243 0 CA-C-O 121.493 0.496 . . . . 0.0 112.1 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -80.96 -7.94 59.64 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 31.6 t -64.57 -61.74 2.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.41 -29.2 68.63 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.723 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -62.97 -39.12 93.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.5 tp -75.89 -45.96 32.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.214 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -53.7 -49.27 68.41 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.933 0.396 . . . . 0.0 110.884 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -66.87 -37.25 84.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.103 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.28 91.33 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 120.951 0.405 . . . . 0.0 110.734 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.4 -42.35 71.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -62.71 -40.74 98.1 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.426 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.89 66.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 110.942 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -91.04 4.19 52.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.663 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 61.23 29.64 18.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 111.584 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.95 131.52 33.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.97 35.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.11 164.34 30.04 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.974 0.416 . . . . 0.0 111.799 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.82 122.52 34.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.225 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.31 129.61 56.66 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.958 0.409 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.1 138.7 53.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.43 141.33 28.85 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.004 -1.478 . . . . 0.0 111.092 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.599 HG21 HG11 ' A' ' 46' ' ' VAL . 29.2 pt -85.1 5.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.8 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.88 -45.29 12.4 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -85.27 -34.66 21.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.759 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.91 92.95 7.15 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.722 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -72.25 -28.29 63.05 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.14 76.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.6 -39.52 70.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.332 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.16 90.86 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 110.831 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.03 -48.67 77.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.692 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.87 -56.83 16.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.438 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.15 -33.29 61.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.6 73.82 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.935 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -76.18 -45.63 32.39 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.047 0.451 . . . . 0.0 110.164 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.96 3.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.458 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.78 -172.37 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.187 0.518 . . . . 0.0 109.948 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.07 64.23 2.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.14 -73.81 0.22 Allowed Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.483 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 39.9 t-20 -135.89 169.65 17.24 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -70.94 107.01 3.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.349 0.977 . . . . 0.0 110.799 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.1 t -138.14 -23.24 1.02 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.004 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.38 154.6 79.18 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 39.0 Cg_endo -67.84 145.56 69.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.316 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.8 m -128.87 143.65 50.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.4 m -111.17 134.25 54.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 123.164 0.29 . . . . 0.0 110.417 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -111.76 118.88 36.82 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 93.2 m-85 -80.09 178.59 8.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.96 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.71 58.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.563 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 33.7 p-10 -88.3 -18.48 28.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.784 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.37 -1.63 53.81 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.99 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -84.48 144.65 28.58 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.96 140.94 48.87 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.754 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.79 140.75 50.31 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.7 m -77.73 147.45 35.38 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -5.53 83.27 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.833 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -98.51 139.53 0.41 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 123.57 2.847 . . . . 0.0 112.269 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -72.11 174.53 7.01 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.648 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.01 -47.03 78.55 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 123.829 0.851 . . . . 0.0 113.176 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 15.7 m-20 -76.29 -19.76 57.96 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.383 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.28 -44.17 65.74 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 -34.99 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.812 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 55.6 mtpt -56.68 -36.53 69.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.199 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.61 73.98 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.903 0.752 . . . . 0.0 111.628 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -84.05 -40.82 17.88 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.613 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 tp -60.27 -38.27 83.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.941 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.8 -32.94 57.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.079 0 CA-C-O 121.499 0.666 . . . . 0.0 110.753 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.75 -31.24 32.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.41 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.08 -36.49 68.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.322 0.582 . . . . 0.0 109.86 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.177 177.014 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.9 -54.75 41.29 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.683 0.614 . . . . 0.0 111.519 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.15 137.87 19.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -103.45 119.39 38.8 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 59' ' ' VAL . 92.2 mt -88.76 122.48 40.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 54.1 m-85 -102.61 121.9 43.33 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 173.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -163.51 171.41 15.9 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 149.13 27.86 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.1 t -67.35 -20.95 65.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.471 0.177 . . . . 0.0 110.594 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.86 5.25 41.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.4 t -85.85 132.37 34.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.97 -32.91 58.2 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 56' ' ' VAL . 50.5 m-85 -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 51.5 t -57.11 -56.43 21.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 123.585 0.553 . . . . 0.0 110.307 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.65 -21.69 61.78 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 36.7 mmt180 -65.28 -51.1 62.97 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.09 -40.35 96.05 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.731 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.8 mmtp -60.31 -41.13 92.83 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.8 m -59.96 -45.28 93.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.052 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.35 -51.25 66.7 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.671 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.65 -44.49 86.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.9 m -64.02 -34.28 77.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.748 0.309 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.39 -25.18 67.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.141 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.83 9.26 36.99 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 122.082 -0.386 . . . . 0.0 110.74 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 54.92 41.18 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.828 0.851 . . . . 0.0 111.298 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.4 mt -84.38 138.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.15 119.31 24.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.33 168.14 20.22 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.872 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.08 142.26 47.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.15 137.78 46.38 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.442 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.94 142.4 36.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -89.25 141.7 28.29 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.508 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 46' ' ' VAL . 43.2 pt -84.21 -7.53 10.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.664 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -71.92 -31.69 66.62 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 121.729 0.776 . . . . 0.0 108.919 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -90.16 -15.52 31.35 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.231 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -125.45 95.53 4.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.673 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.08 -34.89 79.1 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.044 0.215 . . . . 0.0 111.409 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.93 98.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.037 0.446 . . . . 0.0 110.023 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.1 -37.93 81.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.777 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.85 98.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.744 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.15 -39.23 94.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.03 -59.29 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.453 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -62.39 -31.38 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.331 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.74 -37.4 94.65 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.617 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -82.27 -13.71 56.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 58' ' ' THR . 27.5 m -110.75 13.34 8.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.182 0.992 . . . . 0.0 109.458 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -172.11 3.12 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.32 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.79 60.71 0.57 Allowed Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.187 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.89 -56.74 0.49 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.73 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -144.77 167.41 22.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -71.29 103.21 2.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.89 0.768 . . . . 0.0 110.005 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 -32.54 0.36 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.755 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' A' ' 16' ' ' TYR . 9.1 m -115.55 149.3 42.73 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 28.2 Cg_endo -63.57 147.03 93.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.906 2.404 . . . . 0.0 111.223 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 49' ' ' VAL . 32.2 m -134.65 140.05 45.74 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' THR . 34.1 m -105.93 132.18 53.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.03 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.15 115.66 30.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.98 162.19 22.75 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.319 0.387 . . . . 0.0 110.579 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.98 56.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.567 0.699 . . . . 0.0 109.7 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.32 -12.63 59.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.595 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.1 -22.93 31.99 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 171.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -105.48 174.36 5.91 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.448 1.124 . . . . 0.0 111.11 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 p -113.62 160.23 18.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.962 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -134.15 125.97 29.02 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -67.82 141.78 56.37 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -5.13 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.519 3.014 0 C-N-CA 126.449 1.9 . . . . 0.0 115.313 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.6 Cg_endo -96.54 138.48 0.62 Allowed 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 124.271 3.314 . . . . 0.0 111.895 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -72.71 173.2 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.897 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.93 86.98 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 5.4 t70 -81.07 -19.91 42.69 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.968 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.24 -43.41 70.62 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.679 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 7.6 m -68.92 -40.6 81.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.939 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 48.4 mtpt -53.11 -39.33 63.35 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.484 0.49 . . . . 0.0 111.649 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.5 84.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.545 0.528 . . . . 0.0 111.869 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -85.96 -35.94 20.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.626 0.727 . . . . 0.0 110.573 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.492 HD11 ' HB1' ' A' ' 5' ' ' ALA . 65.1 tp -66.74 -35.31 79.8 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.394 1.478 . . . . 0.0 112.517 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.18 -31.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.929 0.492 . . . . 0.0 111.772 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -70.4 -26.39 63.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.353 0.597 . . . . 0.0 110.276 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -83.93 -51.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.063 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.927 -177.187 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.82 -64.19 1.07 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.17 146.69 12.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.812 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 28.0 m -118.17 132.31 56.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.512 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.6 mt -92.71 128.7 44.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 124.061 0.944 . . . . 0.0 111.503 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 69.1 m-85 -110.09 119.09 38.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 173.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.09 -172.02 2.64 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.2 p -121.64 164.27 17.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.6 m -78.71 -7.85 58.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -102.8 2.48 35.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.175 0.512 . . . . 0.0 111.32 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 45.6 t -82.94 118.56 23.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.36 69.94 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.818 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.16 -10.48 59.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.092 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 23.0 t -61.09 -62.55 1.77 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.39 -29.21 69.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.494 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.72 -44.19 96.87 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.364 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.65 -37.87 67.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.6 mmtp -56.93 -43.13 81.17 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 m -57.4 -53.33 59.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.962 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.24 82.94 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.097 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -70.27 -37.24 74.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.559 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -70.98 -39.09 72.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.84 64.17 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.296 0.57 . . . . 0.0 111.259 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.92 14.52 27.9 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 44.55 59.8 3.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.597 1.159 . . . . 0.0 113.054 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.53 135.15 50.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.45 131.99 34.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.61 157.29 42.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 7' ' ' THR . 33.9 t70 -120.7 142.32 49.61 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -127.25 138.13 53.02 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.054 0.454 . . . . 0.0 110.528 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.8 141.23 37.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.46 143.83 26.08 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.326 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 48.6 pt -82.99 -0.36 4.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.939 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.7 -38.18 16.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -76.51 -35.96 58.02 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.463 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -105.35 99.99 9.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.783 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -68.82 -32.93 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -66.13 -41.77 90.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.54 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.66 75.78 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.323 0.582 . . . . 0.0 110.987 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -70.86 -44.52 66.22 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.127 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.07 -56.62 15.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.917 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 8.6 p -65.2 -27.0 41.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.36 -20.86 77.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.538 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -84.07 -24.41 30.4 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 122.616 0.366 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -115.12 13.12 7.98 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.07 167.58 11.69 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.315 -175.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.7 80.28 1.59 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.19 -82.92 0.34 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 32.7 t-20 -144.65 172.68 12.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -63.37 121.32 13.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.343 0.974 . . . . 0.0 111.833 -175.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 HG13 ' A' ' 56' ' ' VAL . 9.7 t -166.73 -25.62 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.43 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG23 ' A' ' 55' ' ' THR . 17.7 m -115.99 148.38 41.26 Favored Pre-proline 0 N--CA 1.445 -0.7 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 27.2 Cg_endo -62.22 138.02 69.53 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.894 2.396 . . . . 0.0 111.583 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 49' ' ' VAL . 40.5 m -129.22 144.29 51.16 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.8 m -109.82 129.61 64.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.855 0.359 . . . . 0.0 111.14 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -104.58 118.63 37.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -83.58 171.17 13.59 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.499 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.85 14.84 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.15 -10.46 49.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.154 0.502 . . . . 0.0 109.881 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.07 -15.15 58.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.878 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 m -94.4 166.61 11.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.476 0.638 . . . . 0.0 111.262 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -120.0 157.89 27.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.4 mt -128.19 122.31 31.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 167.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.4 m -61.73 141.33 57.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -5.18 89.67 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 127.513 2.325 . . . . 0.0 115.458 -171.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -96.24 154.8 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 124.265 3.31 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.2 t -84.96 175.32 9.14 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.31 73.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.08 -36.96 75.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.16 0.505 . . . . 0.0 110.095 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.72 -47.38 72.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -64.7 -41.0 90.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.842 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.8 -35.17 79.72 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.95 88.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.886 0.741 . . . . 0.0 111.679 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -85.35 -42.49 14.52 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.86 -37.76 77.23 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 112.302 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -31.39 45.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.438 0.637 . . . . 0.0 110.701 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -81.07 -31.04 34.59 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.045 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.51 -44.62 76.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.411 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.513 177.377 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -75.24 -51.99 11.97 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.335 0.588 . . . . 0.0 110.314 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -149.02 128.47 13.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.839 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.3 m -104.9 119.1 38.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 24' ' ' LEU . 80.0 mt -88.99 124.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.424 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 36' ' ' ILE . 28.0 m-85 -103.01 113.25 26.56 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.06 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -155.34 160.34 40.65 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -93.67 151.7 19.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.827 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -69.79 -22.11 63.35 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.936 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -88.07 -1.18 57.84 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -75.28 145.84 41.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 -33.17 25.93 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.89 -8.3 57.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.0 p -57.04 -57.05 14.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.53 -21.73 60.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.586 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -67.9 -46.85 70.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.36 -34.49 78.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.3 mmtp -62.43 -45.53 92.68 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 m -60.46 -41.66 94.6 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.94 75.43 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.492 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' A' ' 8' ' ' ILE . 57.6 mt -70.38 -45.25 66.4 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -63.38 -35.86 81.81 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 120.708 0.289 . . . . 0.0 111.632 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -10.04 59.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -110.78 14.84 22.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.777 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 63.96 27.41 14.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 113.154 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 64.3 mt -90.21 131.52 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.854 0.359 . . . . 0.0 111.175 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.86 39.1 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -148.05 174.92 11.45 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.53 137.28 51.67 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -125.94 132.57 52.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.722 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 p -139.14 151.86 23.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.05 141.38 28.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.991 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 46' ' ' VAL . 30.9 pt -83.68 -31.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -79.97 -15.05 58.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.092 0.949 . . . . 0.0 109.006 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -91.73 -1.27 57.47 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.528 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -135.98 104.92 5.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -50.7 -51.83 45.93 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.755 0.822 . . . . 0.0 112.426 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.94 79.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.341 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.78 -43.42 75.74 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.85 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -60.89 -43.71 98.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.448 0.699 . . . . 0.0 112.129 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -22.49 62.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 112.084 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -76.97 -61.54 1.95 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.608 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.6 p -62.22 -37.04 77.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.469 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.75 90.72 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.461 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -77.74 -29.84 51.32 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.758 0.314 . . . . 0.0 111.394 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.44 11.5 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 0.0 110.855 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.18 -172.74 3.93 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.311 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.56 85.33 0.39 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.6 -116.39 4.87 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -95.32 -175.84 3.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 98.82 7.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.647 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 t -139.27 -27.67 0.8 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.641 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.43 138.56 20.24 Favored Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.29 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.47 122.31 11.29 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.177 2.585 . . . . 0.0 111.258 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -112.0 132.42 54.8 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.9 p -103.5 121.59 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.249 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -100.41 118.49 36.75 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -86.34 165.88 16.05 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.658 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.98 51.58 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -85.37 -3.45 58.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.084 -0.385 . . . . 0.0 110.67 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.18 18.38 59.32 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.721 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 t -106.76 143.14 35.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.91 141.39 48.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.483 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.52 132.35 52.63 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -67.32 136.73 55.29 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -5.98 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.564 0 C-N-CA 126.828 2.051 . . . . 0.0 116.186 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 31.5 Cg_endo -97.52 169.34 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.678 3.586 . . . . 0.0 113.495 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -83.9 161.43 20.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -62.73 -40.07 96.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.759 0.424 . . . . 0.0 111.214 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.57 -43.22 93.68 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.012 0.434 . . . . 0.0 110.611 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -63.15 -48.99 76.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.901 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 17.5 m -68.45 -33.49 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 54.7 mtpt -62.87 -34.92 78.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.67 0.213 . . . . 0.0 110.614 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.68 67.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.263 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -84.17 -46.7 11.62 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.426 HD11 ' HB1' ' A' ' 5' ' ' ALA . 53.1 tp -55.69 -39.71 71.37 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.35 1.46 . . . . 0.0 112.936 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.27 -35.27 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.66 -22.38 46.88 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.81 0.814 . . . . 0.0 110.514 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.3 mt -84.99 -53.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.607 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.966 -175.754 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.86 -59.08 5.94 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.955 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.05 134.91 11.89 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.047 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -102.15 129.16 48.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.947 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG12 HG12 ' A' ' 59' ' ' VAL . 49.9 mt -93.48 120.44 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.18 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 60.6 m-85 -102.54 115.77 31.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -158.26 175.97 13.07 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.86 155.93 43.36 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -70.19 -15.86 62.99 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -85.46 -4.82 59.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.6 m -77.07 133.54 39.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.8 -38.9 35.28 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.979 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -75.78 -7.53 54.65 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 52.5 t -57.26 -61.74 2.26 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.4 -23.78 64.69 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 5.1 tpm_? -67.65 -43.08 81.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.648 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.96 -35.63 66.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -55.95 -48.41 75.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -66.28 -34.41 77.94 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.736 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.65 87.2 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.252 0.549 . . . . 0.0 110.4 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 mt -73.63 -41.96 62.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.0 m -65.31 -35.16 80.15 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.54 87.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.837 0.827 . . . . 0.0 109.974 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.46 3.03 48.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.8 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 58.7 31.54 21.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.792 0.837 . . . . 0.0 112.065 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.3 mt -75.14 137.24 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.32 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.49 119.74 32.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -134.27 163.74 28.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -128.87 135.25 48.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.61 141.19 46.67 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.606 0.241 . . . . 0.0 111.319 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.74 138.18 39.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 170.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -77.97 143.39 37.62 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.777 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.639 HG21 HG11 ' A' ' 46' ' ' VAL . 42.8 pt -83.32 -9.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.092 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.94 -32.13 27.33 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.76 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -88.04 -10.83 49.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.881 0.372 . . . . 0.0 110.761 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.73 98.06 6.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.69 -49.28 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.43 74.14 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.95 -42.96 72.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.388 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 110.207 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.48 -50.7 72.92 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.519 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -58.29 -56.24 24.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.406 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.639 HG11 HG21 ' A' ' 36' ' ' ILE . 7.1 p -64.39 -35.32 73.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.722 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.21 -34.91 89.53 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.558 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -66.75 -44.5 81.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.003 0.521 . . . . 0.0 109.91 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 58' ' ' THR . 33.2 m -92.58 13.11 2.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 111.868 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -172.88 3.21 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.27 2.72 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.0 -44.72 2.85 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-O 121.258 0.366 . . . . 0.0 113.044 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -119.79 142.58 48.46 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.47 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -77.4 94.22 4.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.587 176.607 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -139.68 -17.26 0.99 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.965 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -124.1 144.85 46.48 Favored Pre-proline 0 C--O 1.244 0.779 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 13.2 Cg_endo -56.63 131.61 46.69 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.682 2.922 . . . . 0.0 111.542 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 49' ' ' VAL . 23.4 m -124.18 138.46 54.41 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.0 m -104.78 127.44 59.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 123.377 0.423 . . . . 0.0 110.978 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -106.71 113.89 27.66 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.1 163.23 21.01 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.954 0.407 . . . . 0.0 110.843 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -62.54 -17.32 59.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.014 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.82 -6.4 59.42 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.35 39.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.103 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.5 p -111.21 154.06 24.94 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.803 0.801 . . . . 0.0 111.199 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -121.21 142.03 50.3 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.948 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.29 124.99 40.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.6 m -67.36 145.76 54.76 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -4.64 85.81 0.03 OUTLIER Pre-proline 0 N--CA 1.522 3.139 0 C-N-CA 126.56 1.944 . . . . 0.0 114.793 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -97.83 161.09 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.522 3.481 . . . . 0.0 113.455 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -80.57 159.33 25.49 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.43 66.17 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.31 -43.93 98.05 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.576 0.751 . . . . 0.0 110.737 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.78 -44.9 72.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.532 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.6 m -68.22 -35.94 73.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.618 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -61.62 -42.17 98.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.537 0.335 . . . . 0.0 110.818 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.09 67.56 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.827 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -84.3 -51.85 6.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.821 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.85 -36.77 65.42 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.947 0.899 . . . . 0.0 113.272 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.09 -34.54 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.029 0.442 . . . . 0.0 111.833 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -81.38 -48.63 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.35 -45.14 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.546 1.138 . . . . 0.0 112.76 -175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.946 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.031 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.43 85.78 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.064 0.853 . . . . 0.0 109.906 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.59 131.65 14.35 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.901 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -102.5 120.48 40.6 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 59' ' ' VAL . 60.3 mt -88.43 119.57 35.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.791 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 45.6 m-85 -104.89 114.82 29.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.589 174.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -163.85 -174.44 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -118.02 166.99 11.87 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 123.844 0.858 . . . . 0.0 109.253 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 m -78.84 -17.57 55.44 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.939 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -93.05 -1.93 56.1 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.3 t -81.34 131.2 35.28 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.838 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.2 -46.26 51.29 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -63.88 -15.71 59.63 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.721 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.6 t -59.14 -63.71 1.2 Allowed 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.347 0.404 . . . . 0.0 110.536 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.06 -24.62 61.55 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.823 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 29.1 mmm180 -65.8 -48.25 72.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.335 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.07 -32.14 68.73 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.07 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.5 mmmm -57.72 -43.41 85.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 m -64.1 -49.78 70.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.35 87.17 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.238 0.615 . . . . 0.0 112.492 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.78 -41.88 82.52 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.1 m -62.32 -42.12 99.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.451 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.03 66.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.781 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -103.58 9.35 37.48 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.884 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 3.6 mmp_? 62.32 43.34 8.34 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.608 0.718 . . . . 0.0 111.567 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.44 132.52 48.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.3 34.87 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -136.75 163.77 29.83 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.14 0.495 . . . . 0.0 112.198 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -121.49 142.48 50.01 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.31 139.89 48.36 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 117.918 0.326 . . . . 0.0 110.77 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.32 147.3 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.15 141.31 34.36 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.023 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.622 HG21 HG11 ' A' ' 46' ' ' VAL . 41.6 pt -83.76 -32.23 8.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.29 -14.88 60.53 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.147 -0.346 . . . . 0.0 111.648 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.53 -25.84 33.02 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.3 94.34 4.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.989 -0.445 . . . . 0.0 109.837 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.01 -45.34 64.53 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.86 92.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.631 0.253 . . . . 0.0 110.994 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.93 -41.44 78.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -65.82 -35.39 80.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 9.4 tp10 -70.41 -38.73 74.68 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.16 -58.46 7.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.282 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 36' ' ' ILE . 6.2 p -61.79 -35.35 67.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.1 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.77 72.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.551 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 m -83.66 -34.15 25.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.757 0.313 . . . . 0.0 111.523 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.4 m -94.5 10.62 4.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.776 0.798 . . . . 0.0 110.616 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -175.36 5.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.451 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.72 66.82 3.68 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.56 -66.91 0.26 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 65.3 t30 -142.12 162.06 36.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -57.6 114.33 2.2 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.887 -178.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.2 t -161.22 -30.63 0.05 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.626 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.77 152.04 44.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 36.7 Cg_endo -64.59 139.9 66.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.584 2.19 . . . . 0.0 112.119 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -126.57 136.57 52.72 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' THR . 30.7 m -105.02 129.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.133 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -103.97 119.43 38.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.4 172.25 13.9 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 120.79 0.329 . . . . 0.0 111.079 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.6 68.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.901 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -78.09 -17.96 56.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.941 0.401 . . . . 0.0 110.27 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.52 -19.54 28.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.579 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -71.59 160.51 32.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.322 0.561 . . . . 0.0 111.342 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -127.31 141.9 51.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.444 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.18 120.4 33.08 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -64.64 144.27 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -5.36 84.83 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -92.53 -170.58 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 123.612 2.875 . . . . 0.0 111.389 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 15.3 p -117.55 166.64 12.13 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.97 75.4 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.36 0.412 . . . . 0.0 111.776 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -69.66 -35.96 75.61 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.483 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -68.49 -45.03 73.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' SER . 10.8 m -67.63 -37.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.37 -31.48 71.37 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.81 80.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.553 0.533 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -84.03 -41.88 16.75 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.7 -39.0 89.91 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.528 1.131 . . . . 0.0 112.695 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.49 -35.63 55.39 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-O 120.977 0.417 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.65 -19.73 58.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.206 0.527 . . . . 0.0 111.264 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -80.86 -49.12 18.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.628 -179.546 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.4 -58.63 3.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 123.338 0.399 . . . . 0.0 111.248 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.76 144.27 13.39 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 m -110.05 124.83 52.17 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.948 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.521 HG12 HG12 ' A' ' 59' ' ' VAL . 86.8 mt -89.81 128.4 41.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 124.13 0.972 . . . . 0.0 110.512 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 81.0 m-85 -111.16 127.24 55.52 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -163.13 170.72 17.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 162.93 21.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -59.65 -30.18 68.56 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -87.19 0.13 55.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.87 112.93 16.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.27 70.45 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-N 116.371 -0.377 . . . . 0.0 114.004 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -82.83 -6.73 59.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.3 p -54.09 -60.12 3.75 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.76 -33.76 76.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.482 0.313 . . . . 0.0 111.743 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -59.79 -47.83 84.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.693 0.759 . . . . 0.0 109.794 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 tp -64.47 -38.7 91.93 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.82 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.7 mmtp -61.07 -46.73 89.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.141 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -59.54 -47.04 87.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.36 96.68 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.37 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 75' ' ' VAL . 76.8 mt -74.61 -35.27 62.95 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.316 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -66.47 -38.62 87.72 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 123.309 0.38 . . . . 0.0 110.278 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.68 97.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 111.401 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -86.73 -5.75 59.03 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 64.38 61.73 0.86 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.055 1.342 . . . . 0.0 113.253 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.58 138.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.28 108.23 19.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -120.77 156.68 31.34 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.18 142.16 40.36 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.12 132.36 38.0 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.429 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.4 131.72 40.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.75 140.03 37.08 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.954 0.883 . . . . 0.0 109.442 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 HG11 ' A' ' 46' ' ' VAL . 37.5 pt -84.25 -15.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.359 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.93 -34.18 77.21 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.307 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -78.29 -50.18 12.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -91.44 104.87 17.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -56.53 -44.07 80.45 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 125.626 1.571 . . . . 0.0 111.238 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.43 89.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -70.92 -38.92 72.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.33 91.19 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.698 0.624 . . . . 0.0 110.696 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.44 -51.44 68.69 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.098 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -56.09 -60.43 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.016 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 36' ' ' ILE . 7.2 p -65.5 -29.83 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 0.0 111.749 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.24 75.83 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.057 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -84.04 -36.87 22.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.2 m -98.41 13.33 4.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.33 175.79 10.28 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.514 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.07 88.31 0.89 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.39 -71.96 0.44 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.409 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 27.9 t-20 -144.62 162.31 36.96 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.7 117.18 10.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.627 0.727 . . . . 0.0 110.651 -178.651 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.0 t -163.81 -31.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.59 147.22 36.28 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.9 Cg_endo -60.3 146.52 96.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.072 2.515 . . . . 0.0 111.687 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.66 144.5 50.38 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 8' ' ' ILE . 16.3 m -110.97 131.58 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 123.168 0.293 . . . . 0.0 110.297 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -106.93 122.43 46.41 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 67.8 m-85 -86.83 177.91 7.15 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.275 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.12 66.38 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.516 0.727 . . . . 0.0 112.13 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 18.6 p-10 -82.57 -11.57 58.33 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.15 0.5 . . . . 0.0 110.365 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.8 3.77 68.07 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.319 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -97.43 152.53 18.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.4 p -115.84 154.19 30.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.317 0.58 . . . . 0.0 111.916 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -130.29 125.69 35.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 m -68.99 142.14 54.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -4.76 84.85 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.792 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 35.0 Cg_endo -93.99 150.83 2.16 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 123.934 3.089 . . . . 0.0 113.231 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 m -75.89 165.66 24.66 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.14 -33.96 72.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.98 -35.68 66.93 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.321 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.62 -43.85 88.31 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.999 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.5 m -67.82 -41.97 85.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 51.6 mtpt -60.61 -40.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.288 0.368 . . . . 0.0 110.756 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.95 75.88 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.777 0.673 . . . . 0.0 111.973 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 64.3 tttp -84.14 -45.42 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.584 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.65 -41.01 96.92 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.243 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.41 -38.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.782 0 O-C-N 123.448 0.468 . . . . 0.0 110.604 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.26 -25.29 63.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.78 -40.02 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.956 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.1 -60.55 3.6 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.823 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.0 135.34 12.28 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.696 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 85.5 m -102.63 123.94 47.25 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 59' ' ' VAL . 75.9 mt -88.96 124.69 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 59.3 m-85 -106.51 110.81 23.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.738 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 14.9 t -164.02 -177.2 4.91 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 149.98 51.41 Favored 'General case' 0 N--CA 1.396 -3.143 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -58.53 -8.41 1.23 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -91.37 -1.46 57.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.605 -0.685 . . . . 0.0 112.333 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.7 t -82.6 140.45 33.21 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.49 62.97 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -82.52 -7.8 59.63 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.8 t -61.69 -63.02 1.4 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.151 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.5 pt? -68.3 -28.58 67.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.158 0.504 . . . . 0.0 110.878 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -61.25 -50.59 72.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.86 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.48 -35.42 73.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.194 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.2 mmtp -57.97 -40.41 80.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -67.4 -48.69 66.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.385 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.81 -42.64 84.68 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.601 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 54.5 mt -69.63 -38.83 77.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.662 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -65.93 -35.89 81.87 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.876 0.37 . . . . 0.0 110.798 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.53 64.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.367 0.603 . . . . 0.0 111.38 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -109.91 13.49 23.46 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 43.09 62.64 1.75 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.024 1.729 . . . . 0.0 113.418 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 89.3 mt -105.66 129.85 58.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.402 -177.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.09 28.67 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -136.79 166.68 23.03 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.138 0.494 . . . . 0.0 111.495 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' THR . 17.2 t70 -121.34 126.08 48.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.28 137.2 54.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.262 0.554 . . . . 0.0 111.109 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.94 135.55 42.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 10' ' ' THR . 4.2 m-20 -76.45 140.99 41.49 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 12.1 pt -77.46 -26.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.55 -5.12 30.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.192 0.52 . . . . 0.0 111.665 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -94.45 -26.61 16.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -120.9 108.71 14.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.655 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -51.22 -48.56 62.04 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.766 1.226 . . . . 0.0 112.278 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.73 94.84 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.49 0.662 . . . . 0.0 110.683 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.32 -43.72 66.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.453 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 54' ' ' ARG . . . -59.99 -37.69 80.39 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.259 0.624 . . . . 0.0 112.391 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.13 -34.91 56.55 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.1 -58.23 7.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 6.5 p -62.77 -33.82 62.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.307 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.41 -30.23 74.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.988 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -79.99 -36.86 35.39 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 58' ' ' THR . 33.0 m -90.92 9.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.463 0.649 . . . . 0.0 110.537 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.25 -177.81 4.97 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.319 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.24 79.45 1.79 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.04 -98.18 1.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.58 -175.27 3.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.68 116.48 2.53 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -162.7 -34.26 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.359 172.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.06 150.0 42.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 44.7 Cg_endo -65.94 140.56 61.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.731 2.287 . . . . 0.0 111.48 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.4 HG21 ' CG2' ' A' ' 49' ' ' VAL . 22.9 m -129.86 140.49 50.98 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.9 m -107.38 136.7 41.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.684 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -117.79 114.88 23.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -84.69 168.13 15.53 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.453 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.08 -11.37 48.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.392 1.091 . . . . 0.0 109.546 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.22 -18.13 61.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.684 1.594 . . . . 0.0 109.643 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.09 -21.88 39.61 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.776 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.9 m -80.17 149.27 30.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.759 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.7 p -113.5 151.76 31.08 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.432 175.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.58 125.07 24.99 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -64.5 146.52 54.44 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -5.69 86.38 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.553 0 C-N-CA 127.119 2.168 . . . . 0.0 115.942 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -98.09 150.75 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 124.274 3.316 . . . . 0.0 112.907 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 168.55 19.81 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -60.05 -37.04 78.65 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.99 -34.31 75.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.476 0.655 . . . . 0.0 110.33 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -71.7 -34.85 69.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.798 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -78.34 -35.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.711 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 29.3 mtpp -63.96 -33.34 75.51 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.825 -0.17 . . . . 0.0 110.789 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.42 67.99 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.935 0.772 . . . . 0.0 111.836 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 82' ' ' ILE . 37.1 mttm -83.04 -50.7 8.25 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.898 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 tp -51.62 -37.42 50.08 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.035 0.934 . . . . 0.0 113.053 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.35 -38.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.477 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -80.86 -24.08 38.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.157 0.503 . . . . 0.0 110.313 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 78' ' ' LYS . 70.7 mt -80.22 -49.15 19.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.828 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.035 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.7 -0.19 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.27 34.0 m 51.39 18.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.416 1.487 . . . . 0.0 114.67 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -75.45 -33.55 60.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.32 80.55 3.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.11 27.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.217 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.45 136.74 15.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.128 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -103.35 123.54 47.0 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 31' ' ' TYR . 60.3 mt -88.76 120.25 37.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.71 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -103.54 117.66 34.93 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.004 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -161.25 167.63 25.61 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -100.68 160.44 14.35 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -72.2 -31.0 65.48 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -88.68 14.41 10.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.5 t -79.93 155.86 27.52 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.35 -37.92 13.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.783 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.57 -7.98 59.62 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.2 p -57.16 -61.94 2.11 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.242 0.473 . . . . 0.0 111.775 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.92 -21.82 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.872 0.368 . . . . 0.0 111.661 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -67.53 -51.03 55.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.57 -35.88 75.78 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.15 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.7 mmtt -55.26 -45.52 76.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.29 0.567 . . . . 0.0 110.396 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -65.43 -40.0 92.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.716 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.21 95.94 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 29' ' ' ILE . 71.3 mt -69.07 -43.17 75.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 m -61.9 -38.5 88.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -16.24 63.77 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.413 0.625 . . . . 0.0 111.548 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -110.29 9.47 23.67 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 54.92 32.64 18.34 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.054 1.342 . . . . 0.0 112.454 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 66.1 mt -76.91 128.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 120.888 0.375 . . . . 0.0 110.266 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.38 122.9 29.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 8' ' ' ILE . 52.3 p90 -139.86 165.19 27.97 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.122 0.487 . . . . 0.0 112.294 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.36 142.19 50.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.24 143.55 50.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.381 0.537 . . . . 0.0 111.312 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.55 140.91 36.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.5 141.6 41.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.631 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 37.7 pt -82.81 -26.1 8.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.255 9.6 pt-20 -84.23 -11.47 56.43 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 117.917 -1.513 . . . . 0.0 111.833 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -83.34 -49.43 9.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 170.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.68 96.47 10.66 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.51 -39.16 79.33 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.722 0.809 . . . . 0.0 112.082 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.203 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.09 -43.35 64.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.457 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -56.5 -44.58 80.83 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 124.01 0.819 . . . . 0.0 110.972 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -62.29 -47.23 85.23 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.299 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -59.72 -56.62 19.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.354 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.625 HG11 HG21 ' A' ' 36' ' ' ILE . 7.7 p -62.9 -35.78 72.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.406 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.46 73.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.027 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -79.38 -37.8 36.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.885 0.374 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -94.61 5.5 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.27 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -178.81 6.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.738 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.99 79.25 1.82 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.81 -64.51 3.66 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.86 171.07 14.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -62.0 108.75 1.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.906 0.882 . . . . 0.0 111.856 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.3 t -156.16 -39.75 0.08 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.054 -0.404 . . . . 0.0 111.796 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.21 149.36 39.12 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.914 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 29.1 Cg_endo -64.44 152.65 80.73 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.35 2.033 . . . . 0.0 110.954 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.5 m -140.38 141.05 35.63 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.3 m -107.87 131.7 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.644 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.85 118.67 37.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -84.8 171.63 12.12 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.304 0.573 . . . . 0.0 112.366 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.1 -10.41 14.48 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.978 1.311 . . . . 0.0 112.305 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 -13.46 26.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.368 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.69 -21.27 39.19 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.901 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -85.32 160.83 19.72 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 117.93 0.865 . . . . 0.0 110.75 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.9 p -113.33 166.81 11.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.997 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.5 mt -138.36 116.56 11.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -62.6 139.44 58.63 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -4.69 88.16 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 126.947 2.099 . . . . 0.0 115.623 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -98.37 164.61 0.72 Allowed 'Trans proline' 0 N--CA 1.435 -1.937 0 C-N-CA 124.053 3.168 . . . . 0.0 111.949 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 75' ' ' VAL . 3.1 m -90.81 171.12 9.55 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.5 84.15 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 122.638 0.375 . . . . 0.0 111.483 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.47 -47.99 83.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.126 0.488 . . . . 0.0 110.716 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.02 -42.6 99.34 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.223 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 71' ' ' SER . 11.2 m -72.21 -40.33 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -57.9 -43.55 86.21 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.029 0.443 . . . . 0.0 110.106 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.41 76.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.909 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -84.08 -50.2 8.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.136 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.4 -39.83 70.65 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.123 0.969 . . . . 0.0 113.001 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -59.21 -39.78 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -73.17 -26.79 61.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.884 0.373 . . . . 0.0 110.608 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.1 mt -75.5 -45.19 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.07 -47.76 23.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.109 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.92 -131.31 5.95 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 70.48 -50.82 0.66 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.54 73.22 6.22 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.244 1.021 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -174.65 -177.25 1.14 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 N--CA 1.418 -2.059 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 171.886 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.8 t 73.32 99.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.922 0.867 . . . . 0.0 111.137 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -43.27 68.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.105 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.2 75.32 6.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.17 73.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.941 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.43 140.88 21.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.18 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 22.0 m -106.83 124.13 49.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.384 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.49 HG12 HG12 ' A' ' 59' ' ' VAL . 74.8 mt -88.81 122.25 39.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.706 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 68.8 m-85 -99.65 111.6 23.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.696 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -146.18 174.12 11.6 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.62 162.38 30.49 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 t -66.95 -15.9 64.0 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.796 0.331 . . . . 0.0 111.863 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -99.31 5.6 46.47 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.64 112.95 19.3 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.749 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.59 73.63 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.19 -7.52 56.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 47.5 t -65.67 -62.04 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.894 0.378 . . . . 0.0 110.448 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 19' ' ' ARG . 1.4 pp -67.9 -21.08 65.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.966 0.888 . . . . 0.0 112.068 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 18' ' ' LEU . 8.9 tpt180 -66.74 -43.55 83.88 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.969 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -85.36 -32.84 22.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.504 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -53.14 -48.47 67.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.881 0.372 . . . . 0.0 111.82 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 p -64.03 -38.65 91.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.874 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.16 93.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.156 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.87 -47.6 61.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.169 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 m -61.47 -37.3 83.1 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 121.076 0.465 . . . . 0.0 110.827 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -10.06 59.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.746 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -115.75 19.41 15.24 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.194 -0.316 . . . . 0.0 111.625 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 53.87 33.01 16.21 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 125.998 1.719 . . . . 0.0 112.177 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -90.3 131.17 38.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 120.914 0.387 . . . . 0.0 110.948 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.37 143.75 26.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.05 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -158.06 166.87 31.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.691 0.282 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' THR . 24.8 t70 -129.89 142.48 50.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -128.14 142.47 51.18 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.445 0.566 . . . . 0.0 110.62 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.51 141.9 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -89.68 139.39 30.61 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.62 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 46' ' ' VAL . 34.7 pt -85.91 -11.13 11.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.0 -40.29 75.37 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.252 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -93.27 -30.03 15.37 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.703 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -88.09 99.93 12.55 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.518 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -71.79 -35.1 69.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.06 75.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.511 . . . . 0.0 109.638 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -74.28 -43.57 56.35 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.735 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.25 -43.04 99.53 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.103 0.561 . . . . 0.0 111.837 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.34 -45.88 92.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -59.65 -58.49 8.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 36' ' ' ILE . 7.6 p -62.59 -35.26 69.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.746 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.13 93.96 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.035 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 m -71.09 -34.81 71.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.755 0.312 . . . . 0.0 111.339 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.67 7.17 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.255 0.55 . . . . 0.0 111.411 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 -172.62 3.98 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.925 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.92 81.55 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -63.12 3.27 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -144.37 165.08 28.92 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -54.21 101.1 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.767 1.227 . . . . 0.0 112.164 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -146.66 -15.96 0.43 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.1 147.69 63.55 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 122.217 -0.302 . . . . 0.0 111.778 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 32.5 Cg_endo -64.83 137.18 52.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.72 2.28 . . . . 0.0 111.476 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -123.01 137.69 54.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 8' ' ' ILE . 19.3 m -102.43 129.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 120.69 0.281 . . . . 0.0 110.412 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -109.94 115.41 29.75 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -81.05 166.75 20.47 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -12.67 58.85 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.455 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.48 -9.5 49.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.252 0.548 . . . . 0.0 109.567 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.56 38.68 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.765 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -73.34 144.32 46.54 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 117.57 0.685 . . . . 0.0 111.46 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -113.64 143.47 44.52 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.646 1.179 . . . . 0.0 111.399 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -126.02 128.45 47.47 Favored 'General case' 0 C--O 1.253 1.256 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -66.96 137.5 56.56 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -6.07 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.8 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -171.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.51 171.08 3.63 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.636 2.89 . . . . 0.0 112.548 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 75' ' ' VAL . 23.7 t -95.02 170.37 9.47 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . . . -64.89 -32.29 73.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.042 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.94 -48.93 72.51 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.31 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.23 -48.87 63.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.373 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 72' ' ' ALA . 8.7 m -62.55 -35.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.25 -36.27 83.61 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.687 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.91 71.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.71 0.632 . . . . 0.0 111.025 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.1 mtpp -84.2 -50.22 8.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.997 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.59 -39.87 71.28 Favored 'General case' 0 C--O 1.252 1.218 0 C-N-CA 123.219 0.608 . . . . 0.0 112.621 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.74 -32.62 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -81.05 -29.14 35.1 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 78' ' ' LYS . 58.5 mt -71.73 -57.67 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.13 -23.55 47.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.944 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.1 44.13 88.44 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.51 -51.51 12.79 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.214 0.531 . . . . 0.0 109.598 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.82 136.83 51.99 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.123 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -104.96 -45.17 4.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.1 t60 . . . . . 0 C--N 1.311 -1.073 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.713 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.267 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.311 28.4 m -81.96 91.26 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 123.067 1.413 . . . . 0.0 113.559 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -74.44 -46.19 41.47 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.122 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.91 116.3 32.28 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.56 -63.89 1.25 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.462 0.649 . . . . 0.0 109.72 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 132.92 11.86 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.357 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -102.79 123.17 45.96 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.45 0.643 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.7 125.59 41.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -99.79 111.34 23.67 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.658 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.26 167.3 20.09 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 36' ' ' ILE . 25.1 m -138.86 158.0 45.01 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -46.32 -17.46 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 127.127 2.171 . . . . 0.0 115.028 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -77.42 -14.99 59.58 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.838 -0.538 . . . . 0.0 111.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 43.0 t -92.05 120.88 33.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.363 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.63 -30.32 68.76 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.355 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.91 -11.66 61.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 38.8 t -55.58 -55.27 33.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 110.483 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 19' ' ' ARG . 2.2 pp -69.98 -25.81 63.79 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.4 mmm180 -70.67 -44.62 66.64 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.92 -45.07 95.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.889 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.8 mmtp -55.77 -49.61 72.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.218 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 m -59.44 -43.99 93.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.999 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.35 98.42 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.34 -46.5 60.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.448 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.3 m -60.38 -37.33 80.42 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.326 0.391 . . . . 0.0 110.854 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.34 83.31 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 120.935 0.398 . . . . 0.0 112.025 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -99.77 8.76 43.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.289 0.566 . . . . 0.0 111.097 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 63.65 35.33 11.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.144 1.378 . . . . 0.0 113.388 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.86 125.88 38.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.778 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.45 123.63 26.82 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -131.23 161.64 31.77 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.425 0.631 . . . . 0.0 111.659 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.59 142.64 47.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.01 141.38 38.31 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.94 143.22 33.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.28 140.48 38.84 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.998 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.3 pt -83.59 -27.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.193 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -76.92 -25.29 52.77 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -70.74 -49.25 48.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.946 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -102.17 97.77 8.03 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.739 0.304 . . . . 0.0 110.705 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -56.38 -40.1 74.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.0 0.92 . . . . 0.0 112.047 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 -34.45 68.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.305 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -67.62 -38.97 84.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.48 -29.73 70.77 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.639 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 7.3 tp10 -74.75 -48.52 25.22 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -53.21 -56.01 19.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.167 0.987 . . . . 0.0 111.653 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.61 -27.35 42.71 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.972 0 CA-C-O 120.66 0.267 . . . . 0.0 111.094 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.1 -38.79 63.5 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.591 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.0 m -74.27 -34.59 63.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.77 0.319 . . . . 0.0 111.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 46' ' ' VAL . 31.0 m -94.58 13.02 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 0.0 111.541 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 -174.68 3.92 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.129 0.49 . . . . 0.0 110.114 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.53 69.96 3.19 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -61.93 0.79 Allowed Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.573 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 50.1 t30 -144.49 160.06 41.73 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.487 ' NH2' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -62.34 116.79 5.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.635 . . . . 0.0 111.078 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -155.97 -25.27 0.1 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.759 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 m -119.54 144.13 36.13 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 19.6 Cg_endo -60.07 140.54 93.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.834 2.356 . . . . 0.0 111.405 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -124.16 141.0 52.43 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.5 m -107.5 133.04 53.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.549 0.214 . . . . 0.0 110.694 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.0 112.36 23.95 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.461 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.5 m-85 -78.52 166.06 23.02 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.23 -18.05 56.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.496 0.498 . . . . 0.0 112.07 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.76 -11.39 58.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.143 0.496 . . . . 0.0 109.754 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.05 -7.07 56.87 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.208 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -79.61 145.67 32.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.069 0.462 . . . . 0.0 110.879 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -119.09 141.18 49.0 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.0 mt -131.52 143.53 50.45 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -73.91 140.61 45.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -6.75 83.11 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 C-N-CA 126.388 1.875 . . . . 0.0 116.009 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 19.7 Cg_endo -90.25 160.26 4.67 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.781 2.987 . . . . 0.0 112.563 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 m -82.22 173.7 11.86 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -64.48 -39.01 92.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.085 0.469 . . . . 0.0 111.498 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.44 -30.84 67.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.494 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.67 -42.71 73.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 14.1 m -72.24 -35.38 52.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.732 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 10.1 mtpm? -58.13 -36.25 72.68 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 123.124 0.265 . . . . 0.0 111.417 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.61 73.97 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.976 0.797 . . . . 0.0 111.963 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' O ' HG13 ' A' ' 82' ' ' ILE . 8.2 mtpm? -84.08 -48.46 9.86 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.09 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 tp -54.98 -40.59 70.22 Favored 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.02 0.825 . . . . 0.0 112.445 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.83 -43.27 95.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 123.508 0.505 . . . . 0.0 110.328 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -75.15 -21.11 59.03 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.593 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 78' ' ' LYS . 63.4 mt -73.57 -36.05 46.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 -39.61 10.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.686 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.02 80.17 0.88 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.1 mt -130.33 -77.02 0.53 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.45 -41.69 85.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -145.94 -56.05 0.29 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 78.9 t60 . . . . . 0 N--CA 1.409 -2.489 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 169.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 CA--C 1.504 -0.8 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.29 106.81 10.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 122.256 1.027 . . . . 0.0 109.074 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -26.13 29.51 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.051 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.13 94.32 3.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.66 54.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.299 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.27 135.9 23.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.305 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.6 m -103.62 124.85 49.58 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.861 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 59' ' ' VAL . 44.0 mt -89.03 118.73 34.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.856 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 80.6 m-85 -103.81 110.41 22.5 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.949 174.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.456 HG21 ' SG ' ' A' ' 17' ' ' CYS . 13.2 t -163.63 -177.66 5.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.76 152.39 51.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -54.09 -28.38 38.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.277 1.031 . . . . 0.0 113.084 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -77.63 -15.22 59.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -71.53 118.47 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.27 -43.05 93.77 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.667 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 23.7 m-85 -74.1 -7.57 53.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 t -63.6 -62.48 1.64 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 2.4 pp -70.56 -21.02 62.75 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.323 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 16' ' ' TYR . 6.7 tpm_? -72.25 -38.73 68.82 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.123 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -84.33 -24.07 29.94 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.0 mmtt -53.9 -42.87 69.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.792 0.437 . . . . 0.0 111.812 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.8 p -67.91 -37.17 81.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.324 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.87 80.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.793 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.38 -42.97 92.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.8 m -63.11 -46.3 87.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.59 -31.92 72.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.272 0.558 . . . . 0.0 111.093 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.97 11.52 24.84 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.571 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 59.2 32.26 21.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.708 0.803 . . . . 0.0 111.446 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.53 130.59 37.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.0 0.429 . . . . 0.0 109.963 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.3 124.4 36.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.01 162.06 36.42 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.864 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' THR . 37.5 t70 -121.39 133.56 55.09 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.54 139.72 49.34 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.17 147.86 27.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -83.49 138.94 33.21 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.714 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.665 HG21 HG11 ' A' ' 46' ' ' VAL . 39.0 pt -87.04 -23.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.82 -42.63 69.98 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.126 0.488 . . . . 0.0 109.807 -171.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -77.04 -26.72 54.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -103.74 93.16 4.76 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -55.63 -44.39 77.05 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.563 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -30.93 66.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.12 -42.63 68.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -62.92 -36.38 83.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.599 0.562 . . . . 0.0 110.451 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.38 -47.39 79.41 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.05 -58.43 8.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.174 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -64.22 -31.73 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.77 70.33 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.201 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 p -83.02 -26.19 31.45 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 46' ' ' VAL . 21.7 m -89.93 -11.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.124 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -73.13 167.19 21.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.053 -176.663 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.38 4.09 Favored Glycine 0 C--N 1.308 -1.006 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.183 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.56 -90.65 0.41 Allowed Glycine 0 C--N 1.313 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -120.24 172.21 7.95 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -64.27 54.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.56 1.544 . . . . 0.0 112.304 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -88.86 -32.05 17.97 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 122.055 -0.403 . . . . 0.0 111.925 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.37 151.87 63.46 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 12.5 Cg_endo -56.23 123.4 13.73 Favored 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.749 2.966 . . . . 0.0 111.791 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 m -106.51 133.44 51.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 8' ' ' ILE . 28.5 m -103.19 124.8 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.072 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -105.88 125.53 51.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.85 179.22 6.03 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.96 -10.74 58.93 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.237 0.615 . . . . 0.0 111.856 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -88.71 -8.64 54.17 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.15 81.35 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.118 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -99.54 151.52 21.06 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p -117.16 150.11 39.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.504 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.8 mt -124.1 125.08 43.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -68.33 147.35 52.26 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -5.32 83.01 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 C-N-CA 127.015 2.126 . . . . 0.0 114.909 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -98.99 157.67 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.781 2.987 . . . . 0.0 112.583 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 75' ' ' VAL . 30.5 p -84.4 166.2 17.55 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.808 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.41 -33.52 72.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.864 0.466 . . . . 0.0 112.079 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.84 -40.05 91.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.093 0.473 . . . . 0.0 110.521 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.22 -43.32 67.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.593 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 71' ' ' SER . 6.1 m -65.97 -35.5 75.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.116 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.34 -35.17 79.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.62 95.61 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.26 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -76.79 -38.62 53.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.126 0.488 . . . . 0.0 110.345 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.56 -36.46 84.28 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.473 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.7 -22.45 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.126 0.489 . . . . 0.0 111.243 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -80.17 -30.48 38.83 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -83.16 -57.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.5 -45.65 5.74 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.765 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.32 55.64 4.63 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.519 HD22 ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -70.11 -9.8 56.7 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 126.046 1.738 . . . . 0.0 111.736 -178.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.519 ' HG3' HD22 ' A' ' 85' ' ' LEU . 43.7 mt-10 -154.71 169.79 23.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -88.93 -64.9 1.08 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 C--O 1.257 1.472 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 174.858 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 CA--C 1.513 -0.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.12 84.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 t -94.79 -17.69 21.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.78 103.02 3.87 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.76 -56.19 15.16 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.623 0.577 . . . . 0.0 112.222 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 59' ' ' VAL . 1.7 pt? -147.05 137.75 23.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.616 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -106.67 112.13 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.355 1.062 . . . . 0.0 109.648 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.3 mt -88.92 131.81 35.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 111.997 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.423 ' OH ' ' HE2' ' A' ' 60' ' ' LYS . 74.8 m-85 -111.44 104.24 12.66 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 12.6 t -165.27 142.88 5.97 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -102.99 155.99 17.98 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -63.1 -4.85 2.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -77.63 -13.62 59.86 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.558 -0.714 . . . . 0.0 111.168 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.82 144.19 39.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.02 -41.71 39.38 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.652 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.0 -5.67 49.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -50.72 -59.95 3.55 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.019 0.372 . . . . 0.0 111.877 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.4 pt? -72.36 -26.0 61.75 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.432 0.158 . . . . 0.0 111.121 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -59.69 -47.48 85.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.7 tp -67.21 -44.38 79.71 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.74 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 73.8 mmtt -57.4 -55.56 33.2 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.889 0.376 . . . . 0.0 110.723 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 m -59.65 -40.47 87.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.76 -46.74 89.28 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.893 0.377 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 67.2 mt -69.23 -43.66 73.6 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 m -62.97 -37.36 86.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.248 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.74 85.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.38 7.01 38.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 58.53 46.99 14.07 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.812 0.815 . . . . 0.0 111.64 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 24' ' ' LEU . 81.4 mt -97.96 119.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.794 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.94 115.01 11.73 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.684 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -128.29 156.86 42.36 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.809 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -115.43 142.39 46.77 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.22 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.12 139.02 44.34 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.195 -0.316 . . . . 0.0 110.39 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.08 145.12 33.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 37' ' ' GLU . 30.5 t70 -87.73 142.03 28.14 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.918 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG21 HG11 ' A' ' 46' ' ' VAL . 23.6 pt -83.18 -25.7 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.59 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 43.8 tt0 -73.83 -34.41 64.54 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.266 0.555 . . . . 0.0 109.533 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -91.01 -0.19 57.69 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -133.74 99.59 4.51 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -62.5 -43.41 98.87 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.44 72.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.892 0.377 . . . . 0.0 110.749 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.71 -42.15 67.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.85 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.74 84.98 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.557 0.694 . . . . 0.0 110.621 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -63.73 -43.58 96.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.012 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.13 -56.74 9.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.777 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -59.62 -25.66 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.06 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.22 -42.74 96.18 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.641 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.6 m -74.41 -31.31 62.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.065 0.432 . . . . 0.0 111.846 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -91.65 8.43 4.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.904 0.859 . . . . 0.0 111.118 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.49 174.32 9.04 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.34 88.4 1.09 Allowed Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.84 -89.78 0.7 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -134.02 173.92 11.04 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 102.24 1.0 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.112 0.958 . . . . 0.0 113.08 -175.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -146.79 -26.86 0.41 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.15 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 m -113.86 151.44 44.75 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 19.1 Cg_endo -60.9 143.02 99.27 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.31 2.673 . . . . 0.0 111.485 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.441 HG21 ' CG2' ' A' ' 49' ' ' VAL . 19.7 m -132.27 150.55 52.13 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 6' ' ' LEU . 8.4 p -128.96 130.94 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE2' ' OH ' ' A' ' 9' ' ' TYR . 32.3 mtmt -100.58 136.11 40.97 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.97 176.08 6.73 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.58 63.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.142 0.972 . . . . 0.0 109.034 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -74.97 -18.07 60.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.847 1.659 . . . . 0.0 109.534 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.99 30.09 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.354 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -74.58 152.63 39.25 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 122.309 0.244 . . . . 0.0 110.723 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.1 p -113.53 155.11 25.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.331 0.586 . . . . 0.0 112.3 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -132.71 125.26 29.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -70.63 144.52 51.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -4.87 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.477 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -100.51 -177.79 0.17 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 123.686 2.924 . . . . 0.0 112.393 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -114.6 172.73 6.85 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -43.96 78.07 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 122.772 0.429 . . . . 0.0 111.484 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.7 -52.89 54.15 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 111.681 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -62.3 -39.76 94.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.803 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -78.84 -31.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.391 -0.524 . . . . 0.0 112.249 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -60.25 -32.44 71.16 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.142 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.6 71.65 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.894 0.746 . . . . 0.0 111.286 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.9 mtpp -84.88 -44.28 13.35 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.592 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.7 tp -54.42 -41.17 69.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.575 0.75 . . . . 0.0 112.594 -176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.08 -33.2 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.58 0.55 . . . . 0.0 111.642 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 88' ' ' HIS . 65.7 mttm -80.33 -42.51 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.297 0.57 . . . . 0.0 109.835 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 78' ' ' LYS . 53.7 mt -61.07 -31.56 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.859 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.23 -3.11 15.46 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.241 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.11 33.14 12.43 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 mt -131.07 171.89 12.73 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 67.88 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.321 1.448 . . . . 0.0 114.728 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.98 94.29 7.1 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 59.0 t-80 . . . . . 0 C--N 1.31 -1.118 0 CA-C-O 118.383 -0.818 . . . . 0.0 108.972 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 CA--C 1.506 -0.742 0 CA-C-O 120.611 0.243 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.94 121.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 CA-C-O 122.019 0.914 . . . . 0.0 111.721 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -25.44 62.4 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.591 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.18 110.24 12.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.6 -60.19 2.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.29 143.25 22.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.176 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -102.97 124.77 49.1 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.34 112.33 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 123.601 0.761 . . . . 0.0 110.467 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 88.4 m-85 -98.85 114.27 26.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.34 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 t -163.69 149.52 11.32 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.62 152.03 21.59 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -67.37 -20.96 65.63 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.798 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -83.58 1.99 39.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.04 149.79 33.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -34.99 28.18 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.512 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -81.67 -7.11 59.56 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -54.63 -51.59 64.93 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -83.87 -23.28 31.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -64.94 -41.58 95.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.858 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 70' ' ' PRO . 25.0 tp -74.5 -24.21 58.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.617 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 43.2 mmtm -62.67 -36.28 82.38 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.186 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -55.85 -47.72 76.77 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 123.794 0.684 . . . . 0.0 110.128 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.17 77.54 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.976 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 98.3 mt -67.03 -44.8 79.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.359 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.9 m -66.85 -38.29 86.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -23.69 66.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.513 0.673 . . . . 0.0 111.41 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -106.75 4.72 27.96 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.069 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 50.49 44.7 27.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.921 1.288 . . . . 0.0 112.036 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 24' ' ' LEU . 72.0 mt -82.72 127.82 39.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.552 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.91 134.19 35.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -147.55 164.19 34.21 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -118.68 139.11 52.06 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.15 134.99 55.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.844 0.354 . . . . 0.0 111.277 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.95 126.39 26.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.77 141.06 33.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 46' ' ' VAL . 40.8 pt -84.85 -9.35 11.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.29 -43.7 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 109.864 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -92.27 -28.82 16.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.997 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.26 91.64 6.37 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.203 0.525 . . . . 0.0 110.532 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -76.06 -25.8 55.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.321 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -33.23 73.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.71 -40.06 66.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.568 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.04 84.42 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.7 -53.48 56.88 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -56.92 -57.91 10.44 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.861 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.62 -32.37 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.74 75.79 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.374 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -81.24 -22.1 38.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG23 HG21 ' A' ' 58' ' ' THR . 35.9 m -108.6 13.16 8.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.709 0.766 . . . . 0.0 110.347 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.65 -173.16 2.8 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.825 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.35 71.05 2.55 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.91 -67.94 2.88 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.873 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -119.74 151.62 38.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.64 114.72 8.12 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.525 0.678 . . . . 0.0 109.52 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -154.83 -29.86 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.441 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.91 142.44 25.24 Favored Pre-proline 0 C--O 1.241 0.643 0 O-C-N 122.078 -0.389 . . . . 0.0 111.543 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 22.5 Cg_endo -62.48 131.9 35.86 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.738 2.292 . . . . 0.0 111.215 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.421 HG21 HG23 ' A' ' 49' ' ' VAL . 23.2 m -117.51 137.79 52.31 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.77 128.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 120.804 0.335 . . . . 0.0 110.746 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -104.95 119.29 38.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.52 174.4 11.47 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.538 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.81 66.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.362 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -75.92 -14.94 60.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.375 . . . . 0.0 110.77 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.01 -21.98 36.43 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.909 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 m -81.81 158.58 24.04 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 117.82 0.81 . . . . 0.0 110.459 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.1 p -113.84 163.29 15.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -134.58 121.55 21.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.2 m -62.95 137.21 58.21 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.257 24.9 p-10 -5.46 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.875 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HG2' HG13 ' A' ' 75' ' ' VAL . 92.7 Cg_endo -97.35 147.79 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.684 3.59 . . . . 0.0 111.936 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -77.37 174.48 10.76 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.64 77.38 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.546 0.738 . . . . 0.0 111.972 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.68 -41.39 94.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.932 0.396 . . . . 0.0 111.799 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.2 -41.67 81.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.871 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.439 HG13 ' HG2' ' A' ' 70' ' ' PRO . 5.8 m -69.03 -40.88 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.998 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -57.67 -44.39 85.7 Favored 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 123.381 0.426 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.79 73.08 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 124.151 0.907 . . . . 0.0 112.642 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -84.35 -47.57 10.58 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.245 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.82 -36.2 76.3 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.278 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 -32.77 56.61 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.094 0.473 . . . . 0.0 111.083 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.35 -34.75 31.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.431 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.8 mt -67.26 -41.11 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.376 0.608 . . . . 0.0 109.761 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.52 -20.19 60.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.463 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.86 35.1 78.76 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.132 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.7 mt -87.38 -6.61 58.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.008 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -127.25 172.3 10.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.7 -69.77 0.42 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.462 0.167 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 4' ' ' ALA . 26.7 m -117.26 122.55 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.496 0 CA-C-O 122.625 1.202 . . . . 0.0 112.526 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -90.06 -16.94 28.7 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.27 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . -137.55 141.15 41.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.93 -60.17 1.64 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -156.32 131.15 9.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.165 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -101.72 117.54 35.1 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.254 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 59' ' ' VAL . 97.5 mt -89.05 121.06 38.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.522 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.11 123.62 47.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 8.9 t -163.9 171.76 14.92 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.878 0.736 . . . . 0.0 109.187 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 36' ' ' ILE . 9.2 p -108.69 159.17 16.96 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -76.44 -13.55 60.11 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.524 0.202 . . . . 0.0 111.35 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -86.58 -2.2 58.29 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -83.98 132.2 34.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -30.12 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.86 -19.64 62.62 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.7 t -58.6 -61.29 2.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 123.503 0.502 . . . . 0.0 110.435 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 19' ' ' ARG . 3.5 pp -65.47 -29.39 70.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.579 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' N ' HD12 ' A' ' 18' ' ' LEU . 20.3 tpp180 -61.8 -50.18 73.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.83 -39.95 79.72 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.71 -46.66 81.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -59.43 -46.11 89.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.95 95.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.592 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 mt -74.93 -36.84 62.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.076 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -63.68 -41.47 98.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.57 73.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 0.0 111.596 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -92.92 -1.89 56.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 56.17 52.3 10.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.946 0.879 . . . . 0.0 111.581 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.89 140.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.54 114.45 20.26 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -132.92 152.04 51.96 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.671 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' THR . 6.3 m-20 -114.05 116.51 29.28 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.293 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -113.31 131.16 56.05 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.247 0.546 . . . . 0.0 110.845 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.02 130.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -85.89 141.6 29.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.453 HG21 HG11 ' A' ' 46' ' ' VAL . 36.7 pt -83.94 -9.02 11.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.27 -26.1 68.63 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.82 -2.37 30.17 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.998 0.428 . . . . 0.0 110.875 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -124.33 88.47 2.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -69.22 -30.48 68.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.981 -171.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.17 -35.94 78.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.603 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.61 97.97 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.375 0.607 . . . . 0.0 110.443 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.08 -46.48 84.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.18 -58.94 5.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.669 0.787 . . . . 0.0 111.28 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 42' ' ' ALA . 4.4 p -61.69 -32.25 53.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' A' ' 54' ' ' ARG . . . -69.18 -29.06 72.22 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.724 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -78.47 -28.21 46.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.355 0.598 . . . . 0.0 110.889 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG21 ' A' ' 58' ' ' THR . 24.5 m -101.81 13.67 6.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.759 0.79 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -173.59 3.86 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.244 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.72 78.75 0.42 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.69 -89.63 0.61 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -138.89 -175.24 4.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 2.1 mpp_? -54.58 111.78 0.87 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.498 0.499 . . . . 0.0 112.236 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.47 -33.39 0.08 Allowed 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.596 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -123.75 148.79 57.45 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.695 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 22.8 Cg_endo -64.52 155.0 68.88 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.356 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.47 HG21 ' CG2' ' A' ' 49' ' ' VAL . 31.5 m -135.91 140.41 44.05 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.3 m -105.73 133.59 49.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 123.237 0.336 . . . . 0.0 110.497 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -112.41 111.68 22.7 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.4 m-85 -77.65 165.82 23.79 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.654 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.82 -11.99 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.539 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 2.1 p-10 -84.05 -9.84 58.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.5 -2.01 60.53 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.695 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -91.97 145.39 24.58 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 117.359 0.579 . . . . 0.0 110.677 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -113.38 141.25 47.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.097 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -132.53 133.2 43.45 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.0 m -70.51 139.1 51.54 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -5.48 90.87 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.728 0 C-N-CA 126.661 1.984 . . . . 0.0 115.572 -170.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.2 Cg_endo -95.18 152.8 1.67 Allowed 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 124.471 3.448 . . . . 0.0 112.915 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.6 t -71.79 163.07 28.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.38 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.46 77.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.43 0.692 . . . . 0.0 111.695 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.66 -26.72 61.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.719 0.295 . . . . 0.0 110.641 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.21 -45.57 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.4 m -64.19 -37.01 78.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.648 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -59.92 -35.57 75.17 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.334 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.09 79.0 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.435 0.46 . . . . 0.0 111.912 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 7.8 mtpm? -84.29 -45.11 13.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.103 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.69 -33.36 72.74 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.418 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 86' ' ' GLU . 9.5 p -62.97 -31.96 54.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 CA-C-O 121.289 0.566 . . . . 0.0 110.691 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -78.54 -47.34 17.46 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.73 -40.09 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.493 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.79 63.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 111.708 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.63 27.82 41.26 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -99.05 -36.67 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.225 -0.487 . . . . 0.0 109.981 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 80' ' ' VAL . 35.2 tt0 -72.52 113.59 9.72 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.154 0.502 . . . . 0.0 109.964 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -116.43 -60.57 1.84 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 67.9 t60 . . . . . 0 C--N 1.319 -0.731 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.719 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.61 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.93 77.59 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.642 1.21 . . . . 0.0 111.22 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.591 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 7.8 t -85.69 -20.73 28.94 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.139 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.51 148.76 33.58 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.19 -64.03 1.28 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 HD23 HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -157.11 133.04 9.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.944 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.1 m -105.52 123.72 48.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.915 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.18 130.21 42.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 124.115 0.966 . . . . 0.0 111.147 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -106.6 119.17 38.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -163.84 162.2 23.55 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.11 175.56 5.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.1 t -76.11 -21.63 56.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.491 0.186 . . . . 0.0 111.037 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -77.62 -15.31 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.499 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.42 109.37 8.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.39 -22.8 59.33 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' HG12 ' A' ' 56' ' ' VAL . 86.7 m-85 -82.55 -7.31 59.65 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 25.2 p -54.88 -59.46 4.7 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.3 pt? -69.98 -25.93 63.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -59.47 -50.17 74.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.988 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.37 -40.09 85.73 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.399 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.02 -45.75 79.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.613 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -56.09 -40.54 73.79 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.63 77.41 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.099 0.476 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 29' ' ' ILE . 57.1 mt -72.87 -42.31 63.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.716 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -64.33 -32.31 73.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.8 -27.79 69.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.627 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.96 3.27 25.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 47.36 58.44 4.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.109 0.964 . . . . 0.0 112.145 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 75.7 mt -89.62 128.86 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.157 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.7 10.81 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.199 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -116.79 175.12 5.72 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.0 t70 -139.93 139.41 36.16 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.69 141.24 50.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.97 142.61 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.28 140.49 44.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.544 0.688 . . . . 0.0 111.481 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 46' ' ' VAL . 38.4 pt -86.19 -24.85 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.387 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.05 -39.19 66.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.825 0.345 . . . . 0.0 111.855 -169.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -89.29 3.58 51.61 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.56 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -129.75 93.23 3.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -47.11 -55.74 7.84 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.7 74.97 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 123.481 0.488 . . . . 0.0 111.399 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.96 -47.22 66.16 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.269 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.2 -36.9 84.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.356 0.598 . . . . 0.0 111.25 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.61 -37.17 85.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.11 -60.99 1.93 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.076 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 36' ' ' ILE . 5.8 p -59.16 -36.12 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.52 74.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.6 m -82.94 -30.28 28.47 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.156 0.503 . . . . 0.0 110.837 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 46' ' ' VAL . 34.2 m -98.2 13.55 4.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-O 121.414 0.626 . . . . 0.0 111.245 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.07 173.62 12.4 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.932 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.4 63.34 3.36 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.92 -119.29 4.43 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' THR . 4.2 p-10 -93.77 164.27 13.2 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.7 110.03 0.59 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.945 0.898 . . . . 0.0 110.416 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.2 t -162.33 -26.66 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.275 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 16' ' ' TYR . 10.7 m -113.4 150.41 43.09 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 120.486 0.184 . . . . 0.0 111.241 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.18 150.53 65.8 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.258 1.972 . . . . 0.0 110.454 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.427 HG21 HG23 ' A' ' 49' ' ' VAL . 28.3 m -132.12 136.7 47.31 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.474 HG21 HD23 ' A' ' 6' ' ' LEU . 10.4 p -104.77 127.87 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.017 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -113.59 111.86 22.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 64.1 m-85 -81.83 171.51 14.42 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.434 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.35 -16.83 62.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.274 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.34 -12.32 52.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.187 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.14 -18.22 42.89 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.579 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -80.69 148.95 29.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 117.27 0.535 . . . . 0.0 111.972 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.1 p -115.5 143.53 45.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.841 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.32 129.06 50.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -71.04 141.02 50.93 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -5.75 87.81 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 C-N-CA 126.565 1.946 . . . . 0.0 115.583 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -90.68 -172.48 0.52 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 124.048 3.165 . . . . 0.0 111.378 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.533 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 23.3 m -118.02 173.87 6.53 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -59.37 -43.67 92.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.92 -37.43 81.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.831 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 12.8 mp0 -63.15 -45.7 90.65 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.751 0.82 . . . . 0.0 110.877 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 71' ' ' SER . 13.7 m -70.53 -35.14 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.772 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 56.3 mtpt -61.17 -41.71 97.27 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.43 73.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.929 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -84.07 -48.03 10.31 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.27 -42.44 73.54 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.445 1.098 . . . . 0.0 112.82 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.23 -32.89 49.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.69 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -80.82 -19.94 43.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.195 0.521 . . . . 0.0 110.841 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -85.67 -46.06 17.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.59 -26.78 18.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.85 49.46 22.97 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.689 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.76 -70.14 0.56 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.55 81.11 7.19 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -139.04 90.39 2.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.844 -174.61 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 ttp . . . . . 0 CA--C 1.502 -0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -82.27 111.66 19.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.417 0.627 . . . . 0.0 110.323 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -100.89 -19.3 15.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.63 39.19 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.24 -62.21 1.54 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -151.78 130.0 11.97 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.27 119.31 38.63 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.545 0.528 . . . . 0.0 111.402 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.02 130.63 38.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.9 m-85 -114.88 109.04 17.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.271 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 6.9 t -164.28 -178.75 5.67 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.895 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.486 ' HB ' ' CD1' ' A' ' 13' ' ' TRP . 33.0 m -152.84 154.79 35.84 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 m -48.82 -18.35 0.26 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.486 ' CD1' ' HB ' ' A' ' 11' ' ' THR . 68.2 p-90 -77.37 -18.45 57.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 64.0 m -74.52 141.88 44.82 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.02 -49.95 43.95 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.002 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -72.93 -6.1 42.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 26.6 p -47.53 -62.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -76.96 -25.88 53.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -61.58 -43.92 97.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.537 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.62 -40.65 84.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.27 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.9 mmmm -58.62 -50.62 73.15 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -61.28 -46.13 91.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.519 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.37 83.46 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.405 0.44 . . . . 0.0 111.113 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 62.8 mt -71.71 -42.24 67.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.241 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.3 m -64.24 -38.2 90.19 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.249 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.76 -30.52 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 111.622 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -100.11 22.18 11.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.025 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.258 10.9 ptp180 43.82 61.34 2.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 125.477 1.511 . . . . 0.0 114.245 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 68.8 mt -113.45 119.09 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.971 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 127.96 32.87 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.714 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -139.91 168.72 19.16 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.681 0.753 . . . . 0.0 112.599 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.03 139.98 51.69 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.631 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.44 145.71 51.92 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.52 147.37 25.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.35 140.74 41.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.732 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.512 HG21 HG11 ' A' ' 46' ' ' VAL . 25.3 pt -86.79 -29.22 5.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.483 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.94 -55.63 27.54 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.346 0.658 . . . . 0.0 112.39 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -93.97 15.49 16.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.39 0.614 . . . . 0.0 112.158 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -130.68 91.39 3.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.38 -47.35 79.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.26 -22.79 65.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.729 0.3 . . . . 0.0 111.524 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -86.65 -47.06 9.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.86 -43.74 98.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.257 0.551 . . . . 0.0 111.201 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.73 -38.13 89.94 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.174 0.99 . . . . 0.0 110.049 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.75 -60.0 3.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.19 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -60.44 -35.02 60.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.62 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.64 72.92 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.843 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.0 m -83.83 -32.54 25.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.767 0.317 . . . . 0.0 111.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.2 m -94.72 9.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.038 0.447 . . . . 0.0 111.043 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 175.98 8.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.198 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.32 87.06 1.55 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.12 -72.06 0.72 Allowed Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -144.73 172.62 12.75 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -61.51 109.22 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.442 0.639 . . . . 0.0 111.115 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -149.37 -34.76 0.18 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.824 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.75 152.03 50.87 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 14.6 Cg_endo -58.33 139.33 90.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.58 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' HG23 ' A' ' 46' ' ' VAL . 23.7 m -125.26 147.83 48.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 6' ' ' LEU . 14.6 p -122.13 128.64 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.797 0 O-C-N 123.491 0.494 . . . . 0.0 110.229 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.63 129.94 55.55 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -94.07 166.2 12.26 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.497 0.189 . . . . 0.0 111.359 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.31 -16.18 59.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.947 0.899 . . . . 0.0 112.898 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.71 -5.17 58.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 109.882 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.94 18.42 47.3 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.23 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -107.06 149.76 27.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.68 0.74 . . . . 0.0 110.541 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 p -114.87 154.65 28.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.995 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -131.26 126.85 36.53 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -68.46 136.04 52.59 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 11.0 t30 -5.89 91.62 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -171.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.425 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 28.9 Cg_endo -100.41 174.05 0.33 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.498 3.465 . . . . 0.0 112.439 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.46 168.2 10.53 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.415 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.48 71.01 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 24.3 t70 -79.65 -28.31 40.84 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.489 -1.284 . . . . 0.0 111.339 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.61 -40.67 97.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.387 0.613 . . . . 0.0 109.908 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 13.5 m -77.86 -30.95 16.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.969 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 9.5 mtpm? -57.41 -40.52 78.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.95 -35.24 66.45 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 123.941 0.776 . . . . 0.0 112.009 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.4 mtpp -84.03 -50.5 7.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.038 0.447 . . . . 0.0 111.115 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.64 -38.25 71.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.829 0.852 . . . . 0.0 112.828 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.27 -32.14 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 120.899 0.38 . . . . 0.0 111.268 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.06 -44.1 18.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.35 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 72.2 mt -56.97 -53.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.75 0.656 . . . . 0.0 110.789 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -33.12 73.22 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.396 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.25 27.66 35.98 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.869 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -87.15 122.04 30.42 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 63.3 -169.44 0.19 Allowed 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.036 0.835 . . . . 0.0 110.001 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -129.9 100.28 5.41 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 C--N 1.292 -1.902 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.099 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.238 0.485 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.68 132.89 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.671 0.748 . . . . 0.0 110.426 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -45.05 72.92 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.243 -177.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -119.31 114.01 21.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -64.03 1.28 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.017 0.437 . . . . 0.0 111.478 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt? -152.5 139.25 18.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -105.96 124.22 49.23 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 HG23 ' A' ' 10' ' ' THR . 91.4 mt -104.62 134.09 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.295 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -114.59 116.3 28.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.589 0.756 . . . . 0.0 109.412 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 57' ' ' PRO . 49.5 p -129.88 156.91 43.61 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD11 ' A' ' 36' ' ' ILE . 26.8 p -99.47 164.92 11.89 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -78.94 -22.51 45.65 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.393 0.615 . . . . 0.0 110.561 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 55' ' ' THR . 31.3 p-90 -101.46 -8.42 21.98 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 42.5 t -84.73 142.13 30.06 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.326 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.36 -19.21 67.07 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.707 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.62 -14.43 58.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.778 -0.836 . . . . 0.0 111.906 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 77.8 m -59.34 -59.16 5.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.336 0.398 . . . . 0.0 111.403 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.471 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.3 pt? -74.4 -26.44 60.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -65.61 -42.79 91.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.363 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.44 -39.28 92.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.319 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -59.02 -44.9 91.78 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -58.38 -49.37 77.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.961 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.19 98.32 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.905 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 29' ' ' ILE . 50.0 mt -70.49 -42.3 71.55 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.395 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -64.45 -34.33 77.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.612 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.39 73.75 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.21 0.529 . . . . 0.0 110.694 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -96.79 10.65 38.22 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 63.65 20.51 12.27 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.308 1.043 . . . . 0.0 111.917 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 24' ' ' LEU . 73.3 mt -73.95 128.55 36.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.319 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.69 143.42 27.59 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -152.98 172.81 16.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.116 0.484 . . . . 0.0 112.242 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -119.68 119.61 34.2 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -114.35 124.04 50.97 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.264 0.554 . . . . 0.0 110.257 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.04 137.7 48.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.11 141.73 28.27 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 117.88 -1.528 . . . . 0.0 110.729 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 HG21 HG11 ' A' ' 46' ' ' VAL . 26.2 pt -84.93 -2.85 7.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.403 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -76.27 -37.58 57.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -87.01 -42.86 12.78 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.062 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -86.67 97.34 10.52 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.435 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -71.95 -28.9 63.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.077 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.41 74.53 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.47 -37.84 77.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.343 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.06 98.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.175 0.59 . . . . 0.0 110.905 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.13 -45.61 92.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -56.73 -60.71 3.16 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.916 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG11 HG21 ' A' ' 36' ' ' ILE . 4.3 p -61.21 -34.34 60.14 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.089 -178.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.08 90.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.586 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.8 p -80.11 -11.37 59.77 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -115.23 13.73 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 121.813 0.816 . . . . 0.0 109.525 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -98.88 -171.84 2.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 -174.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 69.4 2.83 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.96 -96.87 1.6 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.2 174.46 5.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -76.79 111.16 12.01 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.267 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.402 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . 9.8 t -133.46 -17.49 2.29 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.796 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 152.9 81.03 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 10' ' ' THR . 36.5 Cg_endo -67.29 157.72 60.39 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.204 1.936 . . . . 0.0 111.924 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -141.74 148.59 39.25 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.589 HG21 HD12 ' A' ' 6' ' ' LEU . 7.1 p -120.47 136.65 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 O-C-N 123.666 0.604 . . . . 0.0 109.899 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -113.15 127.55 56.22 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.43 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 97.0 m-85 -85.77 169.57 13.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -60.79 -27.66 68.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.574 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.19 -16.68 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.661 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.11 -19.07 27.87 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-O 119.741 -0.477 . . . . 0.0 114.236 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -73.76 153.3 40.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.788 0.794 . . . . 0.0 112.616 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 p -118.26 153.66 33.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.142 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.9 mt -132.75 123.18 25.74 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.6 m -65.41 138.49 58.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -5.03 92.16 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.506 0 C-N-CA 126.873 2.069 . . . . 0.0 115.949 -170.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -98.85 -169.75 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.724 2.95 . . . . 0.0 111.913 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 75' ' ' VAL . 48.2 t -117.94 172.1 7.62 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.84 -50.14 66.87 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 11.1 m-20 -71.89 -30.2 65.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.81 -43.53 98.07 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.351 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 71' ' ' SER . 15.5 m -80.28 -30.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 52.5 mtpt -60.08 -40.87 91.07 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.41 -36.8 64.34 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.122 0.889 . . . . 0.0 111.707 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -84.11 -48.58 9.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.18 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.58 -41.14 72.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.735 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.35 -34.54 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.217 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 91.6 mttt -82.37 -19.6 38.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.014 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' LYS . 78.2 mt -84.67 -46.21 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.79 66.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.258 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.57 -123.74 2.23 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 41.33 -87.84 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 126.661 1.984 . . . . 0.0 115.994 168.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' HIS . 37.2 tt0 -99.76 109.55 21.99 Favored 'General case' 0 C--O 1.209 -1.027 0 C-N-CA 122.156 0.182 . . . . 0.0 110.546 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 86' ' ' GLU . 63.6 t-80 162.72 -45.31 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.421 -1.895 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.486 -178.349 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 49.6 tpp . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 120.86 0.362 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.445 HG12 HG22 ' A' ' 3' ' ' THR . 22.0 t 66.04 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.072 1.349 . . . . 0.0 111.659 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 HG12 ' A' ' 2' ' ' VAL . 7.9 t 173.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.04 157.62 17.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.92 -64.43 1.13 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.531 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.5 131.98 6.64 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.918 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -102.68 127.27 49.87 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.942 -174.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.23 123.7 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 124.983 1.313 . . . . 0.0 110.659 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.8 m-85 -103.68 115.79 31.14 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -163.64 169.81 18.03 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.461 HG23 ' CG1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -123.77 161.15 25.8 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -74.36 -8.19 55.43 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.699 0.285 . . . . 0.0 111.76 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -86.95 -5.48 59.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -78.69 144.21 35.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.97 -42.8 84.48 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.218 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -82.11 -5.67 58.59 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.4 p -50.29 -63.13 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -68.67 -29.53 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.282 0.563 . . . . 0.0 111.543 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -59.88 -47.19 86.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.775 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.8 tp -70.55 -34.75 72.58 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.574 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 10.2 mmmm -62.14 -47.17 85.74 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -65.41 -43.77 89.54 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.767 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -45.53 84.22 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.872 0.368 . . . . 0.0 111.675 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.85 -37.7 70.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.208 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.2 m -65.99 -43.7 86.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.78 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.23 -34.34 77.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.232 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -91.41 6.69 44.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.89 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 54.95 62.29 2.58 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.422 1.089 . . . . 0.0 112.004 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.56 133.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.537 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.85 125.35 29.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.72 159.67 41.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.323 0.582 . . . . 0.0 110.895 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' THR . 20.6 m-20 -122.43 142.35 50.64 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -137.14 139.17 41.0 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.558 0.617 . . . . 0.0 111.762 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.23 144.78 28.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.33 143.14 26.7 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 117.915 -1.514 . . . . 0.0 110.738 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 HG11 ' A' ' 46' ' ' VAL . 35.6 pt -84.13 -3.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.407 -1.27 . . . . 0.0 113.184 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.06 -36.94 16.67 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.493 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -77.82 -33.62 52.32 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.023 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -103.52 102.88 12.79 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -65.53 -36.5 83.99 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.486 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.79 -32.05 72.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 111.068 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -75.8 -41.03 54.0 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.043 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.85 -44.38 89.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.122 0.569 . . . . 0.0 111.38 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.82 -38.23 81.44 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.751 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.48 -61.44 1.77 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.207 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -57.34 -35.79 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.04 73.12 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.843 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.53 -25.78 30.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.054 0.454 . . . . 0.0 111.177 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.23 13.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.029 0.919 . . . . 0.0 110.438 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 165.83 16.22 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.986 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.62 87.18 1.39 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.67 -97.74 1.86 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 48.4 t30 -86.21 149.89 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -72.87 102.41 3.42 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 53' ' ' ASN . 8.9 t -157.93 -8.08 0.08 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.051 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 55' ' ' THR . 5.7 m -126.71 144.68 50.73 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.4 Cg_endo -58.85 140.08 93.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.28 2.653 . . . . 0.0 111.477 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.7 m -128.66 138.9 52.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.9 m -102.71 133.73 45.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.378 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -110.63 112.72 24.8 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 87.7 m-85 -78.78 159.79 27.71 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 123.557 0.535 . . . . 0.0 109.732 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.42 -14.02 46.08 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 13.4 p-10 -85.63 -12.45 51.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.18 15.77 24.91 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.1 p -105.45 157.01 17.65 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.195 -0.591 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.5 p -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.58 0.229 . . . . 0.0 110.537 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -128.45 127.51 42.63 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 m -66.78 145.68 55.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -5.11 85.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 C-N-CA 126.295 1.838 . . . . 0.0 115.887 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -95.0 159.64 1.72 Allowed 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 123.761 2.974 . . . . 0.0 112.486 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 p -83.49 168.62 16.31 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.59 77.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.367 0.603 . . . . 0.0 110.634 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.97 -25.45 62.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.665 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.24 -43.88 22.88 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 122.257 -0.277 . . . . 0.0 111.538 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.89 -40.77 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.83 -34.59 71.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.39 77.41 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.652 0.595 . . . . 0.0 112.207 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -85.84 -44.69 12.23 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.061 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -53.35 -40.09 64.65 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.505 1.122 . . . . 0.0 113.15 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.91 -39.17 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.43 0.456 . . . . 0.0 111.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -79.28 -31.4 43.33 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.162 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 78' ' ' LYS . 62.8 mt -74.96 -52.85 17.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.079 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB1' ' SD ' ' A' ' 1' ' ' MET . . . -81.3 -36.97 29.15 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.895 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.27 77.41 1.15 Allowed Glycine 0 CA--C 1.459 -3.45 0 CA-C-O 123.247 1.471 . . . . 0.0 111.335 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -132.96 123.88 26.75 Favored 'General case' 1 N--CA 1.376 -4.126 0 CA-C-N 112.149 -2.025 . . . . 0.0 107.45 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 62.41 81.35 0.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.959 0.885 . . . . 0.0 112.725 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -97.0 149.89 21.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--N 1.295 -1.802 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.705 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.74 124.15 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -72.72 -41.43 65.21 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.355 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.67 77.93 1.09 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.34 -58.89 6.59 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.421 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.19 132.16 18.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.348 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -112.18 122.64 48.31 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' LEU . 96.4 mt -91.63 123.77 43.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.003 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.49 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 29.7 m-85 -105.43 118.88 37.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -163.84 164.31 23.55 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 162.84 14.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -71.01 -19.44 62.52 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -83.82 -1.22 53.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -80.6 123.23 27.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.14 92.98 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.549 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -82.27 -7.15 59.62 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 37.0 t -52.52 -59.41 4.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.187 0.305 . . . . 0.0 111.655 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.13 -23.15 63.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.14 -48.25 65.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.8 tp -63.88 -40.15 95.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.602 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.3 mmtp -60.16 -51.79 68.08 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.258 0.552 . . . . 0.0 110.409 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 25' ' ' THR . 17.1 p -67.73 -31.85 72.07 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.428 -177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.53 84.57 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 120.941 0.4 . . . . 0.0 110.488 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 55.4 mt -72.03 -40.96 68.04 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.439 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' THR . 4.1 t -64.76 -29.6 70.58 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.411 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.41 -31.75 58.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.206 0.526 . . . . 0.0 111.006 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -91.53 12.86 19.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 61.18 33.36 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.583 1.153 . . . . 0.0 110.43 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 24' ' ' LEU . 78.3 mt -87.26 133.57 29.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.408 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.67 123.57 34.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -145.81 175.44 10.41 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.059 0.457 . . . . 0.0 111.4 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -129.27 142.08 50.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.82 126.77 38.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 133.9 43.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.01 140.69 57.71 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 40.5 pt -84.35 -18.8 9.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.99 -45.37 74.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.572 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -72.2 -36.97 69.35 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.613 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -91.05 93.4 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.024 0.44 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -55.25 -46.02 76.06 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.969 0.907 . . . . 0.0 111.802 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.19 70.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.41 81.2 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . . . -64.24 -41.59 96.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.173 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.78 -43.01 90.06 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.47 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.95 -52.79 63.54 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.566 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 49' ' ' VAL . 14.3 m -68.35 -21.97 26.9 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.52 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.27 68.35 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.058 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.89 -23.5 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.026 0.441 . . . . 0.0 110.795 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 46' ' ' VAL . 32.1 m -114.74 13.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.706 0.765 . . . . 0.0 110.606 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -88.87 -171.61 3.37 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.134 -172.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 65.87 3.18 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.87 -73.07 1.6 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -110.47 161.73 15.39 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -71.16 100.67 2.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.211 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -149.67 -17.89 0.27 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.286 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -116.91 145.62 35.97 Favored Pre-proline 0 C--O 1.248 1.013 0 O-C-N 121.907 -0.496 . . . . 0.0 111.82 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.53 127.42 26.13 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.581 2.854 . . . . 0.0 111.342 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -113.71 135.31 54.07 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.26 125.29 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.771 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.07 111.85 23.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -82.16 171.03 14.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.347 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -15.3 63.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.939 0.875 . . . . 0.0 109.104 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.47 -17.98 61.72 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.709 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 -22.67 21.35 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.508 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -73.42 151.94 40.97 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 p -119.53 143.4 47.6 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.8 mt -125.32 132.97 52.77 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -72.32 139.53 48.02 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -5.49 88.39 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' O ' HD13 ' A' ' 20' ' ' LEU . 19.7 Cg_endo -99.23 153.38 0.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 123.998 3.132 . . . . 0.0 111.145 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -86.34 172.88 10.1 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.718 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.65 55.59 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.774 0.829 . . . . 0.0 113.065 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 19.0 m-20 -69.92 -19.74 63.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -82.49 -39.35 22.59 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.36 -31.03 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 51.0 mtpt -54.5 -40.23 68.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.94 0.496 . . . . 0.0 110.832 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.73 71.38 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 124.238 0.961 . . . . 0.0 112.0 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.5 mtpp -84.15 -47.24 11.07 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.953 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 5' ' ' ALA . 60.7 tp -57.8 -39.89 78.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.797 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.95 -31.2 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.341 0.591 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -81.09 -43.04 20.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 78' ' ' LYS . 76.1 mt -59.3 -34.8 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.67 -16.33 64.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.91 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.15 3.26 70.07 Favored Glycine 0 CA--C 1.505 -0.592 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.27 161.43 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 58.5 22.7 9.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.545 0.528 . . . . 0.0 111.685 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -128.46 98.34 5.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.3 m80 . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.45 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 CA--C 1.5 -0.98 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.51 82.97 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.47 0.652 . . . . 0.0 110.471 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -94.42 -21.57 18.85 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.08 143.45 30.43 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 -53.18 4.23 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.877 0.846 . . . . 0.0 108.788 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.07 136.83 17.07 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.727 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.8 m -102.26 110.07 21.93 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 59' ' ' VAL . 89.9 mt -88.49 130.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.817 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.83 105.44 13.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.334 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -164.66 -171.12 2.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -149.62 164.59 34.73 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -56.01 -20.67 17.58 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.664 1.185 . . . . 0.0 113.812 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -82.09 -2.07 50.69 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.9 t -95.92 129.32 43.21 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.68 -31.94 81.52 Favored Glycine 0 N--CA 1.46 0.243 0 CA-C-O 121.493 0.496 . . . . 0.0 112.1 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -80.96 -7.94 59.64 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 31.6 t -64.57 -61.74 2.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.41 -29.2 68.63 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.723 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -62.97 -39.12 93.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.5 tp -75.89 -45.96 32.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.214 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -53.7 -49.27 68.41 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.933 0.396 . . . . 0.0 110.884 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -66.87 -37.25 84.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.103 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.28 91.33 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 120.951 0.405 . . . . 0.0 110.734 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.4 -42.35 71.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -62.71 -40.74 98.1 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.426 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.89 66.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 110.942 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -91.04 4.19 52.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.663 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 61.23 29.64 18.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 111.584 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.95 131.52 33.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.97 35.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.11 164.34 30.04 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.974 0.416 . . . . 0.0 111.799 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.82 122.52 34.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.225 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.31 129.61 56.66 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.958 0.409 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.1 138.7 53.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.43 141.33 28.85 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.004 -1.478 . . . . 0.0 111.092 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.599 HG21 HG11 ' A' ' 46' ' ' VAL . 29.2 pt -85.1 5.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.8 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.88 -45.29 12.4 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -85.27 -34.66 21.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.759 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.91 92.95 7.15 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.722 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -72.25 -28.29 63.05 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.14 76.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.6 -39.52 70.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.332 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.16 90.86 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 110.831 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.03 -48.67 77.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.692 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.87 -56.83 16.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.438 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.15 -33.29 61.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.6 73.82 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.935 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -76.18 -45.63 32.39 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.047 0.451 . . . . 0.0 110.164 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.96 3.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.458 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.78 -172.37 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.187 0.518 . . . . 0.0 109.948 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.07 64.23 2.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.14 -73.81 0.22 Allowed Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.483 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 39.9 t-20 -135.89 169.65 17.24 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -70.94 107.01 3.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.349 0.977 . . . . 0.0 110.799 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.1 t -138.14 -23.24 1.02 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.004 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.38 154.6 79.18 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 39.0 Cg_endo -67.84 145.56 69.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.316 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.8 m -128.87 143.65 50.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.4 m -111.17 134.25 54.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 123.164 0.29 . . . . 0.0 110.417 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -111.76 118.88 36.82 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 93.2 m-85 -80.09 178.59 8.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.96 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.71 58.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.563 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 33.7 p-10 -88.3 -18.48 28.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.784 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.37 -1.63 53.81 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.99 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -84.48 144.65 28.58 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.96 140.94 48.87 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.754 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.79 140.75 50.31 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.7 m -77.73 147.45 35.38 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -5.53 83.27 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.833 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -98.51 139.53 0.41 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 123.57 2.847 . . . . 0.0 112.269 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -72.11 174.53 7.01 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.648 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.01 -47.03 78.55 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 123.829 0.851 . . . . 0.0 113.176 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 15.7 m-20 -76.29 -19.76 57.96 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.383 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.28 -44.17 65.74 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 -34.99 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.812 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 55.6 mtpt -56.68 -36.53 69.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.199 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.61 73.98 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.903 0.752 . . . . 0.0 111.628 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -84.05 -40.82 17.88 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.613 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 tp -60.27 -38.27 83.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.941 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.8 -32.94 57.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.079 0 CA-C-O 121.499 0.666 . . . . 0.0 110.753 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 87' ' ' HIS . 8.8 mtpm? -81.75 -31.24 32.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.41 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.08 -36.49 68.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.322 0.582 . . . . 0.0 109.86 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.4 62.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.177 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.47 18.77 79.51 Favored Glycine 0 CA--C 1.5 -0.897 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.626 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.93 -40.92 27.13 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.064 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -89.51 -48.01 7.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.675 0.75 . . . . 0.0 109.133 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 56.6 t-80 -168.82 168.88 10.24 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.0 m80 . . . . . 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.234 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.836 0.35 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.69 113.28 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.279 1.038 . . . . 0.0 111.611 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 m -102.08 -42.87 5.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.705 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.49 129.95 46.8 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.9 -54.75 41.29 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.683 0.614 . . . . 0.0 111.519 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.15 137.87 19.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -103.45 119.39 38.8 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 59' ' ' VAL . 92.2 mt -88.76 122.48 40.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 54.1 m-85 -102.61 121.9 43.33 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 173.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -163.51 171.41 15.9 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 149.13 27.86 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.1 t -67.35 -20.95 65.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.471 0.177 . . . . 0.0 110.594 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.86 5.25 41.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.4 t -85.85 132.37 34.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.97 -32.91 58.2 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 56' ' ' VAL . 50.5 m-85 -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 51.5 t -57.11 -56.43 21.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 123.585 0.553 . . . . 0.0 110.307 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.65 -21.69 61.78 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 36.7 mmt180 -65.28 -51.1 62.97 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.09 -40.35 96.05 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.731 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.8 mmtp -60.31 -41.13 92.83 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.8 m -59.96 -45.28 93.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.052 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.35 -51.25 66.7 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.671 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.65 -44.49 86.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.9 m -64.02 -34.28 77.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.748 0.309 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.39 -25.18 67.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.141 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.83 9.26 36.99 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 122.082 -0.386 . . . . 0.0 110.74 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 54.92 41.18 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.828 0.851 . . . . 0.0 111.298 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.4 mt -84.38 138.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.15 119.31 24.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.33 168.14 20.22 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.872 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.08 142.26 47.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.15 137.78 46.38 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.442 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.94 142.4 36.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -89.25 141.7 28.29 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.508 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 46' ' ' VAL . 43.2 pt -84.21 -7.53 10.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.664 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -71.92 -31.69 66.62 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 121.729 0.776 . . . . 0.0 108.919 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -90.16 -15.52 31.35 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.231 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -125.45 95.53 4.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.673 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.08 -34.89 79.1 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.044 0.215 . . . . 0.0 111.409 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.93 98.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.037 0.446 . . . . 0.0 110.023 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.1 -37.93 81.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.777 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.85 98.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.744 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.15 -39.23 94.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.03 -59.29 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.453 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -62.39 -31.38 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.331 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.74 -37.4 94.65 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.617 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -82.27 -13.71 56.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 58' ' ' THR . 27.5 m -110.75 13.34 8.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.182 0.992 . . . . 0.0 109.458 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -172.11 3.12 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.32 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.79 60.71 0.57 Allowed Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.187 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.89 -56.74 0.49 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.73 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -144.77 167.41 22.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -71.29 103.21 2.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.89 0.768 . . . . 0.0 110.005 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 -32.54 0.36 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.755 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' A' ' 16' ' ' TYR . 9.1 m -115.55 149.3 42.73 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 28.2 Cg_endo -63.57 147.03 93.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.906 2.404 . . . . 0.0 111.223 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 49' ' ' VAL . 32.2 m -134.65 140.05 45.74 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' THR . 34.1 m -105.93 132.18 53.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.03 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.15 115.66 30.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.98 162.19 22.75 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.319 0.387 . . . . 0.0 110.579 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.98 56.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.567 0.699 . . . . 0.0 109.7 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.32 -12.63 59.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.595 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.1 -22.93 31.99 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 171.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -105.48 174.36 5.91 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.448 1.124 . . . . 0.0 111.11 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 p -113.62 160.23 18.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.962 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -134.15 125.97 29.02 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -67.82 141.78 56.37 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -5.13 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.519 3.014 0 C-N-CA 126.449 1.9 . . . . 0.0 115.313 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.6 Cg_endo -96.54 138.48 0.62 Allowed 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 124.271 3.314 . . . . 0.0 111.895 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -72.71 173.2 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.897 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.93 86.98 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 5.4 t70 -81.07 -19.91 42.69 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.968 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.24 -43.41 70.62 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.679 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 7.6 m -68.92 -40.6 81.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.939 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 48.4 mtpt -53.11 -39.33 63.35 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.484 0.49 . . . . 0.0 111.649 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.5 84.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.545 0.528 . . . . 0.0 111.869 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -85.96 -35.94 20.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.626 0.727 . . . . 0.0 110.573 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.492 HD11 ' HB1' ' A' ' 5' ' ' ALA . 65.1 tp -66.74 -35.31 79.8 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.394 1.478 . . . . 0.0 112.517 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.18 -31.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.929 0.492 . . . . 0.0 111.772 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -70.4 -26.39 63.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.353 0.597 . . . . 0.0 110.276 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -83.93 -51.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.063 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.66 76.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.927 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 88' ' ' HIS . . . 81.09 65.36 1.7 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.158 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.3 mt -118.07 -71.56 0.73 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.135 0.493 . . . . 0.0 110.074 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.38 131.71 34.73 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.7 m80 72.75 -51.39 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.178 1.391 . . . . 0.0 113.905 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 3.4 p80 . . . . . 0 C--N 1.294 -1.843 0 C-N-CA 122.608 0.363 . . . . 0.0 111.767 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.25 144.83 36.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 t -115.67 -0.2 13.05 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.423 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.47 148.96 52.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.82 -64.19 1.07 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.17 146.69 12.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.812 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 28.0 m -118.17 132.31 56.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.512 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.6 mt -92.71 128.7 44.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 124.061 0.944 . . . . 0.0 111.503 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 69.1 m-85 -110.09 119.09 38.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 173.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.09 -172.02 2.64 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.2 p -121.64 164.27 17.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.6 m -78.71 -7.85 58.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -102.8 2.48 35.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.175 0.512 . . . . 0.0 111.32 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 45.6 t -82.94 118.56 23.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.36 69.94 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.818 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.16 -10.48 59.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.092 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 23.0 t -61.09 -62.55 1.77 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.39 -29.21 69.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.494 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.72 -44.19 96.87 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.364 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.65 -37.87 67.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.6 mmtp -56.93 -43.13 81.17 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 m -57.4 -53.33 59.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.962 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.24 82.94 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.097 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -70.27 -37.24 74.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.559 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -70.98 -39.09 72.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.84 64.17 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.296 0.57 . . . . 0.0 111.259 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.92 14.52 27.9 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 44.55 59.8 3.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.597 1.159 . . . . 0.0 113.054 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.53 135.15 50.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.45 131.99 34.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.61 157.29 42.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 7' ' ' THR . 33.9 t70 -120.7 142.32 49.61 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -127.25 138.13 53.02 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.054 0.454 . . . . 0.0 110.528 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.8 141.23 37.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.46 143.83 26.08 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.326 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 48.6 pt -82.99 -0.36 4.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.939 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.7 -38.18 16.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -76.51 -35.96 58.02 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.463 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -105.35 99.99 9.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.783 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -68.82 -32.93 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -66.13 -41.77 90.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.54 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.66 75.78 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.323 0.582 . . . . 0.0 110.987 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -70.86 -44.52 66.22 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.127 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.07 -56.62 15.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.917 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 8.6 p -65.2 -27.0 41.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.36 -20.86 77.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.538 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -84.07 -24.41 30.4 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 122.616 0.366 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -115.12 13.12 7.98 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.07 167.58 11.69 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.315 -175.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.7 80.28 1.59 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.19 -82.92 0.34 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 32.7 t-20 -144.65 172.68 12.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -63.37 121.32 13.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.343 0.974 . . . . 0.0 111.833 -175.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 HG13 ' A' ' 56' ' ' VAL . 9.7 t -166.73 -25.62 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.43 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG23 ' A' ' 55' ' ' THR . 17.7 m -115.99 148.38 41.26 Favored Pre-proline 0 N--CA 1.445 -0.7 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 27.2 Cg_endo -62.22 138.02 69.53 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.894 2.396 . . . . 0.0 111.583 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 49' ' ' VAL . 40.5 m -129.22 144.29 51.16 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.8 m -109.82 129.61 64.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.855 0.359 . . . . 0.0 111.14 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -104.58 118.63 37.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -83.58 171.17 13.59 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.499 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.85 14.84 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.15 -10.46 49.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.154 0.502 . . . . 0.0 109.881 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.07 -15.15 58.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.878 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 m -94.4 166.61 11.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.476 0.638 . . . . 0.0 111.262 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -120.0 157.89 27.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.4 mt -128.19 122.31 31.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 167.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.4 m -61.73 141.33 57.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -5.18 89.67 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 127.513 2.325 . . . . 0.0 115.458 -171.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -96.24 154.8 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 124.265 3.31 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.2 t -84.96 175.32 9.14 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.31 73.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.08 -36.96 75.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.16 0.505 . . . . 0.0 110.095 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.72 -47.38 72.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -64.7 -41.0 90.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.842 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.8 -35.17 79.72 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.95 88.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.886 0.741 . . . . 0.0 111.679 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -85.35 -42.49 14.52 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.86 -37.76 77.23 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 112.302 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -31.39 45.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.438 0.637 . . . . 0.0 110.701 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -81.07 -31.04 34.59 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.045 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.51 -44.62 76.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.34 -27.71 66.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.513 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.41 50.85 Favored Glycine 0 CA--C 1.495 -1.193 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.083 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 mt -96.96 14.7 24.57 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -89.6 4.18 50.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.803 0.811 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -108.97 147.32 32.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 C--N 1.304 -1.37 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.405 179.091 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.07 140.22 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 t -84.81 -31.69 23.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.271 0.557 . . . . 0.0 109.565 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.04 111.3 17.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -75.24 -51.99 11.97 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.335 0.588 . . . . 0.0 110.314 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -149.02 128.47 13.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.839 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.3 m -104.9 119.1 38.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 24' ' ' LEU . 80.0 mt -88.99 124.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.424 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 36' ' ' ILE . 28.0 m-85 -103.01 113.25 26.56 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.06 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -155.34 160.34 40.65 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -93.67 151.7 19.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.827 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -69.79 -22.11 63.35 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.936 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -88.07 -1.18 57.84 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -75.28 145.84 41.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 -33.17 25.93 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.89 -8.3 57.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.0 p -57.04 -57.05 14.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.53 -21.73 60.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.586 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -67.9 -46.85 70.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.36 -34.49 78.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.3 mmtp -62.43 -45.53 92.68 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 m -60.46 -41.66 94.6 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.94 75.43 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.492 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' A' ' 8' ' ' ILE . 57.6 mt -70.38 -45.25 66.4 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -63.38 -35.86 81.81 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 120.708 0.289 . . . . 0.0 111.632 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -10.04 59.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -110.78 14.84 22.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.777 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 63.96 27.41 14.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 113.154 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 64.3 mt -90.21 131.52 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.854 0.359 . . . . 0.0 111.175 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.86 39.1 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -148.05 174.92 11.45 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.53 137.28 51.67 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -125.94 132.57 52.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.722 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 p -139.14 151.86 23.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.05 141.38 28.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.991 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 46' ' ' VAL . 30.9 pt -83.68 -31.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -79.97 -15.05 58.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.092 0.949 . . . . 0.0 109.006 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -91.73 -1.27 57.47 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.528 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -135.98 104.92 5.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -50.7 -51.83 45.93 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.755 0.822 . . . . 0.0 112.426 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.94 79.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.341 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.78 -43.42 75.74 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.85 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -60.89 -43.71 98.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.448 0.699 . . . . 0.0 112.129 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -22.49 62.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 112.084 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -76.97 -61.54 1.95 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.608 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.6 p -62.22 -37.04 77.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.469 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.75 90.72 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.461 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -77.74 -29.84 51.32 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.758 0.314 . . . . 0.0 111.394 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.44 11.5 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 0.0 110.855 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.18 -172.74 3.93 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.311 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.56 85.33 0.39 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.6 -116.39 4.87 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -95.32 -175.84 3.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 98.82 7.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.647 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 t -139.27 -27.67 0.8 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.641 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.43 138.56 20.24 Favored Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.29 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.47 122.31 11.29 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.177 2.585 . . . . 0.0 111.258 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -112.0 132.42 54.8 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.9 p -103.5 121.59 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.249 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -100.41 118.49 36.75 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -86.34 165.88 16.05 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.658 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.98 51.58 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -85.37 -3.45 58.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.084 -0.385 . . . . 0.0 110.67 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.18 18.38 59.32 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.721 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 t -106.76 143.14 35.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.91 141.39 48.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.483 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.52 132.35 52.63 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -67.32 136.73 55.29 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -5.98 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.564 0 C-N-CA 126.828 2.051 . . . . 0.0 116.186 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 31.5 Cg_endo -97.52 169.34 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.678 3.586 . . . . 0.0 113.495 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -83.9 161.43 20.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -62.73 -40.07 96.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.759 0.424 . . . . 0.0 111.214 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.57 -43.22 93.68 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.012 0.434 . . . . 0.0 110.611 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -63.15 -48.99 76.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.901 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 17.5 m -68.45 -33.49 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 54.7 mtpt -62.87 -34.92 78.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.67 0.213 . . . . 0.0 110.614 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.68 67.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.263 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -84.17 -46.7 11.62 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.426 HD11 ' HB1' ' A' ' 5' ' ' ALA . 53.1 tp -55.69 -39.71 71.37 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.35 1.46 . . . . 0.0 112.936 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 8.0 p -60.27 -35.27 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.66 -22.38 46.88 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.81 0.814 . . . . 0.0 110.514 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.3 mt -84.99 -53.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.607 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.96 -32.49 15.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.966 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.05 40.73 61.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.3 pt? -65.52 -37.16 85.96 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 109.858 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.35 126.5 32.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -81.3 -23.05 38.13 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.76 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.451 1.095 . . . . 0.0 111.351 174.177 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mmm . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.41 129.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.105 0.478 . . . . 0.0 111.241 -175.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -90.5 -23.99 20.78 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -102.48 88.58 3.29 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.86 -59.08 5.94 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.955 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.05 134.91 11.89 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.047 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -102.15 129.16 48.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.947 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG12 HG12 ' A' ' 59' ' ' VAL . 49.9 mt -93.48 120.44 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.18 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 60.6 m-85 -102.54 115.77 31.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -158.26 175.97 13.07 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.86 155.93 43.36 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -70.19 -15.86 62.99 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -85.46 -4.82 59.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.6 m -77.07 133.54 39.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.8 -38.9 35.28 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.979 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -75.78 -7.53 54.65 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 52.5 t -57.26 -61.74 2.26 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.4 -23.78 64.69 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 5.1 tpm_? -67.65 -43.08 81.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.648 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.96 -35.63 66.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -55.95 -48.41 75.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -66.28 -34.41 77.94 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.736 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.65 87.2 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.252 0.549 . . . . 0.0 110.4 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 mt -73.63 -41.96 62.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.0 m -65.31 -35.16 80.15 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.54 87.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.837 0.827 . . . . 0.0 109.974 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.46 3.03 48.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.8 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 58.7 31.54 21.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.792 0.837 . . . . 0.0 112.065 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.3 mt -75.14 137.24 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.32 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.49 119.74 32.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -134.27 163.74 28.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -128.87 135.25 48.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.61 141.19 46.67 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.606 0.241 . . . . 0.0 111.319 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.74 138.18 39.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 170.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -77.97 143.39 37.62 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.777 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.639 HG21 HG11 ' A' ' 46' ' ' VAL . 42.8 pt -83.32 -9.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.092 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.94 -32.13 27.33 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.76 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -88.04 -10.83 49.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.881 0.372 . . . . 0.0 110.761 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.73 98.06 6.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.69 -49.28 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.43 74.14 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.95 -42.96 72.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.388 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 110.207 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.48 -50.7 72.92 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.519 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -58.29 -56.24 24.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.406 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.639 HG11 HG21 ' A' ' 36' ' ' ILE . 7.1 p -64.39 -35.32 73.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.722 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.21 -34.91 89.53 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.558 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -66.75 -44.5 81.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.003 0.521 . . . . 0.0 109.91 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 58' ' ' THR . 33.2 m -92.58 13.11 2.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 111.868 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -172.88 3.21 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.27 2.72 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.0 -44.72 2.85 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-O 121.258 0.366 . . . . 0.0 113.044 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -119.79 142.58 48.46 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.47 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -77.4 94.22 4.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.587 176.607 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -139.68 -17.26 0.99 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.965 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -124.1 144.85 46.48 Favored Pre-proline 0 C--O 1.244 0.779 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 13.2 Cg_endo -56.63 131.61 46.69 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.682 2.922 . . . . 0.0 111.542 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 49' ' ' VAL . 23.4 m -124.18 138.46 54.41 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.0 m -104.78 127.44 59.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 123.377 0.423 . . . . 0.0 110.978 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -106.71 113.89 27.66 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.1 163.23 21.01 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.954 0.407 . . . . 0.0 110.843 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -62.54 -17.32 59.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.014 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.82 -6.4 59.42 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.35 39.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.103 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.5 p -111.21 154.06 24.94 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.803 0.801 . . . . 0.0 111.199 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -121.21 142.03 50.3 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.948 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.29 124.99 40.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.6 m -67.36 145.76 54.76 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -4.64 85.81 0.03 OUTLIER Pre-proline 0 N--CA 1.522 3.139 0 C-N-CA 126.56 1.944 . . . . 0.0 114.793 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -97.83 161.09 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.522 3.481 . . . . 0.0 113.455 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -80.57 159.33 25.49 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.43 66.17 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.31 -43.93 98.05 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.576 0.751 . . . . 0.0 110.737 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.78 -44.9 72.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.532 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.6 m -68.22 -35.94 73.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.618 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -61.62 -42.17 98.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.537 0.335 . . . . 0.0 110.818 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.09 67.56 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.827 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -84.3 -51.85 6.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.821 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.85 -36.77 65.42 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.947 0.899 . . . . 0.0 113.272 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.09 -34.54 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.029 0.442 . . . . 0.0 111.833 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -81.38 -48.63 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.35 -45.14 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.546 1.138 . . . . 0.0 112.76 -175.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.45 -3.42 33.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.38 54.77 8.39 Favored Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.4 mt -124.36 -6.56 7.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.995 0.426 . . . . 0.0 110.71 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.7 -50.0 5.12 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 62.69 77.43 0.33 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.746 1.218 . . . . 0.0 111.39 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.62 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.233 0.224 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.36 79.42 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.292 1.044 . . . . 0.0 113.1 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -96.95 -30.89 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.34 107.23 9.59 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.43 85.78 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.064 0.853 . . . . 0.0 109.906 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.59 131.65 14.35 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.901 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -102.5 120.48 40.6 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 59' ' ' VAL . 60.3 mt -88.43 119.57 35.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.791 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 45.6 m-85 -104.89 114.82 29.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.589 174.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -163.85 -174.44 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -118.02 166.99 11.87 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 123.844 0.858 . . . . 0.0 109.253 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 m -78.84 -17.57 55.44 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.939 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -93.05 -1.93 56.1 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.3 t -81.34 131.2 35.28 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.838 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.2 -46.26 51.29 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -63.88 -15.71 59.63 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.721 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.6 t -59.14 -63.71 1.2 Allowed 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.347 0.404 . . . . 0.0 110.536 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.06 -24.62 61.55 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.823 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 29.1 mmm180 -65.8 -48.25 72.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.335 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.07 -32.14 68.73 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.07 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.5 mmmm -57.72 -43.41 85.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 m -64.1 -49.78 70.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.35 87.17 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.238 0.615 . . . . 0.0 112.492 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.78 -41.88 82.52 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.1 m -62.32 -42.12 99.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.451 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.03 66.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.781 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -103.58 9.35 37.48 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.884 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 3.6 mmp_? 62.32 43.34 8.34 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.608 0.718 . . . . 0.0 111.567 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.44 132.52 48.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.3 34.87 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -136.75 163.77 29.83 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.14 0.495 . . . . 0.0 112.198 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -121.49 142.48 50.01 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.31 139.89 48.36 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 117.918 0.326 . . . . 0.0 110.77 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.32 147.3 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.15 141.31 34.36 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.023 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.622 HG21 HG11 ' A' ' 46' ' ' VAL . 41.6 pt -83.76 -32.23 8.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.29 -14.88 60.53 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.147 -0.346 . . . . 0.0 111.648 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.53 -25.84 33.02 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.3 94.34 4.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.989 -0.445 . . . . 0.0 109.837 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.01 -45.34 64.53 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.86 92.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.631 0.253 . . . . 0.0 110.994 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.93 -41.44 78.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -65.82 -35.39 80.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 9.4 tp10 -70.41 -38.73 74.68 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.16 -58.46 7.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.282 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 36' ' ' ILE . 6.2 p -61.79 -35.35 67.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.1 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.77 72.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.551 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 m -83.66 -34.15 25.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.757 0.313 . . . . 0.0 111.523 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.4 m -94.5 10.62 4.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.776 0.798 . . . . 0.0 110.616 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -175.36 5.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.451 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.72 66.82 3.68 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.56 -66.91 0.26 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 65.3 t30 -142.12 162.06 36.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -57.6 114.33 2.2 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.887 -178.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.2 t -161.22 -30.63 0.05 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.626 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.77 152.04 44.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 36.7 Cg_endo -64.59 139.9 66.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.584 2.19 . . . . 0.0 112.119 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -126.57 136.57 52.72 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' THR . 30.7 m -105.02 129.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.133 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -103.97 119.43 38.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.4 172.25 13.9 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 120.79 0.329 . . . . 0.0 111.079 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.6 68.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.901 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -78.09 -17.96 56.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.941 0.401 . . . . 0.0 110.27 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.52 -19.54 28.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.579 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -71.59 160.51 32.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.322 0.561 . . . . 0.0 111.342 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -127.31 141.9 51.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.444 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.18 120.4 33.08 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -64.64 144.27 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -5.36 84.83 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -92.53 -170.58 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 123.612 2.875 . . . . 0.0 111.389 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 15.3 p -117.55 166.64 12.13 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.97 75.4 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.36 0.412 . . . . 0.0 111.776 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -69.66 -35.96 75.61 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.483 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -68.49 -45.03 73.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' SER . 10.8 m -67.63 -37.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.37 -31.48 71.37 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.81 80.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.553 0.533 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -84.03 -41.88 16.75 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.7 -39.0 89.91 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.528 1.131 . . . . 0.0 112.695 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.49 -35.63 55.39 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-O 120.977 0.417 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.65 -19.73 58.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.206 0.527 . . . . 0.0 111.264 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -80.86 -49.12 18.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.44 66.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.628 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.84 -99.83 2.29 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt 58.2 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.047 1.339 . . . . 0.0 112.298 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -88.32 -7.93 55.93 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.16 0.984 . . . . 0.0 110.597 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -136.35 159.44 41.76 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.598 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 tpp . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.421 0.153 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -83.78 132.56 31.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 O-C-N 121.894 -0.504 . . . . 0.0 111.178 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.8 t -103.87 -11.92 17.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.548 0.69 . . . . 0.0 109.905 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.63 126.05 14.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.4 -58.63 3.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 123.338 0.399 . . . . 0.0 111.248 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.76 144.27 13.39 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 m -110.05 124.83 52.17 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.948 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.521 HG12 HG12 ' A' ' 59' ' ' VAL . 86.8 mt -89.81 128.4 41.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 124.13 0.972 . . . . 0.0 110.512 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 81.0 m-85 -111.16 127.24 55.52 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -163.13 170.72 17.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 162.93 21.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -59.65 -30.18 68.56 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -87.19 0.13 55.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.87 112.93 16.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.27 70.45 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-N 116.371 -0.377 . . . . 0.0 114.004 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -82.83 -6.73 59.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.3 p -54.09 -60.12 3.75 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.76 -33.76 76.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.482 0.313 . . . . 0.0 111.743 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -59.79 -47.83 84.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.693 0.759 . . . . 0.0 109.794 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 tp -64.47 -38.7 91.93 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.82 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.7 mmtp -61.07 -46.73 89.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.141 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -59.54 -47.04 87.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.36 96.68 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.37 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 75' ' ' VAL . 76.8 mt -74.61 -35.27 62.95 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.316 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -66.47 -38.62 87.72 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 123.309 0.38 . . . . 0.0 110.278 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.68 97.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 111.401 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -86.73 -5.75 59.03 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 64.38 61.73 0.86 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.055 1.342 . . . . 0.0 113.253 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.58 138.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.28 108.23 19.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -120.77 156.68 31.34 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.18 142.16 40.36 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.12 132.36 38.0 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.429 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.4 131.72 40.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.75 140.03 37.08 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.954 0.883 . . . . 0.0 109.442 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 HG11 ' A' ' 46' ' ' VAL . 37.5 pt -84.25 -15.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.359 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.93 -34.18 77.21 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.307 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -78.29 -50.18 12.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -91.44 104.87 17.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -56.53 -44.07 80.45 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 125.626 1.571 . . . . 0.0 111.238 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.43 89.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -70.92 -38.92 72.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.33 91.19 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.698 0.624 . . . . 0.0 110.696 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.44 -51.44 68.69 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.098 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -56.09 -60.43 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.016 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 36' ' ' ILE . 7.2 p -65.5 -29.83 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 0.0 111.749 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.24 75.83 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.057 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -84.04 -36.87 22.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.2 m -98.41 13.33 4.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.33 175.79 10.28 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.514 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.07 88.31 0.89 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.39 -71.96 0.44 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.409 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 27.9 t-20 -144.62 162.31 36.96 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.7 117.18 10.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.627 0.727 . . . . 0.0 110.651 -178.651 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.0 t -163.81 -31.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.59 147.22 36.28 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.9 Cg_endo -60.3 146.52 96.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.072 2.515 . . . . 0.0 111.687 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.66 144.5 50.38 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 8' ' ' ILE . 16.3 m -110.97 131.58 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 123.168 0.293 . . . . 0.0 110.297 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -106.93 122.43 46.41 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 67.8 m-85 -86.83 177.91 7.15 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.275 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.12 66.38 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.516 0.727 . . . . 0.0 112.13 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 18.6 p-10 -82.57 -11.57 58.33 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.15 0.5 . . . . 0.0 110.365 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.8 3.77 68.07 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.319 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -97.43 152.53 18.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.4 p -115.84 154.19 30.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.317 0.58 . . . . 0.0 111.916 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -130.29 125.69 35.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 m -68.99 142.14 54.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -4.76 84.85 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.792 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 35.0 Cg_endo -93.99 150.83 2.16 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 123.934 3.089 . . . . 0.0 113.231 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 m -75.89 165.66 24.66 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.14 -33.96 72.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.98 -35.68 66.93 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.321 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.62 -43.85 88.31 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.999 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.5 m -67.82 -41.97 85.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 51.6 mtpt -60.61 -40.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.288 0.368 . . . . 0.0 110.756 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.95 75.88 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.777 0.673 . . . . 0.0 111.973 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 64.3 tttp -84.14 -45.42 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.584 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.65 -41.01 96.92 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.243 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.41 -38.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.782 0 O-C-N 123.448 0.468 . . . . 0.0 110.604 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 87' ' ' HIS . 60.4 mttm -70.26 -25.29 63.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.78 -40.02 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.37 -38.6 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.956 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.6 -129.65 9.26 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.9 mt 68.7 -71.12 0.12 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -126.12 106.22 9.43 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.361 0.664 . . . . 0.0 110.242 -174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.3 m-70 68.67 99.31 0.06 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.072 0.949 . . . . 0.0 113.536 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--N 1.295 -1.764 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.138 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.21 86.23 2.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -89.21 -26.25 21.33 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.18 100.08 5.94 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.1 -60.55 3.6 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.823 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.0 135.34 12.28 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.696 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 85.5 m -102.63 123.94 47.25 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 59' ' ' VAL . 75.9 mt -88.96 124.69 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 59.3 m-85 -106.51 110.81 23.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.738 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 14.9 t -164.02 -177.2 4.91 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 149.98 51.41 Favored 'General case' 0 N--CA 1.396 -3.143 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -58.53 -8.41 1.23 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -91.37 -1.46 57.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.605 -0.685 . . . . 0.0 112.333 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.7 t -82.6 140.45 33.21 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.49 62.97 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -82.52 -7.8 59.63 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.8 t -61.69 -63.02 1.4 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.151 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.5 pt? -68.3 -28.58 67.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.158 0.504 . . . . 0.0 110.878 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -61.25 -50.59 72.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.86 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.48 -35.42 73.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.194 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.2 mmtp -57.97 -40.41 80.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -67.4 -48.69 66.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.385 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.81 -42.64 84.68 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.601 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 54.5 mt -69.63 -38.83 77.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.662 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -65.93 -35.89 81.87 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.876 0.37 . . . . 0.0 110.798 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.53 64.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.367 0.603 . . . . 0.0 111.38 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -109.91 13.49 23.46 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 43.09 62.64 1.75 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.024 1.729 . . . . 0.0 113.418 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 89.3 mt -105.66 129.85 58.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.402 -177.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.09 28.67 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -136.79 166.68 23.03 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.138 0.494 . . . . 0.0 111.495 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' THR . 17.2 t70 -121.34 126.08 48.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.28 137.2 54.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.262 0.554 . . . . 0.0 111.109 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.94 135.55 42.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 10' ' ' THR . 4.2 m-20 -76.45 140.99 41.49 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 12.1 pt -77.46 -26.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.55 -5.12 30.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.192 0.52 . . . . 0.0 111.665 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -94.45 -26.61 16.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -120.9 108.71 14.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.655 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -51.22 -48.56 62.04 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.766 1.226 . . . . 0.0 112.278 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.73 94.84 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.49 0.662 . . . . 0.0 110.683 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.32 -43.72 66.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.453 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 54' ' ' ARG . . . -59.99 -37.69 80.39 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.259 0.624 . . . . 0.0 112.391 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.13 -34.91 56.55 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.1 -58.23 7.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 6.5 p -62.77 -33.82 62.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.307 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.41 -30.23 74.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.988 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -79.99 -36.86 35.39 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 58' ' ' THR . 33.0 m -90.92 9.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.463 0.649 . . . . 0.0 110.537 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.25 -177.81 4.97 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.319 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.24 79.45 1.79 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.04 -98.18 1.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.58 -175.27 3.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.68 116.48 2.53 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -162.7 -34.26 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.359 172.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.06 150.0 42.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 44.7 Cg_endo -65.94 140.56 61.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.731 2.287 . . . . 0.0 111.48 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.4 HG21 ' CG2' ' A' ' 49' ' ' VAL . 22.9 m -129.86 140.49 50.98 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.9 m -107.38 136.7 41.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.684 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -117.79 114.88 23.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -84.69 168.13 15.53 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.453 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.08 -11.37 48.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.392 1.091 . . . . 0.0 109.546 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.22 -18.13 61.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.684 1.594 . . . . 0.0 109.643 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.09 -21.88 39.61 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.776 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.9 m -80.17 149.27 30.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.759 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.7 p -113.5 151.76 31.08 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.432 175.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.58 125.07 24.99 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -64.5 146.52 54.44 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -5.69 86.38 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.553 0 C-N-CA 127.119 2.168 . . . . 0.0 115.942 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -98.09 150.75 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 124.274 3.316 . . . . 0.0 112.907 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 168.55 19.81 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -60.05 -37.04 78.65 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.99 -34.31 75.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.476 0.655 . . . . 0.0 110.33 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -71.7 -34.85 69.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.798 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -78.34 -35.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.711 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 29.3 mtpp -63.96 -33.34 75.51 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.825 -0.17 . . . . 0.0 110.789 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.42 67.99 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.935 0.772 . . . . 0.0 111.836 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 82' ' ' ILE . 37.1 mttm -83.04 -50.7 8.25 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.898 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 tp -51.62 -37.42 50.08 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.035 0.934 . . . . 0.0 113.053 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.35 -38.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.477 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -80.86 -24.08 38.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.157 0.503 . . . . 0.0 110.313 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 78' ' ' LYS . 70.7 mt -80.22 -49.15 19.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.87 14.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.29 87.59 0.71 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -175.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.1 mt -128.73 -83.01 0.58 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.365 -0.491 . . . . 0.0 109.826 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 45.55 87.03 0.02 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.305 1.842 . . . . 0.0 113.775 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -172.29 -44.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 26.9 t60 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 175.072 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.815 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.11 27.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.217 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.45 136.74 15.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.128 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -103.35 123.54 47.0 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 31' ' ' TYR . 60.3 mt -88.76 120.25 37.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.71 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -103.54 117.66 34.93 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.004 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -161.25 167.63 25.61 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -100.68 160.44 14.35 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -72.2 -31.0 65.48 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -88.68 14.41 10.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.5 t -79.93 155.86 27.52 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.35 -37.92 13.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.783 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.57 -7.98 59.62 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.2 p -57.16 -61.94 2.11 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.242 0.473 . . . . 0.0 111.775 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.92 -21.82 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.872 0.368 . . . . 0.0 111.661 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -67.53 -51.03 55.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.57 -35.88 75.78 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.15 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.7 mmtt -55.26 -45.52 76.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.29 0.567 . . . . 0.0 110.396 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -65.43 -40.0 92.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.716 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.21 95.94 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 29' ' ' ILE . 71.3 mt -69.07 -43.17 75.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 m -61.9 -38.5 88.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -16.24 63.77 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.413 0.625 . . . . 0.0 111.548 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -110.29 9.47 23.67 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 54.92 32.64 18.34 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.054 1.342 . . . . 0.0 112.454 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 66.1 mt -76.91 128.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 120.888 0.375 . . . . 0.0 110.266 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.38 122.9 29.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 8' ' ' ILE . 52.3 p90 -139.86 165.19 27.97 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.122 0.487 . . . . 0.0 112.294 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.36 142.19 50.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.24 143.55 50.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.381 0.537 . . . . 0.0 111.312 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.55 140.91 36.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.5 141.6 41.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.631 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 37.7 pt -82.81 -26.1 8.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.255 9.6 pt-20 -84.23 -11.47 56.43 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 117.917 -1.513 . . . . 0.0 111.833 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -83.34 -49.43 9.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 170.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.68 96.47 10.66 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.51 -39.16 79.33 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.722 0.809 . . . . 0.0 112.082 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.203 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.09 -43.35 64.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.457 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -56.5 -44.58 80.83 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 124.01 0.819 . . . . 0.0 110.972 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -62.29 -47.23 85.23 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.299 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -59.72 -56.62 19.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.354 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.625 HG11 HG21 ' A' ' 36' ' ' ILE . 7.7 p -62.9 -35.78 72.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.406 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.46 73.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.027 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -79.38 -37.8 36.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.885 0.374 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -94.61 5.5 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.27 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -178.81 6.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.738 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.99 79.25 1.82 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.81 -64.51 3.66 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.86 171.07 14.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -62.0 108.75 1.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.906 0.882 . . . . 0.0 111.856 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.3 t -156.16 -39.75 0.08 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.054 -0.404 . . . . 0.0 111.796 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.21 149.36 39.12 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.914 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 29.1 Cg_endo -64.44 152.65 80.73 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.35 2.033 . . . . 0.0 110.954 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.5 m -140.38 141.05 35.63 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.3 m -107.87 131.7 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.644 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.85 118.67 37.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -84.8 171.63 12.12 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.304 0.573 . . . . 0.0 112.366 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.1 -10.41 14.48 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.978 1.311 . . . . 0.0 112.305 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 -13.46 26.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.368 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.69 -21.27 39.19 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.901 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -85.32 160.83 19.72 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 117.93 0.865 . . . . 0.0 110.75 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.9 p -113.33 166.81 11.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.997 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.5 mt -138.36 116.56 11.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -62.6 139.44 58.63 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -4.69 88.16 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 126.947 2.099 . . . . 0.0 115.623 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -98.37 164.61 0.72 Allowed 'Trans proline' 0 N--CA 1.435 -1.937 0 C-N-CA 124.053 3.168 . . . . 0.0 111.949 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 75' ' ' VAL . 3.1 m -90.81 171.12 9.55 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.5 84.15 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 122.638 0.375 . . . . 0.0 111.483 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.47 -47.99 83.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.126 0.488 . . . . 0.0 110.716 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.02 -42.6 99.34 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.223 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 71' ' ' SER . 11.2 m -72.21 -40.33 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -57.9 -43.55 86.21 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.029 0.443 . . . . 0.0 110.106 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.41 76.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.909 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -84.08 -50.2 8.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.136 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.4 -39.83 70.65 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.123 0.969 . . . . 0.0 113.001 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -59.21 -39.78 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -73.17 -26.79 61.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.884 0.373 . . . . 0.0 110.608 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.1 mt -75.5 -45.19 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.109 -176.533 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.17 73.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.941 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.43 140.88 21.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.18 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 22.0 m -106.83 124.13 49.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.384 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.49 HG12 HG12 ' A' ' 59' ' ' VAL . 74.8 mt -88.81 122.25 39.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.706 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 68.8 m-85 -99.65 111.6 23.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.696 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -146.18 174.12 11.6 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.62 162.38 30.49 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 t -66.95 -15.9 64.0 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.796 0.331 . . . . 0.0 111.863 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -99.31 5.6 46.47 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.64 112.95 19.3 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.749 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.59 73.63 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.19 -7.52 56.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 47.5 t -65.67 -62.04 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.894 0.378 . . . . 0.0 110.448 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 19' ' ' ARG . 1.4 pp -67.9 -21.08 65.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.966 0.888 . . . . 0.0 112.068 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 18' ' ' LEU . 8.9 tpt180 -66.74 -43.55 83.88 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.969 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -85.36 -32.84 22.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.504 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -53.14 -48.47 67.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.881 0.372 . . . . 0.0 111.82 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 p -64.03 -38.65 91.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.874 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.16 93.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.156 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.87 -47.6 61.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.169 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 m -61.47 -37.3 83.1 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 121.076 0.465 . . . . 0.0 110.827 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -10.06 59.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.746 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -115.75 19.41 15.24 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.194 -0.316 . . . . 0.0 111.625 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 53.87 33.01 16.21 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 125.998 1.719 . . . . 0.0 112.177 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -90.3 131.17 38.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 120.914 0.387 . . . . 0.0 110.948 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.37 143.75 26.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.05 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -158.06 166.87 31.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.691 0.282 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' THR . 24.8 t70 -129.89 142.48 50.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -128.14 142.47 51.18 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.445 0.566 . . . . 0.0 110.62 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.51 141.9 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -89.68 139.39 30.61 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.62 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 46' ' ' VAL . 34.7 pt -85.91 -11.13 11.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.0 -40.29 75.37 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.252 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -93.27 -30.03 15.37 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.703 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -88.09 99.93 12.55 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.518 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -71.79 -35.1 69.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.06 75.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.511 . . . . 0.0 109.638 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -74.28 -43.57 56.35 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.735 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.25 -43.04 99.53 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.103 0.561 . . . . 0.0 111.837 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.34 -45.88 92.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -59.65 -58.49 8.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 36' ' ' ILE . 7.6 p -62.59 -35.26 69.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.746 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.13 93.96 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.035 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 m -71.09 -34.81 71.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.755 0.312 . . . . 0.0 111.339 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.67 7.17 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.255 0.55 . . . . 0.0 111.411 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 -172.62 3.98 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.925 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.92 81.55 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -63.12 3.27 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -144.37 165.08 28.92 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -54.21 101.1 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.767 1.227 . . . . 0.0 112.164 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -146.66 -15.96 0.43 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.1 147.69 63.55 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 122.217 -0.302 . . . . 0.0 111.778 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 32.5 Cg_endo -64.83 137.18 52.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.72 2.28 . . . . 0.0 111.476 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -123.01 137.69 54.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 8' ' ' ILE . 19.3 m -102.43 129.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 120.69 0.281 . . . . 0.0 110.412 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -109.94 115.41 29.75 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -81.05 166.75 20.47 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -12.67 58.85 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.455 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.48 -9.5 49.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.252 0.548 . . . . 0.0 109.567 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.56 38.68 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.765 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -73.34 144.32 46.54 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 117.57 0.685 . . . . 0.0 111.46 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -113.64 143.47 44.52 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.646 1.179 . . . . 0.0 111.399 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -126.02 128.45 47.47 Favored 'General case' 0 C--O 1.253 1.256 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -66.96 137.5 56.56 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -6.07 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.8 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -171.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.51 171.08 3.63 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.636 2.89 . . . . 0.0 112.548 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 75' ' ' VAL . 23.7 t -95.02 170.37 9.47 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . . . -64.89 -32.29 73.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.042 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.94 -48.93 72.51 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.31 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.23 -48.87 63.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.373 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 72' ' ' ALA . 8.7 m -62.55 -35.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.25 -36.27 83.61 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.687 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.91 71.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.71 0.632 . . . . 0.0 111.025 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.1 mtpp -84.2 -50.22 8.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.997 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.59 -39.87 71.28 Favored 'General case' 0 C--O 1.252 1.218 0 C-N-CA 123.219 0.608 . . . . 0.0 112.621 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.74 -32.62 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -81.05 -29.14 35.1 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 78' ' ' LYS . 58.5 mt -71.73 -57.67 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.936 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.944 -176.414 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.632 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.56 -63.89 1.25 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.462 0.649 . . . . 0.0 109.72 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 132.92 11.86 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.357 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -102.79 123.17 45.96 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.45 0.643 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.7 125.59 41.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -99.79 111.34 23.67 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.658 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.26 167.3 20.09 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 36' ' ' ILE . 25.1 m -138.86 158.0 45.01 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -46.32 -17.46 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 127.127 2.171 . . . . 0.0 115.028 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -77.42 -14.99 59.58 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.838 -0.538 . . . . 0.0 111.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 43.0 t -92.05 120.88 33.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.363 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.63 -30.32 68.76 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.355 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.91 -11.66 61.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 38.8 t -55.58 -55.27 33.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 110.483 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 19' ' ' ARG . 2.2 pp -69.98 -25.81 63.79 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.4 mmm180 -70.67 -44.62 66.64 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.92 -45.07 95.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.889 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.8 mmtp -55.77 -49.61 72.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.218 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 m -59.44 -43.99 93.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.999 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.35 98.42 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.34 -46.5 60.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.448 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.3 m -60.38 -37.33 80.42 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.326 0.391 . . . . 0.0 110.854 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.34 83.31 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 120.935 0.398 . . . . 0.0 112.025 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -99.77 8.76 43.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.289 0.566 . . . . 0.0 111.097 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 63.65 35.33 11.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.144 1.378 . . . . 0.0 113.388 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.86 125.88 38.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.778 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.45 123.63 26.82 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -131.23 161.64 31.77 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.425 0.631 . . . . 0.0 111.659 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.59 142.64 47.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.01 141.38 38.31 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.94 143.22 33.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.28 140.48 38.84 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.998 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.3 pt -83.59 -27.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.193 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -76.92 -25.29 52.77 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -70.74 -49.25 48.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.946 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -102.17 97.77 8.03 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.739 0.304 . . . . 0.0 110.705 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -56.38 -40.1 74.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.0 0.92 . . . . 0.0 112.047 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 -34.45 68.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.305 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -67.62 -38.97 84.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.48 -29.73 70.77 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.639 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.487 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 7.3 tp10 -74.75 -48.52 25.22 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -53.21 -56.01 19.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.167 0.987 . . . . 0.0 111.653 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.61 -27.35 42.71 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.972 0 CA-C-O 120.66 0.267 . . . . 0.0 111.094 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.1 -38.79 63.5 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.591 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.0 m -74.27 -34.59 63.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.77 0.319 . . . . 0.0 111.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 46' ' ' VAL . 31.0 m -94.58 13.02 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 0.0 111.541 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 -174.68 3.92 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.129 0.49 . . . . 0.0 110.114 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.53 69.96 3.19 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -61.93 0.79 Allowed Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.573 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 50.1 t30 -144.49 160.06 41.73 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.487 ' NH2' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -62.34 116.79 5.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.635 . . . . 0.0 111.078 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -155.97 -25.27 0.1 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.759 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 m -119.54 144.13 36.13 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 19.6 Cg_endo -60.07 140.54 93.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.834 2.356 . . . . 0.0 111.405 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -124.16 141.0 52.43 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.5 m -107.5 133.04 53.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.549 0.214 . . . . 0.0 110.694 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.0 112.36 23.95 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.461 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.5 m-85 -78.52 166.06 23.02 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.23 -18.05 56.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.496 0.498 . . . . 0.0 112.07 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.76 -11.39 58.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.143 0.496 . . . . 0.0 109.754 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.05 -7.07 56.87 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.208 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -79.61 145.67 32.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.069 0.462 . . . . 0.0 110.879 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -119.09 141.18 49.0 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.0 mt -131.52 143.53 50.45 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -73.91 140.61 45.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -6.75 83.11 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 C-N-CA 126.388 1.875 . . . . 0.0 116.009 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 19.7 Cg_endo -90.25 160.26 4.67 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.781 2.987 . . . . 0.0 112.563 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 m -82.22 173.7 11.86 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -64.48 -39.01 92.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.085 0.469 . . . . 0.0 111.498 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.44 -30.84 67.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.494 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.67 -42.71 73.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 14.1 m -72.24 -35.38 52.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.732 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 10.1 mtpm? -58.13 -36.25 72.68 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 123.124 0.265 . . . . 0.0 111.417 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.61 73.97 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.976 0.797 . . . . 0.0 111.963 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' O ' HG13 ' A' ' 82' ' ' ILE . 8.2 mtpm? -84.08 -48.46 9.86 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.09 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 tp -54.98 -40.59 70.22 Favored 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.02 0.825 . . . . 0.0 112.445 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.83 -43.27 95.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 123.508 0.505 . . . . 0.0 110.328 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -75.15 -21.11 59.03 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.593 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 78' ' ' LYS . 63.4 mt -73.57 -36.05 46.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.315 -0.91 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.686 -179.173 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.66 54.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.299 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.27 135.9 23.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.305 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.6 m -103.62 124.85 49.58 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.861 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 59' ' ' VAL . 44.0 mt -89.03 118.73 34.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.856 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 80.6 m-85 -103.81 110.41 22.5 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.949 174.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.456 HG21 ' SG ' ' A' ' 17' ' ' CYS . 13.2 t -163.63 -177.66 5.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.76 152.39 51.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -54.09 -28.38 38.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.277 1.031 . . . . 0.0 113.084 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -77.63 -15.22 59.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -71.53 118.47 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.27 -43.05 93.77 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.667 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 23.7 m-85 -74.1 -7.57 53.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 t -63.6 -62.48 1.64 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 2.4 pp -70.56 -21.02 62.75 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.323 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 16' ' ' TYR . 6.7 tpm_? -72.25 -38.73 68.82 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.123 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -84.33 -24.07 29.94 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.0 mmtt -53.9 -42.87 69.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.792 0.437 . . . . 0.0 111.812 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.8 p -67.91 -37.17 81.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.324 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.87 80.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.793 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.38 -42.97 92.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.8 m -63.11 -46.3 87.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.59 -31.92 72.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.272 0.558 . . . . 0.0 111.093 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.97 11.52 24.84 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.571 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 59.2 32.26 21.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.708 0.803 . . . . 0.0 111.446 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.53 130.59 37.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.0 0.429 . . . . 0.0 109.963 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.3 124.4 36.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.01 162.06 36.42 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.864 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' THR . 37.5 t70 -121.39 133.56 55.09 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.54 139.72 49.34 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.17 147.86 27.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -83.49 138.94 33.21 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.714 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.665 HG21 HG11 ' A' ' 46' ' ' VAL . 39.0 pt -87.04 -23.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.82 -42.63 69.98 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.126 0.488 . . . . 0.0 109.807 -171.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -77.04 -26.72 54.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -103.74 93.16 4.76 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -55.63 -44.39 77.05 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.563 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -30.93 66.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.12 -42.63 68.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -62.92 -36.38 83.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.599 0.562 . . . . 0.0 110.451 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.38 -47.39 79.41 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.05 -58.43 8.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.174 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -64.22 -31.73 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.77 70.33 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.201 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 p -83.02 -26.19 31.45 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 46' ' ' VAL . 21.7 m -89.93 -11.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.124 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -73.13 167.19 21.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.053 -176.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.38 4.09 Favored Glycine 0 C--N 1.308 -1.006 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.183 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.56 -90.65 0.41 Allowed Glycine 0 C--N 1.313 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -120.24 172.21 7.95 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -64.27 54.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.56 1.544 . . . . 0.0 112.304 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -88.86 -32.05 17.97 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 122.055 -0.403 . . . . 0.0 111.925 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.37 151.87 63.46 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 12.5 Cg_endo -56.23 123.4 13.73 Favored 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.749 2.966 . . . . 0.0 111.791 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 m -106.51 133.44 51.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 8' ' ' ILE . 28.5 m -103.19 124.8 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.072 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -105.88 125.53 51.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.85 179.22 6.03 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.96 -10.74 58.93 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.237 0.615 . . . . 0.0 111.856 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -88.71 -8.64 54.17 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.15 81.35 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.118 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -99.54 151.52 21.06 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p -117.16 150.11 39.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.504 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.8 mt -124.1 125.08 43.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -68.33 147.35 52.26 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -5.32 83.01 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 C-N-CA 127.015 2.126 . . . . 0.0 114.909 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -98.99 157.67 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.781 2.987 . . . . 0.0 112.583 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 75' ' ' VAL . 30.5 p -84.4 166.2 17.55 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.808 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.41 -33.52 72.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.864 0.466 . . . . 0.0 112.079 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.84 -40.05 91.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.093 0.473 . . . . 0.0 110.521 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.22 -43.32 67.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.593 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 71' ' ' SER . 6.1 m -65.97 -35.5 75.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.116 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.34 -35.17 79.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.62 95.61 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.26 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -76.79 -38.62 53.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.126 0.488 . . . . 0.0 110.345 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.56 -36.46 84.28 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.473 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.7 -22.45 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.126 0.489 . . . . 0.0 111.243 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -80.17 -30.48 38.83 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -83.16 -57.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.765 -175.613 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.681 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.76 -56.19 15.16 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.623 0.577 . . . . 0.0 112.222 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 59' ' ' VAL . 1.7 pt? -147.05 137.75 23.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.616 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -106.67 112.13 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.355 1.062 . . . . 0.0 109.648 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.3 mt -88.92 131.81 35.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 111.997 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.423 ' OH ' ' HE2' ' A' ' 60' ' ' LYS . 74.8 m-85 -111.44 104.24 12.66 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 12.6 t -165.27 142.88 5.97 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -102.99 155.99 17.98 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -63.1 -4.85 2.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -77.63 -13.62 59.86 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.558 -0.714 . . . . 0.0 111.168 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.82 144.19 39.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.02 -41.71 39.38 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.652 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.0 -5.67 49.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -50.72 -59.95 3.55 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.019 0.372 . . . . 0.0 111.877 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.4 pt? -72.36 -26.0 61.75 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.432 0.158 . . . . 0.0 111.121 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -59.69 -47.48 85.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.7 tp -67.21 -44.38 79.71 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.74 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 73.8 mmtt -57.4 -55.56 33.2 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.889 0.376 . . . . 0.0 110.723 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 m -59.65 -40.47 87.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.76 -46.74 89.28 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.893 0.377 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 67.2 mt -69.23 -43.66 73.6 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 m -62.97 -37.36 86.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.248 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.74 85.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.38 7.01 38.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 58.53 46.99 14.07 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.812 0.815 . . . . 0.0 111.64 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 24' ' ' LEU . 81.4 mt -97.96 119.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.794 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.94 115.01 11.73 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.684 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -128.29 156.86 42.36 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.809 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -115.43 142.39 46.77 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.22 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.12 139.02 44.34 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.195 -0.316 . . . . 0.0 110.39 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.08 145.12 33.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 37' ' ' GLU . 30.5 t70 -87.73 142.03 28.14 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.918 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.466 HG21 HG11 ' A' ' 46' ' ' VAL . 23.6 pt -83.18 -25.7 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.59 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 43.8 tt0 -73.83 -34.41 64.54 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.266 0.555 . . . . 0.0 109.533 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -91.01 -0.19 57.69 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -133.74 99.59 4.51 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -62.5 -43.41 98.87 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.44 72.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.892 0.377 . . . . 0.0 110.749 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.71 -42.15 67.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.85 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.74 84.98 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.557 0.694 . . . . 0.0 110.621 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -63.73 -43.58 96.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.012 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.13 -56.74 9.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.777 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -59.62 -25.66 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.06 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.22 -42.74 96.18 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.641 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.6 m -74.41 -31.31 62.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.065 0.432 . . . . 0.0 111.846 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -91.65 8.43 4.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.904 0.859 . . . . 0.0 111.118 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.49 174.32 9.04 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.34 88.4 1.09 Allowed Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.84 -89.78 0.7 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -134.02 173.92 11.04 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 102.24 1.0 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.112 0.958 . . . . 0.0 113.08 -175.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -146.79 -26.86 0.41 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.15 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 m -113.86 151.44 44.75 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 19.1 Cg_endo -60.9 143.02 99.27 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.31 2.673 . . . . 0.0 111.485 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.441 HG21 ' CG2' ' A' ' 49' ' ' VAL . 19.7 m -132.27 150.55 52.13 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 6' ' ' LEU . 8.4 p -128.96 130.94 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE2' ' OH ' ' A' ' 9' ' ' TYR . 32.3 mtmt -100.58 136.11 40.97 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.97 176.08 6.73 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.58 63.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.142 0.972 . . . . 0.0 109.034 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -74.97 -18.07 60.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.847 1.659 . . . . 0.0 109.534 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.99 30.09 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.354 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -74.58 152.63 39.25 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 122.309 0.244 . . . . 0.0 110.723 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.1 p -113.53 155.11 25.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.331 0.586 . . . . 0.0 112.3 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -132.71 125.26 29.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -70.63 144.52 51.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -4.87 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.477 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -100.51 -177.79 0.17 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 123.686 2.924 . . . . 0.0 112.393 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -114.6 172.73 6.85 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -43.96 78.07 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 122.772 0.429 . . . . 0.0 111.484 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.7 -52.89 54.15 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 111.681 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -62.3 -39.76 94.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.803 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -78.84 -31.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.391 -0.524 . . . . 0.0 112.249 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -60.25 -32.44 71.16 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.142 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.6 71.65 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.894 0.746 . . . . 0.0 111.286 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.9 mtpp -84.88 -44.28 13.35 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.592 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.7 tp -54.42 -41.17 69.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.575 0.75 . . . . 0.0 112.594 -176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.08 -33.2 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.58 0.55 . . . . 0.0 111.642 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -80.33 -42.51 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.297 0.57 . . . . 0.0 109.835 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 78' ' ' LYS . 53.7 mt -61.07 -31.56 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.859 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.241 -179.762 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.6 -60.19 2.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.29 143.25 22.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.176 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -102.97 124.77 49.1 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.34 112.33 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 123.601 0.761 . . . . 0.0 110.467 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 88.4 m-85 -98.85 114.27 26.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.34 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 t -163.69 149.52 11.32 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.62 152.03 21.59 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -67.37 -20.96 65.63 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.798 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -83.58 1.99 39.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.04 149.79 33.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -34.99 28.18 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.512 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -81.67 -7.11 59.56 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -54.63 -51.59 64.93 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -83.87 -23.28 31.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -64.94 -41.58 95.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.858 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 70' ' ' PRO . 25.0 tp -74.5 -24.21 58.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.617 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 43.2 mmtm -62.67 -36.28 82.38 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.186 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -55.85 -47.72 76.77 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 123.794 0.684 . . . . 0.0 110.128 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.17 77.54 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.976 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 98.3 mt -67.03 -44.8 79.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.359 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.9 m -66.85 -38.29 86.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -23.69 66.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.513 0.673 . . . . 0.0 111.41 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -106.75 4.72 27.96 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.069 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 50.49 44.7 27.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.921 1.288 . . . . 0.0 112.036 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 24' ' ' LEU . 72.0 mt -82.72 127.82 39.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.552 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.91 134.19 35.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -147.55 164.19 34.21 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -118.68 139.11 52.06 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.15 134.99 55.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.844 0.354 . . . . 0.0 111.277 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.95 126.39 26.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.77 141.06 33.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 46' ' ' VAL . 40.8 pt -84.85 -9.35 11.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.29 -43.7 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 109.864 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -92.27 -28.82 16.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.997 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.26 91.64 6.37 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.203 0.525 . . . . 0.0 110.532 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -76.06 -25.8 55.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.321 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -33.23 73.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.71 -40.06 66.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.568 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.04 84.42 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.7 -53.48 56.88 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -56.92 -57.91 10.44 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.861 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.62 -32.37 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.74 75.79 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.374 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -81.24 -22.1 38.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG23 HG21 ' A' ' 58' ' ' THR . 35.9 m -108.6 13.16 8.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.709 0.766 . . . . 0.0 110.347 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.65 -173.16 2.8 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.825 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.35 71.05 2.55 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.91 -67.94 2.88 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.873 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -119.74 151.62 38.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.64 114.72 8.12 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.525 0.678 . . . . 0.0 109.52 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -154.83 -29.86 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.441 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.91 142.44 25.24 Favored Pre-proline 0 C--O 1.241 0.643 0 O-C-N 122.078 -0.389 . . . . 0.0 111.543 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 22.5 Cg_endo -62.48 131.9 35.86 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.738 2.292 . . . . 0.0 111.215 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.421 HG21 HG23 ' A' ' 49' ' ' VAL . 23.2 m -117.51 137.79 52.31 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.77 128.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 120.804 0.335 . . . . 0.0 110.746 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -104.95 119.29 38.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.52 174.4 11.47 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.538 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.81 66.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.362 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -75.92 -14.94 60.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.375 . . . . 0.0 110.77 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.01 -21.98 36.43 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.909 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 m -81.81 158.58 24.04 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 117.82 0.81 . . . . 0.0 110.459 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.1 p -113.84 163.29 15.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -134.58 121.55 21.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.2 m -62.95 137.21 58.21 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.257 24.9 p-10 -5.46 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.875 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HG2' HG13 ' A' ' 75' ' ' VAL . 92.7 Cg_endo -97.35 147.79 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.684 3.59 . . . . 0.0 111.936 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -77.37 174.48 10.76 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.64 77.38 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.546 0.738 . . . . 0.0 111.972 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.68 -41.39 94.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.932 0.396 . . . . 0.0 111.799 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.2 -41.67 81.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.871 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.439 HG13 ' HG2' ' A' ' 70' ' ' PRO . 5.8 m -69.03 -40.88 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.998 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -57.67 -44.39 85.7 Favored 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 123.381 0.426 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.79 73.08 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 124.151 0.907 . . . . 0.0 112.642 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -84.35 -47.57 10.58 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.245 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.82 -36.2 76.3 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.278 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 -32.77 56.61 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.094 0.473 . . . . 0.0 111.083 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.35 -34.75 31.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.431 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.8 mt -67.26 -41.11 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.376 0.608 . . . . 0.0 109.761 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.463 178.523 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.93 -60.17 1.64 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -156.32 131.15 9.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.165 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -101.72 117.54 35.1 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.254 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 59' ' ' VAL . 97.5 mt -89.05 121.06 38.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.522 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.11 123.62 47.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 8.9 t -163.9 171.76 14.92 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.878 0.736 . . . . 0.0 109.187 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 36' ' ' ILE . 9.2 p -108.69 159.17 16.96 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -76.44 -13.55 60.11 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.524 0.202 . . . . 0.0 111.35 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -86.58 -2.2 58.29 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -83.98 132.2 34.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -30.12 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.86 -19.64 62.62 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.7 t -58.6 -61.29 2.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 123.503 0.502 . . . . 0.0 110.435 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 19' ' ' ARG . 3.5 pp -65.47 -29.39 70.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.579 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' N ' HD12 ' A' ' 18' ' ' LEU . 20.3 tpp180 -61.8 -50.18 73.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.83 -39.95 79.72 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.71 -46.66 81.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -59.43 -46.11 89.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.95 95.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.592 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 mt -74.93 -36.84 62.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.076 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -63.68 -41.47 98.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.57 73.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 0.0 111.596 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -92.92 -1.89 56.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 56.17 52.3 10.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.946 0.879 . . . . 0.0 111.581 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.89 140.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.54 114.45 20.26 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -132.92 152.04 51.96 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.671 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' THR . 6.3 m-20 -114.05 116.51 29.28 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.293 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -113.31 131.16 56.05 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.247 0.546 . . . . 0.0 110.845 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.02 130.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -85.89 141.6 29.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.453 HG21 HG11 ' A' ' 46' ' ' VAL . 36.7 pt -83.94 -9.02 11.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.27 -26.1 68.63 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.82 -2.37 30.17 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.998 0.428 . . . . 0.0 110.875 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -124.33 88.47 2.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -69.22 -30.48 68.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.981 -171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.17 -35.94 78.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.603 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.61 97.97 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.375 0.607 . . . . 0.0 110.443 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.08 -46.48 84.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.18 -58.94 5.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.669 0.787 . . . . 0.0 111.28 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 42' ' ' ALA . 4.4 p -61.69 -32.25 53.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' A' ' 54' ' ' ARG . . . -69.18 -29.06 72.22 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.724 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -78.47 -28.21 46.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.355 0.598 . . . . 0.0 110.889 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG21 ' A' ' 58' ' ' THR . 24.5 m -101.81 13.67 6.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.759 0.79 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -173.59 3.86 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.244 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.72 78.75 0.42 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.69 -89.63 0.61 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -138.89 -175.24 4.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 2.1 mpp_? -54.58 111.78 0.87 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.498 0.499 . . . . 0.0 112.236 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.47 -33.39 0.08 Allowed 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.596 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -123.75 148.79 57.45 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.695 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 22.8 Cg_endo -64.52 155.0 68.88 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.356 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.47 HG21 ' CG2' ' A' ' 49' ' ' VAL . 31.5 m -135.91 140.41 44.05 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.3 m -105.73 133.59 49.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 123.237 0.336 . . . . 0.0 110.497 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -112.41 111.68 22.7 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.4 m-85 -77.65 165.82 23.79 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.654 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.82 -11.99 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.539 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 2.1 p-10 -84.05 -9.84 58.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.5 -2.01 60.53 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.695 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -91.97 145.39 24.58 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 117.359 0.579 . . . . 0.0 110.677 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -113.38 141.25 47.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.097 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -132.53 133.2 43.45 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.0 m -70.51 139.1 51.54 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -5.48 90.87 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.728 0 C-N-CA 126.661 1.984 . . . . 0.0 115.572 -170.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.2 Cg_endo -95.18 152.8 1.67 Allowed 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 124.471 3.448 . . . . 0.0 112.915 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.6 t -71.79 163.07 28.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.38 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.46 77.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.43 0.692 . . . . 0.0 111.695 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.66 -26.72 61.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.719 0.295 . . . . 0.0 110.641 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.21 -45.57 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.4 m -64.19 -37.01 78.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.648 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -59.92 -35.57 75.17 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.334 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.09 79.0 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.435 0.46 . . . . 0.0 111.912 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 7.8 mtpm? -84.29 -45.11 13.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.103 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.69 -33.36 72.74 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.418 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.97 -31.96 54.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 CA-C-O 121.289 0.566 . . . . 0.0 110.691 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -78.54 -47.34 17.46 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.73 -40.09 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.493 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 111.708 179.456 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -1.936 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.19 -64.03 1.28 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 HD23 HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -157.11 133.04 9.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.944 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.1 m -105.52 123.72 48.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.915 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.18 130.21 42.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 124.115 0.966 . . . . 0.0 111.147 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -106.6 119.17 38.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -163.84 162.2 23.55 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.11 175.56 5.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.1 t -76.11 -21.63 56.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.491 0.186 . . . . 0.0 111.037 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -77.62 -15.31 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.499 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.42 109.37 8.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.39 -22.8 59.33 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' HG12 ' A' ' 56' ' ' VAL . 86.7 m-85 -82.55 -7.31 59.65 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 25.2 p -54.88 -59.46 4.7 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.3 pt? -69.98 -25.93 63.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -59.47 -50.17 74.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.988 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.37 -40.09 85.73 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.399 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.02 -45.75 79.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.613 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -56.09 -40.54 73.79 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.63 77.41 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.099 0.476 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 29' ' ' ILE . 57.1 mt -72.87 -42.31 63.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.716 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -64.33 -32.31 73.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.8 -27.79 69.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.627 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.96 3.27 25.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 47.36 58.44 4.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.109 0.964 . . . . 0.0 112.145 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 75.7 mt -89.62 128.86 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.157 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.7 10.81 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.199 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -116.79 175.12 5.72 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.0 t70 -139.93 139.41 36.16 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.69 141.24 50.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.97 142.61 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.28 140.49 44.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.544 0.688 . . . . 0.0 111.481 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 46' ' ' VAL . 38.4 pt -86.19 -24.85 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.387 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.05 -39.19 66.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.825 0.345 . . . . 0.0 111.855 -169.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -89.29 3.58 51.61 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.56 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -129.75 93.23 3.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -47.11 -55.74 7.84 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.7 74.97 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 123.481 0.488 . . . . 0.0 111.399 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.96 -47.22 66.16 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.269 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.2 -36.9 84.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.356 0.598 . . . . 0.0 111.25 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.61 -37.17 85.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.11 -60.99 1.93 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.076 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 36' ' ' ILE . 5.8 p -59.16 -36.12 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.52 74.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.6 m -82.94 -30.28 28.47 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.156 0.503 . . . . 0.0 110.837 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 46' ' ' VAL . 34.2 m -98.2 13.55 4.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-O 121.414 0.626 . . . . 0.0 111.245 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.07 173.62 12.4 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.932 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.4 63.34 3.36 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.92 -119.29 4.43 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' THR . 4.2 p-10 -93.77 164.27 13.2 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.7 110.03 0.59 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.945 0.898 . . . . 0.0 110.416 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.2 t -162.33 -26.66 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.275 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 16' ' ' TYR . 10.7 m -113.4 150.41 43.09 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 120.486 0.184 . . . . 0.0 111.241 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.18 150.53 65.8 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.258 1.972 . . . . 0.0 110.454 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.427 HG21 HG23 ' A' ' 49' ' ' VAL . 28.3 m -132.12 136.7 47.31 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.474 HG21 HD23 ' A' ' 6' ' ' LEU . 10.4 p -104.77 127.87 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.017 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -113.59 111.86 22.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 64.1 m-85 -81.83 171.51 14.42 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.434 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.35 -16.83 62.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.274 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.34 -12.32 52.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.187 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.14 -18.22 42.89 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.579 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -80.69 148.95 29.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 117.27 0.535 . . . . 0.0 111.972 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.1 p -115.5 143.53 45.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.841 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.32 129.06 50.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -71.04 141.02 50.93 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -5.75 87.81 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 C-N-CA 126.565 1.946 . . . . 0.0 115.583 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -90.68 -172.48 0.52 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 124.048 3.165 . . . . 0.0 111.378 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.533 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 23.3 m -118.02 173.87 6.53 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -59.37 -43.67 92.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.92 -37.43 81.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.831 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 12.8 mp0 -63.15 -45.7 90.65 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.751 0.82 . . . . 0.0 110.877 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 71' ' ' SER . 13.7 m -70.53 -35.14 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.772 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 56.3 mtpt -61.17 -41.71 97.27 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.43 73.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.929 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -84.07 -48.03 10.31 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.27 -42.44 73.54 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.445 1.098 . . . . 0.0 112.82 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.23 -32.89 49.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.69 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -80.82 -19.94 43.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.195 0.521 . . . . 0.0 110.841 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -85.67 -46.06 17.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.665 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -1.855 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.24 -62.21 1.54 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -151.78 130.0 11.97 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.27 119.31 38.63 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.545 0.528 . . . . 0.0 111.402 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.02 130.63 38.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.9 m-85 -114.88 109.04 17.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.271 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 6.9 t -164.28 -178.75 5.67 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.895 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.486 ' HB ' ' CD1' ' A' ' 13' ' ' TRP . 33.0 m -152.84 154.79 35.84 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 m -48.82 -18.35 0.26 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.486 ' CD1' ' HB ' ' A' ' 11' ' ' THR . 68.2 p-90 -77.37 -18.45 57.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 64.0 m -74.52 141.88 44.82 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.02 -49.95 43.95 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.002 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -72.93 -6.1 42.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 26.6 p -47.53 -62.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -76.96 -25.88 53.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -61.58 -43.92 97.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.537 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.62 -40.65 84.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.27 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.9 mmmm -58.62 -50.62 73.15 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -61.28 -46.13 91.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.519 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.37 83.46 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.405 0.44 . . . . 0.0 111.113 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 62.8 mt -71.71 -42.24 67.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.241 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.3 m -64.24 -38.2 90.19 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.249 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.76 -30.52 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 111.622 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -100.11 22.18 11.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.025 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.258 10.9 ptp180 43.82 61.34 2.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 125.477 1.511 . . . . 0.0 114.245 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 68.8 mt -113.45 119.09 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.971 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 127.96 32.87 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.714 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -139.91 168.72 19.16 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.681 0.753 . . . . 0.0 112.599 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.03 139.98 51.69 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.631 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.44 145.71 51.92 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.52 147.37 25.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.35 140.74 41.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.732 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.512 HG21 HG11 ' A' ' 46' ' ' VAL . 25.3 pt -86.79 -29.22 5.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.483 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.94 -55.63 27.54 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.346 0.658 . . . . 0.0 112.39 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -93.97 15.49 16.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.39 0.614 . . . . 0.0 112.158 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -130.68 91.39 3.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.38 -47.35 79.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.26 -22.79 65.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.729 0.3 . . . . 0.0 111.524 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -86.65 -47.06 9.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.86 -43.74 98.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.257 0.551 . . . . 0.0 111.201 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.73 -38.13 89.94 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.174 0.99 . . . . 0.0 110.049 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.75 -60.0 3.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.19 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -60.44 -35.02 60.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.62 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.64 72.92 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.843 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.0 m -83.83 -32.54 25.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.767 0.317 . . . . 0.0 111.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.2 m -94.72 9.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.038 0.447 . . . . 0.0 111.043 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 175.98 8.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.198 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.32 87.06 1.55 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.12 -72.06 0.72 Allowed Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -144.73 172.62 12.75 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -61.51 109.22 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.442 0.639 . . . . 0.0 111.115 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -149.37 -34.76 0.18 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.824 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.75 152.03 50.87 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 14.6 Cg_endo -58.33 139.33 90.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.58 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' HG23 ' A' ' 46' ' ' VAL . 23.7 m -125.26 147.83 48.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 6' ' ' LEU . 14.6 p -122.13 128.64 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.797 0 O-C-N 123.491 0.494 . . . . 0.0 110.229 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.63 129.94 55.55 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -94.07 166.2 12.26 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.497 0.189 . . . . 0.0 111.359 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.31 -16.18 59.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.947 0.899 . . . . 0.0 112.898 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.71 -5.17 58.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 109.882 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.94 18.42 47.3 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.23 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -107.06 149.76 27.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.68 0.74 . . . . 0.0 110.541 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 p -114.87 154.65 28.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.995 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -131.26 126.85 36.53 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -68.46 136.04 52.59 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 11.0 t30 -5.89 91.62 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -171.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.425 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 28.9 Cg_endo -100.41 174.05 0.33 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.498 3.465 . . . . 0.0 112.439 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.46 168.2 10.53 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.415 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.48 71.01 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 24.3 t70 -79.65 -28.31 40.84 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.489 -1.284 . . . . 0.0 111.339 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.61 -40.67 97.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.387 0.613 . . . . 0.0 109.908 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 13.5 m -77.86 -30.95 16.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.969 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 9.5 mtpm? -57.41 -40.52 78.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.95 -35.24 66.45 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 123.941 0.776 . . . . 0.0 112.009 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.4 mtpp -84.03 -50.5 7.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.038 0.447 . . . . 0.0 111.115 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.64 -38.25 71.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.829 0.852 . . . . 0.0 112.828 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.27 -32.14 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 120.899 0.38 . . . . 0.0 111.268 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.06 -44.1 18.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.35 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 72.2 mt -56.97 -53.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.75 0.656 . . . . 0.0 110.789 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.675 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.396 -178.674 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . . . . . . 0 N--CA 1.435 -1.215 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -64.03 1.28 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.017 0.437 . . . . 0.0 111.478 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt? -152.5 139.25 18.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -105.96 124.22 49.23 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 HG23 ' A' ' 10' ' ' THR . 91.4 mt -104.62 134.09 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.295 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -114.59 116.3 28.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.589 0.756 . . . . 0.0 109.412 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 57' ' ' PRO . 49.5 p -129.88 156.91 43.61 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD11 ' A' ' 36' ' ' ILE . 26.8 p -99.47 164.92 11.89 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -78.94 -22.51 45.65 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.393 0.615 . . . . 0.0 110.561 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 55' ' ' THR . 31.3 p-90 -101.46 -8.42 21.98 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 42.5 t -84.73 142.13 30.06 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.326 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.36 -19.21 67.07 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.707 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.62 -14.43 58.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.778 -0.836 . . . . 0.0 111.906 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 77.8 m -59.34 -59.16 5.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.336 0.398 . . . . 0.0 111.403 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 18' ' ' LEU . 2.3 pt? -74.4 -26.44 60.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -65.61 -42.79 91.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.363 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.44 -39.28 92.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.319 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -59.02 -44.9 91.78 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -58.38 -49.37 77.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.961 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.19 98.32 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.905 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 29' ' ' ILE . 50.0 mt -70.49 -42.3 71.55 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.395 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -64.45 -34.33 77.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.612 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.39 73.75 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.21 0.529 . . . . 0.0 110.694 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -96.79 10.65 38.22 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 63.65 20.51 12.27 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.308 1.043 . . . . 0.0 111.917 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 24' ' ' LEU . 73.3 mt -73.95 128.55 36.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.319 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.69 143.42 27.59 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -152.98 172.81 16.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.116 0.484 . . . . 0.0 112.242 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -119.68 119.61 34.2 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -114.35 124.04 50.97 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.264 0.554 . . . . 0.0 110.257 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.04 137.7 48.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.11 141.73 28.27 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 117.88 -1.528 . . . . 0.0 110.729 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 HG21 HG11 ' A' ' 46' ' ' VAL . 26.2 pt -84.93 -2.85 7.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.403 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -76.27 -37.58 57.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -87.01 -42.86 12.78 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.062 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -86.67 97.34 10.52 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.435 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -71.95 -28.9 63.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.077 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.41 74.53 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.47 -37.84 77.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.343 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.06 98.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.175 0.59 . . . . 0.0 110.905 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.13 -45.61 92.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -56.73 -60.71 3.16 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.916 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG11 HG21 ' A' ' 36' ' ' ILE . 4.3 p -61.21 -34.34 60.14 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.089 -178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.08 90.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.586 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.8 p -80.11 -11.37 59.77 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -115.23 13.73 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 121.813 0.816 . . . . 0.0 109.525 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -98.88 -171.84 2.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 -174.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 69.4 2.83 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.96 -96.87 1.6 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.2 174.46 5.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -76.79 111.16 12.01 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.267 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.402 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . 9.8 t -133.46 -17.49 2.29 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.796 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 152.9 81.03 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 10' ' ' THR . 36.5 Cg_endo -67.29 157.72 60.39 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.204 1.936 . . . . 0.0 111.924 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -141.74 148.59 39.25 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.589 HG21 HD12 ' A' ' 6' ' ' LEU . 7.1 p -120.47 136.65 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 O-C-N 123.666 0.604 . . . . 0.0 109.899 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -113.15 127.55 56.22 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.43 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 97.0 m-85 -85.77 169.57 13.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -60.79 -27.66 68.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.574 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.19 -16.68 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.661 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.11 -19.07 27.87 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-O 119.741 -0.477 . . . . 0.0 114.236 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -73.76 153.3 40.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.788 0.794 . . . . 0.0 112.616 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 p -118.26 153.66 33.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.142 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.9 mt -132.75 123.18 25.74 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.6 m -65.41 138.49 58.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -5.03 92.16 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.506 0 C-N-CA 126.873 2.069 . . . . 0.0 115.949 -170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -98.85 -169.75 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.724 2.95 . . . . 0.0 111.913 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 75' ' ' VAL . 48.2 t -117.94 172.1 7.62 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.84 -50.14 66.87 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 11.1 m-20 -71.89 -30.2 65.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.81 -43.53 98.07 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.351 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 71' ' ' SER . 15.5 m -80.28 -30.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 52.5 mtpt -60.08 -40.87 91.07 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.41 -36.8 64.34 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.122 0.889 . . . . 0.0 111.707 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -84.11 -48.58 9.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.18 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.58 -41.14 72.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.735 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.35 -34.54 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.217 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.37 -19.6 38.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.014 -178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' LYS . 78.2 mt -84.67 -46.21 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.263 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.258 -176.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.92 -64.43 1.13 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.531 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.5 131.98 6.64 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.918 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -102.68 127.27 49.87 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.942 -174.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.23 123.7 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 124.983 1.313 . . . . 0.0 110.659 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.8 m-85 -103.68 115.79 31.14 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -163.64 169.81 18.03 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.461 HG23 ' CG1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -123.77 161.15 25.8 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -74.36 -8.19 55.43 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.699 0.285 . . . . 0.0 111.76 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -86.95 -5.48 59.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -78.69 144.21 35.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.97 -42.8 84.48 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.218 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -82.11 -5.67 58.59 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.4 p -50.29 -63.13 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -68.67 -29.53 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.282 0.563 . . . . 0.0 111.543 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -59.88 -47.19 86.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.775 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.8 tp -70.55 -34.75 72.58 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.574 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 10.2 mmmm -62.14 -47.17 85.74 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -65.41 -43.77 89.54 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.767 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -45.53 84.22 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.872 0.368 . . . . 0.0 111.675 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.85 -37.7 70.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.208 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.2 m -65.99 -43.7 86.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.78 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.23 -34.34 77.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.232 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -91.41 6.69 44.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.89 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 54.95 62.29 2.58 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.422 1.089 . . . . 0.0 112.004 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.56 133.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.537 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.85 125.35 29.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.72 159.67 41.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.323 0.582 . . . . 0.0 110.895 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' THR . 20.6 m-20 -122.43 142.35 50.64 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -137.14 139.17 41.0 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.558 0.617 . . . . 0.0 111.762 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.23 144.78 28.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.33 143.14 26.7 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 117.915 -1.514 . . . . 0.0 110.738 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 HG11 ' A' ' 46' ' ' VAL . 35.6 pt -84.13 -3.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.407 -1.27 . . . . 0.0 113.184 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.06 -36.94 16.67 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.493 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -77.82 -33.62 52.32 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.023 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -103.52 102.88 12.79 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -65.53 -36.5 83.99 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.486 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.79 -32.05 72.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 111.068 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -75.8 -41.03 54.0 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.043 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.85 -44.38 89.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.122 0.569 . . . . 0.0 111.38 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.82 -38.23 81.44 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.751 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.48 -61.44 1.77 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.207 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -57.34 -35.79 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.04 73.12 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.843 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.53 -25.78 30.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.054 0.454 . . . . 0.0 111.177 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.23 13.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.029 0.919 . . . . 0.0 110.438 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 165.83 16.22 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.986 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.62 87.18 1.39 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.67 -97.74 1.86 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 48.4 t30 -86.21 149.89 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -72.87 102.41 3.42 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 53' ' ' ASN . 8.9 t -157.93 -8.08 0.08 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.051 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 55' ' ' THR . 5.7 m -126.71 144.68 50.73 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.4 Cg_endo -58.85 140.08 93.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.28 2.653 . . . . 0.0 111.477 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.7 m -128.66 138.9 52.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.9 m -102.71 133.73 45.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.378 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -110.63 112.72 24.8 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.417 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 87.7 m-85 -78.78 159.79 27.71 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 123.557 0.535 . . . . 0.0 109.732 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.42 -14.02 46.08 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 13.4 p-10 -85.63 -12.45 51.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.18 15.77 24.91 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.1 p -105.45 157.01 17.65 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.195 -0.591 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.5 p -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.58 0.229 . . . . 0.0 110.537 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -128.45 127.51 42.63 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 m -66.78 145.68 55.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -5.11 85.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 C-N-CA 126.295 1.838 . . . . 0.0 115.887 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -95.0 159.64 1.72 Allowed 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 123.761 2.974 . . . . 0.0 112.486 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 p -83.49 168.62 16.31 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.59 77.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.367 0.603 . . . . 0.0 110.634 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.97 -25.45 62.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.665 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.24 -43.88 22.88 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 122.257 -0.277 . . . . 0.0 111.538 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.89 -40.77 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.83 -34.59 71.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.39 77.41 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.652 0.595 . . . . 0.0 112.207 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -85.84 -44.69 12.23 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.061 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -53.35 -40.09 64.65 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.505 1.122 . . . . 0.0 113.15 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.91 -39.17 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.43 0.456 . . . . 0.0 111.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -79.28 -31.4 43.33 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.162 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 78' ' ' LYS . 62.8 mt -74.96 -52.85 17.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.079 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.125 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.895 -176.465 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.996 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.34 -58.89 6.59 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.421 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.19 132.16 18.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.348 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -112.18 122.64 48.31 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' LEU . 96.4 mt -91.63 123.77 43.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.003 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.49 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 29.7 m-85 -105.43 118.88 37.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -163.84 164.31 23.55 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 162.84 14.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -71.01 -19.44 62.52 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -83.82 -1.22 53.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -80.6 123.23 27.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.14 92.98 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.549 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -82.27 -7.15 59.62 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 37.0 t -52.52 -59.41 4.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.187 0.305 . . . . 0.0 111.655 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.13 -23.15 63.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.14 -48.25 65.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.8 tp -63.88 -40.15 95.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.602 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.3 mmtp -60.16 -51.79 68.08 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.258 0.552 . . . . 0.0 110.409 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 25' ' ' THR . 17.1 p -67.73 -31.85 72.07 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.428 -177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.53 84.57 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 120.941 0.4 . . . . 0.0 110.488 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 55.4 mt -72.03 -40.96 68.04 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.439 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' THR . 4.1 t -64.76 -29.6 70.58 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.411 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.41 -31.75 58.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.206 0.526 . . . . 0.0 111.006 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -91.53 12.86 19.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 61.18 33.36 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.583 1.153 . . . . 0.0 110.43 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 24' ' ' LEU . 78.3 mt -87.26 133.57 29.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.408 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.67 123.57 34.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -145.81 175.44 10.41 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.059 0.457 . . . . 0.0 111.4 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -129.27 142.08 50.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.82 126.77 38.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 133.9 43.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.01 140.69 57.71 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 40.5 pt -84.35 -18.8 9.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.99 -45.37 74.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.572 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -72.2 -36.97 69.35 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.613 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -91.05 93.4 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.024 0.44 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -55.25 -46.02 76.06 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.969 0.907 . . . . 0.0 111.802 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.19 70.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.41 81.2 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . . . -64.24 -41.59 96.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.173 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.78 -43.01 90.06 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.47 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.95 -52.79 63.54 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.566 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 49' ' ' VAL . 14.3 m -68.35 -21.97 26.9 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.52 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.27 68.35 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.058 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.89 -23.5 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.026 0.441 . . . . 0.0 110.795 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 46' ' ' VAL . 32.1 m -114.74 13.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.706 0.765 . . . . 0.0 110.606 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -88.87 -171.61 3.37 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.134 -172.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 65.87 3.18 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.87 -73.07 1.6 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -110.47 161.73 15.39 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.421 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -71.16 100.67 2.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -149.67 -17.89 0.27 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.286 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -116.91 145.62 35.97 Favored Pre-proline 0 C--O 1.248 1.013 0 O-C-N 121.907 -0.496 . . . . 0.0 111.82 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.53 127.42 26.13 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.581 2.854 . . . . 0.0 111.342 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -113.71 135.31 54.07 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.26 125.29 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.771 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.07 111.85 23.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -82.16 171.03 14.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.347 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -15.3 63.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.939 0.875 . . . . 0.0 109.104 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.47 -17.98 61.72 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.709 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 -22.67 21.35 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.508 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -73.42 151.94 40.97 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 p -119.53 143.4 47.6 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.8 mt -125.32 132.97 52.77 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -72.32 139.53 48.02 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -5.49 88.39 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' O ' HD13 ' A' ' 20' ' ' LEU . 19.7 Cg_endo -99.23 153.38 0.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 123.998 3.132 . . . . 0.0 111.145 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -86.34 172.88 10.1 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.718 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.65 55.59 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.774 0.829 . . . . 0.0 113.065 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 19.0 m-20 -69.92 -19.74 63.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -82.49 -39.35 22.59 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.36 -31.03 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 51.0 mtpt -54.5 -40.23 68.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.94 0.496 . . . . 0.0 110.832 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.73 71.38 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 124.238 0.961 . . . . 0.0 112.0 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.5 mtpp -84.15 -47.24 11.07 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.953 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 5' ' ' ALA . 60.7 tp -57.8 -39.89 78.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.797 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.95 -31.2 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.341 0.591 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -81.09 -43.04 20.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 78' ' ' LYS . 76.1 mt -59.3 -34.8 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.91 179.627 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -2.576 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 -53.18 4.23 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.877 0.846 . . . . 0.0 108.788 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.07 136.83 17.07 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.727 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.8 m -102.26 110.07 21.93 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 59' ' ' VAL . 89.9 mt -88.49 130.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.817 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.83 105.44 13.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.334 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -164.66 -171.12 2.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -149.62 164.59 34.73 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -56.01 -20.67 17.58 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.664 1.185 . . . . 0.0 113.812 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -82.09 -2.07 50.69 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.9 t -95.92 129.32 43.21 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.68 -31.94 81.52 Favored Glycine 0 N--CA 1.46 0.243 0 CA-C-O 121.493 0.496 . . . . 0.0 112.1 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -80.96 -7.94 59.64 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 31.6 t -64.57 -61.74 2.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.41 -29.2 68.63 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.723 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -62.97 -39.12 93.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.5 tp -75.89 -45.96 32.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.214 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -53.7 -49.27 68.41 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.933 0.396 . . . . 0.0 110.884 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -66.87 -37.25 84.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.103 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.28 91.33 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 120.951 0.405 . . . . 0.0 110.734 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.4 -42.35 71.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -62.71 -40.74 98.1 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.426 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.89 66.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 110.942 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -91.04 4.19 52.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.663 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 61.23 29.64 18.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 111.584 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.95 131.52 33.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.97 35.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.11 164.34 30.04 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.974 0.416 . . . . 0.0 111.799 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.82 122.52 34.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.225 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.31 129.61 56.66 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.958 0.409 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.1 138.7 53.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.43 141.33 28.85 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.004 -1.478 . . . . 0.0 111.092 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.599 HG21 HG11 ' A' ' 46' ' ' VAL . 29.2 pt -85.1 5.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.8 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.88 -45.29 12.4 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -85.27 -34.66 21.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.759 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.91 92.95 7.15 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.722 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -72.25 -28.29 63.05 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.14 76.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.6 -39.52 70.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.332 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.16 90.86 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 110.831 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.03 -48.67 77.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.692 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.87 -56.83 16.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.438 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.15 -33.29 61.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.6 73.82 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.935 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -76.18 -45.63 32.39 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.047 0.451 . . . . 0.0 110.164 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.96 3.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.458 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.78 -172.37 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.187 0.518 . . . . 0.0 109.948 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.07 64.23 2.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.14 -73.81 0.22 Allowed Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.483 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 39.9 t-20 -135.89 169.65 17.24 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -70.94 107.01 3.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.349 0.977 . . . . 0.0 110.799 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.1 t -138.14 -23.24 1.02 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.004 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.38 154.6 79.18 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 39.0 Cg_endo -67.84 145.56 69.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.316 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.8 m -128.87 143.65 50.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.4 m -111.17 134.25 54.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 123.164 0.29 . . . . 0.0 110.417 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -111.76 118.88 36.82 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 93.2 m-85 -80.09 178.59 8.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.96 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.71 58.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.563 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 33.7 p-10 -88.3 -18.48 28.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.784 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.37 -1.63 53.81 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.99 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -84.48 144.65 28.58 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.96 140.94 48.87 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.754 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.79 140.75 50.31 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.7 m -77.73 147.45 35.38 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -5.53 83.27 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.833 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -98.51 139.53 0.41 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 123.57 2.847 . . . . 0.0 112.269 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -72.11 174.53 7.01 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.648 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.01 -47.03 78.55 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 123.829 0.851 . . . . 0.0 113.176 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 15.7 m-20 -76.29 -19.76 57.96 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.383 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.28 -44.17 65.74 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 -34.99 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.812 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 55.6 mtpt -56.68 -36.53 69.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.199 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.61 73.98 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.903 0.752 . . . . 0.0 111.628 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -84.05 -40.82 17.88 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.613 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 tp -60.27 -38.27 83.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.941 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.8 -32.94 57.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.079 0 CA-C-O 121.499 0.666 . . . . 0.0 110.753 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -81.75 -31.24 32.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.41 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.08 -36.49 68.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.322 0.582 . . . . 0.0 109.86 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.177 177.014 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.9 -54.75 41.29 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.683 0.614 . . . . 0.0 111.519 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.15 137.87 19.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -103.45 119.39 38.8 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 59' ' ' VAL . 92.2 mt -88.76 122.48 40.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 54.1 m-85 -102.61 121.9 43.33 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 173.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -163.51 171.41 15.9 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 149.13 27.86 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.1 t -67.35 -20.95 65.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.471 0.177 . . . . 0.0 110.594 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.86 5.25 41.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.4 t -85.85 132.37 34.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.97 -32.91 58.2 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 56' ' ' VAL . 50.5 m-85 -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 51.5 t -57.11 -56.43 21.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 123.585 0.553 . . . . 0.0 110.307 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.65 -21.69 61.78 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 36.7 mmt180 -65.28 -51.1 62.97 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.09 -40.35 96.05 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.731 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.8 mmtp -60.31 -41.13 92.83 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.8 m -59.96 -45.28 93.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.052 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.35 -51.25 66.7 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.671 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.65 -44.49 86.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.9 m -64.02 -34.28 77.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.748 0.309 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.39 -25.18 67.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.141 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.83 9.26 36.99 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 122.082 -0.386 . . . . 0.0 110.74 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 54.92 41.18 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.828 0.851 . . . . 0.0 111.298 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.4 mt -84.38 138.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.15 119.31 24.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.33 168.14 20.22 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.872 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.08 142.26 47.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.15 137.78 46.38 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.442 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.94 142.4 36.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -89.25 141.7 28.29 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.508 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 46' ' ' VAL . 43.2 pt -84.21 -7.53 10.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.664 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -71.92 -31.69 66.62 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 121.729 0.776 . . . . 0.0 108.919 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -90.16 -15.52 31.35 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.231 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -125.45 95.53 4.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.673 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.08 -34.89 79.1 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.044 0.215 . . . . 0.0 111.409 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.93 98.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.037 0.446 . . . . 0.0 110.023 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.1 -37.93 81.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.777 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.85 98.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.744 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.15 -39.23 94.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.03 -59.29 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.453 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -62.39 -31.38 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.331 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.74 -37.4 94.65 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.617 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -82.27 -13.71 56.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 58' ' ' THR . 27.5 m -110.75 13.34 8.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.182 0.992 . . . . 0.0 109.458 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -172.11 3.12 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.32 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.79 60.71 0.57 Allowed Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.187 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.89 -56.74 0.49 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.73 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -144.77 167.41 22.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -71.29 103.21 2.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.89 0.768 . . . . 0.0 110.005 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 -32.54 0.36 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.755 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' A' ' 16' ' ' TYR . 9.1 m -115.55 149.3 42.73 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 28.2 Cg_endo -63.57 147.03 93.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.906 2.404 . . . . 0.0 111.223 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 49' ' ' VAL . 32.2 m -134.65 140.05 45.74 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' THR . 34.1 m -105.93 132.18 53.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.03 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.15 115.66 30.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.98 162.19 22.75 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.319 0.387 . . . . 0.0 110.579 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.98 56.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.567 0.699 . . . . 0.0 109.7 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.32 -12.63 59.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.595 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.1 -22.93 31.99 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 171.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -105.48 174.36 5.91 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.448 1.124 . . . . 0.0 111.11 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 p -113.62 160.23 18.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.962 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -134.15 125.97 29.02 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -67.82 141.78 56.37 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -5.13 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.519 3.014 0 C-N-CA 126.449 1.9 . . . . 0.0 115.313 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.6 Cg_endo -96.54 138.48 0.62 Allowed 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 124.271 3.314 . . . . 0.0 111.895 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -72.71 173.2 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.897 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.93 86.98 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 5.4 t70 -81.07 -19.91 42.69 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.968 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.24 -43.41 70.62 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.679 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 7.6 m -68.92 -40.6 81.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.939 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 48.4 mtpt -53.11 -39.33 63.35 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.484 0.49 . . . . 0.0 111.649 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.5 84.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.545 0.528 . . . . 0.0 111.869 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -85.96 -35.94 20.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.626 0.727 . . . . 0.0 110.573 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.492 HD11 ' HB1' ' A' ' 5' ' ' ALA . 65.1 tp -66.74 -35.31 79.8 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.394 1.478 . . . . 0.0 112.517 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.18 -31.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.929 0.492 . . . . 0.0 111.772 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -70.4 -26.39 63.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.353 0.597 . . . . 0.0 110.276 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -83.93 -51.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.063 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.927 -177.187 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.243 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.82 -64.19 1.07 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.17 146.69 12.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.812 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 28.0 m -118.17 132.31 56.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.512 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.6 mt -92.71 128.7 44.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 124.061 0.944 . . . . 0.0 111.503 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 69.1 m-85 -110.09 119.09 38.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 173.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.09 -172.02 2.64 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.2 p -121.64 164.27 17.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.6 m -78.71 -7.85 58.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -102.8 2.48 35.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.175 0.512 . . . . 0.0 111.32 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 45.6 t -82.94 118.56 23.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.36 69.94 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.818 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.16 -10.48 59.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.092 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 23.0 t -61.09 -62.55 1.77 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.39 -29.21 69.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.494 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.72 -44.19 96.87 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.364 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.65 -37.87 67.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.6 mmtp -56.93 -43.13 81.17 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 m -57.4 -53.33 59.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.962 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.24 82.94 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.097 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -70.27 -37.24 74.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.559 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -70.98 -39.09 72.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.84 64.17 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.296 0.57 . . . . 0.0 111.259 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.92 14.52 27.9 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 44.55 59.8 3.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.597 1.159 . . . . 0.0 113.054 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.53 135.15 50.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.45 131.99 34.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.61 157.29 42.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 7' ' ' THR . 33.9 t70 -120.7 142.32 49.61 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -127.25 138.13 53.02 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.054 0.454 . . . . 0.0 110.528 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.8 141.23 37.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.46 143.83 26.08 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.326 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 48.6 pt -82.99 -0.36 4.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.939 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.7 -38.18 16.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -76.51 -35.96 58.02 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.463 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -105.35 99.99 9.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.783 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -68.82 -32.93 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -66.13 -41.77 90.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.54 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.66 75.78 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.323 0.582 . . . . 0.0 110.987 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -70.86 -44.52 66.22 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.127 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.07 -56.62 15.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.917 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 8.6 p -65.2 -27.0 41.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.36 -20.86 77.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.538 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -84.07 -24.41 30.4 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 122.616 0.366 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -115.12 13.12 7.98 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.07 167.58 11.69 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.315 -175.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.7 80.28 1.59 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.19 -82.92 0.34 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 32.7 t-20 -144.65 172.68 12.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -63.37 121.32 13.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.343 0.974 . . . . 0.0 111.833 -175.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 HG13 ' A' ' 56' ' ' VAL . 9.7 t -166.73 -25.62 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.43 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG23 ' A' ' 55' ' ' THR . 17.7 m -115.99 148.38 41.26 Favored Pre-proline 0 N--CA 1.445 -0.7 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 27.2 Cg_endo -62.22 138.02 69.53 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.894 2.396 . . . . 0.0 111.583 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 49' ' ' VAL . 40.5 m -129.22 144.29 51.16 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.8 m -109.82 129.61 64.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.855 0.359 . . . . 0.0 111.14 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -104.58 118.63 37.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -83.58 171.17 13.59 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.499 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.85 14.84 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.15 -10.46 49.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.154 0.502 . . . . 0.0 109.881 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.07 -15.15 58.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.878 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 m -94.4 166.61 11.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.476 0.638 . . . . 0.0 111.262 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -120.0 157.89 27.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.4 mt -128.19 122.31 31.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 167.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.4 m -61.73 141.33 57.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -5.18 89.67 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 127.513 2.325 . . . . 0.0 115.458 -171.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -96.24 154.8 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 124.265 3.31 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.2 t -84.96 175.32 9.14 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.31 73.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.08 -36.96 75.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.16 0.505 . . . . 0.0 110.095 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.72 -47.38 72.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -64.7 -41.0 90.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.842 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.8 -35.17 79.72 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.95 88.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.886 0.741 . . . . 0.0 111.679 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -85.35 -42.49 14.52 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.86 -37.76 77.23 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 112.302 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -31.39 45.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.438 0.637 . . . . 0.0 110.701 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -81.07 -31.04 34.59 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.045 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.51 -44.62 76.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.411 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.513 177.377 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.324 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -75.24 -51.99 11.97 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.335 0.588 . . . . 0.0 110.314 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -149.02 128.47 13.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.839 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.3 m -104.9 119.1 38.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 24' ' ' LEU . 80.0 mt -88.99 124.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.424 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 36' ' ' ILE . 28.0 m-85 -103.01 113.25 26.56 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.06 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -155.34 160.34 40.65 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -93.67 151.7 19.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.827 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -69.79 -22.11 63.35 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.936 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -88.07 -1.18 57.84 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -75.28 145.84 41.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 -33.17 25.93 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.89 -8.3 57.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.645 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.0 p -57.04 -57.05 14.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.53 -21.73 60.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.586 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -67.9 -46.85 70.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.36 -34.49 78.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.3 mmtp -62.43 -45.53 92.68 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 m -60.46 -41.66 94.6 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.94 75.43 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.492 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' A' ' 8' ' ' ILE . 57.6 mt -70.38 -45.25 66.4 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -63.38 -35.86 81.81 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 120.708 0.289 . . . . 0.0 111.632 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -10.04 59.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -110.78 14.84 22.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.777 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 63.96 27.41 14.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 113.154 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 64.3 mt -90.21 131.52 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.854 0.359 . . . . 0.0 111.175 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.86 39.1 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -148.05 174.92 11.45 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.53 137.28 51.67 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -125.94 132.57 52.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.722 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 p -139.14 151.86 23.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.05 141.38 28.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.991 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 46' ' ' VAL . 30.9 pt -83.68 -31.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -79.97 -15.05 58.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.092 0.949 . . . . 0.0 109.006 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -91.73 -1.27 57.47 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.528 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -135.98 104.92 5.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -50.7 -51.83 45.93 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.755 0.822 . . . . 0.0 112.426 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.94 79.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.341 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.78 -43.42 75.74 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.85 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -60.89 -43.71 98.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.448 0.699 . . . . 0.0 112.129 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -22.49 62.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 112.084 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -76.97 -61.54 1.95 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.608 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.6 p -62.22 -37.04 77.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.469 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.75 90.72 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.461 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -77.74 -29.84 51.32 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.758 0.314 . . . . 0.0 111.394 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.44 11.5 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 0.0 110.855 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.18 -172.74 3.93 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.311 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.56 85.33 0.39 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.6 -116.39 4.87 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -95.32 -175.84 3.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 98.82 7.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.647 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 t -139.27 -27.67 0.8 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.641 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.43 138.56 20.24 Favored Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.29 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.47 122.31 11.29 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.177 2.585 . . . . 0.0 111.258 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -112.0 132.42 54.8 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.9 p -103.5 121.59 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.249 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -100.41 118.49 36.75 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -86.34 165.88 16.05 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.658 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.98 51.58 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -85.37 -3.45 58.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.084 -0.385 . . . . 0.0 110.67 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.18 18.38 59.32 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.721 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 t -106.76 143.14 35.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.91 141.39 48.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.483 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.52 132.35 52.63 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -67.32 136.73 55.29 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -5.98 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.564 0 C-N-CA 126.828 2.051 . . . . 0.0 116.186 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 31.5 Cg_endo -97.52 169.34 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.678 3.586 . . . . 0.0 113.495 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -83.9 161.43 20.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -62.73 -40.07 96.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.759 0.424 . . . . 0.0 111.214 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.57 -43.22 93.68 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.012 0.434 . . . . 0.0 110.611 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -63.15 -48.99 76.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.901 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 17.5 m -68.45 -33.49 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 54.7 mtpt -62.87 -34.92 78.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.67 0.213 . . . . 0.0 110.614 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.68 67.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.263 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -84.17 -46.7 11.62 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.426 HD11 ' HB1' ' A' ' 5' ' ' ALA . 53.1 tp -55.69 -39.71 71.37 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.35 1.46 . . . . 0.0 112.936 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.0 p -60.27 -35.27 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.66 -22.38 46.88 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.81 0.814 . . . . 0.0 110.514 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.3 mt -84.99 -53.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.607 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.119 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.966 -175.754 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . . . . . . 0 N--CA 1.427 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.86 -59.08 5.94 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.955 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.05 134.91 11.89 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.047 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -102.15 129.16 48.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.947 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG12 HG12 ' A' ' 59' ' ' VAL . 49.9 mt -93.48 120.44 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.18 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 60.6 m-85 -102.54 115.77 31.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -158.26 175.97 13.07 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.86 155.93 43.36 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -70.19 -15.86 62.99 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -85.46 -4.82 59.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.6 m -77.07 133.54 39.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.8 -38.9 35.28 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.979 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -75.78 -7.53 54.65 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 52.5 t -57.26 -61.74 2.26 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.4 -23.78 64.69 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 5.1 tpm_? -67.65 -43.08 81.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.648 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.96 -35.63 66.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -55.95 -48.41 75.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -66.28 -34.41 77.94 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.736 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.65 87.2 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.252 0.549 . . . . 0.0 110.4 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 mt -73.63 -41.96 62.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.0 m -65.31 -35.16 80.15 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.54 87.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.837 0.827 . . . . 0.0 109.974 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.46 3.03 48.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.8 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 58.7 31.54 21.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.792 0.837 . . . . 0.0 112.065 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.3 mt -75.14 137.24 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.32 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.49 119.74 32.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -134.27 163.74 28.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -128.87 135.25 48.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.61 141.19 46.67 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.606 0.241 . . . . 0.0 111.319 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.74 138.18 39.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 170.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -77.97 143.39 37.62 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.777 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.639 HG21 HG11 ' A' ' 46' ' ' VAL . 42.8 pt -83.32 -9.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.092 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.94 -32.13 27.33 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.76 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -88.04 -10.83 49.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.881 0.372 . . . . 0.0 110.761 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.73 98.06 6.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.69 -49.28 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.43 74.14 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.95 -42.96 72.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.388 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 110.207 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.48 -50.7 72.92 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.519 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -58.29 -56.24 24.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.406 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.639 HG11 HG21 ' A' ' 36' ' ' ILE . 7.1 p -64.39 -35.32 73.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.722 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.21 -34.91 89.53 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.558 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -66.75 -44.5 81.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.003 0.521 . . . . 0.0 109.91 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 58' ' ' THR . 33.2 m -92.58 13.11 2.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 111.868 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -172.88 3.21 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.27 2.72 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.0 -44.72 2.85 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-O 121.258 0.366 . . . . 0.0 113.044 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -119.79 142.58 48.46 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.47 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -77.4 94.22 4.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.587 176.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -139.68 -17.26 0.99 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.965 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -124.1 144.85 46.48 Favored Pre-proline 0 C--O 1.244 0.779 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 13.2 Cg_endo -56.63 131.61 46.69 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.682 2.922 . . . . 0.0 111.542 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 49' ' ' VAL . 23.4 m -124.18 138.46 54.41 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.0 m -104.78 127.44 59.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 123.377 0.423 . . . . 0.0 110.978 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -106.71 113.89 27.66 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.1 163.23 21.01 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.954 0.407 . . . . 0.0 110.843 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -62.54 -17.32 59.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.014 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.82 -6.4 59.42 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.35 39.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.103 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.5 p -111.21 154.06 24.94 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.803 0.801 . . . . 0.0 111.199 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -121.21 142.03 50.3 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.948 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.29 124.99 40.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.6 m -67.36 145.76 54.76 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -4.64 85.81 0.03 OUTLIER Pre-proline 0 N--CA 1.522 3.139 0 C-N-CA 126.56 1.944 . . . . 0.0 114.793 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -97.83 161.09 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.522 3.481 . . . . 0.0 113.455 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -80.57 159.33 25.49 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.43 66.17 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.31 -43.93 98.05 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.576 0.751 . . . . 0.0 110.737 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.78 -44.9 72.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.532 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.6 m -68.22 -35.94 73.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.618 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -61.62 -42.17 98.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.537 0.335 . . . . 0.0 110.818 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.09 67.56 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.827 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -84.3 -51.85 6.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.821 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.85 -36.77 65.42 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.947 0.899 . . . . 0.0 113.272 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.09 -34.54 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.029 0.442 . . . . 0.0 111.833 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -81.38 -48.63 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.35 -45.14 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.546 1.138 . . . . 0.0 112.76 -175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.946 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.031 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.43 85.78 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.064 0.853 . . . . 0.0 109.906 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.59 131.65 14.35 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.901 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -102.5 120.48 40.6 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 59' ' ' VAL . 60.3 mt -88.43 119.57 35.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.791 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 45.6 m-85 -104.89 114.82 29.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.589 174.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -163.85 -174.44 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -118.02 166.99 11.87 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 123.844 0.858 . . . . 0.0 109.253 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 m -78.84 -17.57 55.44 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.939 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -93.05 -1.93 56.1 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.3 t -81.34 131.2 35.28 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.838 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.2 -46.26 51.29 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -63.88 -15.71 59.63 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.721 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.6 t -59.14 -63.71 1.2 Allowed 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.347 0.404 . . . . 0.0 110.536 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.06 -24.62 61.55 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.823 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 29.1 mmm180 -65.8 -48.25 72.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.335 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.07 -32.14 68.73 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.07 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.5 mmmm -57.72 -43.41 85.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 m -64.1 -49.78 70.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.35 87.17 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.238 0.615 . . . . 0.0 112.492 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.78 -41.88 82.52 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.1 m -62.32 -42.12 99.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.451 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.03 66.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.781 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -103.58 9.35 37.48 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.884 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 3.6 mmp_? 62.32 43.34 8.34 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.608 0.718 . . . . 0.0 111.567 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.44 132.52 48.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.3 34.87 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -136.75 163.77 29.83 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.14 0.495 . . . . 0.0 112.198 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -121.49 142.48 50.01 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.31 139.89 48.36 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 117.918 0.326 . . . . 0.0 110.77 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.32 147.3 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.15 141.31 34.36 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.023 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.622 HG21 HG11 ' A' ' 46' ' ' VAL . 41.6 pt -83.76 -32.23 8.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.29 -14.88 60.53 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.147 -0.346 . . . . 0.0 111.648 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.53 -25.84 33.02 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.3 94.34 4.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.989 -0.445 . . . . 0.0 109.837 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.01 -45.34 64.53 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.86 92.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.631 0.253 . . . . 0.0 110.994 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.93 -41.44 78.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -65.82 -35.39 80.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 9.4 tp10 -70.41 -38.73 74.68 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.16 -58.46 7.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.282 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 36' ' ' ILE . 6.2 p -61.79 -35.35 67.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.1 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.77 72.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.551 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 m -83.66 -34.15 25.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.757 0.313 . . . . 0.0 111.523 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.4 m -94.5 10.62 4.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.776 0.798 . . . . 0.0 110.616 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -175.36 5.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.451 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.72 66.82 3.68 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.56 -66.91 0.26 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 65.3 t30 -142.12 162.06 36.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -57.6 114.33 2.2 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.887 -178.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.2 t -161.22 -30.63 0.05 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.626 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.77 152.04 44.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 36.7 Cg_endo -64.59 139.9 66.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.584 2.19 . . . . 0.0 112.119 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -126.57 136.57 52.72 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' THR . 30.7 m -105.02 129.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.133 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -103.97 119.43 38.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.4 172.25 13.9 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 120.79 0.329 . . . . 0.0 111.079 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.6 68.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.901 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -78.09 -17.96 56.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.941 0.401 . . . . 0.0 110.27 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.52 -19.54 28.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.579 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -71.59 160.51 32.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.322 0.561 . . . . 0.0 111.342 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -127.31 141.9 51.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.444 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.18 120.4 33.08 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -64.64 144.27 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -5.36 84.83 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -92.53 -170.58 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 123.612 2.875 . . . . 0.0 111.389 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 15.3 p -117.55 166.64 12.13 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.97 75.4 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.36 0.412 . . . . 0.0 111.776 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -69.66 -35.96 75.61 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.483 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -68.49 -45.03 73.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' SER . 10.8 m -67.63 -37.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.37 -31.48 71.37 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.81 80.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.553 0.533 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -84.03 -41.88 16.75 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.7 -39.0 89.91 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.528 1.131 . . . . 0.0 112.695 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.49 -35.63 55.39 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-O 120.977 0.417 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.65 -19.73 58.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.206 0.527 . . . . 0.0 111.264 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -80.86 -49.12 18.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.628 -179.546 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.455 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.4 -58.63 3.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 123.338 0.399 . . . . 0.0 111.248 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.76 144.27 13.39 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 m -110.05 124.83 52.17 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.948 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.521 HG12 HG12 ' A' ' 59' ' ' VAL . 86.8 mt -89.81 128.4 41.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 124.13 0.972 . . . . 0.0 110.512 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 81.0 m-85 -111.16 127.24 55.52 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -163.13 170.72 17.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 162.93 21.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -59.65 -30.18 68.56 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -87.19 0.13 55.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.87 112.93 16.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.27 70.45 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-N 116.371 -0.377 . . . . 0.0 114.004 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -82.83 -6.73 59.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.3 p -54.09 -60.12 3.75 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.76 -33.76 76.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.482 0.313 . . . . 0.0 111.743 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -59.79 -47.83 84.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.693 0.759 . . . . 0.0 109.794 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 tp -64.47 -38.7 91.93 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.82 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.7 mmtp -61.07 -46.73 89.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.141 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -59.54 -47.04 87.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.36 96.68 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.37 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 75' ' ' VAL . 76.8 mt -74.61 -35.27 62.95 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.316 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -66.47 -38.62 87.72 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 123.309 0.38 . . . . 0.0 110.278 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.68 97.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 111.401 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -86.73 -5.75 59.03 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 64.38 61.73 0.86 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.055 1.342 . . . . 0.0 113.253 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.58 138.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.28 108.23 19.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -120.77 156.68 31.34 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.18 142.16 40.36 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.12 132.36 38.0 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.429 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.4 131.72 40.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.75 140.03 37.08 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.954 0.883 . . . . 0.0 109.442 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 HG11 ' A' ' 46' ' ' VAL . 37.5 pt -84.25 -15.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.359 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.93 -34.18 77.21 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.307 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -78.29 -50.18 12.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -91.44 104.87 17.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -56.53 -44.07 80.45 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 125.626 1.571 . . . . 0.0 111.238 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.43 89.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -70.92 -38.92 72.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.33 91.19 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.698 0.624 . . . . 0.0 110.696 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.44 -51.44 68.69 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.098 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -56.09 -60.43 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.016 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 36' ' ' ILE . 7.2 p -65.5 -29.83 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 0.0 111.749 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.24 75.83 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.057 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -84.04 -36.87 22.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.2 m -98.41 13.33 4.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.33 175.79 10.28 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.514 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.07 88.31 0.89 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.39 -71.96 0.44 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.409 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 27.9 t-20 -144.62 162.31 36.96 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.7 117.18 10.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.627 0.727 . . . . 0.0 110.651 -178.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.0 t -163.81 -31.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.59 147.22 36.28 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.9 Cg_endo -60.3 146.52 96.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.072 2.515 . . . . 0.0 111.687 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.66 144.5 50.38 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 8' ' ' ILE . 16.3 m -110.97 131.58 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 123.168 0.293 . . . . 0.0 110.297 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -106.93 122.43 46.41 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 67.8 m-85 -86.83 177.91 7.15 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.275 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.12 66.38 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.516 0.727 . . . . 0.0 112.13 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 18.6 p-10 -82.57 -11.57 58.33 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.15 0.5 . . . . 0.0 110.365 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.8 3.77 68.07 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.319 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -97.43 152.53 18.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.4 p -115.84 154.19 30.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.317 0.58 . . . . 0.0 111.916 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -130.29 125.69 35.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 m -68.99 142.14 54.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -4.76 84.85 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.792 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 35.0 Cg_endo -93.99 150.83 2.16 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 123.934 3.089 . . . . 0.0 113.231 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 m -75.89 165.66 24.66 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.14 -33.96 72.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.98 -35.68 66.93 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.321 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.62 -43.85 88.31 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.999 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.5 m -67.82 -41.97 85.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 51.6 mtpt -60.61 -40.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.288 0.368 . . . . 0.0 110.756 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.95 75.88 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.777 0.673 . . . . 0.0 111.973 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 64.3 tttp -84.14 -45.42 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.584 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.65 -41.01 96.92 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.243 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.41 -38.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.782 0 O-C-N 123.448 0.468 . . . . 0.0 110.604 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -70.26 -25.29 63.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.78 -40.02 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.956 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.1 -60.55 3.6 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.823 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.0 135.34 12.28 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.696 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 85.5 m -102.63 123.94 47.25 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 59' ' ' VAL . 75.9 mt -88.96 124.69 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 59.3 m-85 -106.51 110.81 23.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.738 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 14.9 t -164.02 -177.2 4.91 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 149.98 51.41 Favored 'General case' 0 N--CA 1.396 -3.143 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -58.53 -8.41 1.23 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -91.37 -1.46 57.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.605 -0.685 . . . . 0.0 112.333 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.7 t -82.6 140.45 33.21 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.49 62.97 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -82.52 -7.8 59.63 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.8 t -61.69 -63.02 1.4 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.151 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.5 pt? -68.3 -28.58 67.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.158 0.504 . . . . 0.0 110.878 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -61.25 -50.59 72.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.86 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.48 -35.42 73.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.194 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.2 mmtp -57.97 -40.41 80.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -67.4 -48.69 66.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.385 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.81 -42.64 84.68 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.601 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 54.5 mt -69.63 -38.83 77.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.662 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -65.93 -35.89 81.87 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.876 0.37 . . . . 0.0 110.798 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.53 64.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.367 0.603 . . . . 0.0 111.38 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -109.91 13.49 23.46 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 43.09 62.64 1.75 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.024 1.729 . . . . 0.0 113.418 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 89.3 mt -105.66 129.85 58.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.402 -177.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.09 28.67 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -136.79 166.68 23.03 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.138 0.494 . . . . 0.0 111.495 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' THR . 17.2 t70 -121.34 126.08 48.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.28 137.2 54.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.262 0.554 . . . . 0.0 111.109 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.94 135.55 42.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 10' ' ' THR . 4.2 m-20 -76.45 140.99 41.49 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 12.1 pt -77.46 -26.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.55 -5.12 30.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.192 0.52 . . . . 0.0 111.665 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -94.45 -26.61 16.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -120.9 108.71 14.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.655 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -51.22 -48.56 62.04 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.766 1.226 . . . . 0.0 112.278 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.73 94.84 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.49 0.662 . . . . 0.0 110.683 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.32 -43.72 66.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.453 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 54' ' ' ARG . . . -59.99 -37.69 80.39 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.259 0.624 . . . . 0.0 112.391 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.13 -34.91 56.55 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.1 -58.23 7.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 6.5 p -62.77 -33.82 62.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.307 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.41 -30.23 74.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.988 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -79.99 -36.86 35.39 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 58' ' ' THR . 33.0 m -90.92 9.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.463 0.649 . . . . 0.0 110.537 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.25 -177.81 4.97 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.319 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.24 79.45 1.79 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.04 -98.18 1.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.58 -175.27 3.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.68 116.48 2.53 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -162.7 -34.26 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.359 172.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.06 150.0 42.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 44.7 Cg_endo -65.94 140.56 61.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.731 2.287 . . . . 0.0 111.48 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.4 HG21 ' CG2' ' A' ' 49' ' ' VAL . 22.9 m -129.86 140.49 50.98 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.9 m -107.38 136.7 41.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.684 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -117.79 114.88 23.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -84.69 168.13 15.53 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.453 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.08 -11.37 48.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.392 1.091 . . . . 0.0 109.546 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.22 -18.13 61.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.684 1.594 . . . . 0.0 109.643 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.09 -21.88 39.61 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.776 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.9 m -80.17 149.27 30.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.759 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.7 p -113.5 151.76 31.08 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.432 175.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.58 125.07 24.99 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -64.5 146.52 54.44 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -5.69 86.38 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.553 0 C-N-CA 127.119 2.168 . . . . 0.0 115.942 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -98.09 150.75 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 124.274 3.316 . . . . 0.0 112.907 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 168.55 19.81 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -60.05 -37.04 78.65 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.99 -34.31 75.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.476 0.655 . . . . 0.0 110.33 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -71.7 -34.85 69.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.798 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -78.34 -35.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.711 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 29.3 mtpp -63.96 -33.34 75.51 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.825 -0.17 . . . . 0.0 110.789 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.42 67.99 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.935 0.772 . . . . 0.0 111.836 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 82' ' ' ILE . 37.1 mttm -83.04 -50.7 8.25 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.898 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 tp -51.62 -37.42 50.08 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.035 0.934 . . . . 0.0 113.053 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.35 -38.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.477 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -80.86 -24.08 38.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.157 0.503 . . . . 0.0 110.313 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 78' ' ' LYS . 70.7 mt -80.22 -49.15 19.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.828 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.035 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 119.7 -0.19 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.27 34.0 m 51.39 18.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 C-N-CA 125.416 1.487 . . . . 0.0 114.67 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -75.45 -33.55 60.88 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.32 80.55 3.54 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.09 -53.11 27.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.217 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -153.45 136.74 15.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.128 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.8 m -103.35 123.54 47.0 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.427 HD12 ' CD2' ' A' ' 31' ' ' TYR . 60.3 mt -88.76 120.25 37.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.71 178.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -103.54 117.66 34.93 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.004 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -161.25 167.63 25.61 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 p -100.68 160.44 14.35 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.9 t -72.2 -31.0 65.48 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -88.68 14.41 10.13 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.745 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.5 t -79.93 155.86 27.52 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 176.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.35 -37.92 13.76 Favored Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 120.19 -1.005 . . . . 0.0 111.783 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -82.57 -7.98 59.62 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.668 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.2 p -57.16 -61.94 2.11 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 118.242 0.473 . . . . 0.0 111.775 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -68.92 -21.82 64.19 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.872 0.368 . . . . 0.0 111.661 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -67.53 -51.03 55.73 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.9 tp -69.57 -35.88 75.78 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.103 -1.408 . . . . 0.0 112.15 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.7 mmtt -55.26 -45.52 76.09 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.29 0.567 . . . . 0.0 110.396 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -65.43 -40.0 92.78 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.716 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.21 95.94 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 29' ' ' ILE . 71.3 mt -69.07 -43.17 75.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.7 m -61.9 -38.5 88.58 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.65 -16.24 63.77 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.413 0.625 . . . . 0.0 111.548 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -110.29 9.47 23.67 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 54.92 32.64 18.34 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.054 1.342 . . . . 0.0 112.454 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 66.1 mt -76.91 128.17 37.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 120.888 0.375 . . . . 0.0 110.266 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.38 122.9 29.59 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.17 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.427 ' CD2' HD12 ' A' ' 8' ' ' ILE . 52.3 p90 -139.86 165.19 27.97 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.122 0.487 . . . . 0.0 112.294 -177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.36 142.19 50.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -132.24 143.55 50.0 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 118.381 0.537 . . . . 0.0 111.312 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.55 140.91 36.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 172.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.5 141.6 41.21 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.631 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 37.7 pt -82.81 -26.1 8.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . 0.255 9.6 pt-20 -84.23 -11.47 56.43 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 117.917 -1.513 . . . . 0.0 111.833 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -83.34 -49.43 9.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 170.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -90.68 96.47 10.66 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.51 -39.16 79.33 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 123.722 0.809 . . . . 0.0 112.082 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.06 -34.27 76.12 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.992 0.425 . . . . 0.0 110.203 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.579 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.09 -43.35 64.93 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.457 178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -56.5 -44.58 80.83 Favored 'General case' 0 CA--C 1.505 -0.784 0 O-C-N 124.01 0.819 . . . . 0.0 110.972 177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -62.29 -47.23 85.23 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.299 179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.1 t80 -59.72 -56.62 19.53 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.354 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.625 HG11 HG21 ' A' ' 36' ' ' ILE . 7.7 p -62.9 -35.78 72.74 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.406 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.46 73.07 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 121.289 -0.481 . . . . 0.0 112.027 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -79.38 -37.8 36.47 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 120.885 0.374 . . . . 0.0 110.582 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.6 m -94.61 5.5 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.27 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.82 -178.81 6.95 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.738 -178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.99 79.25 1.82 Allowed Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 87.81 -64.51 3.66 Favored Glycine 0 N--CA 1.441 -1.005 0 N-CA-C 111.864 -0.495 . . . . 0.0 111.864 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -138.86 171.07 14.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -62.0 108.75 1.1 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.906 0.882 . . . . 0.0 111.856 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.3 t -156.16 -39.75 0.08 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.054 -0.404 . . . . 0.0 111.796 178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.4 m -108.21 149.36 39.12 Favored Pre-proline 0 C--N 1.306 -1.305 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.914 -175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 29.1 Cg_endo -64.44 152.65 80.73 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.35 2.033 . . . . 0.0 110.954 178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 35.5 m -140.38 141.05 35.63 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.3 m -107.87 131.7 57.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.644 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -104.85 118.67 37.12 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -84.8 171.63 12.12 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 121.304 0.573 . . . . 0.0 112.366 -175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.1 -10.41 14.48 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.978 1.311 . . . . 0.0 112.305 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -94.2 -13.46 26.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.368 177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.69 -21.27 39.19 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.952 -0.642 . . . . 0.0 113.901 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -85.32 160.83 19.72 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 117.93 0.865 . . . . 0.0 110.75 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 4.9 p -113.33 166.81 11.12 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.997 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.5 mt -138.36 116.56 11.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 167.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 m -62.6 139.44 58.63 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -4.69 88.16 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.177 0 C-N-CA 126.947 2.099 . . . . 0.0 115.623 -169.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -98.37 164.61 0.72 Allowed 'Trans proline' 0 N--CA 1.435 -1.937 0 C-N-CA 124.053 3.168 . . . . 0.0 111.949 177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.429 ' O ' HG22 ' A' ' 75' ' ' VAL . 3.1 m -90.81 171.12 9.55 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.54 -39.5 84.15 Favored 'General case' 0 C--O 1.217 -0.631 0 C-N-CA 122.638 0.375 . . . . 0.0 111.483 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.47 -47.99 83.71 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.126 0.488 . . . . 0.0 110.716 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.02 -42.6 99.34 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.223 -177.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 71' ' ' SER . 11.2 m -72.21 -40.33 65.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -57.9 -43.55 86.21 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.029 0.443 . . . . 0.0 110.106 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.85 -37.41 76.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.909 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -84.08 -50.2 8.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.136 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.4 -39.83 70.65 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.123 0.969 . . . . 0.0 113.001 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -59.21 -39.78 79.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.25 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -73.17 -26.79 61.31 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 120.884 0.373 . . . . 0.0 110.608 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.1 mt -75.5 -45.19 40.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.692 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -76.07 -47.76 23.38 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.109 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.92 -131.31 5.95 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mm? 70.48 -50.82 0.66 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 172.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -79.54 73.22 6.22 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.244 1.021 . . . . 0.0 111.321 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -174.65 -177.25 1.14 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 N--CA 1.418 -2.059 0 N-CA-C 106.349 -1.722 . . . . 0.0 106.349 171.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 CA--C 1.497 -1.07 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.8 t 73.32 99.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.922 0.867 . . . . 0.0 111.137 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -43.27 68.8 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.105 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.2 75.32 6.17 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -49.17 73.91 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 114.315 -1.312 . . . . 0.0 109.941 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -151.43 140.88 21.54 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.18 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 22.0 m -106.83 124.13 49.17 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.384 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.49 HG12 HG12 ' A' ' 59' ' ' VAL . 74.8 mt -88.81 122.25 39.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.706 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 68.8 m-85 -99.65 111.6 23.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.696 173.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -146.18 174.12 11.6 Favored 'General case' 0 N--CA 1.422 -1.833 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.62 162.38 30.49 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.1 t -66.95 -15.9 64.0 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.796 0.331 . . . . 0.0 111.863 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -99.31 5.6 46.47 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.1 m -81.64 112.95 19.3 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.749 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.0 -27.59 73.63 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.19 -7.52 56.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 47.5 t -65.67 -62.04 1.74 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.894 0.378 . . . . 0.0 110.448 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 19' ' ' ARG . 1.4 pp -67.9 -21.08 65.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.966 0.888 . . . . 0.0 112.068 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' N ' HD12 ' A' ' 18' ' ' LEU . 8.9 tpt180 -66.74 -43.55 83.88 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.969 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.9 tp -85.36 -32.84 22.21 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.504 -175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -53.14 -48.47 67.88 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 120.881 0.372 . . . . 0.0 111.82 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 p -64.03 -38.65 91.85 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.874 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -39.16 93.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.156 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.2 mt -69.87 -47.6 61.98 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.592 -0.277 . . . . 0.0 111.169 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.1 m -61.47 -37.3 83.1 Favored 'General case' 0 CA--C 1.554 1.117 0 CA-C-O 121.076 0.465 . . . . 0.0 110.827 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -10.06 59.38 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.138 0.494 . . . . 0.0 111.746 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -115.75 19.41 15.24 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.194 -0.316 . . . . 0.0 111.625 178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 53.87 33.01 16.21 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 125.998 1.719 . . . . 0.0 112.177 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.2 mt -90.3 131.17 38.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-O 120.914 0.387 . . . . 0.0 110.948 -177.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.37 143.75 26.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.05 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -158.06 166.87 31.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.691 0.282 . . . . 0.0 110.415 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 7' ' ' THR . 24.8 t70 -129.89 142.48 50.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -128.14 142.47 51.18 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 118.445 0.566 . . . . 0.0 110.62 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.51 141.9 36.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -89.68 139.39 30.61 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.62 -174.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.605 HG21 HG11 ' A' ' 46' ' ' VAL . 34.7 pt -85.91 -11.13 11.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -70.0 -40.29 75.37 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.799 -0.761 . . . . 0.0 110.252 -172.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -93.27 -30.03 15.37 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.703 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -88.09 99.93 12.55 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.518 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.2 ttt85 -71.79 -35.1 69.88 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.62 -33.06 75.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.172 0.511 . . . . 0.0 109.638 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -74.28 -43.57 56.35 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.735 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.25 -43.04 99.53 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.103 0.561 . . . . 0.0 111.837 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -61.34 -45.88 92.55 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -59.65 -58.49 8.37 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.926 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 36' ' ' ILE . 7.6 p -62.59 -35.26 69.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.746 -178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.72 -37.13 93.96 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.035 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.1 m -71.09 -34.81 71.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.755 0.312 . . . . 0.0 111.339 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.8 m -96.67 7.17 7.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.255 0.55 . . . . 0.0 111.411 -177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.54 -172.62 3.98 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.925 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.92 81.55 1.31 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.76 -63.12 3.27 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.531 -0.628 . . . . 0.0 111.531 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -144.37 165.08 28.92 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -54.21 101.1 0.04 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.767 1.227 . . . . 0.0 112.164 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.8 t -146.66 -15.96 0.43 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.754 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.9 m -135.1 147.69 63.55 Favored Pre-proline 0 C--O 1.241 0.609 0 O-C-N 122.217 -0.302 . . . . 0.0 111.778 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 32.5 Cg_endo -64.83 137.18 52.33 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.72 2.28 . . . . 0.0 111.476 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -123.01 137.69 54.89 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HG12 ' A' ' 8' ' ' ILE . 19.3 m -102.43 129.9 53.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 120.69 0.281 . . . . 0.0 110.412 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -109.94 115.41 29.75 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -81.05 166.75 20.47 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.56 -12.67 58.85 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.455 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -89.48 -9.5 49.84 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.252 0.548 . . . . 0.0 109.567 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.56 38.68 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.765 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.9 t -73.34 144.32 46.54 Favored 'General case' 0 C--O 1.253 1.269 0 CA-C-N 117.57 0.685 . . . . 0.0 111.46 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -113.64 143.47 44.52 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 124.646 1.179 . . . . 0.0 111.399 -178.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -126.02 128.45 47.47 Favored 'General case' 0 C--O 1.253 1.256 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.9 m -66.96 137.5 56.56 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -6.07 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.8 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 -171.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.51 171.08 3.63 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.636 2.89 . . . . 0.0 112.548 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.432 ' O ' HG22 ' A' ' 75' ' ' VAL . 23.7 t -95.02 170.37 9.47 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 173.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . . . -64.89 -32.29 73.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.911 0.386 . . . . 0.0 111.042 -177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.94 -48.93 72.51 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.31 174.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -68.23 -48.87 63.96 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.373 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 72' ' ' ALA . 8.7 m -62.55 -35.86 72.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.25 -36.27 83.61 Favored 'General case' 0 CA--C 1.506 -0.748 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.687 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.93 -35.91 71.77 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.71 0.632 . . . . 0.0 111.025 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.1 mtpp -84.2 -50.22 8.1 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.997 176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.59 -39.87 71.28 Favored 'General case' 0 C--O 1.252 1.218 0 C-N-CA 123.219 0.608 . . . . 0.0 112.621 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.5 p -62.74 -32.62 56.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -81.05 -29.14 35.1 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.179 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 78' ' ' LYS . 58.5 mt -71.73 -57.67 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.389 0.614 . . . . 0.0 110.369 -177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.13 -23.55 47.75 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.944 -176.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.1 44.13 88.44 Favored Glycine 0 CA--C 1.501 -0.783 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.51 -51.51 12.79 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.214 0.531 . . . . 0.0 109.598 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -127.82 136.83 51.99 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.123 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -104.96 -45.17 4.62 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 172.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.1 t60 . . . . . 0 C--N 1.311 -1.073 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.713 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.267 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . 0.311 28.4 m -81.96 91.26 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.258 0 CA-C-O 123.067 1.413 . . . . 0.0 113.559 -176.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 m -74.44 -46.19 41.47 Favored 'General case' 0 N--CA 1.401 -2.908 0 CA-C-N 112.344 -2.207 . . . . 0.0 107.122 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.91 116.3 32.28 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 171.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.56 -63.89 1.25 Allowed 'General case' 0 C--N 1.29 -1.989 0 CA-C-O 121.462 0.649 . . . . 0.0 109.72 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.61 132.92 11.86 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.357 176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 m -102.79 123.17 45.96 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.45 0.643 . . . . 0.0 110.795 -173.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.7 125.59 41.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -99.79 111.34 23.67 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.658 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.26 167.3 20.09 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.501 ' OG1' HG12 ' A' ' 36' ' ' ILE . 25.1 m -138.86 158.0 45.01 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -46.32 -17.46 0.04 OUTLIER 'General case' 0 CA--C 1.569 1.703 0 C-N-CA 127.127 2.171 . . . . 0.0 115.028 -177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -77.42 -14.99 59.58 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 121.838 -0.538 . . . . 0.0 111.936 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.651 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 43.0 t -92.05 120.88 33.09 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 120.266 -0.574 . . . . 0.0 110.363 -177.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.63 -30.32 68.76 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.355 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -70.91 -11.66 61.09 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 38.8 t -55.58 -55.27 33.96 Favored 'General case' 0 N--CA 1.441 -0.899 0 O-C-N 123.47 0.481 . . . . 0.0 110.483 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 19' ' ' ARG . 2.2 pp -69.98 -25.81 63.79 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.407 ' N ' HD12 ' A' ' 18' ' ' LEU . 29.4 mmm180 -70.67 -44.62 66.64 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 55.5 tp -61.92 -45.07 95.31 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.889 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.8 mmtp -55.77 -49.61 72.67 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.218 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 m -59.44 -43.99 93.01 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.999 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.35 98.42 Favored 'General case' 0 C--O 1.248 0.98 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.316 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 50.0 mt -71.34 -46.5 60.39 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.448 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 90.3 m -60.38 -37.33 80.42 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 123.326 0.391 . . . . 0.0 110.854 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.19 -36.34 83.31 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-O 120.935 0.398 . . . . 0.0 112.025 179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -99.77 8.76 43.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.289 0.566 . . . . 0.0 111.097 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 63.65 35.33 11.63 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.144 1.378 . . . . 0.0 113.388 174.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.2 mp -78.86 125.88 38.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.778 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.45 123.63 26.82 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 172.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.7 p90 -131.23 161.64 31.77 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.425 0.631 . . . . 0.0 111.659 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -118.59 142.64 47.43 Favored 'General case' 0 C--N 1.287 -2.119 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -139.01 141.38 38.31 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.94 143.22 33.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.047 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -78.28 140.48 38.84 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.998 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.3 pt -83.59 -27.11 7.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.193 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -76.92 -25.29 52.77 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -70.74 -49.25 48.88 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.946 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -102.17 97.77 8.03 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.739 0.304 . . . . 0.0 110.705 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -56.38 -40.1 74.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 124.0 0.92 . . . . 0.0 112.047 -175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.96 -34.45 68.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 0.0 110.305 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.498 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -67.62 -38.97 84.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.743 178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.511 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.48 -29.73 70.77 Favored 'General case' 0 C--O 1.25 1.123 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.639 177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.487 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 7.3 tp10 -74.75 -48.52 25.22 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -53.21 -56.01 19.85 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.167 0.987 . . . . 0.0 111.653 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.498 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.4 p -62.61 -27.35 42.71 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.972 0 CA-C-O 120.66 0.267 . . . . 0.0 111.094 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.1 -38.79 63.5 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.591 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.0 m -74.27 -34.59 63.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.77 0.319 . . . . 0.0 111.364 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 46' ' ' VAL . 31.0 m -94.58 13.02 3.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.086 0.47 . . . . 0.0 111.541 -177.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 -174.68 3.92 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.129 0.49 . . . . 0.0 110.114 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.53 69.96 3.19 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -61.93 0.79 Allowed Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 115.341 -0.429 . . . . 0.0 112.573 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 50.1 t30 -144.49 160.06 41.73 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.487 ' NH2' ' HA ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -62.34 116.79 5.35 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.435 0.635 . . . . 0.0 111.078 -179.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.8 t -155.97 -25.27 0.1 Allowed 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.759 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.3 m -119.54 144.13 36.13 Favored Pre-proline 0 N--CA 1.446 -0.639 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.188 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.651 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 19.6 Cg_endo -60.07 140.54 93.03 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.834 2.356 . . . . 0.0 111.405 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.2 m -124.16 141.0 52.43 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.5 m -107.5 133.04 53.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-O 120.549 0.214 . . . . 0.0 110.694 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -112.0 112.36 23.95 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 173.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.461 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.5 m-85 -78.52 166.06 23.02 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.23 -18.05 56.36 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.496 0.498 . . . . 0.0 112.07 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.76 -11.39 58.32 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.143 0.496 . . . . 0.0 109.754 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.05 -7.07 56.87 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.208 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -79.61 145.67 32.94 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.069 0.462 . . . . 0.0 110.879 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -119.09 141.18 49.0 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.494 178.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.0 mt -131.52 143.53 50.45 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 m -73.91 140.61 45.76 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -6.75 83.11 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.696 0 C-N-CA 126.388 1.875 . . . . 0.0 116.009 -176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 19.7 Cg_endo -90.25 160.26 4.67 Favored 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.781 2.987 . . . . 0.0 112.563 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.0 m -82.22 173.7 11.86 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -64.48 -39.01 92.99 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.085 0.469 . . . . 0.0 111.498 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.44 -30.84 67.78 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.494 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -69.67 -42.71 73.82 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 14.1 m -72.24 -35.38 52.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.732 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 10.1 mtpm? -58.13 -36.25 72.68 Favored 'General case' 0 C--O 1.213 -0.864 0 O-C-N 123.124 0.265 . . . . 0.0 111.417 177.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.68 -41.61 73.97 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.976 0.797 . . . . 0.0 111.963 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' O ' HG13 ' A' ' 82' ' ' ILE . 8.2 mtpm? -84.08 -48.46 9.86 Favored 'General case' 0 CA--C 1.498 -1.05 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.09 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.1 tp -54.98 -40.59 70.22 Favored 'General case' 0 C--O 1.243 0.734 0 O-C-N 124.02 0.825 . . . . 0.0 112.445 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.83 -43.27 95.14 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 O-C-N 123.508 0.505 . . . . 0.0 110.328 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -75.15 -21.11 59.03 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.593 -175.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 78' ' ' LYS . 63.4 mt -73.57 -36.05 46.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.0 -39.61 10.09 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.686 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.02 80.17 0.88 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.1 mt -130.33 -77.02 0.53 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -58.45 -41.69 85.73 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -172.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -145.94 -56.05 0.29 Allowed 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.094 -2.187 . . . . 0.0 105.094 174.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 78.9 t60 . . . . . 0 N--CA 1.409 -2.489 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 169.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.8 mtt . . . . . 0 CA--C 1.504 -0.8 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 60.1 t -79.29 106.81 10.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-O 122.256 1.027 . . . . 0.0 109.074 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.95 -26.13 29.51 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.051 -175.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.13 94.32 3.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.7 -53.66 54.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.299 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -146.27 135.9 23.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.305 175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 13.6 m -103.62 124.85 49.58 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 115.23 -0.896 . . . . 0.0 108.861 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 59' ' ' VAL . 44.0 mt -89.03 118.73 34.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.856 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 80.6 m-85 -103.81 110.41 22.5 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.057 -0.974 . . . . 0.0 108.949 174.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.456 HG21 ' SG ' ' A' ' 17' ' ' CYS . 13.2 t -163.63 -177.66 5.34 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.76 152.39 51.72 Favored 'General case' 0 N--CA 1.42 -1.964 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 175.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.5 t -54.09 -28.38 38.91 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.277 1.031 . . . . 0.0 113.084 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.3 p-90 -77.63 -15.22 59.34 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.7 m -71.53 118.47 14.39 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 -177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.27 -43.05 93.77 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 113.667 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 23.7 m-85 -74.1 -7.57 53.02 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 16.3 t -63.6 -62.48 1.64 Allowed 'General case' 0 C--O 1.232 0.18 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 18' ' ' LEU . 2.4 pp -70.56 -21.02 62.75 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.323 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 16' ' ' TYR . 6.7 tpm_? -72.25 -38.73 68.82 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.123 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.4 tp -84.33 -24.07 29.94 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 71.0 mmtt -53.9 -42.87 69.16 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.792 0.437 . . . . 0.0 111.812 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.8 p -67.91 -37.17 81.36 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.324 -177.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.33 -43.87 80.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.793 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.38 -42.97 92.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.8 m -63.11 -46.3 87.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.053 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.59 -31.92 72.0 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.272 0.558 . . . . 0.0 111.093 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -91.97 11.52 24.84 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.571 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.4 mtm180 59.2 32.26 21.9 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.708 0.803 . . . . 0.0 111.446 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.53 130.59 37.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.0 0.429 . . . . 0.0 109.963 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.3 124.4 36.34 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -142.01 162.06 36.42 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.864 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' THR . 37.5 t70 -121.39 133.56 55.09 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.54 139.72 49.34 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -136.17 147.86 27.82 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -83.49 138.94 33.21 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.714 -176.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.665 HG21 HG11 ' A' ' 46' ' ' VAL . 39.0 pt -87.04 -23.54 6.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -70.82 -42.63 69.98 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 121.126 0.488 . . . . 0.0 109.807 -171.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.9 t60 -77.04 -26.72 54.0 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.58 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -103.74 93.16 4.76 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.594 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -55.63 -44.39 77.05 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.563 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -71.25 -30.93 66.91 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.822 0.344 . . . . 0.0 111.162 -176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.572 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.12 -42.63 68.99 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -62.92 -36.38 83.18 Favored 'General case' 0 CA--C 1.514 -0.41 0 O-C-N 123.599 0.562 . . . . 0.0 110.451 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -64.38 -47.39 79.41 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -60.05 -58.43 8.57 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.174 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.665 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -64.22 -31.73 54.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.24 -35.77 70.33 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.201 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.0 p -83.02 -26.19 31.45 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 46' ' ' VAL . 21.7 m -89.93 -11.34 10.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.546 -0.461 . . . . 0.0 111.124 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -73.13 167.19 21.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.053 -176.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.54 65.38 4.09 Favored Glycine 0 C--N 1.308 -1.006 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.183 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.56 -90.65 0.41 Allowed Glycine 0 C--N 1.313 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -120.24 172.21 7.95 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -64.27 54.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 125.56 1.544 . . . . 0.0 112.304 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 t -88.86 -32.05 17.97 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 122.055 -0.403 . . . . 0.0 111.925 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.7 m -123.37 151.87 63.46 Favored Pre-proline 0 C--O 1.245 0.848 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 12.5 Cg_endo -56.23 123.4 13.73 Favored 'Trans proline' 0 C--N 1.363 1.334 0 C-N-CA 123.749 2.966 . . . . 0.0 111.791 176.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.5 m -106.51 133.44 51.19 Favored 'General case' 0 N--CA 1.411 -2.408 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 8' ' ' ILE . 28.5 m -103.19 124.8 57.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.072 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -105.88 125.53 51.1 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -89.85 179.22 6.03 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.917 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.96 -10.74 58.93 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.237 0.615 . . . . 0.0 111.856 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.1 p-10 -88.71 -8.64 54.17 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.95 10.15 81.35 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.118 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.4 t -99.54 151.52 21.06 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 p -117.16 150.11 39.26 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.504 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.8 mt -124.1 125.08 43.88 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 171.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.5 m -68.33 147.35 52.26 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -5.32 83.01 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.6 0 C-N-CA 127.015 2.126 . . . . 0.0 114.909 -174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -98.99 157.67 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.267 0 C-N-CA 123.781 2.987 . . . . 0.0 112.583 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 75' ' ' VAL . 30.5 p -84.4 166.2 17.55 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.808 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.41 -33.52 72.62 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 122.864 0.466 . . . . 0.0 112.079 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -65.84 -40.05 91.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.093 0.473 . . . . 0.0 110.521 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.22 -43.32 67.57 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.593 -177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 71' ' ' SER . 6.1 m -65.97 -35.5 75.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 C-N-CA 120.244 -0.582 . . . . 0.0 112.116 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -64.34 -35.17 79.99 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 175.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.82 -41.62 95.61 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.26 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -76.79 -38.62 53.69 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.126 0.488 . . . . 0.0 110.345 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.9 tp -64.56 -36.46 84.28 Favored 'General case' 0 C--O 1.252 1.224 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.473 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.7 -22.45 21.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.126 0.489 . . . . 0.0 111.243 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -80.17 -30.48 38.83 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -83.16 -57.05 4.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.777 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.5 -45.65 5.74 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.765 -175.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.32 55.64 4.63 Favored Glycine 0 CA--C 1.486 -1.775 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.519 HD22 ' HG3' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -70.11 -9.8 56.7 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 126.046 1.738 . . . . 0.0 111.736 -178.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.519 ' HG3' HD22 ' A' ' 85' ' ' LEU . 43.7 mt-10 -154.71 169.79 23.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 104.3 -2.482 . . . . 0.0 104.3 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -88.93 -64.9 1.08 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 C--O 1.257 1.472 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 174.858 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 CA--C 1.513 -0.454 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.12 84.05 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.5 t -94.79 -17.69 21.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 171.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.78 103.02 3.87 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 104.692 -2.336 . . . . 0.0 104.692 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.76 -56.19 15.16 Favored 'General case' 0 C--N 1.308 -1.211 0 O-C-N 123.623 0.577 . . . . 0.0 112.222 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 59' ' ' VAL . 1.7 pt? -147.05 137.75 23.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.616 -178.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.2 m -106.67 112.13 24.98 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.355 1.062 . . . . 0.0 109.648 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.3 mt -88.92 131.81 35.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 C-N-CA 123.472 0.709 . . . . 0.0 111.997 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.423 ' OH ' ' HE2' ' A' ' 60' ' ' LYS . 74.8 m-85 -111.44 104.24 12.66 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.274 173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 12.6 t -165.27 142.88 5.97 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.9 m -102.99 155.99 17.98 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -63.1 -4.85 2.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -174.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -77.63 -13.62 59.86 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.558 -0.714 . . . . 0.0 111.168 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -76.82 144.19 39.27 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.02 -41.71 39.38 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.652 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -77.0 -5.67 49.63 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.653 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -50.72 -59.95 3.55 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 118.019 0.372 . . . . 0.0 111.877 -175.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.409 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.4 pt? -72.36 -26.0 61.75 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-O 120.432 0.158 . . . . 0.0 111.121 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 -59.69 -47.48 85.47 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 45.7 tp -67.21 -44.38 79.71 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.421 -1.263 . . . . 0.0 110.74 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.653 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 73.8 mmtt -57.4 -55.56 33.2 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.889 0.376 . . . . 0.0 110.723 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.1 m -59.65 -40.47 87.8 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.223 -177.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.76 -46.74 89.28 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.893 0.377 . . . . 0.0 110.787 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 67.2 mt -69.23 -43.66 73.6 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 -178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.5 m -62.97 -37.36 86.79 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.248 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.12 -36.74 85.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.449 178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.38 7.01 38.03 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 58.53 46.99 14.07 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.812 0.815 . . . . 0.0 111.64 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 24' ' ' LEU . 81.4 mt -97.96 119.17 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.671 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.794 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.94 115.01 11.73 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.684 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -128.29 156.86 42.36 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.679 -0.809 . . . . 0.0 112.809 -177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -115.43 142.39 46.77 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.22 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.12 139.02 44.34 Favored 'General case' 0 C--N 1.291 -1.961 0 O-C-N 122.195 -0.316 . . . . 0.0 110.39 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.08 145.12 33.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB3' ' A' ' 37' ' ' GLU . 30.5 t70 -87.73 142.03 28.14 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.744 -0.783 . . . . 0.0 111.918 -173.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.466 HG21 HG11 ' A' ' 46' ' ' VAL . 23.6 pt -83.18 -25.7 7.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.59 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 43.8 tt0 -73.83 -34.41 64.54 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.266 0.555 . . . . 0.0 109.533 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -91.01 -0.19 57.69 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 112.675 0.621 . . . . 0.0 112.675 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 -133.74 99.59 4.51 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -62.5 -43.41 98.87 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -175.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.44 72.51 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.892 0.377 . . . . 0.0 110.749 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.71 -42.15 67.72 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.85 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.04 -36.74 84.98 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.557 0.694 . . . . 0.0 110.621 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -63.73 -43.58 96.09 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.015 -0.993 . . . . 0.0 109.012 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -66.13 -56.74 9.92 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.777 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.5 p -59.62 -25.66 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.06 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.22 -42.74 96.18 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.641 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.6 m -74.41 -31.31 62.28 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.065 0.432 . . . . 0.0 111.846 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.441 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -91.65 8.43 4.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-O 121.904 0.859 . . . . 0.0 111.118 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.49 174.32 9.04 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.565 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -95.34 88.4 1.09 Allowed Glycine 0 N--CA 1.433 -1.544 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.84 -89.78 0.7 Allowed Glycine 0 N--CA 1.433 -1.53 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -134.02 173.92 11.04 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.15 102.24 1.0 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.112 0.958 . . . . 0.0 113.08 -175.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.6 t -146.79 -26.86 0.41 Allowed 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.15 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.6 m -113.86 151.44 44.75 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 113.412 0.894 . . . . 0.0 113.412 -175.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 19.1 Cg_endo -60.9 143.02 99.27 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.31 2.673 . . . . 0.0 111.485 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.441 HG21 ' CG2' ' A' ' 49' ' ' VAL . 19.7 m -132.27 150.55 52.13 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.647 HG21 HD12 ' A' ' 6' ' ' LEU . 8.4 p -128.96 130.94 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.297 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -175.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.423 ' HE2' ' OH ' ' A' ' 9' ' ' TYR . 32.3 mtmt -100.58 136.11 40.97 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 171.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -90.97 176.08 6.73 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.36 -14.58 63.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 122.142 0.972 . . . . 0.0 109.034 171.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -74.97 -18.07 60.44 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.847 1.659 . . . . 0.0 109.534 176.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.65 -21.99 30.09 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.813 -0.63 . . . . 0.0 113.354 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -74.58 152.63 39.25 Favored 'General case' 0 C--O 1.254 1.326 0 C-N-CA 122.309 0.244 . . . . 0.0 110.723 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.1 p -113.53 155.11 25.96 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-O 121.331 0.586 . . . . 0.0 112.3 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 69.1 mt -132.71 125.26 29.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 169.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 m -70.63 144.52 51.11 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -4.87 86.95 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.477 0 N-CA-C 116.272 1.953 . . . . 0.0 116.272 -171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -100.51 -177.79 0.17 Allowed 'Trans proline' 0 N--CA 1.433 -2.054 0 C-N-CA 123.686 2.924 . . . . 0.0 112.393 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -114.6 172.73 6.85 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -43.96 78.07 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 122.772 0.429 . . . . 0.0 111.484 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -52.7 -52.89 54.15 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.493 0.496 . . . . 0.0 111.681 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -62.3 -39.76 94.08 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.963 -1.017 . . . . 0.0 112.803 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.6 m -78.84 -31.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 C-N-CA 120.391 -0.524 . . . . 0.0 112.249 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -60.25 -32.44 71.16 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.142 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.6 71.65 Favored 'General case' 0 C--O 1.231 0.108 0 O-C-N 123.894 0.746 . . . . 0.0 111.286 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.9 mtpp -84.88 -44.28 13.35 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.592 176.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.7 tp -54.42 -41.17 69.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.575 0.75 . . . . 0.0 112.594 -176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.0 p -58.08 -33.2 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 O-C-N 123.58 0.55 . . . . 0.0 111.642 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 88' ' ' HIS . 65.7 mttm -80.33 -42.51 22.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.297 0.57 . . . . 0.0 109.835 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 78' ' ' LYS . 53.7 mt -61.07 -31.56 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.859 -175.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.23 -3.11 15.46 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.241 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 87.11 33.14 12.43 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.6 mt -131.07 171.89 12.73 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 67.88 119.97 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.321 1.448 . . . . 0.0 114.728 172.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -96.98 94.29 7.1 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 172.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.43 ' HB3' ' NZ ' ' A' ' 81' ' ' LYS . 46.1 t60 . . . . . 0 C--N 1.31 -1.118 0 CA-C-O 118.383 -0.818 . . . . 0.0 108.972 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.8 mmm . . . . . 0 CA--C 1.506 -0.742 0 CA-C-O 120.611 0.243 . . . . 0.0 111.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.1 m -86.94 121.09 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.254 0 CA-C-O 122.019 0.914 . . . . 0.0 111.721 -177.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.34 -25.44 62.4 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 113.582 -1.644 . . . . 0.0 109.591 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.18 110.24 12.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.6 -60.19 2.34 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.09 0.471 . . . . 0.0 110.697 -177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -153.29 143.25 22.15 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.176 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -102.97 124.77 49.1 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.34 112.33 25.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 123.601 0.761 . . . . 0.0 110.467 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.447 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 88.4 m-85 -98.85 114.27 26.78 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.34 175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.8 t -163.69 149.52 11.32 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.426 HG23 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -89.62 152.03 21.59 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 170.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -67.37 -20.96 65.63 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 120.824 0.345 . . . . 0.0 111.798 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -83.58 1.99 39.45 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.3 m -78.04 149.79 33.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -80.19 -34.99 28.18 Favored Glycine 0 C--N 1.308 -1.027 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.512 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -81.67 -7.11 59.56 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.3 p -54.63 -51.59 64.93 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -174.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -83.87 -23.28 31.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.969 0.414 . . . . 0.0 111.333 178.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.2 tpp180 -64.94 -41.58 95.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.858 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 70' ' ' PRO . 25.0 tp -74.5 -24.21 58.96 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.617 -178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 43.2 mmtm -62.67 -36.28 82.38 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.186 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 m -55.85 -47.72 76.77 Favored 'General case' 0 N--CA 1.447 -0.625 0 O-C-N 123.794 0.684 . . . . 0.0 110.128 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.39 -40.17 77.54 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.976 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 98.3 mt -67.03 -44.8 79.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.359 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.9 m -66.85 -38.29 86.1 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.68 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -23.69 66.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.513 0.673 . . . . 0.0 111.41 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -106.75 4.72 27.96 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.069 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 50.49 44.7 27.01 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.921 1.288 . . . . 0.0 112.036 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 24' ' ' LEU . 72.0 mt -82.72 127.82 39.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.552 -178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.91 134.19 35.69 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -147.55 164.19 34.21 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -118.68 139.11 52.06 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.15 134.99 55.24 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.844 0.354 . . . . 0.0 111.277 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.95 126.39 26.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.77 141.06 33.85 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.579 HG21 HG11 ' A' ' 46' ' ' VAL . 40.8 pt -84.85 -9.35 11.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 -175.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.29 -43.7 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 109.864 -178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -92.27 -28.82 16.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.997 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -95.26 91.64 6.37 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.203 0.525 . . . . 0.0 110.532 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -76.06 -25.8 55.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.321 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.87 -33.23 73.46 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.571 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -72.71 -40.06 66.46 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.568 176.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.04 84.42 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.056 0.455 . . . . 0.0 110.532 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.7 -53.48 56.88 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -56.92 -57.91 10.44 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.861 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.62 -32.37 57.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -178.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.29 -30.74 75.79 Favored Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.374 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -81.24 -22.1 38.98 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG23 HG21 ' A' ' 58' ' ' THR . 35.9 m -108.6 13.16 8.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 CA-C-O 121.709 0.766 . . . . 0.0 110.347 -178.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.65 -173.16 2.8 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.825 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.35 71.05 2.55 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.91 -67.94 2.88 Favored Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 121.408 -0.425 . . . . 0.0 112.873 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -119.74 151.62 38.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.64 114.72 8.12 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.525 0.678 . . . . 0.0 109.52 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -154.83 -29.86 0.11 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.441 -178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.1 m -107.91 142.44 25.24 Favored Pre-proline 0 C--O 1.241 0.643 0 O-C-N 122.078 -0.389 . . . . 0.0 111.543 -178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 22.5 Cg_endo -62.48 131.9 35.86 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.738 2.292 . . . . 0.0 111.215 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.421 HG21 HG23 ' A' ' 49' ' ' VAL . 23.2 m -117.51 137.79 52.31 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m -105.77 128.45 59.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-O 120.804 0.335 . . . . 0.0 110.746 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -104.95 119.29 38.66 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -81.52 174.4 11.47 Favored 'General case' 0 C--N 1.292 -1.895 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.538 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.31 -27.81 66.21 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.362 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -75.92 -14.94 60.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.886 0.375 . . . . 0.0 110.77 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.01 -21.98 36.43 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.079 -0.581 . . . . 0.0 113.909 176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.7 m -81.81 158.58 24.04 Favored 'General case' 0 C--O 1.251 1.154 0 CA-C-N 117.82 0.81 . . . . 0.0 110.459 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.1 p -113.84 163.29 15.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.201 0.524 . . . . 0.0 111.838 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.2 mt -134.58 121.55 21.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 169.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 24.2 m -62.95 137.21 58.21 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.257 24.9 p-10 -5.46 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.875 0 N-CA-C 117.175 2.287 . . . . 0.0 117.175 -170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HG2' HG13 ' A' ' 75' ' ' VAL . 92.7 Cg_endo -97.35 147.79 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 124.684 3.59 . . . . 0.0 111.936 176.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 t -77.37 174.48 10.76 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.64 77.38 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.546 0.738 . . . . 0.0 111.972 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -60.68 -41.39 94.99 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.932 0.396 . . . . 0.0 111.799 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -68.2 -41.67 81.01 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.871 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.439 HG13 ' HG2' ' A' ' 70' ' ' PRO . 5.8 m -69.03 -40.88 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.998 177.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -57.67 -44.39 85.7 Favored 'General case' 0 CA--C 1.508 -0.642 0 O-C-N 123.381 0.426 . . . . 0.0 110.764 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.79 73.08 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 124.151 0.907 . . . . 0.0 112.642 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -84.35 -47.57 10.58 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.245 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.82 -36.2 76.3 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.865 -1.061 . . . . 0.0 112.278 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.63 -32.77 56.61 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 CA-C-O 121.094 0.473 . . . . 0.0 111.083 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -81.35 -34.75 31.58 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.431 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 60.8 mt -67.26 -41.11 86.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-O 121.376 0.608 . . . . 0.0 109.761 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.52 -20.19 60.07 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.463 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.86 35.1 78.76 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.694 -0.685 . . . . 0.0 112.132 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.7 mt -87.38 -6.61 58.39 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.417 0.627 . . . . 0.0 110.008 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -127.25 172.3 10.71 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 173.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.7 -69.77 0.42 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 . . . . . 0 CA--C 1.51 -0.582 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.065 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.462 0.167 0 N-CA-C 110.516 -0.179 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 4' ' ' ALA . 26.7 m -117.26 122.55 70.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.496 0 CA-C-O 122.625 1.202 . . . . 0.0 112.526 -177.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.0 m -90.06 -16.94 28.7 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-N 112.501 -2.136 . . . . 0.0 108.27 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 2' ' ' VAL . . . -137.55 141.15 41.39 Favored 'General case' 0 N--CA 1.423 -1.792 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.93 -60.17 1.64 Allowed 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.276 0.0 OUTLIER -156.32 131.15 9.04 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.5 -1.227 . . . . 0.0 109.165 173.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -101.72 117.54 35.1 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.254 -173.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.499 HG12 HG12 ' A' ' 59' ' ' VAL . 97.5 mt -89.05 121.06 38.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.522 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.11 123.62 47.6 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 8.9 t -163.9 171.76 14.92 Favored 'General case' 0 N--CA 1.423 -1.816 0 O-C-N 123.878 0.736 . . . . 0.0 109.187 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.421 HG23 HD11 ' A' ' 36' ' ' ILE . 9.2 p -108.69 159.17 16.96 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 173.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.7 m -76.44 -13.55 60.11 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 120.524 0.202 . . . . 0.0 111.35 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 38.5 p-90 -86.58 -2.2 58.29 Favored 'General case' 0 C--N 1.342 0.244 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -83.98 132.2 34.77 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.14 -30.12 57.66 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -70.86 -19.64 62.62 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 177.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 36.7 t -58.6 -61.29 2.71 Favored 'General case' 0 CA--C 1.509 -0.626 0 O-C-N 123.503 0.502 . . . . 0.0 110.435 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 19' ' ' ARG . 3.5 pp -65.47 -29.39 70.04 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.579 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' N ' HD12 ' A' ' 18' ' ' LEU . 20.3 tpp180 -61.8 -50.18 73.36 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.799 0.809 . . . . 0.0 109.069 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.83 -39.95 79.72 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.507 -178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.643 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.71 -46.66 81.12 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.6 m -59.43 -46.11 89.66 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.225 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.25 -40.95 95.98 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.592 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.2 mt -74.93 -36.84 62.15 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.076 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.9 m -63.68 -41.47 98.15 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.715 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.99 -32.57 73.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.132 0.491 . . . . 0.0 111.596 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -92.92 -1.89 56.31 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 56.17 52.3 10.52 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.946 0.879 . . . . 0.0 111.581 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.3 mt -91.89 140.45 16.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.54 114.45 20.26 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.7 p90 -132.92 152.04 51.96 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.427 0.632 . . . . 0.0 111.671 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 7' ' ' THR . 6.3 m-20 -114.05 116.51 29.28 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 114.546 -1.206 . . . . 0.0 108.293 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -113.31 131.16 56.05 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-O 121.247 0.546 . . . . 0.0 110.845 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.02 130.51 40.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -85.89 141.6 29.47 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.453 HG21 HG11 ' A' ' 46' ' ' VAL . 36.7 pt -83.94 -9.02 11.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -173.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.27 -26.1 68.63 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -101.82 -2.37 30.17 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 120.998 0.428 . . . . 0.0 110.875 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -124.33 88.47 2.91 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -69.22 -30.48 68.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.981 -171.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.69 -37.5 67.85 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.564 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.17 -35.94 78.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.603 177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.8 -41.61 97.97 Favored 'General case' 0 C--O 1.249 1.036 0 CA-C-O 121.375 0.607 . . . . 0.0 110.443 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.08 -46.48 84.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -55.18 -58.94 5.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.669 0.787 . . . . 0.0 111.28 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG12 ' O ' ' A' ' 42' ' ' ALA . 4.4 p -61.69 -32.25 53.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.519 ' HA3' ' NH1' ' A' ' 54' ' ' ARG . . . -69.18 -29.06 72.22 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.724 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.2 m -78.47 -28.21 46.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.355 0.598 . . . . 0.0 110.889 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.47 ' CG2' HG21 ' A' ' 58' ' ' THR . 24.5 m -101.81 13.67 6.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-O 121.759 0.79 . . . . 0.0 110.328 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.3 -173.59 3.86 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.244 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -100.72 78.75 0.42 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.69 -89.63 0.61 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -138.89 -175.24 4.08 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' NH1' ' HA3' ' A' ' 47' ' ' GLY . 2.1 mpp_? -54.58 111.78 0.87 Allowed 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.498 0.499 . . . . 0.0 112.236 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.9 t -157.47 -33.39 0.08 Allowed 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.596 175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.7 m -123.75 148.79 57.45 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.695 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HB3' ' HB ' ' A' ' 10' ' ' THR . 22.8 Cg_endo -64.52 155.0 68.88 Favored 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 122.638 2.225 . . . . 0.0 111.356 176.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.47 HG21 ' CG2' ' A' ' 49' ' ' VAL . 31.5 m -135.91 140.41 44.05 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 66' ' ' THR . 28.3 m -105.73 133.59 49.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 123.237 0.336 . . . . 0.0 110.497 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -112.41 111.68 22.7 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.496 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 93.4 m-85 -77.65 165.82 23.79 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.654 -178.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.82 -11.99 50.7 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.539 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 2.1 p-10 -84.05 -9.84 58.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.5 -2.01 60.53 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.875 -0.602 . . . . 0.0 113.695 176.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 t -91.97 145.39 24.58 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 117.359 0.579 . . . . 0.0 110.677 -176.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -113.38 141.25 47.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.097 179.063 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.4 mt -132.53 133.2 43.45 Favored 'General case' 0 C--O 1.249 1.042 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 173.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.0 m -70.51 139.1 51.54 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -5.48 90.87 0.03 OUTLIER Pre-proline 0 N--CA 1.514 2.728 0 C-N-CA 126.661 1.984 . . . . 0.0 115.572 -170.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.426 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.2 Cg_endo -95.18 152.8 1.67 Allowed 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 124.471 3.448 . . . . 0.0 112.915 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 46.6 t -71.79 163.07 28.47 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.38 177.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.98 -36.46 77.21 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.43 0.692 . . . . 0.0 111.695 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -72.66 -26.72 61.74 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 120.719 0.295 . . . . 0.0 110.641 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -76.21 -45.57 32.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.567 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.4 m -64.19 -37.01 78.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.648 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -59.92 -35.57 75.17 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.334 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.09 79.0 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.435 0.46 . . . . 0.0 111.912 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 7.8 mtpm? -84.29 -45.11 13.17 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.103 177.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.7 tp -60.69 -33.36 72.74 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.418 -175.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.426 HG22 ' HB2' ' A' ' 86' ' ' GLU . 9.5 p -62.97 -31.96 54.39 Favored 'Isoleucine or valine' 0 C--O 1.251 1.177 0 CA-C-O 121.289 0.566 . . . . 0.0 110.691 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -78.54 -47.34 17.46 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 109.335 -0.616 . . . . 0.0 109.335 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.73 -40.09 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.493 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.51 -19.79 63.72 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 111.708 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.63 27.82 41.26 Favored Glycine 0 CA--C 1.5 -0.889 0 N-CA-C 110.961 -0.855 . . . . 0.0 110.961 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.4 mt -99.05 -36.67 9.63 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.225 -0.487 . . . . 0.0 109.981 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HB2' HG22 ' A' ' 80' ' ' VAL . 35.2 tt0 -72.52 113.59 9.72 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.154 0.502 . . . . 0.0 109.964 177.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -116.43 -60.57 1.84 Allowed 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 67.9 t60 . . . . . 0 C--N 1.319 -0.731 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.719 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' HB ' ' A' ' 3' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.61 0 N-CA-C 107.275 -1.379 . . . . 0.0 107.275 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -84.93 77.59 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-O 122.642 1.21 . . . . 0.0 111.22 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.591 ' HB ' ' SD ' ' A' ' 1' ' ' MET . 7.8 t -85.69 -20.73 28.94 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.139 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.51 148.76 33.58 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 176.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -81.19 -64.03 1.28 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 HD23 HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -157.11 133.04 9.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.944 177.183 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.1 m -105.52 123.72 48.37 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.915 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.0 mt -93.18 130.21 42.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 C-N-CA 124.115 0.966 . . . . 0.0 111.147 -178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -106.6 119.17 38.59 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.4 t -163.84 162.2 23.55 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.11 175.56 5.72 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.1 t -76.11 -21.63 56.43 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.491 0.186 . . . . 0.0 111.037 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 p-90 -77.62 -15.31 59.29 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.499 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.4 m -75.42 109.37 8.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.39 -22.8 59.33 Favored Glycine 0 N--CA 1.47 0.931 0 N-CA-C 113.975 0.35 . . . . 0.0 113.975 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' CD2' HG12 ' A' ' 56' ' ' VAL . 86.7 m-85 -82.55 -7.31 59.65 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.62 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 25.2 p -54.88 -59.46 4.7 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -175.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.3 pt? -69.98 -25.93 63.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.964 0.412 . . . . 0.0 110.923 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -59.47 -50.17 74.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.988 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.37 -40.09 85.73 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.399 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.6 mmtp -56.02 -45.75 79.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.613 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -56.09 -40.54 73.79 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.23 -36.63 77.41 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.099 0.476 . . . . 0.0 110.531 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HA ' HD12 ' A' ' 29' ' ' ILE . 57.1 mt -72.87 -42.31 63.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.716 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 61.8 m -64.33 -32.31 73.86 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.91 0.386 . . . . 0.0 110.886 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.8 -27.79 69.13 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.627 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -106.96 3.27 25.9 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.937 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 42.9 mtp180 47.36 58.44 4.89 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.109 0.964 . . . . 0.0 112.145 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 24' ' ' LEU . 75.7 mt -89.62 128.86 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.998 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.157 179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.06 107.7 10.81 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.199 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -116.79 175.12 5.72 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 7' ' ' THR . 35.0 t70 -139.93 139.41 36.16 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.69 141.24 50.4 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.3 p -137.97 142.61 35.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -74.28 140.49 44.98 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.544 0.688 . . . . 0.0 111.481 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.648 HG21 HG11 ' A' ' 46' ' ' VAL . 38.4 pt -86.19 -24.85 6.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.387 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.05 -39.19 66.11 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.825 0.345 . . . . 0.0 111.855 -169.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -89.29 3.58 51.61 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.292 0.568 . . . . 0.0 111.56 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -129.75 93.23 3.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.157 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -47.11 -55.74 7.84 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.67 -35.7 74.97 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 123.481 0.488 . . . . 0.0 111.399 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.96 -47.22 66.16 Favored 'General case' 0 N--CA 1.436 -1.125 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.269 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.2 -36.9 84.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.356 0.598 . . . . 0.0 111.25 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -65.61 -37.17 85.83 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.025 178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.11 -60.99 1.93 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.076 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.648 HG11 HG21 ' A' ' 36' ' ' ILE . 5.8 p -59.16 -36.12 61.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.71 -26.52 74.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.6 m -82.94 -30.28 28.47 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.156 0.503 . . . . 0.0 110.837 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.445 HG22 ' HA ' ' A' ' 46' ' ' VAL . 34.2 m -98.2 13.55 4.55 Favored 'Isoleucine or valine' 0 C--O 1.245 0.859 0 CA-C-O 121.414 0.626 . . . . 0.0 111.245 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.07 173.62 12.4 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.932 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.4 63.34 3.36 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 116.92 -119.29 4.43 Favored Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.496 ' O ' HG22 ' A' ' 55' ' ' THR . 4.2 p-10 -93.77 164.27 13.2 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -54.7 110.03 0.59 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.945 0.898 . . . . 0.0 110.416 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.2 t -162.33 -26.66 0.05 OUTLIER 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.275 -178.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 16' ' ' TYR . 10.7 m -113.4 150.41 43.09 Favored Pre-proline 0 C--N 1.316 -0.887 0 CA-C-O 120.486 0.184 . . . . 0.0 111.241 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.18 150.53 65.8 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.258 1.972 . . . . 0.0 110.454 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.427 HG21 HG23 ' A' ' 49' ' ' VAL . 28.3 m -132.12 136.7 47.31 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.474 HG21 HD23 ' A' ' 6' ' ' LEU . 10.4 p -104.77 127.87 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.952 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.017 -177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -113.59 111.86 22.57 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 6' ' ' LEU . 64.1 m-85 -81.83 171.51 14.42 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.434 -176.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.35 -16.83 62.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.274 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.34 -12.32 52.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.892 0.377 . . . . 0.0 110.187 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.14 -18.22 42.89 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.579 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -80.69 148.95 29.95 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 117.27 0.535 . . . . 0.0 111.972 -177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.1 p -115.5 143.53 45.17 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.841 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.32 129.06 50.06 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 172.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 26.4 m -71.04 141.02 50.93 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -5.75 87.81 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 C-N-CA 126.565 1.946 . . . . 0.0 115.583 -170.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -90.68 -172.48 0.52 Allowed 'Trans proline' 0 N--CA 1.436 -1.883 0 C-N-CA 124.048 3.165 . . . . 0.0 111.378 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.533 ' HB2' ' OE1' ' A' ' 74' ' ' GLU . 23.3 m -118.02 173.87 6.53 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -59.37 -43.67 92.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -171.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -67.92 -37.43 81.67 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.831 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.533 ' OE1' ' HB2' ' A' ' 71' ' ' SER . 12.8 mp0 -63.15 -45.7 90.65 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 123.751 0.82 . . . . 0.0 110.877 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 71' ' ' SER . 13.7 m -70.53 -35.14 60.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.321 -0.552 . . . . 0.0 111.772 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 56.3 mtpt -61.17 -41.71 97.27 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -34.43 73.01 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.929 -178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -84.07 -48.03 10.31 Favored 'General case' 0 N--CA 1.427 -1.577 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -55.27 -42.44 73.54 Favored 'General case' 0 C--O 1.248 1.023 0 C-N-CA 124.445 1.098 . . . . 0.0 112.82 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.23 -32.89 49.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.69 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -80.82 -19.94 43.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.195 0.521 . . . . 0.0 110.841 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.7 mt -85.67 -46.06 17.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.59 -26.78 18.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.85 49.46 22.97 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.689 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.3 mt -81.76 -70.14 0.56 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.55 81.11 7.19 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -139.04 90.39 2.43 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 C--N 1.287 -2.128 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.844 -174.61 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.8 ttp . . . . . 0 CA--C 1.502 -0.886 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.3 m -82.27 111.66 19.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.417 0.627 . . . . 0.0 110.323 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -100.89 -19.3 15.97 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 176.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.36 161.63 39.19 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.24 -62.21 1.54 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -151.78 130.0 11.97 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.27 119.31 38.63 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.545 0.528 . . . . 0.0 111.402 -174.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.02 130.63 38.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 96.9 m-85 -114.88 109.04 17.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.271 176.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 57' ' ' PRO . 6.9 t -164.28 -178.75 5.67 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.895 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.486 ' HB ' ' CD1' ' A' ' 13' ' ' TRP . 33.0 m -152.84 154.79 35.84 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.5 m -48.82 -18.35 0.26 Allowed 'General case' 0 CA--C 1.557 1.219 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.486 ' CD1' ' HB ' ' A' ' 11' ' ' THR . 68.2 p-90 -77.37 -18.45 57.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 118.856 0.753 . . . . 0.0 112.436 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 64.0 m -74.52 141.88 44.82 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.02 -49.95 43.95 Favored Glycine 0 C--N 1.313 -0.746 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.002 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -72.93 -6.1 42.97 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.63 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 26.6 p -47.53 -62.18 1.57 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -174.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -76.96 -25.88 53.33 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.1 tpt180 -61.58 -43.92 97.96 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.537 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.5 tp -67.62 -40.65 84.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.27 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.9 mmmm -58.62 -50.62 73.15 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.9 m -61.28 -46.13 91.59 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.519 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.17 -44.37 83.46 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 123.405 0.44 . . . . 0.0 111.113 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 62.8 mt -71.71 -42.24 67.61 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.241 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 52.3 m -64.24 -38.2 90.19 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.009 0.433 . . . . 0.0 111.249 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.76 -30.52 69.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 0.0 111.622 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -100.11 22.18 11.74 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.025 -178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.258 10.9 ptp180 43.82 61.34 2.33 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 125.477 1.511 . . . . 0.0 114.245 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 68.8 mt -113.45 119.09 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 CA-C-N 115.254 -0.885 . . . . 0.0 108.971 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.54 127.96 32.87 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.714 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -139.91 168.72 19.16 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.681 0.753 . . . . 0.0 112.599 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -120.03 139.98 51.69 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 114.201 -1.363 . . . . 0.0 107.631 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.44 145.71 51.92 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.6 p -138.52 147.37 25.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.932 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -76.35 140.74 41.57 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.732 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.512 HG21 HG11 ' A' ' 46' ' ' VAL . 25.3 pt -86.79 -29.22 5.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.483 175.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.94 -55.63 27.54 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 123.346 0.658 . . . . 0.0 112.39 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 -93.97 15.49 16.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.39 0.614 . . . . 0.0 112.158 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -130.68 91.39 3.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.685 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -56.38 -47.35 79.1 Favored 'General case' 0 C--O 1.207 -1.146 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.32 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.26 -22.79 65.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.729 0.3 . . . . 0.0 111.524 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -86.65 -47.06 9.5 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.86 -43.74 98.24 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.257 0.551 . . . . 0.0 111.201 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.73 -38.13 89.94 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.174 0.99 . . . . 0.0 110.049 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -66.75 -60.0 3.07 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.19 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 42' ' ' ALA . 7.6 p -60.44 -35.02 60.2 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.6 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.62 -177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.83 -28.64 72.92 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.843 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.0 m -83.83 -32.54 25.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.767 0.317 . . . . 0.0 111.408 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.2 m -94.72 9.34 5.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.038 0.447 . . . . 0.0 111.043 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 175.98 8.53 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.198 -175.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.32 87.06 1.55 Allowed Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.12 -72.06 0.72 Allowed Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -144.73 172.62 12.75 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.491 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -61.51 109.22 1.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.442 0.639 . . . . 0.0 111.115 178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -149.37 -34.76 0.18 Allowed 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.824 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.75 152.03 50.87 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 14.6 Cg_endo -58.33 139.33 90.16 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.337 2.691 . . . . 0.0 111.58 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.432 ' OG1' HG23 ' A' ' 46' ' ' VAL . 23.7 m -125.26 147.83 48.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 6' ' ' LEU . 14.6 p -122.13 128.64 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.797 0 O-C-N 123.491 0.494 . . . . 0.0 110.229 -177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -109.63 129.94 55.55 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -94.07 166.2 12.26 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.497 0.189 . . . . 0.0 111.359 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.31 -16.18 59.55 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.947 0.899 . . . . 0.0 112.898 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -87.71 -5.17 58.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.02 0.438 . . . . 0.0 109.882 177.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.94 18.42 47.3 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 116.117 -0.492 . . . . 0.0 114.23 175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -107.06 149.76 27.26 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.68 0.74 . . . . 0.0 110.541 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 p -114.87 154.65 28.27 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.995 178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.7 mt -131.26 126.85 36.53 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 m -68.46 136.04 52.59 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 11.0 t30 -5.89 91.62 0.03 OUTLIER Pre-proline 0 N--CA 1.506 2.352 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -171.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.425 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 28.9 Cg_endo -100.41 174.05 0.33 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 124.498 3.465 . . . . 0.0 112.439 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.9 m -97.46 168.2 10.53 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.415 176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.48 71.01 Favored 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 24.3 t70 -79.65 -28.31 40.84 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 118.489 -1.284 . . . . 0.0 111.339 -176.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.61 -40.67 97.7 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.387 0.613 . . . . 0.0 109.908 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 13.5 m -77.86 -30.95 16.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.969 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 9.5 mtpm? -57.41 -40.52 78.48 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.927 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.95 -35.24 66.45 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 123.941 0.776 . . . . 0.0 112.009 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.4 mtpp -84.03 -50.5 7.93 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.038 0.447 . . . . 0.0 111.115 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.3 tp -56.64 -38.25 71.89 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.829 0.852 . . . . 0.0 112.828 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.27 -32.14 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 120.899 0.38 . . . . 0.0 111.268 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -81.06 -44.1 18.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.35 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 72.2 mt -56.97 -53.5 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 123.75 0.656 . . . . 0.0 110.789 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.92 -33.12 73.22 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.396 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.25 27.66 35.98 Favored Glycine 0 N--CA 1.434 -1.463 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.869 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -87.15 122.04 30.42 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 63.3 -169.44 0.19 Allowed 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.036 0.835 . . . . 0.0 110.001 -177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -129.9 100.28 5.41 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 75.7 m80 . . . . . 0 C--N 1.292 -1.902 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.099 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.238 0.485 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p -120.68 132.89 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-O 121.671 0.748 . . . . 0.0 110.426 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.62 -45.05 72.92 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 113.929 -1.487 . . . . 0.0 111.243 -177.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -119.31 114.01 21.72 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.27 -64.03 1.28 Allowed 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.017 0.437 . . . . 0.0 111.478 -174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.589 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt? -152.5 139.25 18.87 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.491 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -105.96 124.22 49.23 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 HG23 ' A' ' 10' ' ' THR . 91.4 mt -104.62 134.09 46.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.295 -176.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -114.59 116.3 28.54 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.589 0.756 . . . . 0.0 109.412 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.571 HG22 ' HB3' ' A' ' 57' ' ' PRO . 49.5 p -129.88 156.91 43.61 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.447 HG23 HD11 ' A' ' 36' ' ' ILE . 26.8 p -99.47 164.92 11.89 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 171.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.9 m -78.94 -22.51 45.65 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.393 0.615 . . . . 0.0 110.561 178.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 55' ' ' THR . 31.3 p-90 -101.46 -8.42 21.98 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -171.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.734 ' HB3' ' SG ' ' A' ' 17' ' ' CYS . 42.5 t -84.73 142.13 30.06 Favored 'General case' 0 C--O 1.246 0.915 0 C-N-CA 119.717 -0.793 . . . . 0.0 110.326 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -81.36 -19.21 67.07 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.707 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -80.62 -14.43 58.19 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 121.778 -0.836 . . . . 0.0 111.906 178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.734 ' SG ' ' HB3' ' A' ' 14' ' ' CYS . 77.8 m -59.34 -59.16 5.9 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.336 0.398 . . . . 0.0 111.403 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 18' ' ' LEU . 2.3 pt? -74.4 -26.44 60.09 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.453 -178.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 tpp180 -65.61 -42.79 91.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.363 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.0 tp -62.44 -39.28 92.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.319 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -59.02 -44.9 91.78 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.248 178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.4 m -58.38 -49.37 77.48 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.961 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.58 -42.19 98.32 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.905 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HA ' HD12 ' A' ' 29' ' ' ILE . 50.0 mt -70.49 -42.3 71.55 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.395 -178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -64.45 -34.33 77.95 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 120.955 0.407 . . . . 0.0 110.612 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.08 -32.39 73.75 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.21 0.529 . . . . 0.0 110.694 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -96.79 10.65 38.22 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.169 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.4 mtm180 63.65 20.51 12.27 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.308 1.043 . . . . 0.0 111.917 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 24' ' ' LEU . 73.3 mt -73.95 128.55 36.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.319 -176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.69 143.42 27.59 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -152.98 172.81 16.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.116 0.484 . . . . 0.0 112.242 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -119.68 119.61 34.2 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -114.35 124.04 50.97 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 121.264 0.554 . . . . 0.0 110.257 -176.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.04 137.7 48.31 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -92.11 141.73 28.27 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 117.88 -1.528 . . . . 0.0 110.729 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 HG21 HG11 ' A' ' 46' ' ' VAL . 26.2 pt -84.93 -2.85 7.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.403 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -76.27 -37.58 57.36 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -176.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -87.01 -42.86 12.78 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.062 171.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -86.67 97.34 10.52 Favored 'General case' 0 CA--C 1.496 -1.105 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.435 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -71.95 -28.9 63.75 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.077 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.22 -36.41 74.53 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.47 -37.84 77.47 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.343 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.06 98.39 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.175 0.59 . . . . 0.0 110.905 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -62.13 -45.61 92.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -56.73 -60.71 3.16 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.916 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG11 HG21 ' A' ' 36' ' ' ILE . 4.3 p -61.21 -34.34 60.14 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.089 -178.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.06 -35.08 90.09 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.586 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.8 p -80.11 -11.37 59.77 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 33.6 m -115.23 13.73 7.97 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 CA-C-O 121.813 0.816 . . . . 0.0 109.525 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -98.88 -171.84 2.18 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.994 -174.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.15 69.4 2.83 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.96 -96.87 1.6 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -177.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -106.2 174.46 5.88 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.43 ' HA ' ' OD1' ' A' ' 50' ' ' ASN . 0.1 OUTLIER -76.79 111.16 12.01 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.267 -179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.402 ' HA ' ' CH2' ' A' ' 13' ' ' TRP . 9.8 t -133.46 -17.49 2.29 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.796 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.07 152.9 81.03 Favored Pre-proline 0 N--CA 1.441 -0.888 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.571 ' HB3' HG22 ' A' ' 10' ' ' THR . 36.5 Cg_endo -67.29 157.72 60.39 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.204 1.936 . . . . 0.0 111.924 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -141.74 148.59 39.25 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.589 HG21 HD12 ' A' ' 6' ' ' LEU . 7.1 p -120.47 136.65 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.947 0 O-C-N 123.666 0.604 . . . . 0.0 109.899 -177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -113.15 127.55 56.22 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.43 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 97.0 m-85 -85.77 169.57 13.27 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -60.79 -27.66 68.18 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.574 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -75.19 -16.68 60.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.661 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.11 -19.07 27.87 Favored Glycine 0 N--CA 1.442 -0.916 0 CA-C-O 119.741 -0.477 . . . . 0.0 114.236 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -73.76 153.3 40.06 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-N 117.788 0.794 . . . . 0.0 112.616 -177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 11.8 p -118.26 153.66 33.55 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.142 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 73.9 mt -132.75 123.18 25.74 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.6 m -65.41 138.49 58.17 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -5.03 92.16 0.03 OUTLIER Pre-proline 0 N--CA 1.509 2.506 0 C-N-CA 126.873 2.069 . . . . 0.0 115.949 -170.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -98.85 -169.75 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.511 0 C-N-CA 123.724 2.95 . . . . 0.0 111.913 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 75' ' ' VAL . 48.2 t -117.94 172.1 7.62 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.84 -50.14 66.87 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 11.1 m-20 -71.89 -30.2 65.15 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -60.81 -43.53 98.07 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 121.278 0.561 . . . . 0.0 110.351 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 71' ' ' SER . 15.5 m -80.28 -30.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.246 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.328 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 52.5 mtpt -60.08 -40.87 91.07 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 174.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.41 -36.8 64.34 Favored 'General case' 0 C--O 1.223 -0.339 0 O-C-N 124.122 0.889 . . . . 0.0 111.707 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -84.11 -48.58 9.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.18 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 56.1 tp -55.58 -41.14 72.94 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.735 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.35 -34.54 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-O 121.095 0.474 . . . . 0.0 110.217 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 91.6 mttt -82.37 -19.6 38.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.014 -178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' LYS . 78.2 mt -84.67 -46.21 17.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.55 -24.79 66.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.258 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 142.57 -123.74 2.23 Favored Glycine 0 CA--C 1.479 -2.165 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 41.33 -87.84 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 126.661 1.984 . . . . 0.0 115.994 168.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 87' ' ' HIS . 37.2 tt0 -99.76 109.55 21.99 Favored 'General case' 0 C--O 1.209 -1.027 0 C-N-CA 122.156 0.182 . . . . 0.0 110.546 -173.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 86' ' ' GLU . 63.6 t-80 162.72 -45.31 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 74.9 m80 . . . . . 0 N--CA 1.421 -1.895 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.486 -178.349 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' SD ' ' HB1' ' A' ' 83' ' ' ALA . 49.6 tpp . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 120.86 0.362 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.445 HG12 HG22 ' A' ' 3' ' ' THR . 22.0 t 66.04 -91.49 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.072 1.349 . . . . 0.0 111.659 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.445 HG22 HG12 ' A' ' 2' ' ' VAL . 7.9 t 173.48 -45.1 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.04 157.62 17.4 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.92 -64.43 1.13 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.531 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.5 131.98 6.64 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.918 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 17.4 m -102.68 127.27 49.87 Favored 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.942 -174.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.2 mt -88.23 123.7 40.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 C-N-CA 124.983 1.313 . . . . 0.0 110.659 -178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 33.8 m-85 -103.68 115.79 31.14 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 173.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -163.64 169.81 18.03 Favored 'General case' 0 N--CA 1.422 -1.839 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.461 HG23 ' CG1' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -123.77 161.15 25.8 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 170.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.9 m -74.36 -8.19 55.43 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.699 0.285 . . . . 0.0 111.76 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.6 p-90 -86.95 -5.48 59.08 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 174.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -78.69 144.21 35.55 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.97 -42.8 84.48 Favored Glycine 0 C--N 1.315 -0.607 0 C-N-CA 121.012 -0.614 . . . . 0.0 113.218 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -82.11 -5.67 58.59 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.538 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.4 p -50.29 -63.13 1.21 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.442 ' HA ' ' HG2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -68.67 -29.53 68.01 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.282 0.563 . . . . 0.0 111.543 -177.629 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -59.88 -47.19 86.75 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.775 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 62.8 tp -70.55 -34.75 72.58 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.574 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 10.2 mmmm -62.14 -47.17 85.74 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.6 m -65.41 -43.77 89.54 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.767 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.34 -45.53 84.22 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-O 120.872 0.368 . . . . 0.0 111.675 -178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.5 mt -71.85 -37.7 70.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.208 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.2 m -65.99 -43.7 86.99 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.78 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.23 -34.34 77.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.229 0.538 . . . . 0.0 111.232 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -91.41 6.69 44.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.89 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 54.95 62.29 2.58 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.422 1.089 . . . . 0.0 112.004 177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.56 133.59 61.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.537 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.85 125.35 29.21 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -140.72 159.67 41.69 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.323 0.582 . . . . 0.0 110.895 -178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' THR . 20.6 m-20 -122.43 142.35 50.64 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -137.14 139.17 41.0 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.558 0.617 . . . . 0.0 111.762 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.8 p -139.23 144.78 28.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.33 143.14 26.7 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 117.915 -1.514 . . . . 0.0 110.738 -178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.629 HG21 HG11 ' A' ' 46' ' ' VAL . 35.6 pt -84.13 -3.83 8.12 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 CA-C-N 114.407 -1.27 . . . . 0.0 113.184 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -88.06 -36.94 16.67 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 119.112 -1.035 . . . . 0.0 109.493 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -77.82 -33.62 52.32 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.023 173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -103.52 102.88 12.79 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.082 -177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -65.53 -36.5 83.99 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.486 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -61.79 -32.05 72.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.03 0.443 . . . . 0.0 111.068 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -75.8 -41.03 54.0 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.043 177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -64.85 -44.38 89.93 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.122 0.569 . . . . 0.0 111.38 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.82 -38.23 81.44 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.751 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -70.48 -61.44 1.77 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 114.298 -1.319 . . . . 0.0 111.207 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.629 HG11 HG21 ' A' ' 36' ' ' ILE . 7.5 p -57.34 -35.79 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 -176.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.31 -28.04 73.12 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.335 -0.936 . . . . 0.0 112.843 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.53 -25.78 30.72 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.054 0.454 . . . . 0.0 111.177 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.23 13.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.029 0.919 . . . . 0.0 110.438 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.2 165.83 16.22 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.986 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.62 87.18 1.39 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.67 -97.74 1.86 Allowed Glycine 0 N--CA 1.438 -1.228 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 48.4 t30 -86.21 149.89 24.77 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -72.87 102.41 3.42 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 53' ' ' ASN . 8.9 t -157.93 -8.08 0.08 Allowed 'General case' 0 CA--C 1.557 1.228 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.051 -172.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG13 HG23 ' A' ' 55' ' ' THR . 5.7 m -126.71 144.68 50.73 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.4 Cg_endo -58.85 140.08 93.62 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.28 2.653 . . . . 0.0 111.477 176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.7 m -128.66 138.9 52.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.9 m -102.71 133.73 45.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 120.914 -0.315 . . . . 0.0 110.378 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.4 ttpm? -110.63 112.72 24.8 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 173.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.417 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 87.7 m-85 -78.78 159.79 27.71 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 123.557 0.535 . . . . 0.0 109.732 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.42 -14.02 46.08 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 13.4 p-10 -85.63 -12.45 51.38 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.18 15.77 24.91 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.328 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 76.1 p -105.45 157.01 17.65 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 122.195 -0.591 . . . . 0.0 110.669 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.5 p -127.79 143.29 51.13 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 120.58 0.229 . . . . 0.0 110.537 176.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 81.7 mt -128.45 127.51 42.63 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.6 m -66.78 145.68 55.26 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -5.11 85.35 0.03 OUTLIER Pre-proline 0 N--CA 1.511 2.612 0 C-N-CA 126.295 1.838 . . . . 0.0 115.887 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -95.0 159.64 1.72 Allowed 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 123.761 2.974 . . . . 0.0 112.486 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 p -83.49 168.62 16.31 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.59 77.43 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.367 0.603 . . . . 0.0 110.634 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -70.97 -25.45 62.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.641 -0.708 . . . . 0.0 112.665 177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -79.24 -43.88 22.88 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 122.257 -0.277 . . . . 0.0 111.538 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.89 -40.77 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -58.83 -34.59 71.72 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.23 -37.39 77.41 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.652 0.595 . . . . 0.0 112.207 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' O ' HG13 ' A' ' 82' ' ' ILE . 9.0 mtpm? -85.84 -44.69 12.23 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.061 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 60.3 tp -53.35 -40.09 64.65 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 124.505 1.122 . . . . 0.0 113.15 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -55.91 -39.17 55.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 O-C-N 123.43 0.456 . . . . 0.0 111.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -79.28 -31.4 43.33 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.162 -177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 78' ' ' LYS . 62.8 mt -74.96 -52.85 17.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.079 -175.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.435 ' HB1' ' SD ' ' A' ' 1' ' ' MET . . . -81.3 -36.97 29.15 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.895 -176.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.27 77.41 1.15 Allowed Glycine 0 CA--C 1.459 -3.45 0 CA-C-O 123.247 1.471 . . . . 0.0 111.335 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 tp -132.96 123.88 26.75 Favored 'General case' 1 N--CA 1.376 -4.126 0 CA-C-N 112.149 -2.025 . . . . 0.0 107.45 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 62.41 81.35 0.2 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.959 0.885 . . . . 0.0 112.725 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 41.6 m-70 -97.0 149.89 21.39 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 C--N 1.295 -1.802 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.705 179.86 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 CA--C 1.51 -0.564 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -92.74 124.15 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.0 t -72.72 -41.43 65.21 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-O 120.822 0.344 . . . . 0.0 111.355 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -112.67 77.93 1.09 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 175.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.447 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.34 -58.89 6.59 Favored 'General case' 0 C--O 1.247 0.953 0 CA-C-N 114.135 -1.393 . . . . 0.0 111.421 -175.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.19 132.16 18.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.348 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.9 m -112.18 122.64 48.31 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.197 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.409 HD11 ' CD1' ' A' ' 24' ' ' LEU . 96.4 mt -91.63 123.77 43.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.003 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.49 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 29.7 m-85 -105.43 118.88 37.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -163.84 164.31 23.55 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.09 162.84 14.49 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 171.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.3 m -71.01 -19.44 62.52 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -83.82 -1.22 53.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -80.6 123.23 27.96 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.46 -36.14 92.98 Favored Glycine 0 C--O 1.22 -0.745 0 CA-C-N 116.392 -0.367 . . . . 0.0 113.549 -175.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -82.27 -7.15 59.62 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -178.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 37.0 t -52.52 -59.41 4.47 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.187 0.305 . . . . 0.0 111.655 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -69.13 -23.15 63.94 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -68.14 -48.25 65.9 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.446 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.8 tp -63.88 -40.15 95.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.602 178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.601 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.3 mmtp -60.16 -51.79 68.08 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-O 121.258 0.552 . . . . 0.0 110.409 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' HG22 ' A' ' 25' ' ' THR . 17.1 p -67.73 -31.85 72.07 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.428 -177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.99 -44.53 84.57 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 120.941 0.4 . . . . 0.0 110.488 177.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 55.4 mt -72.03 -40.96 68.04 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.439 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 22' ' ' THR . 4.1 t -64.76 -29.6 70.58 Favored 'General case' 0 CA--C 1.558 1.275 0 CA-C-O 120.892 0.377 . . . . 0.0 110.411 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.41 -31.75 58.12 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.206 0.526 . . . . 0.0 111.006 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -91.53 12.86 19.48 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmt180 61.18 33.36 19.32 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.583 1.153 . . . . 0.0 110.43 175.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 24' ' ' LEU . 78.3 mt -87.26 133.57 29.82 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.408 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.67 123.57 34.38 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -145.81 175.44 10.41 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.059 0.457 . . . . 0.0 111.4 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -129.27 142.08 50.94 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.82 126.77 38.87 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -138.32 133.9 43.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-O 121.179 0.514 . . . . 0.0 109.839 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.01 140.69 57.71 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 9' ' ' TYR . 40.5 pt -84.35 -18.8 9.49 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.99 -45.37 74.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.376 -0.53 . . . . 0.0 109.572 -177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -72.2 -36.97 69.35 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.613 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -91.05 93.4 9.16 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.024 0.44 . . . . 0.0 111.141 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -55.25 -46.02 76.06 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 123.969 0.907 . . . . 0.0 111.802 -178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.19 70.28 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.212 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.9 -42.41 81.2 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.721 0.296 . . . . 0.0 110.314 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . . . -64.24 -41.59 96.91 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.173 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.78 -43.01 90.06 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.47 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -60.95 -52.79 63.54 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.566 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.558 ' HA ' HG22 ' A' ' 49' ' ' VAL . 14.3 m -68.35 -21.97 26.9 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.156 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.52 -178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.37 -25.27 68.35 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.31 -0.472 . . . . 0.0 112.058 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.0 m -83.89 -23.5 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.026 0.441 . . . . 0.0 110.795 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 46' ' ' VAL . 32.1 m -114.74 13.94 8.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.706 0.765 . . . . 0.0 110.606 -175.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 0.7 OUTLIER -88.87 -171.61 3.37 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.134 -172.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.9 65.87 3.18 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.87 -73.07 1.6 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -110.47 161.73 15.39 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -71.16 100.67 2.11 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 177.211 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.4 t -149.67 -17.89 0.27 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.286 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.9 m -116.91 145.62 35.97 Favored Pre-proline 0 C--O 1.248 1.013 0 O-C-N 121.907 -0.496 . . . . 0.0 111.82 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.53 127.42 26.13 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 123.581 2.854 . . . . 0.0 111.342 177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.3 m -113.71 135.31 54.07 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.26 125.29 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.771 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.07 111.85 23.06 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -82.16 171.03 14.77 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.347 -178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.58 -15.3 63.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.939 0.875 . . . . 0.0 109.104 171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -72.47 -17.98 61.72 Favored 'General case' 0 C--O 1.212 -0.91 0 CA-C-N 114.023 -1.444 . . . . 0.0 109.709 174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.04 -22.67 21.35 Favored Glycine 0 C--O 1.237 0.293 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.508 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 m -73.42 151.94 40.97 Favored 'General case' 0 C--O 1.254 1.338 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 p -119.53 143.4 47.6 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.753 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.8 mt -125.32 132.97 52.77 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -72.32 139.53 48.02 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -5.49 88.39 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.12 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 -170.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' O ' HD13 ' A' ' 20' ' ' LEU . 19.7 Cg_endo -99.23 153.38 0.61 Allowed 'Trans proline' 0 N--CA 1.441 -1.596 0 C-N-CA 123.998 3.132 . . . . 0.0 111.145 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -86.34 172.88 10.1 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.718 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.31 -46.65 55.59 Favored 'General case' 0 C--O 1.217 -0.654 0 C-N-CA 123.774 0.829 . . . . 0.0 113.065 -174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 19.0 m-20 -69.92 -19.74 63.38 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -82.49 -39.35 22.59 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 m -77.36 -31.03 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 51.0 mtpt -54.5 -40.23 68.34 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.94 0.496 . . . . 0.0 110.832 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.2 -38.73 71.38 Favored 'General case' 0 C--O 1.22 -0.489 0 O-C-N 124.238 0.961 . . . . 0.0 112.0 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 82' ' ' ILE . 29.5 mtpp -84.15 -47.24 11.07 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.953 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' A' ' 5' ' ' ALA . 60.7 tp -57.8 -39.89 78.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.797 -174.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.95 -31.2 51.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.971 0 CA-C-O 121.341 0.591 . . . . 0.0 110.311 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -81.09 -43.04 20.06 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.276 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 78' ' ' LYS . 76.1 mt -59.3 -34.8 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.565 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.67 -16.33 64.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.91 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.15 3.26 70.07 Favored Glycine 0 CA--C 1.505 -0.592 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.27 161.43 16.4 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 58.5 22.7 9.93 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 123.545 0.528 . . . . 0.0 111.685 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -128.46 98.34 5.01 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.3 m80 . . . . . 0 C--N 1.294 -1.823 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -176.45 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtm . . . . . 0 CA--C 1.5 -0.98 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.51 82.97 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 121.47 0.652 . . . . 0.0 110.471 -176.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -94.42 -21.57 18.85 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 171.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.08 143.45 30.43 Favored 'General case' 0 N--CA 1.407 -2.576 0 N-CA-C 103.269 -2.863 . . . . 0.0 103.269 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.13 -53.18 4.23 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-O 121.877 0.846 . . . . 0.0 108.788 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -152.07 136.83 17.07 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.727 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.8 m -102.26 110.07 21.93 Favored 'General case' 0 N--CA 1.412 -2.359 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.422 HG12 HG12 ' A' ' 59' ' ' VAL . 89.9 mt -88.49 130.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.817 -176.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -112.83 105.44 13.55 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.334 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -164.66 -171.12 2.2 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 174.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.9 m -149.62 164.59 34.73 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -56.01 -20.67 17.58 Favored 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 124.664 1.185 . . . . 0.0 113.812 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -82.09 -2.07 50.69 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.9 t -95.92 129.32 43.21 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.68 -31.94 81.52 Favored Glycine 0 N--CA 1.46 0.243 0 CA-C-O 121.493 0.496 . . . . 0.0 112.1 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -80.96 -7.94 59.64 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 31.6 t -64.57 -61.74 2.02 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 110.318 -0.252 . . . . 0.0 110.318 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.41 -29.2 68.63 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.723 -178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -62.97 -39.12 93.72 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 49.5 tp -75.89 -45.96 32.66 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.214 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.9 mmtp -53.7 -49.27 68.41 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.933 0.396 . . . . 0.0 110.884 -178.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -66.87 -37.25 84.06 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.781 -0.645 . . . . 0.0 112.103 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.28 91.33 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-O 120.951 0.405 . . . . 0.0 110.734 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 73.0 mt -70.4 -42.35 71.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -62.71 -40.74 98.1 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.426 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.89 66.86 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.28 0.562 . . . . 0.0 110.942 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -91.04 4.19 52.75 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.663 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 61.23 29.64 18.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.611 1.164 . . . . 0.0 111.584 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 79.7 mt -81.95 131.52 33.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.05 129.97 35.01 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -139.11 164.34 30.04 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.974 0.416 . . . . 0.0 111.799 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.82 122.52 34.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.225 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -115.31 129.61 56.66 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-O 120.958 0.409 . . . . 0.0 110.941 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p -125.1 138.7 53.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -90.43 141.33 28.85 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.004 -1.478 . . . . 0.0 111.092 -175.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.599 HG21 HG11 ' A' ' 46' ' ' VAL . 29.2 pt -85.1 5.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.143 -1.39 . . . . 0.0 110.8 176.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -84.88 -45.29 12.4 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -85.27 -34.66 21.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.759 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -94.91 92.95 7.15 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.722 -177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -72.25 -28.29 63.05 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.764 -177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.69 -34.14 76.31 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.6 -39.52 70.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.332 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.84 -39.16 90.86 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.319 0.58 . . . . 0.0 110.831 177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -63.03 -48.67 77.76 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.692 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -59.87 -56.83 16.89 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.078 -0.965 . . . . 0.0 111.438 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -64.15 -33.29 61.5 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.812 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -178.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 -28.6 73.82 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.935 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -76.18 -45.63 32.39 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.047 0.451 . . . . 0.0 110.164 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.6 m -86.96 3.0 4.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.458 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.78 -172.37 3.85 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.187 0.518 . . . . 0.0 109.948 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.07 64.23 2.71 Favored Glycine 0 N--CA 1.432 -1.605 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 113.14 -73.81 0.22 Allowed Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.078 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.483 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 39.9 t-20 -135.89 169.65 17.24 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 104.891 -2.262 . . . . 0.0 104.891 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -70.94 107.01 3.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.349 0.977 . . . . 0.0 110.799 -178.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.1 t -138.14 -23.24 1.02 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.004 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.4 m -128.38 154.6 79.18 Favored Pre-proline 0 N--CA 1.448 -0.536 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.875 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 39.0 Cg_endo -67.84 145.56 69.1 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.602 2.201 . . . . 0.0 111.316 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.8 m -128.87 143.65 50.95 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.4 m -111.17 134.25 54.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 123.164 0.29 . . . . 0.0 110.417 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -111.76 118.88 36.82 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 171.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HB2' ' OD1' ' A' ' 63' ' ' ASP . 93.2 m-85 -80.09 178.59 8.14 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.96 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.91 -10.71 58.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.323 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.563 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 33.7 p-10 -88.3 -18.48 28.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.784 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.37 -1.63 53.81 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.99 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.6 t -84.48 144.65 28.58 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.96 140.94 48.87 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.754 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -130.79 140.75 50.31 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.7 m -77.73 147.45 35.38 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -5.53 83.27 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.833 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 -173.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -98.51 139.53 0.41 Allowed 'Trans proline' 0 N--CA 1.435 -1.925 0 C-N-CA 123.57 2.847 . . . . 0.0 112.269 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.3 t -72.11 174.53 7.01 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.648 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.01 -47.03 78.55 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 123.829 0.851 . . . . 0.0 113.176 -173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 15.7 m-20 -76.29 -19.76 57.96 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.961 -0.696 . . . . 0.0 112.383 -177.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.28 -44.17 65.74 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.7 m -73.71 -34.99 42.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.812 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 55.6 mtpt -56.68 -36.53 69.72 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.199 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.61 73.98 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.903 0.752 . . . . 0.0 111.628 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -84.05 -40.82 17.88 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.311 -0.556 . . . . 0.0 111.613 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 tp -60.27 -38.27 83.03 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.941 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.5 p -62.8 -32.94 57.54 Favored 'Isoleucine or valine' 0 C--O 1.249 1.079 0 CA-C-O 121.499 0.666 . . . . 0.0 110.753 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 87' ' ' HIS . 8.8 mtpm? -81.75 -31.24 32.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.41 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 75.8 mt -70.08 -36.49 68.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.322 0.582 . . . . 0.0 109.86 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.57 -18.4 62.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.177 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.47 18.77 79.51 Favored Glycine 0 CA--C 1.5 -0.897 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.626 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 98.8 mt -79.93 -40.92 27.13 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 121.179 -0.209 . . . . 0.0 111.064 -176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -89.51 -48.01 7.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.675 0.75 . . . . 0.0 109.133 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LYS . 17.1 t60 -168.82 168.88 10.24 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 49.0 m80 . . . . . 0 C--N 1.301 -1.515 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.234 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.836 0.35 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 p -118.69 113.28 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 122.279 1.038 . . . . 0.0 111.611 -176.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.5 m -102.08 -42.87 5.93 Favored 'General case' 0 N--CA 1.406 -2.628 0 CA-C-N 113.431 -1.713 . . . . 0.0 107.705 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.49 129.95 46.8 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -60.9 -54.75 41.29 Favored 'General case' 0 C--N 1.315 -0.907 0 O-C-N 123.683 0.614 . . . . 0.0 111.519 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -150.15 137.87 19.99 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 m -103.45 119.39 38.8 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG12 HG12 ' A' ' 59' ' ' VAL . 92.2 mt -88.76 122.48 40.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.188 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 54.1 m-85 -102.61 121.9 43.33 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 173.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -163.51 171.41 15.9 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 p -106.99 149.13 27.86 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.1 t -67.35 -20.95 65.65 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 120.471 0.177 . . . . 0.0 110.594 178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -87.86 5.25 41.26 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.4 t -85.85 132.37 34.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.442 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -73.97 -32.91 58.2 Favored Glycine 0 N--CA 1.436 -1.323 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.421 ' CD2' HG12 ' A' ' 56' ' ' VAL . 50.5 m-85 -67.58 -17.54 64.67 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 51.5 t -57.11 -56.43 21.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 123.585 0.553 . . . . 0.0 110.307 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.65 -21.69 61.78 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 36.7 mmt180 -65.28 -51.1 62.97 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 51.6 tp -64.09 -40.35 96.05 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 113.91 -1.495 . . . . 0.0 111.731 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.8 mmtp -60.31 -41.13 92.83 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 84.8 m -59.96 -45.28 93.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.052 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.35 -51.25 66.7 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.671 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 mt -65.65 -44.49 86.23 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -176.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 36.9 m -64.02 -34.28 77.64 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 120.748 0.309 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.39 -25.18 67.44 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.141 177.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -103.83 9.26 36.99 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 122.082 -0.386 . . . . 0.0 110.74 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 54.92 41.18 32.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.828 0.851 . . . . 0.0 111.298 179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.4 mt -84.38 138.51 19.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.767 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.15 119.31 24.84 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -137.33 168.14 20.22 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.872 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.08 142.26 47.48 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -133.15 137.78 46.38 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 120.787 0.327 . . . . 0.0 110.442 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -137.94 142.4 36.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 177.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -89.25 141.7 28.29 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.508 -175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.616 HG21 HG11 ' A' ' 46' ' ' VAL . 43.2 pt -84.21 -7.53 10.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.664 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -71.92 -31.69 66.62 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-O 121.729 0.776 . . . . 0.0 108.919 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -90.16 -15.52 31.35 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.231 -177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -125.45 95.53 4.49 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.673 -177.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -66.08 -34.89 79.1 Favored 'General case' 0 C--N 1.316 -0.863 0 O-C-N 123.044 0.215 . . . . 0.0 111.409 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.57 -41.93 98.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.037 0.446 . . . . 0.0 110.023 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.537 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.1 -37.93 81.73 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.777 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.68 -41.85 98.1 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.744 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.15 -39.23 94.07 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.03 -59.29 5.0 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.453 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.616 HG11 HG21 ' A' ' 36' ' ' ILE . 7.4 p -62.39 -31.38 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.331 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.74 -37.4 94.65 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.617 178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.0 p -82.27 -13.71 56.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 58' ' ' THR . 27.5 m -110.75 13.34 8.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 122.182 0.992 . . . . 0.0 109.458 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.66 -172.11 3.12 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.32 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -101.79 60.71 0.57 Allowed Glycine 0 N--CA 1.432 -1.604 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.187 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 114.89 -56.74 0.49 Allowed Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.73 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -144.77 167.41 22.65 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.483 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.3 OUTLIER -71.29 103.21 2.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 118.89 0.768 . . . . 0.0 110.005 178.139 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 -32.54 0.36 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.755 -176.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG12 ' CD2' ' A' ' 16' ' ' TYR . 9.1 m -115.55 149.3 42.73 Favored Pre-proline 0 N--CA 1.447 -0.601 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 28.2 Cg_endo -63.57 147.03 93.21 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.906 2.404 . . . . 0.0 111.223 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.434 HG21 HG23 ' A' ' 49' ' ' VAL . 32.2 m -134.65 140.05 45.74 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 66' ' ' THR . 34.1 m -105.93 132.18 53.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 121.064 -0.255 . . . . 0.0 111.03 -178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -106.15 115.66 30.61 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 174.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -81.98 162.19 22.75 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 123.319 0.387 . . . . 0.0 110.579 -177.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -9.98 56.05 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.567 0.699 . . . . 0.0 109.7 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -77.32 -12.63 59.97 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.928 -1.033 . . . . 0.0 108.595 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.1 -22.93 31.99 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 115.916 1.127 . . . . 0.0 115.916 171.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -105.48 174.36 5.91 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 118.448 1.124 . . . . 0.0 111.11 -177.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.6 p -113.62 160.23 18.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.962 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.8 mt -134.15 125.97 29.02 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 169.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 m -67.82 141.78 56.37 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -5.13 84.7 0.03 OUTLIER Pre-proline 0 N--CA 1.519 3.014 0 C-N-CA 126.449 1.9 . . . . 0.0 115.313 -169.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 55.6 Cg_endo -96.54 138.48 0.62 Allowed 'Trans proline' 0 N--CA 1.438 -1.749 0 C-N-CA 124.271 3.314 . . . . 0.0 111.895 178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.1 t -72.71 173.2 9.38 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.897 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.61 -41.93 86.98 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -172.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 76' ' ' LYS . 5.4 t70 -81.07 -19.91 42.69 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 118.163 -1.415 . . . . 0.0 109.968 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -70.24 -43.41 70.62 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.679 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.437 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 7.6 m -68.92 -40.6 81.29 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.939 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 73' ' ' ASP . 48.4 mtpt -53.11 -39.33 63.35 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.484 0.49 . . . . 0.0 111.649 177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.91 -37.5 84.86 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.545 0.528 . . . . 0.0 111.869 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -85.96 -35.94 20.13 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.626 0.727 . . . . 0.0 110.573 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.492 HD11 ' HB1' ' A' ' 5' ' ' ALA . 65.1 tp -66.74 -35.31 79.8 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 125.394 1.478 . . . . 0.0 112.517 -176.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.18 -31.14 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 122.929 0.492 . . . . 0.0 111.772 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.5 mtmp? -70.4 -26.39 63.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.353 0.597 . . . . 0.0 110.276 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -83.93 -51.8 13.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.063 -175.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.66 76.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.927 -177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 88' ' ' HIS . . . 81.09 65.36 1.7 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 120.031 -1.08 . . . . 0.0 111.158 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.3 mt -118.07 -71.56 0.73 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.135 0.493 . . . . 0.0 110.074 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.38 131.71 34.73 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.661 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.7 m80 72.75 -51.39 0.71 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.178 1.391 . . . . 0.0 113.905 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.559 ' O ' ' HA2' ' A' ' 84' ' ' GLY . 3.4 p80 . . . . . 0 C--N 1.294 -1.843 0 C-N-CA 122.608 0.363 . . . . 0.0 111.767 -173.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 CA--C 1.501 -0.911 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.4 p -128.25 144.83 36.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 t -115.67 -0.2 13.05 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.423 -175.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.47 148.96 52.69 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.82 -64.19 1.07 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.17 146.69 12.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.812 177.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 28.0 m -118.17 132.31 56.34 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.512 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 68.6 mt -92.71 128.7 44.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 C-N-CA 124.061 0.944 . . . . 0.0 111.503 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 69.1 m-85 -110.09 119.09 38.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.748 173.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -164.09 -172.02 2.64 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.2 p -121.64 164.27 17.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.6 m -78.71 -7.85 58.13 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -102.8 2.48 35.57 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.175 0.512 . . . . 0.0 111.32 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 45.6 t -82.94 118.56 23.56 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.87 -24.36 69.94 Favored Glycine 0 C--O 1.237 0.323 0 C-N-CA 121.43 -0.414 . . . . 0.0 112.818 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -82.16 -10.48 59.15 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.537 -0.465 . . . . 0.0 112.092 177.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.6 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 23.0 t -61.09 -62.55 1.77 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -66.39 -29.21 69.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.494 -179.398 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -62.72 -44.19 96.87 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.364 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.8 tp -72.65 -37.87 67.84 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.945 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.6 mmtp -56.93 -43.13 81.17 Favored 'General case' 0 C--O 1.246 0.903 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.3 m -57.4 -53.33 59.32 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.962 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.16 -46.24 82.94 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.097 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -70.27 -37.24 74.84 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.559 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 73.0 m -70.98 -39.09 72.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.99 -20.84 64.17 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.296 0.57 . . . . 0.0 111.259 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -105.92 14.52 27.9 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.997 179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 44.55 59.8 3.16 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.597 1.159 . . . . 0.0 113.054 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.53 135.15 50.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.45 131.99 34.61 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -150.61 157.29 42.81 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 7' ' ' THR . 33.9 t70 -120.7 142.32 49.61 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -127.25 138.13 53.02 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.054 0.454 . . . . 0.0 110.528 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.8 141.23 37.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -94.46 143.83 26.08 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.843 -1.143 . . . . 0.0 110.326 -177.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 48.6 pt -82.99 -0.36 4.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.115 0 CA-C-N 114.881 -1.054 . . . . 0.0 112.939 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -87.7 -38.18 16.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -76.51 -35.96 58.02 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.463 172.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -105.35 99.99 9.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.783 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -68.82 -32.93 72.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.849 -177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.2 -40.79 98.51 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -66.13 -41.77 90.03 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.54 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.2 -36.66 75.78 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-O 121.323 0.582 . . . . 0.0 110.987 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -70.86 -44.52 66.22 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.127 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.07 -56.62 15.4 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.917 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 8.6 p -65.2 -27.0 41.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 CA-C-O 120.82 0.343 . . . . 0.0 111.248 -178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.36 -20.86 77.17 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.538 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.4 t -84.07 -24.41 30.4 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 122.616 0.366 . . . . 0.0 110.817 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 58' ' ' THR . 31.0 m -115.12 13.12 7.98 Favored 'Isoleucine or valine' 0 C--O 1.249 1.04 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -93.07 167.58 11.69 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.315 -175.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.7 80.28 1.59 Allowed Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.19 -82.92 0.34 Allowed Glycine 0 N--CA 1.427 -1.947 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 32.7 t-20 -144.65 172.68 12.65 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 0.4 OUTLIER -63.37 121.32 13.47 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 119.343 0.974 . . . . 0.0 111.833 -175.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.421 HG23 HG13 ' A' ' 56' ' ' VAL . 9.7 t -166.73 -25.62 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.43 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG13 HG23 ' A' ' 55' ' ' THR . 17.7 m -115.99 148.38 41.26 Favored Pre-proline 0 N--CA 1.445 -0.7 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 27.2 Cg_endo -62.22 138.02 69.53 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.894 2.396 . . . . 0.0 111.583 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 49' ' ' VAL . 40.5 m -129.22 144.29 51.16 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 66' ' ' THR . 27.8 m -109.82 129.61 64.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 120.855 0.359 . . . . 0.0 111.14 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -104.58 118.63 37.07 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -83.58 171.17 13.59 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.499 -177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.88 -10.85 14.84 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -88.15 -10.46 49.9 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.154 0.502 . . . . 0.0 109.881 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.07 -15.15 58.19 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.878 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.3 m -94.4 166.61 11.98 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 117.476 0.638 . . . . 0.0 111.262 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -120.0 157.89 27.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.4 mt -128.19 122.31 31.53 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 167.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.4 m -61.73 141.33 57.94 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -5.18 89.67 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.195 0 C-N-CA 127.513 2.325 . . . . 0.0 115.458 -171.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -96.24 154.8 1.35 Allowed 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 124.265 3.31 . . . . 0.0 113.149 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.2 t -84.96 175.32 9.14 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.31 73.71 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.875 0.369 . . . . 0.0 111.651 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -70.08 -36.96 75.29 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.16 0.505 . . . . 0.0 110.095 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.72 -47.38 72.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -64.7 -41.0 90.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.842 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -63.8 -35.17 79.72 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.56 -37.95 88.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.886 0.741 . . . . 0.0 111.679 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -85.35 -42.49 14.52 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.693 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.2 tp -58.86 -37.76 77.23 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 112.302 -174.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.6 p -59.04 -31.39 45.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 CA-C-O 121.438 0.637 . . . . 0.0 110.701 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -81.07 -31.04 34.59 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.045 -176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 55.8 mt -70.51 -44.62 76.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.34 -27.71 66.5 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.008 -0.997 . . . . 0.0 109.513 177.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.89 33.41 50.85 Favored Glycine 0 CA--C 1.495 -1.193 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.083 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 mt -96.96 14.7 24.57 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -89.6 4.18 50.19 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.803 0.811 . . . . 0.0 110.186 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -108.97 147.32 32.45 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 C--N 1.304 -1.37 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.405 179.091 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.465 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.07 140.22 19.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.7 t -84.81 -31.69 23.74 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.271 0.557 . . . . 0.0 109.565 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.04 111.3 17.71 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.426 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -75.24 -51.99 11.97 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.335 0.588 . . . . 0.0 110.314 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 59' ' ' VAL . 1.5 pt? -149.02 128.47 13.04 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.839 178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.3 m -104.9 119.1 38.2 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 HD11 ' CD1' ' A' ' 24' ' ' LEU . 80.0 mt -88.99 124.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.424 -178.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 36' ' ' ILE . 28.0 m-85 -103.01 113.25 26.56 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.06 175.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -155.34 160.34 40.65 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.99 179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 p -93.67 151.7 19.48 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.827 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -69.79 -22.11 63.35 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.936 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -88.07 -1.18 57.84 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.232 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -75.28 145.84 41.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.5 -33.17 25.93 Favored Glycine 0 C--N 1.309 -0.918 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -77.89 -8.3 57.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 28.0 p -57.04 -57.05 14.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -175.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 pp -73.53 -21.73 60.3 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.586 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -67.9 -46.85 70.46 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 63.4 tp -66.36 -34.49 78.09 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.891 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 33.3 mmtp -62.43 -45.53 92.68 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.6 m -60.46 -41.66 94.6 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.731 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.55 -48.94 75.43 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.492 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' A' ' 8' ' ' ILE . 57.6 mt -70.38 -45.25 66.4 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.8 m -63.38 -35.86 81.81 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 120.708 0.289 . . . . 0.0 111.632 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.17 -10.04 59.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 111.051 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -110.78 14.84 22.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.777 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 63.96 27.41 14.34 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 124.206 0.941 . . . . 0.0 113.154 175.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 24' ' ' LEU . 64.3 mt -90.21 131.52 37.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 120.854 0.359 . . . . 0.0 111.175 -177.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.06 128.86 39.1 Favored 'General case' 0 N--CA 1.435 -1.201 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -148.05 174.92 11.45 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -128.53 137.28 51.67 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 177.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -125.94 132.57 52.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.508 0.194 . . . . 0.0 110.722 -175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.1 p -139.14 151.86 23.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.05 141.38 28.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.698 -0.801 . . . . 0.0 108.991 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.632 HG21 HG11 ' A' ' 46' ' ' VAL . 30.9 pt -83.68 -31.06 8.03 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -79.97 -15.05 58.06 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.092 0.949 . . . . 0.0 109.006 -171.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -91.73 -1.27 57.47 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.528 176.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -135.98 104.92 5.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -50.7 -51.83 45.93 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.755 0.822 . . . . 0.0 112.426 -175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.94 79.15 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.341 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.655 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.78 -43.42 75.74 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.043 -0.663 . . . . 0.0 109.85 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -60.89 -43.71 98.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.448 0.699 . . . . 0.0 112.129 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.59 -22.49 62.55 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.139 0.495 . . . . 0.0 112.084 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -76.97 -61.54 1.95 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.608 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 42' ' ' ALA . 5.6 p -62.22 -37.04 77.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.469 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.75 -34.75 90.72 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.461 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -77.74 -29.84 51.32 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.758 0.314 . . . . 0.0 111.394 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.44 11.5 5.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.17 0.51 . . . . 0.0 110.855 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.18 -172.74 3.93 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.311 -177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.56 85.33 0.39 Allowed Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 175.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 107.6 -116.39 4.87 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -177.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -95.32 -175.84 3.61 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 175.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.39 98.82 7.66 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 118.304 -1.358 . . . . 0.0 108.647 177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 t -139.27 -27.67 0.8 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.641 -173.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.0 m -108.43 138.56 20.24 Favored Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.29 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.47 122.31 11.29 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 123.177 2.585 . . . . 0.0 111.258 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 m -112.0 132.42 54.8 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.9 p -103.5 121.59 55.06 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.249 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 -176.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -100.41 118.49 36.75 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -86.34 165.88 16.05 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.658 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.43 -19.98 51.58 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -85.37 -3.45 58.84 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.084 -0.385 . . . . 0.0 110.67 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.18 18.38 59.32 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.721 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.3 t -106.76 143.14 35.29 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.3 p -116.91 141.39 48.29 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.483 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.2 mt -125.52 132.35 52.63 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -67.32 136.73 55.29 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -5.98 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.564 0 C-N-CA 126.828 2.051 . . . . 0.0 116.186 -175.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.475 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 31.5 Cg_endo -97.52 169.34 0.8 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 124.678 3.586 . . . . 0.0 113.495 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -83.9 161.43 20.85 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.536 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -62.73 -40.07 96.04 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.759 0.424 . . . . 0.0 111.214 -178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.57 -43.22 93.68 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.012 0.434 . . . . 0.0 110.611 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -63.15 -48.99 76.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.901 -178.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 17.5 m -68.45 -33.49 60.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 54.7 mtpt -62.87 -34.92 78.38 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 117.67 0.213 . . . . 0.0 110.614 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.88 -28.68 67.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.263 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.1 tttm -84.17 -46.7 11.62 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.426 HD11 ' HB1' ' A' ' 5' ' ' ALA . 53.1 tp -55.69 -39.71 71.37 Favored 'General case' 0 C--O 1.248 1.01 0 C-N-CA 125.35 1.46 . . . . 0.0 112.936 -178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.506 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 8.0 p -60.27 -35.27 61.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -78.66 -22.38 46.88 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.81 0.814 . . . . 0.0 110.514 -178.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 86.3 mt -84.99 -53.54 10.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.607 -176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.96 -32.49 15.94 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.966 -175.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.05 40.73 61.83 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -175.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.541 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.3 pt? -65.52 -37.16 85.96 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-O 121.152 0.501 . . . . 0.0 109.858 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -82.35 126.5 32.23 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 108.687 -0.856 . . . . 0.0 108.687 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -81.3 -23.05 38.13 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.76 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.255 1.364 0 O-C-N 124.451 1.095 . . . . 0.0 111.351 174.177 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mmm . . . . . 0 CA--C 1.52 -0.211 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.41 129.06 68.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 121.105 0.478 . . . . 0.0 111.241 -175.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -90.5 -23.99 20.78 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -102.48 88.58 3.29 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 174.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.86 -59.08 5.94 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.955 -176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.05 134.91 11.89 Favored 'General case' 0 N--CA 1.42 -1.946 0 CA-C-N 114.801 -1.09 . . . . 0.0 109.047 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.8 m -102.15 129.16 48.44 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.947 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG12 HG12 ' A' ' 59' ' ' VAL . 49.9 mt -93.48 120.44 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.18 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.484 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 60.6 m-85 -102.54 115.77 31.25 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 172.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.6 t -158.26 175.97 13.07 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.86 155.93 43.36 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.4 t -70.19 -15.86 62.99 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -85.46 -4.82 59.28 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.6 m -77.07 133.54 39.03 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.8 -38.9 35.28 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 116.253 -0.43 . . . . 0.0 112.979 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -75.78 -7.53 54.65 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 52.5 t -57.26 -61.74 2.26 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.625 HD13 ' H ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -68.4 -23.78 64.69 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 5.1 tpm_? -67.65 -43.08 81.13 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.648 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.96 -35.63 66.97 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.091 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.4 mmtp -55.95 -48.41 75.81 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -66.28 -34.41 77.94 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.736 -178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.98 -43.65 87.2 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.252 0.549 . . . . 0.0 110.4 178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 mt -73.63 -41.96 62.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.185 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 62.0 m -65.31 -35.16 80.15 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.54 87.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.837 0.827 . . . . 0.0 109.974 176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -87.46 3.03 48.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.8 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.2 mtm180 58.7 31.54 21.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.792 0.837 . . . . 0.0 112.065 176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.3 mt -75.14 137.24 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.32 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.49 119.74 32.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.328 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -134.27 163.74 28.96 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -128.87 135.25 48.82 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.61 141.19 46.67 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.606 0.241 . . . . 0.0 111.319 -176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -139.74 138.18 39.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 170.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -77.97 143.39 37.62 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 119.087 -1.045 . . . . 0.0 110.777 -178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.639 HG21 HG11 ' A' ' 46' ' ' VAL . 42.8 pt -83.32 -9.51 11.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.092 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.94 -32.13 27.33 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.76 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -88.04 -10.83 49.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.881 0.372 . . . . 0.0 110.761 175.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -115.73 98.06 6.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.68 -178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -64.69 -49.28 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -175.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.43 74.14 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.979 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -69.95 -42.96 72.5 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.388 176.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -61.8 -39.92 93.41 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.514 0.673 . . . . 0.0 110.207 177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.48 -50.7 72.92 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.519 175.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -58.29 -56.24 24.63 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.406 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.639 HG11 HG21 ' A' ' 36' ' ' ILE . 7.1 p -64.39 -35.32 73.94 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.995 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.722 -179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.21 -34.91 89.53 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.558 177.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -66.75 -44.5 81.3 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 123.003 0.521 . . . . 0.0 109.91 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.463 HG23 HG21 ' A' ' 58' ' ' THR . 33.2 m -92.58 13.11 2.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.621 0.724 . . . . 0.0 111.868 -177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.51 -172.88 3.21 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.84 67.27 2.72 Favored Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.0 -44.72 2.85 Favored Glycine 0 N--CA 1.45 -0.389 0 CA-C-O 121.258 0.366 . . . . 0.0 113.044 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -119.79 142.58 48.46 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.47 ' H ' ' HD3' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -77.4 94.22 4.2 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.528 0.68 . . . . 0.0 109.587 176.607 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 t -139.68 -17.26 0.99 Allowed 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.965 -173.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 m -124.1 144.85 46.48 Favored Pre-proline 0 C--O 1.244 0.779 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 13.2 Cg_endo -56.63 131.61 46.69 Favored 'Trans proline' 0 C--O 1.245 0.839 0 C-N-CA 123.682 2.922 . . . . 0.0 111.542 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.463 HG21 HG23 ' A' ' 49' ' ' VAL . 23.4 m -124.18 138.46 54.41 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.0 m -104.78 127.44 59.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 123.377 0.423 . . . . 0.0 110.978 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -106.71 113.89 27.66 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -83.1 163.23 21.01 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-O 120.954 0.407 . . . . 0.0 110.843 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 4' ' ' ALA . . . -62.54 -17.32 59.63 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.443 -0.799 . . . . 0.0 113.014 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.82 -6.4 59.42 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.43 18.35 39.08 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.948 -0.569 . . . . 0.0 114.103 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.5 p -111.21 154.06 24.94 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 117.803 0.801 . . . . 0.0 111.199 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -121.21 142.03 50.3 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.948 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.0 mt -127.29 124.99 40.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.6 m -67.36 145.76 54.76 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -4.64 85.81 0.03 OUTLIER Pre-proline 0 N--CA 1.522 3.139 0 C-N-CA 126.56 1.944 . . . . 0.0 114.793 -173.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -97.83 161.09 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.522 3.481 . . . . 0.0 113.455 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -80.57 159.33 25.49 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.57 -33.43 66.17 Favored 'General case' 0 C--O 1.209 -1.035 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.549 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.31 -43.93 98.05 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.576 0.751 . . . . 0.0 110.737 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -68.78 -44.9 72.66 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.532 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.6 m -68.22 -35.94 73.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.618 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -61.62 -42.17 98.5 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.537 0.335 . . . . 0.0 110.818 176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.09 67.56 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.827 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpp -84.3 -51.85 6.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.821 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.85 -36.77 65.42 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.947 0.899 . . . . 0.0 113.272 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.09 -34.54 57.08 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 CA-C-O 121.029 0.442 . . . . 0.0 111.833 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -81.38 -48.63 11.69 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.003 0.43 . . . . 0.0 110.196 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 81.7 mt -54.35 -45.14 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 124.546 1.138 . . . . 0.0 112.76 -175.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.45 -3.42 33.78 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.38 54.77 8.39 Favored Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.4 mt -124.36 -6.56 7.63 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.995 0.426 . . . . 0.0 110.71 -178.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.7 -50.0 5.12 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -177.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 62.69 77.43 0.33 Allowed 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.746 1.218 . . . . 0.0 111.39 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 53.7 t-80 . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.62 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 C--O 1.233 0.224 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.3 p -120.36 79.42 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.292 1.044 . . . . 0.0 113.1 -177.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.0 t -96.95 -30.89 12.83 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.34 107.23 9.59 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.43 85.78 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.064 0.853 . . . . 0.0 109.906 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -150.59 131.65 14.35 Favored 'General case' 0 N--CA 1.423 -1.791 0 CA-C-N 115.073 -0.967 . . . . 0.0 108.901 174.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.5 m -102.5 120.48 40.6 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 HG12 ' A' ' 59' ' ' VAL . 60.3 mt -88.43 119.57 35.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.791 -176.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 45.6 m-85 -104.89 114.82 29.25 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.589 174.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -163.85 -174.44 3.64 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 p -118.02 166.99 11.87 Favored 'General case' 0 N--CA 1.426 -1.673 0 C-N-CA 123.844 0.858 . . . . 0.0 109.253 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.0 m -78.84 -17.57 55.44 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.939 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -93.05 -1.93 56.1 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 50.3 t -81.34 131.2 35.28 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.838 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 19' ' ' ARG . . . -70.2 -46.26 51.29 Favored Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -63.88 -15.71 59.63 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.721 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.6 t -59.14 -63.71 1.2 Allowed 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 123.347 0.404 . . . . 0.0 110.536 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -72.06 -24.62 61.55 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.823 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 15' ' ' GLY . 29.1 mmm180 -65.8 -48.25 72.4 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.597 -0.728 . . . . 0.0 110.335 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 50.6 tp -71.07 -32.14 68.73 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.07 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 11.5 mmmm -57.72 -43.41 85.25 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.8 m -64.1 -49.78 70.9 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.09 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.35 87.17 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.238 0.615 . . . . 0.0 112.492 -177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.78 -41.88 82.52 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.707 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.1 m -62.32 -42.12 99.11 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.451 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.53 -23.03 66.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.781 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -103.58 9.35 37.48 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.884 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.438 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 3.6 mmp_? 62.32 43.34 8.34 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.608 0.718 . . . . 0.0 111.567 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.2 mt -102.44 132.52 48.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.64 126.3 34.87 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -136.75 163.77 29.83 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.14 0.495 . . . . 0.0 112.198 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -121.49 142.48 50.01 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.31 139.89 48.36 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 117.918 0.326 . . . . 0.0 110.77 -176.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.7 p -139.32 147.3 24.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -81.15 141.31 34.36 Favored 'General case' 0 C--O 1.249 1.077 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.023 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.622 HG21 HG11 ' A' ' 46' ' ' VAL . 41.6 pt -83.76 -32.23 8.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 -176.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -75.29 -14.88 60.53 Favored 'General case' 0 C--N 1.31 -1.136 0 O-C-N 122.147 -0.346 . . . . 0.0 111.648 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.53 -25.84 33.02 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.3 94.34 4.34 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.989 -0.445 . . . . 0.0 109.837 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -52.01 -45.34 64.53 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.86 92.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.631 0.253 . . . . 0.0 110.994 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -68.93 -41.44 78.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -65.82 -35.39 80.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.903 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' HA ' ' NH2' ' A' ' 54' ' ' ARG . 9.4 tp10 -70.41 -38.73 74.68 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.16 -58.46 7.69 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.282 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.622 HG11 HG21 ' A' ' 36' ' ' ILE . 6.2 p -61.79 -35.35 67.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.486 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.1 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.23 -27.77 72.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.551 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.5 m -83.66 -34.15 25.08 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.757 0.313 . . . . 0.0 111.523 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.4 m -94.5 10.62 4.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.776 0.798 . . . . 0.0 110.616 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.3 -175.36 5.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.451 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -85.72 66.82 3.68 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 105.56 -66.91 0.26 Allowed Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.514 ' OD1' ' HD2' ' A' ' 54' ' ' ARG . 65.3 t30 -142.12 162.06 36.44 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -57.6 114.33 2.2 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.291 0.567 . . . . 0.0 111.887 -178.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.2 t -161.22 -30.63 0.05 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.626 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.1 m -112.77 152.04 44.47 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.601 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 36.7 Cg_endo -64.59 139.9 66.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.584 2.19 . . . . 0.0 112.119 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 24.4 m -126.57 136.57 52.72 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 66' ' ' THR . 30.7 m -105.02 129.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.133 -179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 ttpp -103.97 119.43 38.91 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.4 172.25 13.9 Favored 'General case' 0 C--N 1.275 -2.662 0 CA-C-O 120.79 0.329 . . . . 0.0 111.079 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.73 -25.6 68.27 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.901 177.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -78.09 -17.96 56.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.941 0.401 . . . . 0.0 110.27 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.52 -19.54 28.72 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.579 178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.9 t -71.59 160.51 32.55 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 117.322 0.561 . . . . 0.0 111.342 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 7.8 p -127.31 141.9 51.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.444 -178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.2 mt -123.18 120.4 33.08 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 m -64.64 144.27 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -5.36 84.83 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.474 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -172.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -92.53 -170.58 0.29 Allowed 'Trans proline' 0 N--CA 1.435 -1.966 0 C-N-CA 123.612 2.875 . . . . 0.0 111.389 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.503 ' O ' HG22 ' A' ' 75' ' ' VAL . 15.3 p -117.55 166.64 12.13 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.83 -36.97 75.4 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 123.36 0.412 . . . . 0.0 111.776 -179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -69.66 -35.96 75.61 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.483 178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -68.49 -45.03 73.44 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 71' ' ' SER . 10.8 m -67.63 -37.53 78.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -61.37 -31.48 71.37 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.86 -35.81 80.88 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 123.553 0.533 . . . . 0.0 110.859 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -84.03 -41.88 16.75 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.8 tp -61.7 -39.0 89.91 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.528 1.131 . . . . 0.0 112.695 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.8 p -58.49 -35.63 55.39 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.903 0 CA-C-O 120.977 0.417 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -75.65 -19.73 58.96 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.206 0.527 . . . . 0.0 111.264 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 62.0 mt -80.86 -49.12 18.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.89 -30.44 66.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.628 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.84 -99.83 2.29 Favored Glycine 0 N--CA 1.424 -2.106 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.3 mt 58.2 -77.98 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.047 1.339 . . . . 0.0 112.298 176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -88.32 -7.93 55.93 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.16 0.984 . . . . 0.0 110.597 -177.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -136.35 159.44 41.76 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 . . . . . 0 C--N 1.305 -1.338 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 177.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.6 tpp . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 120.421 0.153 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 35.7 m -83.78 132.56 31.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 O-C-N 121.894 -0.504 . . . . 0.0 111.178 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.8 t -103.87 -11.92 17.21 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.548 0.69 . . . . 0.0 109.905 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.63 126.05 14.89 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.4 -58.63 3.15 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 123.338 0.399 . . . . 0.0 111.248 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -160.76 144.27 13.39 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.52 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 m -110.05 124.83 52.17 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.948 176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.521 HG12 HG12 ' A' ' 59' ' ' VAL . 86.8 mt -89.81 128.4 41.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 C-N-CA 124.13 0.972 . . . . 0.0 110.512 178.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 81.0 m-85 -111.16 127.24 55.52 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 175.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -163.13 170.72 17.43 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.77 162.93 21.14 Favored 'General case' 0 N--CA 1.427 -1.579 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 175.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -59.65 -30.18 68.56 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.4 p-90 -87.19 0.13 55.81 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -177.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 73.4 m -78.87 112.93 16.53 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.27 70.45 Favored Glycine 0 C--O 1.222 -0.606 0 CA-C-N 116.371 -0.377 . . . . 0.0 114.004 -173.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -82.83 -6.73 59.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -177.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 27.3 p -54.09 -60.12 3.75 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.76 -33.76 76.62 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 122.482 0.313 . . . . 0.0 111.743 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -59.79 -47.83 84.13 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.693 0.759 . . . . 0.0 109.794 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.6 tp -64.47 -38.7 91.93 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 114.201 -1.363 . . . . 0.0 110.82 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 34.7 mmtp -61.07 -46.73 89.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.141 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.3 m -59.54 -47.04 87.08 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.672 179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.36 96.68 Favored 'General case' 0 C--O 1.247 0.973 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.37 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 HG21 ' A' ' 75' ' ' VAL . 76.8 mt -74.61 -35.27 62.95 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.316 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 89.9 m -66.47 -38.62 87.72 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 123.309 0.38 . . . . 0.0 110.278 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.68 97.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 111.401 178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -86.73 -5.75 59.03 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 64.38 61.73 0.86 Allowed 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 125.055 1.342 . . . . 0.0 113.253 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.4 mp -102.58 138.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.28 108.23 19.5 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -120.77 156.68 31.34 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -109.18 142.16 40.36 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.12 132.36 38.0 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 120.801 0.334 . . . . 0.0 110.429 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.4 131.72 40.57 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.75 140.03 37.08 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 121.954 0.883 . . . . 0.0 109.442 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 HG11 ' A' ' 46' ' ' VAL . 37.5 pt -84.25 -15.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.359 -175.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.93 -34.18 77.21 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.307 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -78.29 -50.18 12.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -91.44 104.87 17.33 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -56.53 -44.07 80.45 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 125.626 1.571 . . . . 0.0 111.238 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.61 -38.43 89.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.039 0.447 . . . . 0.0 110.743 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -70.92 -38.92 72.95 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.274 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.33 91.19 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.698 0.624 . . . . 0.0 110.696 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.44 -51.44 68.69 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.098 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -56.09 -60.43 3.49 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.016 -178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.662 HG11 HG21 ' A' ' 36' ' ' ILE . 7.2 p -65.5 -29.83 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.735 0.302 . . . . 0.0 111.749 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.04 -22.24 75.83 Favored Glycine 0 N--CA 1.44 -1.036 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.057 178.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.3 m -84.04 -36.87 22.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.987 0.422 . . . . 0.0 111.266 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG22 ' HA ' ' A' ' 46' ' ' VAL . 35.2 m -98.41 13.33 4.76 Favored 'Isoleucine or valine' 0 C--O 1.251 1.154 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.33 175.79 10.28 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.285 0.564 . . . . 0.0 111.514 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.07 88.31 0.89 Allowed Glycine 0 N--CA 1.426 -1.978 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.39 -71.96 0.44 Allowed Glycine 0 N--CA 1.433 -1.542 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.409 ' OD1' ' HD3' ' A' ' 54' ' ' ARG . 27.9 t-20 -144.62 162.31 36.96 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.409 ' HD3' ' OD1' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.7 117.18 10.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.627 0.727 . . . . 0.0 110.651 -178.651 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 53' ' ' ASN . 10.0 t -163.81 -31.44 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.662 -176.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.59 147.22 36.28 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 9' ' ' TYR . 17.9 Cg_endo -60.3 146.52 96.36 Favored 'Trans proline' 0 C--O 1.243 0.755 0 C-N-CA 123.072 2.515 . . . . 0.0 111.687 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.3 m -132.66 144.5 50.38 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.521 HG12 HG12 ' A' ' 8' ' ' ILE . 16.3 m -110.97 131.58 61.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 123.168 0.293 . . . . 0.0 110.297 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.2 ttpp -106.93 122.43 46.41 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 172.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.478 ' CE1' ' HD3' ' A' ' 78' ' ' LYS . 67.8 m-85 -86.83 177.91 7.15 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.275 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.79 -22.12 66.38 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 123.516 0.727 . . . . 0.0 112.13 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.415 ' OD1' ' HB2' ' A' ' 61' ' ' PHE . 18.6 p-10 -82.57 -11.57 58.33 Favored 'General case' 0 C--O 1.246 0.875 0 CA-C-O 121.15 0.5 . . . . 0.0 110.365 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 91.8 3.77 68.07 Favored Glycine 0 N--CA 1.44 -1.05 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.319 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.4 t -97.43 152.53 18.87 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 10.4 p -115.84 154.19 30.14 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 121.317 0.58 . . . . 0.0 111.916 -177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 86.8 mt -130.29 125.69 35.39 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 170.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.2 m -68.99 142.14 54.72 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -4.76 84.85 0.03 OUTLIER Pre-proline 0 N--CA 1.515 2.792 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -171.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.444 ' HG2' ' CG1' ' A' ' 75' ' ' VAL . 35.0 Cg_endo -93.99 150.83 2.16 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 123.934 3.089 . . . . 0.0 113.231 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 m -75.89 165.66 24.66 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.14 -33.96 72.87 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.98 -35.68 66.93 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.321 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.62 -43.85 88.31 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.999 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' CG1' ' HG2' ' A' ' 70' ' ' PRO . 5.5 m -67.82 -41.97 85.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 178.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 51.6 mtpt -60.61 -40.59 92.4 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 123.288 0.368 . . . . 0.0 110.756 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.95 75.88 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 123.777 0.673 . . . . 0.0 111.973 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.478 ' HD3' ' CE1' ' A' ' 61' ' ' PHE . 64.3 tttp -84.14 -45.42 12.99 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.584 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 64.2 tp -61.65 -41.01 96.92 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.243 -176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.41 -38.62 70.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.782 0 O-C-N 123.448 0.468 . . . . 0.0 110.604 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 87' ' ' HIS . 60.4 mttm -70.26 -25.29 63.29 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.5 mt -74.78 -40.02 46.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.37 -38.6 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.956 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 111.6 -129.65 9.26 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 -177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.9 mt 68.7 -71.12 0.12 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 173.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -126.12 106.22 9.43 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.361 0.664 . . . . 0.0 110.242 -174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.529 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 30.3 m-70 68.67 99.31 0.06 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.072 0.949 . . . . 0.0 113.536 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 77.2 m80 . . . . . 0 C--N 1.295 -1.764 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.138 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 CA--C 1.512 -0.488 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 m -85.21 86.23 2.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -89.21 -26.25 21.33 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 172.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.18 100.08 5.94 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.1 -60.55 3.6 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.823 -179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.0 135.34 12.28 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.696 175.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 85.5 m -102.63 123.94 47.25 Favored 'General case' 0 N--CA 1.416 -2.172 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 59' ' ' VAL . 75.9 mt -88.96 124.69 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.082 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.076 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' PRO . 59.3 m-85 -106.51 110.81 23.12 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.738 175.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 14.9 t -164.02 -177.2 4.91 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -133.81 149.98 51.41 Favored 'General case' 0 N--CA 1.396 -3.143 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.5 m -58.53 -8.41 1.23 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 -178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -91.37 -1.46 57.6 Favored 'General case' 0 C--O 1.236 0.358 0 O-C-N 121.605 -0.685 . . . . 0.0 112.333 175.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 42.7 t -82.6 140.45 33.21 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.14 -32.49 62.97 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -82.52 -7.8 59.63 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.661 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 22.8 t -61.69 -63.02 1.4 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.151 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 18' ' ' LEU . 2.5 pt? -68.3 -28.58 67.3 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.158 0.504 . . . . 0.0 110.878 -178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? -61.25 -50.59 72.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.86 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.48 -35.42 73.26 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.194 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.661 ' HG2' ' O ' ' A' ' 17' ' ' CYS . 35.2 mmtp -57.97 -40.41 80.56 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 176.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -67.4 -48.69 66.61 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.385 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.81 -42.64 84.68 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.601 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 29' ' ' ILE . 54.5 mt -69.63 -38.83 77.34 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.662 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.5 m -65.93 -35.89 81.87 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 120.876 0.37 . . . . 0.0 110.798 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.77 -20.53 64.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.367 0.603 . . . . 0.0 111.38 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -109.91 13.49 23.46 Favored 'General case' 0 C--O 1.25 1.106 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.107 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 43.09 62.64 1.75 Allowed 'General case' 0 C--N 1.352 0.689 0 C-N-CA 126.024 1.729 . . . . 0.0 113.418 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 89.3 mt -105.66 129.85 58.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.402 -177.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.14 123.09 28.67 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -136.79 166.68 23.03 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.138 0.494 . . . . 0.0 111.495 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 7' ' ' THR . 17.2 t70 -121.34 126.08 48.58 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.28 137.2 54.93 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-O 121.262 0.554 . . . . 0.0 111.109 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.94 135.55 42.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 10' ' ' THR . 4.2 m-20 -76.45 140.99 41.49 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.602 HG21 HG11 ' A' ' 46' ' ' VAL . 12.1 pt -77.46 -26.11 15.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.129 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -169.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -71.55 -5.12 30.92 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.192 0.52 . . . . 0.0 111.665 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -94.45 -26.61 16.41 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.055 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -120.9 108.71 14.23 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.655 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -51.22 -48.56 62.04 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 124.766 1.226 . . . . 0.0 112.278 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.67 -39.73 94.84 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 121.49 0.662 . . . . 0.0 110.683 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' O ' HG12 ' A' ' 46' ' ' VAL . . . -71.32 -43.72 66.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.453 -178.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.583 ' O ' ' HD2' ' A' ' 54' ' ' ARG . . . -59.99 -37.69 80.39 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.259 0.624 . . . . 0.0 112.391 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -77.13 -34.91 56.55 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.529 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.1 -58.23 7.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.602 HG11 HG21 ' A' ' 36' ' ' ILE . 6.5 p -62.77 -33.82 62.24 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.851 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.307 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.41 -30.23 74.99 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.988 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.1 m -79.99 -36.86 35.39 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.14 0.495 . . . . 0.0 110.708 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.4 ' CG2' HG21 ' A' ' 58' ' ' THR . 33.0 m -90.92 9.39 3.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.463 0.649 . . . . 0.0 110.537 -178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.25 -177.81 4.97 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.319 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.24 79.45 1.79 Allowed Glycine 0 N--CA 1.436 -1.307 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.04 -98.18 1.78 Allowed Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -125.58 -175.27 3.28 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 106.587 -1.635 . . . . 0.0 106.587 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.583 ' HD2' ' O ' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -53.68 116.48 2.53 Favored 'General case' 0 CA--C 1.491 -1.29 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 t -162.7 -34.26 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.135 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.359 172.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.06 150.0 42.22 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.493 ' HD3' ' SG ' ' A' ' 14' ' ' CYS . 44.7 Cg_endo -65.94 140.56 61.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.731 2.287 . . . . 0.0 111.48 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.4 HG21 ' CG2' ' A' ' 49' ' ' VAL . 22.9 m -129.86 140.49 50.98 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 66' ' ' THR . 29.9 m -107.38 136.7 41.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.684 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -117.79 114.88 23.94 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -84.69 168.13 15.53 Favored 'General case' 0 C--N 1.29 -1.991 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.453 -178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.08 -11.37 48.2 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 122.392 1.091 . . . . 0.0 109.546 173.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.22 -18.13 61.27 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 125.684 1.594 . . . . 0.0 109.643 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.09 -21.88 39.61 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.776 177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.9 m -80.17 149.27 30.57 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.029 0.442 . . . . 0.0 111.759 -177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.7 p -113.5 151.76 31.08 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.432 175.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 94.8 mt -135.58 125.07 24.99 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 m -64.5 146.52 54.44 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -5.69 86.38 0.03 OUTLIER Pre-proline 0 N--CA 1.51 2.553 0 C-N-CA 127.119 2.168 . . . . 0.0 115.942 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -98.09 150.75 0.79 Allowed 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 124.274 3.316 . . . . 0.0 112.907 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -77.51 168.55 19.81 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' LYS . . . -60.05 -37.04 78.65 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -177.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.99 -34.31 75.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.476 0.655 . . . . 0.0 110.33 179.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -71.7 -34.85 69.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.798 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.9 m -78.34 -35.27 19.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.711 177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 29.3 mtpp -63.96 -33.34 75.51 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 116.825 -0.17 . . . . 0.0 110.789 178.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.42 67.99 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.935 0.772 . . . . 0.0 111.836 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 82' ' ' ILE . 37.1 mttm -83.04 -50.7 8.25 Favored 'General case' 0 CA--C 1.501 -0.926 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.898 175.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 61.2 tp -51.62 -37.42 50.08 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 124.035 0.934 . . . . 0.0 113.053 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.35 -38.82 80.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.477 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -80.86 -24.08 38.62 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.157 0.503 . . . . 0.0 110.313 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 78' ' ' LYS . 70.7 mt -80.22 -49.15 19.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.38 -32.87 14.09 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.29 87.59 0.71 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -175.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.1 mt -128.73 -83.01 0.58 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 122.365 -0.491 . . . . 0.0 109.826 -176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 45.55 87.03 0.02 OUTLIER 'General case' 0 C--O 1.244 0.769 0 C-N-CA 126.305 1.842 . . . . 0.0 113.775 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -172.29 -44.99 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 26.9 t60 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 175.072 . . . . . . . . 0 0 . 1 stop_ save_